Polynucleotides encoding or regulating electron transfer molecules

FIELD OF THE INVENTION

[0003] The present invention relates to polynucleotides encoding or regulating electron transfer molecules. These mammalian polynucleotides may be used in the diagnosis, study, prevention and treatment of disease.

BACKGROUND OF THE INVENTION

[0004] The mitochondrial electron transport (or respiratory) chain is a series of oxidoreductase-type enzyme complexes in the mitochondrial membrane that is responsible for the transport of electrons from NADPH through a series of redox centers within these complexes to oxygen, and the coupling of this oxidation to the synthesis of ATP (oxidative phosphorylation). ATP then provides the primary source of energy for driving a cell's many energy-requiring reactions. The key complexes in the respiratory chain are NADH:ubiquinone oxidoreductase (complex I), succinate:ubiquinone oxidoreductase (complex II), cytochrome c1-b oxidoreductase (complex III), cytochrome c oxidase (complex IV), and ATP synthase (complex V) (Alberts. et al. (1994) Molecular Biology of the Cell, Garland Publishing, Inc., New York, N.Y., p. 677-678). All of these complexes are located on the inner matrix side of the mitochondrial membrane except complex II, which is on the cytosolic side. Complex II transports electrons generated in the citric acid cycle to the respiratory chain. The electrons generated by oxidation of succinate to fumarate in the citric acid cycle are transferred through electron carriers in complex II to membrane bound ubiquinone (coenzyme Q).

[0005] Electron transport through these complexes is mediated by a series of electron transfer proteins, most of which contain prosthetic groups such as flavins, heme, iron-sulfur clusters (FeS), or copper, bound to inner membrane proteins. Adrenodoxin, for example, is an FeS protein specific for adrenal gland tissue that forms a complex with NADPH:adrenodoxin reductase and cytochrome p450 in the conversion of cholesterol to pregnenlone (Pikuleva et at. (1999) J Biol Chem 274:2045-2052). Cytochromes contain a heme prosthetic group, a porphyrin ring containing a tightly bound iron atom. The iron atom serves as the actual electron carrier by changing from the ferric to the ferrous state when accepting an electron.

[0006] Cytochromes are classified into subgroups a, b, and c, according to distinctive absorption spectra conferred on them by differences in their interactions with the heme group. Cytochromes a, a3, b562, b566, c, and c1 are all components of the mammalian mitochondrial membrane respiratory chain involved in oxidative phosphorylation. Cyt b5 exists in both a membrane-bound form in mitochondria and endoplasmic reticulum and a soluble form in erythrocytes. The membrane-bound form has been linked with lipid and drug metabolism, and with NADPH-linked hydroxylation reactions (De Sylsvestris et al. (1995) FEBS Lett 370:69-74; Ozols (1989) Biochim et Biophys Acta 997:121-30).

[0007] Other electron transfer proteins include peroxiredoxin, a protein that serves as an antioxidant to remove cellular peroxides (Sarafian, (1999) J Neurosci Res 56:206-212); thioredoxin, an antioxidant that reduces hydrogen peroxide, scavenges free radicals, and protects cells against oxidative stress (Lee et al. (1998) J Biol Chem 273:19160-19166); and glutaredoxin, a glutathione-dependent hydrogen donor for ribonucleotide reductase and for glutathione reductase (Padilla, et al.(1995) Eur J Biochem 15:227:27-34).

Diseases and Disorders Related to Expression of Electron Transfer Molecules

[0008] Mitochondrial dysfunction leads to impaired calcium buffering, generation of free radicals that may participate in deleterious intracellular and extracellular processes, changes in mitochondrial permeability and oxidative damage which is observed in several neurodegenerative diseases. Neurodegenerative diseases linked to mitochondrial dysfunction include some forms of Alzheimer's disease, Friedreich's ataxia, familial amyotrophic lateral sclerosis, and Huntington's disease (Beal (1998) Biochim Biophys Acta 1366:211-213). The myocardium is heavily dependent on oxidative metabolism, consequently mitochondrial dysfunction often leads to heart disease (DiMauro and Hirano (1998) Curr Opin Cardiol 13:190-197). Mitochondria are implicated in disorders of cell proliferation, since they play an important role in a cell's decision to proliferate or self-destruct through apoptosis. The oncoprotein Bc1-2, for example, promotes cell proliferation by stabilizing mitochondrial membranes so that apoptosis signals are not released (Susin (1998) Biochim Biophys Acta 1366:151-165). Restricted expression of genes encoding peroxiredoxin in brain cells may contribute to selective vulnerability of these cells to a wide variety of neuropathologic conditions (Sarafian, supra).

[0009] In view of the structure and function of electron transfer molecules and the conditions, diseases, disorders and syndromes in which they play a role, it is advantageous to provide mammalian polynucleotides, in particular human and rat polynucleotides, and methods for using these polynucleotides, and the polypeptides that they encode, in the diagnosis, study, prevention, and treatment of such disorders.

SUMMARY OF THE INVENTION

[0010] The invention provides mammalian polynucleotides, in particular human and rat polynucleotides, as presented in the Sequence Listing. These polynucleotides comprise regulatory elements or encode polypeptides or portions thereof identified as electron transfer molecules.

[0011] The invention provides a purified mammalian polynucleotide comprising a nucleic acid sequence selected from SEQ ID NOs: 1-217 1; a fragment of at least 18 consecutive nucleotides selected from SEQ ID NOs: 1-2171; and a complement of the polynucleotide or fragment. The invention also provides a composition which may be used on a substrate. The invention further provides a probe comprising a polynucleotide selected from SEQ ID NOs: 1-2171, a fragment thereof or complement thereof.

[0012] The present invention encompasses oligonucleotides, fragments of polynucleotides, and polynucleotides complementary to the polynucleotides listed in the Sequence Listing, and DNA molecules which may be used in the diagnosis, study, prevention and treatment of disorders in which electron transfer molecules play a role. Additionally these polynucleotides are used to produce a profile of gene activity or in methods to detect normal or altered gene expression. Such methods employ the mammalian polynucleotides disclosed herein or their derivatives.

[0013] The present invention provides a method for diagnosing disorders associated with the expression and function of electron transfer molecules. Such a method comprises providing a plurality of polynucleotides selected from sequences of the Sequence Listing wherein each of the polynucleotides is identified by an abnormal level of expression in an individual at risk compared to the level of expression in a normal individual, providing a sample, hybridizing the sample with the plurality of polynucleotides, and detecting hybridization complexes wherein the formation of hybridization complexes indicates the presence of a disorder.

[0014] The present invention also encompasses the use of gene therapy methods for the introduction of polynucleotides of the present invention into subjects with disorders associated with abnormal gene expression. The coding region of the polynucleotide sequence is used to express polypeptides that are underexpressed or absent in a subject, and a fragment of the polynucleotide that may be an RNA, a DNA molecule or a ribozyme is used to prevent transcription or inhibit translation of an mRNA that is overexpressed in a subject. The present invention contemplates the use of oligonucleotides or fragments of the polynucleotide or their complements as antisense molecules to control gene expression. For example, an antisense molecule may be designed to inhibit translation of mRNA and may be used therapeutically in the treatment of disorders associated with defective or abnormal expression of a polynucleotide.

[0015] As disclosed herein, the polynucleotides of the Sequence Listing are used to detect, screen, amplify, purify, or quantify identical or related genes, DNA molecules, or RNA molecules in a sample, cell, substrate or solution, or in diagnostic assays or kits. The invention contemplates the use of such polynucleotides to identify or to construct a coding sequence for a polypeptide or a portion thereof.

[0016] The invention also provides host cells and expression vectors comprising polynucleotides of the present invention and methods for the production of polypeptides they encode. Such methods comprise culturing the host cells under conditions for the expression of the polynucleotide and recovering the polypeptide from the cell culture.

[0017] The subject invention also comprises a purified polypeptide of which at least a portion is encoded by a polynucleotide selected from the polynucleotides listed in the Sequence Listing.

[0018] The subject invention also comprises a method for making an antibody that specifically binds the polypeptide by immunizing an animal with the polypeptide or a portion thereof under conditions to elicit an immunological response, collecting serum/blood from the immunized animal, combining the serum/blood with the polypeptide under conditions to allow specific binding between the polypeptide and the antibody, recovering the bound polypeptide, and separating the polypeptide from the antibody, thereby producing antibody that specifically binds the polypeptide. The subject invention further comprises a purified antibody that specifically binds to the polypeptide of which at least a portion is encoded by a polynucleotides selected from the Sequence Listing. Antibodies produced by this method are used for diagnostic purposes to detect the polypeptide to which it specifically binds or for therapeutic purposes to neutralize the activity of a polypeptide in conditions, diseases, and disorders associated with altered or abnormal expression of the polypeptide.

[0019] The subject invention also provides methods of using a purified polynucleotide or polypeptide to identify a ligand that specifically binds the polynucleotide or polypeptide. Such a method comprises providing a library or a plurality of molecules or compounds, combining the polynucleotide or polypeptide with each of the molecules or compounds under conditions to allow binding between the polynucleotide or polypeptide and the molecule or compound, and detecting binding to a molecule or compound, thereby identifying a ligand that specifically binds the polynucleotide or polypeptide. Similar methods use the polynucleotide or polypeptide to purify a ligand, molecule or compound from a sample.

[0020] The invention further provides a method for inserting a marker gene into the genomic DNA of a mammal to disrupt the expression of the natural nucleic acid. The invention also provides a method for using a polynucleotide to produce a mammalian model system, the method comprising constructing a vector containing the nucleic acid molecule selected from SEQ ID NOs: 1-2171; transforming the vector into an embryonic stem cell; selecting a transformed embryonic stem; microinjecting the transformed embryonic stem cell into a mammalian blastocyst, thereby forming a chimeric blastocyst; transferring the chimeric blastocyst into a pseudopregnant dam, wherein the dam gives birth to a chimeric offspring containing the nucleic acid molecule in its germ line; and breeding the chimeric mammal to produce a homozygous, mammalian model system.

DESCRIPTION OF THE SEQUENCE LISTING AND TABLES

[0021] A portion of the disclosure of this patent document contains material that is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent file or records, but otherwise reserves all copyright rights whatsoever.

[0022] The Sequence Listing is a compilation of polynucleotides obtained by sequencing clone inserts (isolates) of human and rat cDNA libraries. Each sequence is identified by a sequence identification number (SEQ ID NO) and by an Incyte identification number (INCYTE ID NO). Tables 1, 2 and 3 are compilations of information about the polynucleotides presented in the Sequence Listing.

[0023] TABLE 1 presents a filing history for each of the polynucleotides from human and rat cDNA libraries that have been identified as electron transfer molecules and are found in the Sequence Listing. The first column contains SEQ ID NO; the second column, the INCYTE ID NO; the third column, CLONE number; the fourth column, TEMPLATE number; and the fifth column, LIBRARY name. The sixth column contains Incyte DOCKET NO; original SEQ ID NO; and the application FILING DATE.

[0024] TABLE 2 describes nucleotide alignment of the human and rat polynucleotides presented in the Sequence Listing to the template sequence from which it was annotated. The first column contains SEQ ID NO, the second column, CLONE number; and the third column, TEMPLATE number. The fourth and fifth columns describe the exact position of each of the human and rat polynucleotides, START and STOP nucleotides, along the length of the template sequence.

[0025] TABLE 3 presents GenBank annotations for the human and rat polynucleotides of the Sequence Listing. The first column contains SEQ ID NO; the second column, INCYTE ID NO; the third column, GENBANK ID; and the fourth column, the GENBANK ANNOTATION.

DETAILED DESCRIPTION OF THE INVENTION

Definitions

[0026] Since the list of technical and scientific terms cannot be all encompassing, any undefined terms shall be construed to have the same meaning as is commonly understood by one of skill in the art to which this invention belongs. Furthermore, the singular forms “a”, “an”, and “the” include plural reference unless the context clearly dictates otherwise.

[0027] An “allele” or allelic polynucleotide is an alternative form of a given gene. Alleles result from a mutation in the nucleic acid sequence and produce altered mRNAs or polypeptides whose structure or function may or may not be altered. Any given gene may have none, one, or many allelic forms. Common mutational changes that give rise to alleles are generally ascribed to deletions, insertions, or substitutions of nucleotides. Each of these types of changes may occur alone, or in combination with the others, one or more times in a given sequence.

[0028] “Biological activity” refers to those structural, regulatory, or biochemical functions of a polypeptide that depend on amino acid sequence and molecular conformation, reaction with appropriate receptor or effector molecules, and ability to function in vitro or in vivo. Many enzymes are transported or stored in a “prepro” or “pro” form and activated by cleavage of their N-terminal stabilizing and/or signal sequence after transport to their effective cellular location.

[0029] “Disorders”, as used herein, refers to conditions, diseases, disorders, and syndromes, whether genetic, infectious, or environmental, that are associated with abnormal or altered expression of electron transfer molecules These disorders include a cell proliferative disorder, such as arteriosclerosis, atherosclerosis, mixed connective tissue disease (MCTD), psoriasis, primary thrombocythemia, and cancers such as adenocarcinoma, leukemia, lymphoma, melanoma, myeloma, sarcoma, teratocarcinoma, and, in particular, cancers of the adrenal gland, bladder, bone, bone marrow, brain, breast, cervix, gall bladder, ganglia, gastrointestinal tract, heart, kidney, liver, lung, muscle, ovary, pancreas, parathyroid, penis, prostate, salivary glands, skin, spleen, testis, thymus, thyroid, and uterus; an immune disorder such as inflammation, actinic keratosis, acquired immunodeficiency syndrome (AIDS), Addison's disease, adult respiratory distress syndrome, allergies, anemia, asthma, autoimmune thyroiditis, bronchitis, bursitis, cholecystitis, cirrhosis, contact dermatitis, Crohn's disease, diabetes mellitus, emphysema, gout, Graves' disease, hepatitis, hypereosinophilia, irritable bowel syndrome, multiple sclerosis, myasthenia gravis, myocardial or pericardial inflammation, osteoarthritis, osteoporosis, pancreatitis, rheumatoid arthritis, scleroderma, and ulcerative colitis; and a neuronal disorder such as akathesia, Alzheimer's disease, amnesia, amyotrophic lateral sclerosis, anxiety, hereditary ataxias, cerebral palsy, dementia, dermatomyositis, dystonias, Down's syndrome, epilepsy, ischemic cerebrovascular disease, cerebelloretinal hemangioblastomatosis, Huntington's disease, bacterial and viral meningitis, multiple sclerosis, muscular dystrophy, myasthenia gravis, cerebral neoplasms, neurofibromatosis, Parkinson's disease, Pick's disease, polymyositis, retinitis pigmentosa, schizophrenia, and stroke, particularly as they afflict humans. Such disorders may be studied in rats or mice as they naturally occur or as modeled in transgenic knockout or knockin animals.

[0030] “Deletion” refers to a change in either nucleotide or amino acid sequence in which one or more nucleotides or amino acid residues, respectively, are absent.

[0031] “Derivative” refers to a polynucleotide or a polypeptide that has been subjected to a chemical modification. Illustrative of such modifications would be replacement of a hydrogen by, for example, an acetyl, acyl, alkyl, amino, formyl, or morpholino group. Derivative polynucleotides may encode polypeptides that retain the essential biological characteristics (such as catalytic and regulatory domains) of naturally occurring polypeptides.

[0032] “Fragment” refers to at least 18 consecutive nucleotides of a polynucleotide of the Sequence Listing or its complement. A “unique” fragment refers to at least 18 consecutive nucleotides of a particular polynucleotide or its complement that is specific to a polynucleotide of the Sequence Listing and that under hybridization conditions would not detect related polynucleotides in which it does not appear.

[0033] “Homology” refers to sequence similarity between a reference sequence and at least a fragment of a polynucleotide or a portion of a polypeptide.

[0034] “Hybridization complex” refers to a complex between two polynucleotides by virtue of the formation of hydrogen bonds between purines and pyrimidines.

[0035] “Immunological activity” is the capability of the natural, recombinant, or synthetic polypeptide or portion thereof to induce in an animal a specific immune response that results in the production of antibodies.

[0036] “Insertion” or “addition” is a change in a polynucleotide or polypeptide by incorporation of one or more nucleotides or residues.

[0037] “Ligand” refers to any agent, molecule, or compound that binds specifically to a polynucleotide or polypeptide. Ligands stabilize or modulate the activity of polynucleotides or polypeptides of the invention and may be composed of at least one of the following: inorganic and organic substances including nucleic acids, proteins, carbohydrates, fats, and lipids.

[0038] “Linkers” are synthesized oligonucleotides that may be inserted into or added onto a polynucleotide of interest to create restriction endonuclease sites for ease in cloning the polynucleotide into various vectors. “Polylinkers” are engineered to include multiple restriction enzyme sites. Linkers and polylinkers provide for the use of enzymes that leave 5′ and 3′ overhangs (such as BamHI, EcoRI, PstI, and the like) or that provide a blunt end (such as EcoRV, SnaBI, StuI, and the like).

[0039] “Modulates” refers to any change in activity (increased or decreased; biological, chemical, or immunological) or lifespan resulting from specific binding between a molecule and a polynucleotide or polypeptide of the invention.

[0040] “Naturally occurring” refers to a polynucleotide or polypeptide that is found in nature.

[0041] “Oligonucleotide” or “oligomer” refers to a nucleotide sequence of at least about 15 nucleotides to as many as about 60 nucleotides, preferably about 18 to 30 nucleotides, and most preferably about 20 to 25 nucleotides that are used as a “primer” or “amplimer” in the polymerase chain reaction (PCR) or as an array element.

[0042] “Polynucleotide” refers to an oligonucleotide, nucleotide sequence, nucleic acid molecule, DNA molecule, or any fragment or complement thereof. It may be DNA or RNA of genomic or synthetic origin, double-stranded or single-stranded, coding and/or noncoding, an exon or an intron of a genomic DNA molecule, or combined with carbohydrate, lipids, protein or inorganic elements or substances. “Oligonucleotide” is substantially equivalent to the terms amplimer, primer, oligomer, element, target, and probe and is preferably single stranded.

[0043] “Polypeptide” refers to a protein or any portion thereof including an oligopeptide. A portion of a polypeptide generally retains biological or immunogenic characteristics of a native protein. An “oligopeptide” is an amino acid sequence of at least about 5 residues, more preferably 10 residues and most preferably about 15 residues that are immunogenic and are used as part of a fusion protein to produce an antibody.

[0044] “Portion” refers to at least six contiguous amino acids of a polypeptide encoded by a polynucleotide of the Sequence Listing. A portion may represent an amino acid sequence that is conserved among related proteins (e.g., a catalytic domain such as a kinase domain).

[0045] “Post-translational modification” of a polypeptide may involve lipidation, glycosylation, phosphorylation, acetylation, racemization, proteolytic cleavage, and the like. These processes may occur synthetically or biochemically. Biochemical modifications will vary by cellular location, cell type, pH, enzymatic milieu, and the like.

[0046] “Probe” refers to a polynucleotide or a fragment thereof that hybridizes to a nucleic acid molecule in a sample or on a substrate. A probe is used to detect, amplify, or quantify cDNAs, endogenous genes, or transcript mRNAs by employing conventional, molecular biology techniques. As used herein, probes are the reporter molecule of hybridization reactions including Southern, northern, in situ, dot blot, array, and like technologies used to determine whether electron transfer molecule DNA or RNA is present.

[0047] “Purified” refers to polynucleotides, polypeptides, antibodies, and the like, that are isolated from at least one other component with which they are naturally associated.

[0048] “Regulatory sequences or regions” are noncoding and generally refer to “control elements” including, but not limited to, enhancers, promoters, suppressors, introns, and 5′ and 3′ untranslated regions of a gene. These sequences interact with cellular proteins to carry out replication, transcription, and translation. They may occur as boundary sequences or as spacer regions in between genomic exons. Such sequences function at the molecular level and, along with regulatory genes, are very important in cellular and organismal development, growth, differentiation, and aging processes.

[0049] “Reporter molecules” are chemical or biochemical moieties used for labeling a polynucleotide, a polypeptide, or an antibody. They include, but are not limited to, radionuclides, enzymes, substrates, cofactors, inhibitors, fluorescent agents, chromogenic agents, chemiluminescent agents, magnetic particles, and the like. Reporter molecules specifically bind, establish the presence of, and allow quantification of a particular polynucleotide, polypeptide, or antibody.

[0050] “Sample” is used herein in its broadest sense. A sample containing polynucleotides, polypeptides, antibodies and the like may comprise a bodily fluid; a soluble fraction of a cell preparation, or media in which cells were grown; a chromosome, an organelle, or membrane isolated or extracted from a cell; genomic DNA, RNA, or cDNA in solution or bound to a substrate; a cell; a tissue; a tissue print; a fingerprint, skin or hair; and the like.

[0051] “Single nucleotide polymorphism” (SNP) refers to a change in at least one single nucleotide in a polynucleotide that occurs as a result of a substitution, insertion or deletion. The change may be conservative (purine for purine) or non-conservative (purine to pyrimidine) and may or may not result in a change in an encoded amino acid residue. Such changes may predispose an individual to a specific disease or condition.

[0052] “Specific binding” or “specifically binding” refers to the interaction between two molecules. In the case of a polynucleotide, specific binding may involve hydrogen bonding between sense and antisense strands or between one stand and a protein which affects its replication or transcription, intercalation of a molecule or compound into the major or minor groove of the DNA molecule, or interaction with at least one molecule which functions as a transcription factor, enhancer, repressor, and the like. In the case of a polypeptide, specific binding may involve interactions with polynucleotides, as described above or with molecules or compounds such as agonists, antibodies, antagonists, and the like. Specific binding is dependent upon the presence of structural features that allow appropriate chemical or molecular interactions between molecules.

[0053] “Substitution” results from the replacement of one or more nucleotides or amino acids, respectively, by different nucleotides or amino acids. Due to the inherent degeneracy of the genetic code, other polynucleotides that encode functionally equivalent polypeptides may be used to practice the invention.

[0054] “Substrate” refers to any rigid or semi-rigid support to which polynucleotides or polypeptides are bound and includes membranes, filters, chips, slides, wafers, fibers, magnetic or nonmagnetic beads, gels, capillaries or other tubing, plates, polymers, and microparticles with a variety of surface forms including wells, trenches, pins, channels and pores.

The Invention

[0055] The present invention relates to human and rat polynucleotides that comprise the polynucleotides presented in the Sequence Listing and to the use of these polynucleotides in the diagnosis, study, prevention, and treatment of conditions, diseases, and disorders associated with the presence, absence, or altered expression of the polynucleotide. The polynucleotides have been annotated as electron transfer molecules by their alignment with templates in the LIFESEQ Gold database (Incyte Pharmaceuticals, Palo Alto Calif.) which, in turn, has been annotated with known genes or proteins found in the GenBank or GenPept databases. The polynucleotides claimed herein are regulatory or encoding regions of genes annotated as electron transfer molecules and are described in Tables 1, 2, and 3. The polynucleotides or fragments or complements thereof may be naturally occurring, recombinant, synthetic, or semi-synthetic and are used to identify, isolate or extend identical or related polynucleotides and to identify or purify ligands that specifically bind the polynucleotide from samples or libraries of molecules and compounds. The polynucleotides may also be used in model systems.

[0056] The polynucleotides may be altered or joined to a variety of other nucleotide sequences and vectors of interest by means of well-established recombinant DNA techniques. Mutations may be deliberately introduced using techniques such as site-directed mutagenesis, insertion of new linkers, and modification of GC content. In fact, codons may be engineered to mimic the GC content of a particular host with the effect that the rate at which the recombinant vector is expressed in that host is increased. Other reasons for substantially altering the polynucleotide without altering the encoded amino acid sequence include the production of transcripts having more desirable properties, such as a greater half-life, than transcripts produced from a naturally occurring gene.

[0057] Vectors of interest include cloning vectors, such as plasmids, cosmids, phage derivatives, phagemids, as well as sequencing, replication, and expression vectors, viruses such as adenoviruses and retroviruses, and the like. In general, such vectors contain an origin of replication functional in at least one organism, convenient restriction endonuclease restriction sites, and selectable markers appropriate for particular host cells. A recombinant vector containing a polynucleotide of the Sequence Listing may be transformed into host cells to produce the desired DNA, RNA, or polypeptide.

[0058] The present invention provides for a purified polypeptide or a portion thereof that may be used to screen a library or a plurality of molecules or compounds to identify or purify a ligand that specifically binds the polypeptide. Ligands identified or purified using the polynucleotides or polypeptides of the invention include, but are not limited to, agonists, antagonists, antibodies, carbohydrates, DNA molecules, drug compounds, fatty acids, immunoglobulins, inhibitors, lipids, mimetics, morpholinos, peptide nucleic acids (PNAs), peptides, pharmaceutical agents, proteins, RNA molecules, ribozymes, and the like.

Derivation of Polynucleotides Encoding Electron Transfer Molecules

[0059] mRNA was used to construct cDNA libraries. The cDNA inserts from random isolates of the libraries were sequenced in part, extended, assembled and analyzed as described below. The sequences comprise polynucleotides regulating the expression of or encoding electron transfer molecules as disclosed in the Sequence Listing. These polynucleotides may contain an entire or partial open reading frame or they may encompass splice variants, SNPs, and/or 5′, internal, or 3′ regulatory regions identifiable as or associated with a particular electron transfer molecule.

Construction of cDNA Libraries

[0060] RNA or various samples including bodily fluids, cells, cell lines, or tissues may be purchased from commercial sources such as Clontech Laboratories (Palo Alto Calif.), Stratagene (La Jolla Calif.), the International Institute for Advanced Medicine (Exton Pa.) and the like. Samples may be homogenized and lysed in guanidinium isothiocyanate, in phenol, or in a suitable mixture of denaturants such as TRIZOL reagent (Life Technologies, Gaithersburg Md.). The resulting lysates may be centrifuged over CsCl cushions or extracted with chloroform. RNA may be precipitated with sodium acetate and either isopropanol or ethanol.

[0061] Phenol extraction and precipitation of RNA may be repeated as necessary to increase RNA purity. In most cases, the RNA is treated with DNase. Poly(A+) RNA may be isolated using oligo d(T)-coupled paramagnetic particles (Promega, Madison Wis.), OLIGOTEX latex particles or an OLIGOTEX purification kit (Qiagen, Valencia Calif.), or a POLY(A) PURE mRNA purification kit (Ambion, Austin Tex.).

[0062] In some cases, companies such as Stratagene will construct custom cDNA libraries with customer provided RNA. Otherwise, cDNA may be synthesized, and cDNA libraries constructed with the UNIZAP vector system (Stratagene) or SUPERSCRIPT plasmid system (Life Technologies), using the recommended procedures of the manufacturer or similar methods known in the art (Ausubel et al. (1997) Short Protocols in Molecular Biology, John Wiley & Sons, New York N.Y., pp. 5.1-6.10; Sambrook et al. (1989) Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Press, Plainview N.Y.). Reverse transcription may be initiated using oligo d(T) or random primers. After synthetic oligonucleotide linkers are ligated to double stranded cDNA, the cDNA may be digested with the appropriate restriction enzyme or enzymes. The cDNA may be size-selected (400-5000 bp) using SEPHACRYL S1000, SEPHAROSE CL2B, or SEPHAROSE CL4B column chromatography (Amersham Pharmacia Biotech, Piscataway N.J.) or preparative agarose gel electrophoresis. cDNAs may be ligated into compatible restriction enzyme sites of the polylinker of one of the following plasmids: PBLUESCRIPT plasmid (Stratagene), pSPORT1 plasmid (Life Technologies), or pINCY plasmid (Incyte Pharmaceuticals). Recombinant plasmids may be transformed into competent Escherichia coli cells including XL1-Blue, XL1-BlueMRF, or SOLR (Stratagene) or DH5α, DH10B, or ElectroMAX DH10B (Life Technologies).

Isolation of cDNA Clones

[0063] Plasmids may be recovered from host cells by in vivo excision using the UNIZAP vector system (Stratagene) or by cell lysis. Plasmids may be purified using one of the following: the Magic or WIZARD Minipreps DNA purification system (Promega); the AGTC MINIPREP purification kit (Edge BioSystems, Gaithersburg Md.); and the REAL PREP 96 plasmid purification kit (Qiagen). Following precipitation, plasmids may be resuspended in 0.1 ml of distilled water and stored, with or without lyophilization, at 4° C.

[0064] Alternatively, plasmid DNA may be amplified from host cell lysates using direct link PCR in a high-throughput format (Rao (1994) Anal Biochem 216:1-14). Host cell lysis and thermal cycling steps may be carried out in a single reaction mixture. Samples may be processed and stored in 384-well plates, and the concentration of amplified plasmid DNA may be quantified fluorometrically using PICOGREEN dye (Molecular Probes, Eugene Oreg.) and a FLUOROSKAN II fluorescence scanner (Labsystems Oy, Helsinki Finland).

Sequencing of the cDNA Clones and Determination of Reading Frame

[0065] Methods for DNA sequencing are well known in the art. Conventional enzymatic methods may employ DNA polymerase, Klenow fragment, SEQUENASE, or Taq DNA polymerase (Amersham Pharmacia Biotech) to extend the nucleic acid sequence from an oligonucleotide primer annealed to the DNA template of interest. Methods may use either single-stranded or double-stranded templates. Chain termination reaction products may be electrophoresed on urea-polyacrylamide gels and detected either by autoradiography or by fluorescence. Mechanized reaction preparation, sequencing, and analysis using the fluorescent detection method have permitted expansion in the number of isolates that are prepared and sequenced per day. Machines such as the ABI CATALYST 800 thermal cycler (PE Biosystems, Watertown Mass.) or the DNA ENGINE thermal cycler (MJ Research, Watertown Mass.) may be used in conjunction with the HYDRA microdispenser (Robbins Scientific, Sunnyvale Calif.) or the MICROLAB 2200 liquid transfer system (Hamilton, Reno Nev.) to prepare the cDNAs using reagents provided by Amersham Pharmacia Biotech or supplied in kits such as the ABI PRISM BIGDYE Terminator kit (PE Biosystems). Electrophoretic separation of cDNAs and detection of labeled polynucleotides may be carried out using the MEGABACE 1000 DNA sequencing system (Amersham Pharmacia Biotech) or ABI PRISM 3700, 377 or 373 sequencing systems (PE Biosystems) in conjunction with standard protocols and software known in the art.

[0066] Reading frames within the cDNA sequences may be identified using standard methods. It is well known in the art that the DNA of particular organisms (bacteria, plants, and animals) have different GC ratios and tend to display certain triplet periodicities such as a significant preference for pyrimidines in the third codon position. These tendencies have been incorporated into widely available software that may be used to examine coding potential of a given stretch of DNA. Information derived from the algorithm and analysis of start and stop codons may be used to determine proper reading frame with a high degree of certainty.

[0067] Even though the polynucleotides of the Sequence Listing have been prepared by current, state-of-the-art, automated methods, they may contain occasional sequencing errors and unidentified nucleotides that are designated by an N. The infrequent sequencing errors or Ns in the polynucleotides of the Sequence Listing do not present a problem to those skilled in the art who wish to practice the invention. Several methods employing standard recombinant techniques, described in Ausubel (supra, pp. 5.1-6.10) may be used to correct errors and complete the missing sequence information. The same cloning and PCR techniques used to obtain a full length sequence may be used to confirm a complete and accurate nucleotide sequence.

Identification of Sequences and Templates

[0068] A clone containing a sequence that is identified by BLAST or BLAST2 (Basic Local Alignment Search Tool: Altschul et al. (1997) Nucleic Acids Res 25:3389-3402; Altschul (1993) J Mol Evol 36:290-300; and Altschul et al. (1990) J Mol Biol 215:403410) or other analyses as encoding an electron transfer molecule may be extended using PCR, subjected to shotgun sequencing, or used as a probe to screen the same library or a mixture of different cDNA libraries commercially available from Life Technologies, or other sources, to identify additional clones. In some cases, a random primed library, or even a genomic library, may be used to obtain the full length sequence. In other cases, a second library may be prepared from the original tissue sample, primed with random primers, and larger inserts identified by screening with the sequence of interest.

[0069] PCR is used to extend clones in either direction. U.S. Pat. Nos. 4,683,195 and 4,965,188 describe PCR procedures and enzymes. The oligonucleotides used in such procedures may be designed from the polynucleotides disclosed herein or from adjacent 5′ and 3′ vector sequences. PCR requires two oligomers, that are usually chemically synthesized, to amplify the sequence of interest: one with sense orientation (5′ to 3′), and one with antisense orientation (3′ to 5′). These two oligomers, nested sets of oligomers, or even a degenerate pool of oligomers may be employed under less stringent conditions for identification and/or quantitation of closely related DNA or RNA sequences.

[0070] Full length genes may be cloned utilizing restriction-site PCR, inverse PCR, capture PCR, walking PCR, or the extension method presented in U.S. Ser. No. 08/487,112, filed Jun. 7, 1995, that employs the XL-PCR kit (PE Biosystems) and allows the efficient and timely processing of multiple sequences. If a full length cDNA has not been obtained after one passage through an extension procedure, the entire procedure may be repeated using the original library, a library that was size-selected to include only larger cDNAs, or a pool of libraries. The cDNA library may have been prepared by oligo d(T) or random priming; the latter are preferred since they contain more sequences that have 5′ ends of genes. It must be noted that the larger and more complex the polypeptide, the less likely it is that the complete gene will be found in a single plasmid.

[0071] Shotgun sequencing may also be used to complete the sequence of a particular cloned insert of interest. Shotgun strategy involves randomly breaking the original insert into segments of various sizes and cloning these fragments into vectors. The fragments are sequenced and reassembled using overlapping ends until the entire sequence of the original insert is known. Shotgun sequencing methods are well known in the art and use thermostable DNA polymerases, heat-labile DNA polymerases, and primers chosen from representative regions flanking the polynucleotides of interest.

[0072] A library of plasmids containing inserts of various sizes from about 1 to about 5 kb will provide templates that may be sequenced from both ends to produce sequence that may be assembled using algorithms such as those described below. The size of the DNA insert in new clones may be estimated by agarose gel electrophoresis and the inserts may be sequenced using the techniques and equipment described above or capillary electrophoresis systems (Beckman Coulter, Fullerton Calif.).

[0073] Capillary electrophoresis was initially developed to determine the size or nucleotide sequence of PCR products. Such rapid sequencing systems employ flowable polymers for electrophoretic separation, four different fluorescent dyes (one for each nucleotide) for laser activation, and a charge-coupled camera for detection of the emitted wavelengths. Output/light intensity is converted to electrical signal using appropriate software. The entire process from loading of samples to computer analysis and electronic data display is computer controlled. Capillary electrophoresis may potentially provide greater resolution and speed than standard gel based procedures, and it is particularly well suited to sequencing small pieces of DNA that might be present in limited amounts in a particular sample and to identifying SNPs. Early in the development of this technology, Ruiz-Martinez et al. (1993; Anal Chem 65:2851-2858) reported the reproducible sequencing of up to 350 bp of M13 phage DNA in 30 min.

[0074] In many instances, the random sequencing of clones from a library will result in the identification of more than one clone containing all or part of a particular gene. If the redundant cDNAs differ in their relative size or in the region of the gene transcribed, it is possible to recombinantly synthesize or chemically combine the various overlapping cDNA fragments to create a single full length cDNA (Caruthers et al. (1980) Nucleic Acids Symp Ser (7) 215-233).

[0075] Various programs such as the ABI Assembler and AUTOASSEMBLER software (both PE Biosystems), GCG fragment assembly (Genetics Computer Group, Madison Wis.), CONSED (Gordon (1998) Genome Res 8:195-202), U.S. Pat. No. 5,953,727 and U.S. Ser. No. 09/276,534, filed Mar. 25, 1999, manage sequence assembly projects in a relational database by assembling overlapping sequence fragments into a larger sequence. Generally sequences are placed into assemblages based on relationships between the sequences such as alignment and statistical analysis. Early assembly processes were based on the Meyers Kececioglu model of fragment assembly that uses graph theory as the foundation of a very rigorous multiple sequence alignment program for assembling sequence fragments. Contaminating sequences including vector, mitochondrial, or chimeric sequences may be masked or removed to expedite the assembly of fragments into complete sequences.

Homology Searches

[0076] The polynucleotides of the Sequence Listing may be used to query publically available databases such as GenBank to determine homology to known sequences. Illustrative of computer programs known to those of skill in the art for performing computer-assisted homology searches is BLAST or BLAST2 (Altschul (1997) supra, Altschul (1993) supra, and Altschul (1990) supra). BLAST is especially useful in determining exact matches or in identifying related sequences because of the local nature of the alignments. As described in Karlin and Altschul (1993; Proc Natl Acad Sci 90:5873-5877), the fundamental unit of BLAST algorithm output is the high scoring segment pair (HSP). An HSP consists of two sequence fragments of arbitrary, but equal lengths, whose alignment is locally maximal and for which the alignment score meets or exceeds a threshold or cutoff score set by the user. The parameter E establishes the statistically significant threshold for reporting database sequence matches. E is interpreted as the upper bound of the expected frequency of chance occurrence of an HSP (or set of HSPs) within the context of the entire database search. Any database sequence whose match satisfies E is reported in the BLAST program output.

[0077] BLAST is used with any of the polynucleotides of the present invention to search for HSPs between a query sequence and sequences in a reference nucleotide or protein database. The sequences may be searched against prokaryotic (bacterial) or eukaryotic (animal, fungal or plant) databases and the degree of homology reported. When sequences have sufficiently long regions of agreement or sufficiently high overall agreement, the score of the new cDNA sequence is considered to be an exact match. Allelic sequences, by definition, fit this category in that they differ by about three nucleotides per 100. Exact and homologous matches between the polynucleotides and polypeptides of the present invention and the GenBank databases are shown in Table 3.

[0078] Similarly, BLAST may be used to compare the polypeptides of the invention to protein databases such as Swissprot, PFAM, BLOCKS, PRINTS, and the like to identify regions of amino acid homology or common domains. The statistical significance of any polynucleotide or polypeptide matches is evaluated, and those matches that equal or exceed the user-selected threshold of significance are reported. A variety of software and algorithms, that are well known in the art and may be used to analyze the sequences, are described in Ausubel (1997 supra, pp.7.48-7.69), and Meyers (1995; Molecular Biology and Biotechnology, Wiley VCH, New York N.Y., pp. 856-853).

[0079] To acquire annotation, the polynucleotides of the Sequence Listing were aligned with assembled templates in the LIFESEQ GOLD database (Incyte Pharmaceuticals). Those templates annotated as electron transfer molecules in the protein functional hierarchy provided the grouping and annotation of the polynucleotides claimed herein as regulatory and coding sequences of a particular electron transfer molecule.

Use of the Polynucleotide Sequences

[0080] The polynucleotides of the invention may be used to express a polypeptide, to identify an identical, similar or related polynucleotide, to screen libraries or a plurality of molecules and compounds and to identify or to purify a ligand. The polynucleotides may also be used for genetic analysis, diagnostic and therapeutic applications for disorders associated with electron transfer molecule expression.

Expression of the Polynucleotide Sequences

[0081] Expression of a particular cDNA may be accomplished by cloning the cDNA into an appropriate vector and transforming this vector into an appropriate host cell. The cloning vector used for the construction of the human and rat cDNA libraries may also be used for expression. Such vectors usually contain a promoter and a polylinker useful for cloning, priming, and transcription. An exemplary vector may also contain the promoter for β-galactosidase, an amino-terminal methionine and the subsequent seven amino acid residues of β-galactosidase. The vector may be transformed into an appropriate host strain of E. coli. Induction of the isolated bacterial strain with isopropylthiogalactoside (IPTG) using standard methods will produce a fusion protein that contains an N terminal methionine, the first seven residues of β-galactosidase, about 15 residues of linker, and the polypeptide encoded by the cDNA.

[0082] The cDNA may be shuttled into other vectors known to be useful for expression of protein in specific hosts. Oligonucleotides containing cloning sites and fragments of DNA sufficient to hybridize to stretches at both ends of the cDNA may be chemically synthesized by standard methods. These primers may then be used to amplify the desired fragments by PCR. The fragments may be digested with appropriate restriction enzymes under standard conditions and isolated using gel electrophoresis. Alternatively, similar fragments are produced by digestion of the cDNA with appropriate restriction enzymes and filled in with chemically synthesized oligonucleotides. Fragments of the coding sequence from more than one gene may be ligated together and expressed.

[0083] Signal sequences that dictate secretion of soluble proteins are particularly desirable as component parts of a recombinant sequence. For example, a chimeric protein may be expressed that includes one or more additional purification-facilitating domains. Such domains include, but are not limited to, metal-chelating domains that allow purification on immobilized metals, protein A domains that allow purification on immobilized immunoglobulin, and the domain utilized in the FLAGS extension/affinity purification system (Immunex, Seattle Wash.). The inclusion of a cleavable-linker sequence such as ENTEROKINASEMAX (Invitrogen, San Diego Calif.) between the polypeptide and the purification domain may also be used to recover the polypeptide.

[0084] Suitable expression hosts may include, but are not limited to, mammalian cells such as Chinese Hamster Ovary (CHO) and human 293 cells, insect cells such as Sf9 cells, yeast cells such as Saccharomyces cerevisiae, and bacteria such as E. coli. For each of these cell systems, a useful expression vector may also include an origin of replication and one or two selectable markers to allow selection in bacteria as well as in a transfected eukaryotic host. Vectors for use in eukaryotic expression hosts may require the addition of 3′ poly(A) tail if the polynucleotide lacks poly(A).

[0085] Additionally, the vector may contain promoters or enhancers that increase gene expression. Most promoters are host specific, and they include MMTV, SV40 or metallothionein promoters for CHO cells; trp, lac, tac or T7 promoters for bacterial hosts; or alpha factor, alcohol oxidase or PGH promoters for yeast. Adenoviral vectors with enhancers such as the rous sarcoma virus (RSV) enhancer or retroviral vectors with promoters such as the long terminal repeat (LTR) promoter may be used to drive protein expression in mammalian cell lines. Once homogeneous cultures of recombinant cells are obtained, large quantities of a secreted soluble polypeptide may be recovered from the conditioned medium and analyzed using chromatographic methods well known in the art. An alternative method for the production of large amounts of secreted protein involves the transformation of mammalian embryos and the recovery of the recombinant protein from milk produced by transgenic cows, goats, sheep, and the like.

Hybridization

[0086] The polynucleotides or fragments or complements thereof of the present invention may be used in various hybridization technologies. The polynucleotides may be naturally occurring, recombinant, or chemically synthesized; based on genomic or cDNA sequences; and labeled using a variety of reporter molecules by either PCR or enzymatic techniques. Commercial kits are available for labeling and cleanup of such polynucleotides or probes. Radioactive (Amersham Pharmacia Biotech), fluorescent (Operon Technologies, Alameda Calif.), and chemiluminescent labeling (Promega, Madison Wis.), are well known in the art. Alternatively, a polynucleotide is cloned into a commercially available vector, and probes are produced by transcription. The probe is synthesized and labeled by addition of an appropriate polymerase, such as T7 or SP6 polymerase, and at least one labeled nucleotide.

[0087] A probe may be designed or derived from unique regions such as the 3′ untranslated region or from a conserved motif common to electron transfer molecules and used in protocols to identify naturally occurring molecules encoding the mammalian polypeptide, allelic variants, or related molecules. The probe may be DNA or RNA, is usually single stranded and should have at least 50% sequence identity to any of the nucleic acid sequences. The probe may comprise at least 18 contiguous nucleotides of a polynucleotide. Such a probe may be used under hybridization conditions that allow binding only to an identical sequence or under conditions that allow binding to a related sequence with at least one nucleotide substitution. Discovery of related sequences may also be accomplished using a pool of degenerate probes and appropriate hybridization conditions. Generally, a probe for use in Southern or northern hybridizations may be from about 400 to about 4000 nucleotides long. Such probes may be single-stranded or double-stranded and may have high binding specificity in solution-based or substrate-based hybridizations. A probe may also be an oligonucleotide that is used to detect a polynucleotide of the invention in a sample by PCR.

[0088] The stringency of hybridization is determined by G+C content of the probe, salt concentration, and temperature. In particular, stringency is increased by reducing the concentration of salt or raising the hybridization temperature. In solutions used for some membrane based hybridizations, addition of an organic solvent such as formamide allows the reaction to occur at a lower temperature. Hybridization may be performed with buffers, such as 5×saline sodium citrate (SSC) with 1% sodium dodecyl sulfate (SDS) at 60° C., that permits the formation of a hybridization complex between nucleic acid sequences that contain some mismatches. Subsequent washes are performed with buffers such as 0.2×SSC with 0.1% SDS at either 45° C. (medium stringency) or 65°-68° C. (high stringency). At high stringency, hybridization complexes will remain stable only where the polynucleotides are completely complementary. In some membrane-based hybridizations, preferably 35% or most preferably 50%, formamide may be added to the hybridization solution to reduce the temperature at which hybridization is performed. Background signals may be reduced by the use of detergents such as Sarkosyl or Triton X-100 (Sigma Aldrich, St. Louis Mo.) and a blocking agent such as denatured salmon sperm DNA. Selection of components and conditions for hybridization are well known to those skilled in the art and are reviewed in Ausubel (supra, pp. 6.11-6.19, 14.11-14.36, and A1-43).

[0089] Dot-blot, slot-blot, low density and high density arrays are prepared and analyzed using methods known in the art. Probes or array elements from about 18 consecutive nucleotides to about 5000 consecutive nucleotides are contemplated by the invention and used in array technologies. The preferred number of probes or array elements is at least about 40,000; a more preferred number is at least about 10,000, and a most preferred number is at least about 600 to about 800. The array may be used to monitor the expression level of large numbers of genes simultaneously and to identify genetic variants, mutations, and SNPs. Such information may be used to determine gene function; to understand the genetic basis of a disorder; to diagnose a disorder; and to develop and monitor the activities of therapeutic agents being used to control or cure a disorder. (See, e.g., U.S. Pat. No. 5,474,796; PCT application WO95/11995; PCT application WO95/35505; U.S. Pat. Nos. 5,605,662; and 5,958,342.)

Diagnostic Uses of the Polynucleotide

[0090] The polynucleotides of the Sequence Listing or their fragments or complements may be used as probes, individually or as a plurality of compositions, in diagnostic assays for the detection of an identical or related polynucleotide. A probe for the detection of related sequence is selected from a region of the polynucleotide encoding a “conserved” domain, motif, or region of interest. For the detection of identical sequences, or where maximum specificity is desired, probes are selected from a unique region of the polynucleotide such as the 3′ untranslated region. Such probes may be pretested for their ability to identify or amplify a target sequence. Optimization of the probe in the protocol, as commonly practiced by those of skill in the art, should reduce the frequency of false positives and false negatives.

[0091] Diagnostic assays known to those of skill in the art may be used to detect disorders associated with altered levels of expression. A probe developed from a polynucleotide encoding an electron transfer molecule is labeled with a reporter molecule and added to a sample from a subject under amplifying or hybridizing conditions. After a time sufficient for binding to occur, the signal from the reporter molecule is quantitated and compared with standards derived from samples taken from normal subjects or those diagnosed with the disorder. If polynucleotide expression varies significantly from the normal standard and approximates the level of expression correlated with the presence of the disorder, the assay indicates the presence of the disorder. Such qualitative or quantitative methods for diagnosing a disorder may include Southern, northern, dot blot, or other membrane or dip-stick based technologies or multiple-sample format technologies such as PCR, ELISA-like, pin, or array-based assays.

[0092] Such assays, combining a subject sample with one or more probes, are also applicable in evaluating the efficacy of a particular therapeutic treatment regime. They may also be used in animal studies, preclinical tests, clinical trials, or monitoring the treatment of an individual subject. Standards for use in diagnostic assay are developed as follows: First, the normal standard is developed by processing a statistically significant number of normal samples and evaluating the range and variation of expression of the polynucleotide definitive for those samples. Second, samples from animals or subjects with the disorder are also evaluated to establish range and variation of expression of the polynucleotide. Third, the differences between the normal and diseased samples are compared and deviation is evaluated for statistical significance. If these standards are acceptable and reliable, then samples from subjects who are being treated with an existing therapeutic agent may be compared with the standards to generate a treatment profile. The assay is repeated to determine whether the profile progresses toward or returns to the normal standard or pattern of gene expression. Successive treatment profiles may be used to show the efficacy of treatment over a period of several days or several months.

[0093] Similar assays may be used in animal studies testing potential pharmacological agents. Successive treatment profiles may be used to show the efficacy and toxicity of the agent over a period of several days or several months or in the study of disease progression in model systems described infra.

Transcript Imaging

[0094] Another aspect of the present invention relates to diagnostic or treatment methods based on specific imaging of the polynucleotides of the present invention. As used herein, the profile of polynucleotides that reflect gene transcription activity in a particular tissue at a particular time, is defined as a “transcript image”. Such profiles are generated by naming, matching, and counting all copies of related clones and arranging them in order of abundance. The process of producing a comparative transcript image is fully described in U.S. Pat. No. 5,840,484.

[0095] Subtractions between transcript images of different cells or tissues or of the same cells or tissues under different conditions may be used to discern differences in cellular activities. For example, a transcript image could show differences occurring between two different tissues, such as liver and brain tissues; between normal and diseased tissue, such as normal and cancerous brain tissue; or between untreated and treated tissues, such as brain tissue with astrocytoma before and after chemotherapy or radiation treatment.

[0096] Larger numbers of mRNA transcripts, as represented by their respective cDNA clones, may be compared using computer-based or “electronic subtraction” methods rather than using analogous laboratory methods, such as northern blot analysis. Electronic subtraction between any two transcript images parallels hybrid subtraction between any two cDNA libraries using techniques that are known to those of skill in the art (Meyers, supra, pp. 698-699).

[0097] The entire set or a selected subset of tissue-specific, unique, or homologous genes may be used in hybridization technologies for diagnosis of inherited or acquired conditions. Such markers have the potential to improve diagnosis (even in pre-symptomatic or prenatal conditions), identify appropriate therapeutic molecules, and assess treatment efficacy by monitoring changes in expression of polynucleotides during treatment.

Genetic Analysis

[0098] Gene identification and mapping are important in the investigation and treatment of mammalian disorders. Cancer, arthritis, diabetes, and the like are of interest. Each of these disorders is more complex than the single gene defects of sickle cell anemia or cystic fibrosis and involve genes of predictive and therapeutic value. Mapping of these genes is a complex and reiterative process and generally proceeds from genetic linkage analysis to physical mapping. Individual genetic markers and their known locations often serve to indicate which regions of chromosomes may contain genes coexpressed in the disorders or sequences that could be used in familial investigations for genetic lesions or SNPs attributable to that disorder. Examples of genetic linkage maps are found in various scientific journals or at the Online Mendelian Inheritance in Man (OMIM) world wide web site. Similarly genes mapped to a chromosome that shows an inversion, translocation, or the like associated with a particular disorder may help elucidate the etiology of that disorder.

[0099] The polynucleotides or probes of the invention are useful in mapping naturally occurring genomic sequences. The sequence may be mapped to a particular chromosome or to a specific region of the chromosome using well known techniques. These include hybridization to chromosomal spreads (Verma et al. (1988) Human Chromosomes: A Manual of Basic Techniques, Pergamon Press, New York N.Y.), flow-sorted chromosomal preparations, or cDNA libraries made from artificial chromosome constructions such as yeast artificial chromosomes (YACs), bacterial artificial chromosomes (BACs), bacterial P1 constructions, or single chromosomes.

[0100] Hybridization of chromosomal preparations of another mammalian species, such as mouse, may reveal associated markers even if the number or arm of the corresponding human or rat chromosome is not known. These new marker sequences are mapped to human chromosomes and provide valuable information to investigators searching for disease genes using positional cloning or other gene discovery techniques. Once a disease or syndrome has been crudely correlated by genetic linkage with a particular genomic region, e.g., ataxia-telangiectasia to 11q22-23, any sequences mapping to that area may represent associated or regulatory genes for further investigation (Gatti et al. (1988) Nature 336:577-580). The polynucleotides of the invention may also be used to detect differences in chromosomal architecture due to translocation, inversion, etc., among normal, carrier, or affected individuals and are potentially useful in legal or forensic studies to determine paternity or to establish the presence, absence, or activities of an accused suspect in a particular crime.

[0101] A physical map is necessary for determining the order of marker genes in a particular chromosomal region. Physical mapping techniques are well known in the art and require the generation of overlapping sets of cloned DNA fragments, both expressed sequence tags and sequence tag sites, from a particular artificial chromosome construction, organelle, chromosome, or genome. These clones are analyzed to reconstruct and catalog their order. Once the position of a marker is determined, the DNA from that region is obtained by consulting the catalog and selecting clones from that region. The gene of interest is located through positional cloning techniques using hybridization or similar methods.

Therapeutic Uses of the Polynucleotide

[0102] A polynucleotide may be useful in the treatment of various disorders associated with its altered expression. By introducing polynucleotides into cells, gene therapy may be used to treat disorders in which there is an absence of expression (due to a genetic mutation) or underexpression. For example, delivery of a cDNA or mRNA encoding the cystic fibrosis transmembrane regulator into the lungs of a cystic fibrosis patient may provide transient expression and relief from the symptoms of the disease (Harvey et al. (1999) J Clin Invest 104:1245-1255). Alternatively, disorders associated with an increase in expression of the polynucleotide may also be treated by the introduction of a sense or antisense molecule designed to inhibit the transcription or translation of that specific polynucleotide. Such RNA and DNA molecules and ribozymes that function to inhibit transcription or translation of a native gene are within the scope of the invention. For example, molecules that bind directly to the targeted polynucleotide, between −10 and +10 nucleotides of the coding region start site, will inhibit transcription.

[0103] Similarly, it is contemplated that ribozymes may be designed to catalyze the specific cleavage of an overexpressed mRNA. The mechanism of ribozyme activity involves sequence-specific hybridization of the ribozyme molecule to its complementary target RNA followed by an endonucleolytic cleavage. Specific ribozyme cleavage sites within any potential RNA target are initially identified by scanning the target molecule for ribozyme cleavage sites that include the following triplet nucleotides: GUA, GUU and GUC.

[0104] Sense molecules, antisense molecules and ribozymes of the invention may be prepared by any method known in the art for the synthesis of RNA molecules, including solid phase phosphoramidite chemical synthesis or recombinant in vitro transcription. Expression vectors derived from viruses (such as retroviruses, vaccinia, adenoviruses, herpes, or bovine papilloma viruses) may be used to deliver recombinant polynucleotides into the targeted cell population. Methods that are well known to those of skill in the art and described in Ausubel (supra, pp. 9.1-9.57) may be used to construct recombinant viral vectors containing a polynucleotide of the present invention. Alternately, recombinant polynucleotides, or their full length cDNAs, may be encapsulated in liposomes, frozen into ice microcrystals, precipitated on metal (gold) microparticles, and the like for delivery via electroporation, particle bombardment, microinjection, transfection, and the like into target cells. Transformation techniques will vary according to whether ex vivo or in vivo gene therapy is being attempted.

[0105] Knowledge of the correct, complete cDNA sequence will enable the use of antisense technology in the investigation of new gene functions. In this method, either oligonucleotides or cDNA fragments representing the sense or antisense molecule may be used either in vitro or in vivo to inhibit expression. After transformation with one of these molecules, a gene of interest may be effectively masked or turned off. Frequently, additional functions of that polynucleotide or the encoded polypeptide can be ascertained by observation of cellular or organismic behavior such as changes in surface antigens or changes in mobility or morphology.

Use of the Polypeptides Encoded by the Polynucleotides

[0106] The polynucleotides of this application or their full length cDNAs may be used to produce purified polypeptides using recombinant DNA technologies described herein and taught in Ausubel (sura; pp. 16.1-16.62). One of the advantages of producing polypeptides by these procedures is the ability to obtain highly-enriched sources of the polypeptides thereby simplifying purification procedures.

[0107] The present invention also encompasses amino acid substitutions, deletions or insertions made on the basis of similarity in polarity, charge, solubility, hydrophobicity, hydrophilicity, and/or the amphipathic nature of the residues involved. Such substitutions may be conservative in nature when the substituted residue has structural or chemical properties similar to the original residue (e.g., replacement of leucine with isoleucine or valine) or they may be nonconservative when the replacement residue is radically different (e.g., a glycine replaced by a tryptophan). Computer programs included in LASERGENE software (DNASTAR, Madison Wis.), MACVECTOR software (Genetics Computer Group, Madison Wis.) and RasMol software (www.umass.edu/microbio/rasmol) may be used to help determine which and how many amino acid residues in a particular portion of the polypeptide may be substituted, inserted, or deleted without abolishing biological or immunological activity.

[0108] In addition to recombinant production, polypeptides or portions thereof may be produced using solid-phase techniques (Stewart et al. (1969) Solid-Phase Peptide Synthesis, W H Freeman, San Francisco Calif.; Merrifield (1963) J Am Chem Soc 5:2149-2154), manually, or using machines such as the ABI431A Peptide synthesizer (PE Biosystems). Polypeptides produced by any of the above methods may be used as pharmaceutical compositions to treat disorders associated with underexpression.

Production of Antibodies

[0109] A polypeptide encoded by a polynucleotide of the invention may be used to produce specific antibodies. Antibodies may be produced using an oligopeptide or a portion of the polypeptide with inherent immunological activity. Methods for producing antibodies include: 1) injecting an animal (usually goats, rabbits, or mice) with the polypeptide, or a portion or an oligopeptide thereof, to induce an immune response; 2) engineering hybridomas to produce monoclonal antibodies; 3) inducing in vivo production in the lymphocyte population; or 4) screening libraries of recombinant immunoglobulins. Recombinant immunoglobulins may be produced as taught in U.S. Pat. No. 4,816,567.

[0110] Antibodies produced using the polypeptides of the invention are useful for the diagnosis of prepathologic disorders as well as the diagnosis of chronic or acute diseases characterized by abnormalities in the expression, amount, or distribution of the polypeptide. A variety of protocols for competitive binding or immunoradiometric assays using either polyclonal or monoclonal antibodies specific for polypeptides are well known in the art. Immunoassays typically involve the formation of complexes between a polypeptide and its specific binding molecule or compound and the measurement of complex formation. A two-site, monoclonal-based immunoassay utilizing monoclonal antibodies reactive to two noninterfering epitopes on a specific polypeptide is preferred, but a competitive binding assay may also be employed.

[0111] Immunoassay procedures may be used to quantify expression of the polypeptide in cell cultures, in subjects with a particular disorder or in model animal systems under various conditions. Increased or decreased production of polypeptides as monitored by immunoassay may contribute to knowledge of the cellular activities associated with developmental pathways, engineered conditions or diseases, or treatment efficacy. The quantity of a given polypeptide in a given tissue may be determined by performing immunoassays on freeze-thawed detergent extracts of biological samples and comparing the slope of the binding curves to binding curves generated by purified polypeptide.

[0112] The polypeptides and antibodies may be labeled for purposes of assay by joining them, either covalently or noncovalently, with a reporter molecule that provides for a detectable signal. A wide variety of labels and conjugation techniques are known and have been reported in the scientific and patent literature including, but not limited to U.S. Pat. Nos. 3,817,837; 3,850,752; 3,939,350; 3,996,345; 4,277,437; 4,275,149; and 4,366,241.

Therapeutic Uses of the Polypeptide or an Antibody Produced against the Polypeptide

[0113] The polypeptide encoded by the polynucleotide of the invention may be used therapeutically in subjects diagnosed as lacking sufficient biologically active polypeptide. These subjects may lack a functional gene, may not be able to express the polypeptide, or may underexpress the polypeptide. In such cases, the polypeptide may be supplied in a pharmaceutical composition. Conversely, an antibody produced using the polypeptide or a portion thereof that specifically binds the polypeptide may be administered as a pharmaceutical composition to a subject in which overexpression of the polynucleotide or its encoded polypeptide are contributing to a disorder.

[0114] If the polypeptide is particularly hard to produce, stabilize or formulate as a pharmaceutical composition, rational drug design may be used to produce structural analogs with similar biological activity. In one approach, the three-dimensional structure of a polypeptide, or of a polypeptide-inhibitor complex, is determined by X-ray crystallography, by computer modeling or, most typically, by a combination of the two approaches. Both the shape and charges of the polypeptide must be ascertained to elucidate the structure and to determine active site(s) of the molecule. Less often, useful information regarding the structure of a polypeptide may be gained by modeling based on the structure of homologous proteins. In both cases, relevant structural information is used to design analogous molecules or to identify efficient inhibitors.

[0115] In another approach, ligands that are highly specific for the polypeptide may be used as a pharmacore to screen for small molecules that can be tested for drug efficacy. Drug libraries often contain small peptides or mimetics that are more active or stable than the original polypeptide and may be used in its stead.

[0116] It is also possible to use the polypeptide to isolate a target-specific antibody that can be used as a pharmacore upon which subsequent drug design can be based. By generating anti-idiotypic antibodies (anti-ids) to a functional, pharmacologically active antibody, the binding site of the anti-id is an analog of the original receptor. The anti-id can then be used to identify and isolate peptides or mimetics from libraries of chemically or biologically produced molecules. The isolated peptide can then be tested for inhibition, toxicity, pharmaceutical efficacy and, if appropriate, formulated as a pharmaceutical composition.

Screening for Useful Compounds

[0117] Both the polynucleotides and polypeptides are particularly useful for screening libraries of molecules or test compounds for identification of ligands that bind specifically to them. For example, a polynucleotide or fragment thereof may be combined with a plurality of natural, synthetic, or inorganic molecules to screen for ligands that may function as transcription factors, enhancers, repressors, and the like that modulate gene expression. Similarly, a polypeptide or a portion thereof may be combined with a library or a plurality of molecules or compounds to screen for ligands that specifically bind to them and may function as agonists or antagonists.

Screening and Purification Assays

[0118] The polynucleotide encoding the mammalian polypeptide may be used to screen a library or a plurality of molecules or compounds for a ligand with specific binding affinity. The ligands may be DNA molecules, RNA molecules, PNAs, peptides, proteins such as transcription factors, enhancers, repressors, and other proteins that regulate the activity, replication, transcription, or translation of the polynucleotide in the biological system. The assay involves combining the mammalian polynucleotide or a fragment thereof with the molecules or compounds under conditions that allow specific binding and detecting the bound polynucleotide to identify at least one ligand that specifically binds the polynucleotide.

[0119] In one embodiment, the polynucleotide of the invention may be incubated with a library of isolated and purified molecules or compounds and binding activity determined by methods well known in the art, e.g., a gel-retardation assay (U.S. Pat. No. 6,010,849) or a reticulocyte lysate transcriptional assay. In another embodiment, the polynucleotide may be incubated with nuclear extracts from biopsied and/or cultured cells and tissues. Specific binding between the polynucleotide and a molecule or compound in the nuclear extract is initially determined by gel shift assay and may be later confirmed by raising antibodies against that molecule or compound. When these antibodies are added into the assay, they cause a supershift in the gel-retardation assay.

[0120] In another embodiment, the polynucleotide may be used to purify a molecule or compound using affinity chromatography methods well known in the art. In one embodiment, the polynucleotide is chemically reacted with cyanogen bromide groups on a polymeric resin or gel. Then a sample is passed over and reacts with or binds to the polynucleotide. The molecule or compound which is bound to the polynucleotide may be released from the polynucleotide by increasing the salt concentration of the flow-through medium and collected.

[0121] Similarly the polypeptide or a portion thereof encoded by the polynucleotide may be used to screen libraries or a plurality of molecules or compounds for a ligand with specific binding affinity or to purify a molecule or compound from a sample. The polypeptide or portion thereof employed in such screening may be free in solution, affixed to an abiotic or biotic substrate, or located intracellularly. For example, viable or fixed prokaryotic host cells that are stably transformed with recombinant nucleic acids that have expressed and positioned a polypeptide on their cell surface can be used in screening assays. The cells are screened against libraries or a plurality of ligands and the specificity of binding or formation of complexes between the expressed polypeptide and the ligand may be measured. The ligands may be DNA, RNA, or PNA molecules, agonists, antagonists, antibodies, immunoglobulins, inhibitors, peptides, pharmaceutical agents, proteins, drugs, or any other test molecule or compound that specifically binds the polypeptide. An exemplary assay involves combining the mammalian polypeptide or a portion thereof with the molecules or compounds under conditions that allow specific binding and detecting the bound polypeptide to identify at least one ligand that specifically binds the polypeptide.

[0122] This invention also contemplates the use of competitive drug screening assays in which neutralizing antibodies capable of binding the polypeptide specifically compete with a test compound capable of binding to the polypeptide or oligopeptide or fragment thereof. One method for high throughput screening using very small assay volumes and very small amounts of test compound is described in U.S. Pat. No. 5,876,946. Molecules or compounds identified by screening may be used in a mammalian model system to evaluate their toxicity, diagnostic, or therapeutic potential.

Labeling of Molecules for Use in Arrays or Assays

[0123] A wide variety of reporter molecules and conjugation techniques are known by those skilled in the art and may be used in various polynucleotide, polypeptide or antibody arrays or assays. Synthesis of labeled molecules may be achieved using Promega or Amersham Pharmacia Biotech kits for incorporation of a labeled nucleotide such as 32P-dCTP, Cy3-dCTP or Cy5-dCTP or amino acid such as 35S-methionine. Polynucleotides, polypeptides, or antibodies may be directly labeled with a reporter molecule by chemical conjugation to amines, thiols and other groups present in the molecules using reagents such as BIODIPY or FITC (Molecular Probes, Eugene Oreg.).

Purification of a Ligand

[0124] The polynucleotide or a fragment thereof may be used to purify a ligand from a sample. A method for using a mammalian polynucleotide or a fragment thereof to purify a ligand would involve combining the polynucleotide or a fragment thereof with a sample under conditions to allow specific binding, recovering the bound polynucleotide, and using an appropriate agent to separate the polynucleotide from the purified ligand.

[0125] Similarly, the polypeptide or a portion thereof may be used to purify a ligand from a sample. A method for using a mammalian polypeptide or a portion thereof to purify a ligand would involve combining the polypeptide or a portion thereof with a sample under conditions to allow specific binding, recovering the bound polypeptide, and using an appropriate chaotropic agent to separate the polypeptide from the purified ligand.

Model Systems

[0126] Animal models may be used as bioassays where they exhibit a phenotypic response similar to that of humans and where exposure conditions are relevant to human exposures. Mammals are the most common models, and most infectious agent, cancer, drug, and toxicity studies are performed on rodents such as rats or mice because of low cost, availability, lifespan, reproductive potential, and abundant reference literature. Inbred and outbred rodent strains provide a convenient model for investigation of the physiological consequences of underexpression or overexpression of genes of interest and for the development of methods for diagnosis and treatment of diseases. A mammal inbred to overexpress a particular gene (for example, secreted in milk) may also serve as a convenient source of the protein expressed by that gene.

Toxicology

[0127] Toxicology is the study of the effects of agents on living systems. The majority of toxicity studies are performed on rats or mice. Observation of qualitative and quantitative changes in physiology, behavior, homeostatic processes, and lethality in the rats or mice are used to generate a toxicity profile and to assess potential consequences on human health following exposure to the agent.

[0128] Genetic toxicology identifies and analyzes the effect of an agent on the rate of endogenous, spontaneous, and induced genetic mutations. Genotoxic agents usually have common chemical or physical properties that facilitate interaction with nucleic acids and are most harmful when chromosomal aberrations are transmitted to progeny. Toxicological studies may identify agents that increase the frequency of structural or functional abnormalities in the tissues of the progeny if administered to either parent before conception, to the mother during pregnancy, or to the developing organism. Mice and rats are most frequently used in these tests because their short reproductive cycle allows the production of the numbers of organisms needed to satisfy statistical requirements.

[0129] Acute toxicity tests are based on a single administration of an agent to the subject to determine the symptomology or lethality of the agent. Three experiments are conducted: 1) an initial dose-range-finding experiment, 2) an experiment to narrow the range of effective doses, and 3) a final experiment for establishing the dose-response curve.

[0130] Subchronic toxicity tests are based on the repeated administration of an agent. Rat and dog are commonly used in these studies to provide data from species in different families. With the exception of carcinogenesis, there is considerable evidence that daily administration of an agent at high-dose concentrations for periods of three to four months will reveal most forms of toxicity in adult animals.

[0131] Chronic toxicity tests, with a duration of a year or more, are used to demonstrate either the absence of toxicity or the carcinogenic potential of an agent. When studies are conducted on rats, a minimum of three test groups plus one control group are used, and animals are examined and monitored at the outset and at intervals throughout the experiment.

Transgenic Animal Models

[0132] Transgenic rodents that overexpress or underexpress a gene of interest may be inbred and used to model human diseases or to test therapeutic or toxic agents. (See, e.g., U.S. Pat. Nos. 5,175,383 and 5,767,337.) In some cases, the introduced gene may be activated at a specific time in a specific tissue type during fetal or postnatal development. Expression of the transgene is monitored by analysis of phenotype, of tissue-specific mRNA expression, or of serum and tissue protein levels in transgenic animals before, during, and after challenge with experimental drug therapies.

Embryonic Stem Cells

[0133] Embryonic (ES) stem cells isolated from rodent embryos retain the potential to form embryonic tissues. When ES cells are placed inside a carrier embryo, they resume normal development and contribute to tissues of the live-born animal. ES cells are the preferred cells used in the creation of experimental knockout and knockin rodent strains. Mouse ES cells, such as the mouse 129/SvJ cell line, are derived from the early mouse embryo and are grown under culture conditions well known in the art. Vectors used to produce a transgenic strain contain a disease gene candidate and a marker gene, the latter serves to identify the presence of the introduced disease gene. The vector is transformed into ES cells by methods well known in the art, and transformed ES cells are identified and microinjected into mouse cell blastocysts such as those from the C57BL/6 mouse strain. The blastocysts are surgically transferred to pseudopregnant dams, and the resulting chimeric progeny are genotyped and bred to produce heterozygous or homozygous strains.

[0134] ES cells derived from human blastocysts may be manipulated in vitro to differentiate into at least eight separate cell lineages. These lineages are used to study the differentiation of various cell types and tissues in vitro, and they include endoderm, mesoderm, and ectodermal cell types that differentiate into, for example, neural cells, hematopoietic lineages, and cardiomyocytes.

Knockout Analysis

[0135] In gene knockout analysis, a region of a mammalian gene is enzymatically modified to include a non-mammalian gene such as the neomycin phosphotransferase gene (neo; Capecchi (1989) Science 244:1288-1292). The modified gene is transformed into cultured ES cells and integrates into the endogenous geneome by homologous recombination. The inserted sequence disrupts transcription and translation of the endogenous gene. Transformed cells are injected into rodent blastulae, and the blastulae are implanted into pseudopregnant dams. Transgenic progeny are crossbred to obtain homozygous inbred lines that lack a functional copy of the mammalian gene. In one example, the mammalian gene is a human gene.

Knockin Analysis

[0136] ES cells can be used to create knockin humanized animals (pigs) or transgenic animal models (mice or rats) of human diseases. With knockin technology, a region of a human gene is injected into animal ES cells, and the human sequence integrates into the animal cell genome. Transformed cells are injected into blastulae and the blastulae are implanted as described above. Transgenic progeny or inbred lines are studied and treated with potential pharmaceutical agents to obtain information on treatment of the analogous human condition. These methods have been used to model several human diseases.

[0137] As described herein, the uses of the polynucleotides, provided in the Sequence Listing of this application, and their encoded polypeptides are exemplary of known techniques and are not intended to reflect any limitation on their use in any technique that would be known to the person of average skill in the art. Furthermore, the polynucleotides provided in this application may be used in molecular biology techniques that have not yet been developed, provided the new techniques rely on properties of nucleotide sequences that are currently known to the person of ordinary skill in the art, e.g., the triplet genetic code, specific base pair interactions, and the like. Likewise, reference to a method may include combining more than one method for obtaining or assembling full length cDNA sequences that will be known to those skilled in the art.

[0138] It is to be understood that the invention is not to be limited only to these particular sequences, variants, formulations or methods. The terminology and definitions are not intended to be limiting since the scope of protection will ultimately depend upon the claims. In like manner, the examples below are provided for the purpose of illustrating, rather than limiting, the subject invention.

EXAMPLES

Isolation, Sequence Analysis and Use of Electron Transfer Molecules

[0139] I cDNA Library Construction

[0140] The BRAIFET01 cDNA library was constructed from brain tissue derived from a 23-week-old Caucasian male fetus (specimen #RB96-04-0157-014) who was stillborn. Serology was negative. Patient history included a hypoplastic heart.

[0141] The frozen tissue was homogenized and lysed in TRIZOL reagent (1 g tissue/10 ml TRIZOL; Life Technologies) using a POLYTRON homogenizer (PT-3000; Brinkmann Instruments, Westbury N.Y.). After a brief incubation on ice, chloroform was added (1:5 v/v), and the lysate was centrifuged. The chloroform layer was discarded, and the RNA precipitated with isopropanol, resuspended in DEPC-treated water, and treated with DNase for 25 min at 37 ° C. The mRNA was re-extracted twice with acid phenol-chloroform, pH 4.7, and precipitated using 0.3M sodium acetate and 2.5 volumes ethanol. The mRNA was isolated with the OLIGOTEX kit (Qiagen) and used to construct the cDNA library.

[0142] The mRNA was handled according to the recommended protocols in the SUPERSCRIPT plasmid system (Life Technologies). The cDNAs were fractionated on a SEPHAROSE CL4B column (Amersham Pharmacia Biotech), and those cDNAs exceeding 400 bp were ligated into pINCY 1 plasmid. The plasmid was subsequently transformed into DH5α competent cells (Life Technologies).

[0143] II Construction of pINCY Plasmid

[0144] The plasmid was constructed by digesting the pSPORT1 plasmid (Life Technologies) with EcoRI restriction enzyme (New England Biolabs, Beverly Mass.) and filling the overhanging ends using Klenow enzyme (New England Biolabs) and 2′-deoxynucleotide 5′-triphosphates (dNTPs). The plasmid was self-ligated and transformed into the bacterial host, E. coli strain JM109.

[0145] An intermediate plasmid produced by the bacteria (pSPORT 1-ΔRI) showed no digestion with EcoRI and was digested with Hind III (New England Biolabs) and the overhanging ends were again filled in with Klenow and dNTPs. A linker sequence was phosphorylated, ligated onto the 5′ blunt end, digested with EcoRI, and self-ligated. Following transformation into JM109 host cells, plasmids were isolated and tested for preferential digestibility with EcoRI, but not with Hind III. A single colony that met this criteria was designated pINCY 1 plasmid.

[0146] After testing the plasmid for its ability to incorporate cDNAs from a library prepared using NotI and EcoRI restriction enzymes, several clones were sequenced; and a single clone containing an insert of approximately 0.8 kb was selected from which to prepare a large quantity of the plasmid. After digestion with NotI and EcoRI, the plasmid was isolated on an agarose gel and purified using a QIAQUICK column (Qiagen) for use in library construction.

[0147] III Normalization of cDNA Libraries

[0148] For purposes of example, the normalization of a human brain library is described. About 4.9×106 independent clones of the BRAINON01 plasmid library in E. coli strain DH12S competent cells (Life Technologies) were grown in liquid culture under carbenicillin (25 mg/l) and methicillin (1 mg/ml) selection following transformation by electroporation. To reduce the number of excess cDNA copies according to their abundance levels in the library, the cDNA library was then normalized in a single round according to the procedure of Soares et al. (1994, Proc Natl Acad Sci 91:9228-9232), with the following modifications. The primer to template ratio in the primer extension reaction was increased from 2:1 to 10:1. The ddNTP concentration in the reaction was reduced to 150 μM for each ddNTP to allow the generation of longer (400-1000 nt) primer extension products. The reannealing hybridization was extended from 13 to 48 hr. The single stranded DNA circles of the normalized library were purified by hydroxyapatite chromatography and converted to partially double-stranded by random priming, followed by electroporation into E. coli strain DH10B competent cells (Life Technologies).

[0149] IV Isolation and Sequencing of cDNA Clones

[0150] Plasmid DNA was released from the cells and purified using the REAL PREP 96 plasmid kit (Qiagen). This kit enabled the simultaneous purification of 96 samples in a 96-well block using multi-channel reagent dispensers. The recommended protocol was employed except for the following changes: 1) the bacteria were cultured in 1 ml of sterile Terrific Broth (Life Technologies) with carbenicillin at 25 mg/l and glycerol at 0.4%; 2) after inoculation, the cultures were incubated for 19 hr and at the end of incubation, the cells were lysed with 0.3 ml of lysis buffer; and 3) following isopropanol precipitation, the plasmid DNA pellet was resuspended in 0.1 ml of distilled water. After the last step in the protocol, samples were transferred to a 96-well block for storage at 4° C.

[0151] The cDNAs were prepared using a MICROLAB 2200 (Hamilton) in combination with DNA ENGINE thermal cyclers (MJ Research). The cDNAs were sequenced by the method of Sanger and Coulson (1975; J Mol Biol 94:441-448) using ABI PRISM 377 and 373 DNA sequencing systems (PE Biosystems) and standard ABI protocols and kits. The solution volumes were used at 0.25×-1.0×concentrations. Some of the sequences disclosed herein were sequenced using different solutions and dyes which, unless otherwise noted, came from Amersham Pharmacia Biotech.

[0152] V. Extension of cDNA Sequences

[0153] The polynucleotides were extended using a cDNA clone and oligonucleotide primers. One primer was synthesized to initiate 5′ extension of the known fragment, and the other, to initiate 3′ extension of the known fragment. The initial primers were designed using OLIGO 4.06 software (National Biosciences, Plymouth Minn.), or another appropriate program, to be about 22 to 30 nucleotides in length, to have a GC content of about 50% or more, and to anneal to the target sequence at temperatures of about 68° C. to about 72° C. Any stretch of nucleotides that would result in hairpin structures and primer-primer dimerizations was avoided.

[0154] Selected cDNA libraries were used as templates to extend the sequence. If more than one extension was necessary or desired, additional or nested sets of primers were designed. Preferred libraries are ones that have been size-selected to include larger cDNAs. Also, random primed libraries are preferred because they will contain more sequences with the 5′ and upstream regions of genes. A randomly primed library is particularly useful if an oligo d(T) library does not yield a full length cDNA. Genomic libraries are useful for extension 5′ of the promoter binding region in order to obtain regulatory elements.

[0155] High fidelity amplification was obtained by PCR using methods such as that taught in U.S. Pat. No. 5,932,451. PCR was performed in 96-well plates using the DNA ENGINE thermal cycler (MJ Research). The reaction mix contained DNA template, 200 nmol of each primer, reaction buffer containing Mg2+, (NH4)2SO4, and β-mercaptoethanol, Taq DNA polymerase (Amersham Pharmacia Biotech), ELONGASE enzyme (Life Technologies), and Pfu DNA polymerase (Stratagene), with the following parameters for primer pair PCI A and PCI B (Incyte Pharmaceuticals): Step 1: 94° C., three min; Step 2: 94° C., 15 sec; Step 3: 60° C., one min; Step 4: 68° C., two min; Step 5: Steps 2, 3, and 4 repeated 20 times; Step 6: 68° C., five min; Step 7: storage at 4° C. In the alternative, the parameters for primer pair T7 and SK+ (Stratagene) were as follows: Step 1: 94° C., three min; Step 2: 94° C., 15 sec; Step 3: 57° C., one min; Step 4: 68° C., two min; Step 5: Steps 2, 3, and 4 repeated 20 times; Step 6: 68° C., five min; Step 7: storage at 4° C.

[0156] The concentration of DNA in each well was determined by dispensing 100 μl PICOGREEN quantitation reagent (0.25% reagent in 1×TE, v/v; Molecular Probes) and 0.5 μl of undiluted PCR product into each well of an opaque fluorimeter plate (Corning, Acton Mass.) and allowing the DNA to bind to the reagent. The plate was scanned in a Fluoroskan II (Labsystems Oy) to measure the fluorescence of the sample and to quantify the concentration of DNA. A 5 μl to 10 μl aliquot of the reaction mixture was analyzed by electrophoresis on a 1% agarose mini-gel to determine which reactions were successful in extending the sequence.

[0157] The extended nucleotide sequences were desalted, concentrated, transferred to 384-well plates, digested with CviJI cholera virus endonuclease (Molecular Biology Research, Madison Wis.), and sonicated or sheared prior to religation into pUC18 vector (Amersham Pharmacia Biotech). For shotgun sequences, the digested nucleotide sequences were separated on low concentration (0.6 to 0.8%) agarose gels, fragments were excised, and the agar was digested with AGARACE enzyme (Promega). Extended clones were religated using T4 DNA ligase (New England Biolabs) into pUC 18 vector (Amersham Pharmacia Biotech), treated with Pfu DNA polymerase (Stratagene) to fill-in restriction site overhangs, and transfected into E. coli competent cells. Transformed cells were selected on antibiotic-containing media, and individual colonies were picked and cultured overnight at 37° C. in 384-well plates in LB/2×carbenicillin liquid media.

[0158] The cells were lysed, and DNA was amplified using primers, Taq DNA polymerase (Amersham Pharmacia Biotech) and Pfu DNA polymerase (Stratagene) with the following parameters: Step 1: 94° C., three min; Step 2: 94° C., 15 sec; Step 3: 60° C., one min; Step 4: 72° C., two min; Step 5: steps 2, 3, and 4 repeated 29 times; Step 6: 72° C., five min; Step 7: storage at 4° C. DNA was quantified using PICOGREEN quantitative reagent (Molecular Probes) as described above. Samples with low DNA recoveries were reamplified using the conditions described above. Samples were diluted with 20% dimethylsulfoxide (DMSO; 1:2, v/v), and sequenced using DYENAMIC energy transfer sequencing primers and the DYENAMIC DIRECT cycle sequencing kit (Amersham Pharmacia Biotech) or the ABI PRISM BIGDYE terminator cycle sequencing kit (PE Biosystems).

[0159] VI Homology Searching of cDNA Clones and Their Deduced Polypeptides

[0160] The polynucleotides of the Sequence Listing or their deduced amino acid sequences were used to query databases such as GenBank, SwissProt, BLOCKS, and the like. These databases that contain previously identified and annotated sequences or domains were searched using BLAST or BLAST 2 (Altschul (1997) supra, Altschul (1993) supra, and Altschul (1990) supra) to produce alignments and to determine which sequences were exact matches or homologs. The alignments were to sequences of prokaryotic (bacterial) or eukaryotic (animal, fungal, or plant) origin. Alternatively, algorithms such as the one described in Smith and Smith (1992, Protein Engineering 5:35-51) could have been used to deal with primary sequence patterns and secondary structure gap penalties. All of the sequences disclosed in this application have lengths of at least 49 nucleotides, and no more than 12% uncalled bases (where N is recorded rather than A, C, G, or T).

[0161] As detailed in Karlin (supra), BLAST matches between a query sequence and a database sequence were evaluated statistically and only reported when they satisfied the threshold of 10−25 for nucleotides and 10−14 for peptides. The expressed sequence tags (ESTs) comprising the mammalian polynucleotides regulating or encoding electron transfer molecules were searched against the GenBank databases for homology. Homology of human ESTs was evaluated by product score calculated as follows: the % nucleotide or amino acid identity [between the query and reference sequences] in BLAST is multiplied by the % maximum possible BLAST score [based on the lengths of query and reference sequences] and then divided by 100. In the alternative, the product score for human and rat sequences was calculated as follows: the BLAST score is multiplied by the % nucleotide identity and the product is divided by (5 times the length of the shorter of the two sequences), such that a 100% alignment over the length of the shorter sequence gives a product score of 100. In comparison with hybridization procedures used in the laboratory, the electronic stringency for an exact match was set at 70, and the conservative lower limit for an exact match was set at approximately 40 (with 1-2% error due to uncalled bases).

[0162] The BLAST software suite, freely available sequence comparison algorithms (NCBI, Bethesda Md.; http://www.ncbi.nlm.nih.gov/gorf/bl2.html) includes various sequence analysis programs including “blastn”, that is used to align a known nucleic acid molecules, BLAST 2 that is used for direct pairwise comparison of either nucleic or amino acid molecules. BLAST programs are commonly used with gap and other parameters set to default settings, e.g.: Matrix: BLOSUM62; Reward for match: 1; Penalty for mismatch: −2; Open Gap: 5 and Extension Gap: 2 penalties; Gap x drop-off: 50; Expect: 10; Word Size: 11; and Filter: on. Identity or similarity may be measured over the entire length of a sequence or some smaller portion thereof. Brenner et al. (1998; Proc Natl Acad Sci 95:6073-6078, incorporated herein by reference) analyzed the BLAST for its ability to identify structural homologs by sequence identity and found 30% identity is a reliable threshold for sequence alignments of at least 150 residues and 40%, for alignments of at least 70 residues.

[0163] The mammalian polynucleotides of this application were compared with assembled consensus sequences or templates found in the LIFESEQ GOLD database. Component sequences from cDNA, extension, full length, and shotgun sequencing projects were subjected to PHRED analysis and assigned a quality score. All sequences with an acceptable quality score were subjected to various pre-processing and editing pathways to remove low quality 3′ ends, vector and linker sequences, polyA tails, Alu repeats, mitochondrial and ribosomal sequences, and bacterial contamination sequences. Edited sequences had to be at least 50 bp in length, and low-information sequences and repetitive elements such as dinucleotide repeats, Alu repeats, and the like, were replaced by “Ns”, or masked.

[0164] Edited sequences were subjected to assembly procedures in which the sequences were assigned to gene bins. Each sequence could only belong to one bin, and sequences in each bin were assembled to produce a template. Newly sequenced components were added to existing bins using BLAST and CROSSMATCH. To be added to a bin, the component sequences had to have a BLAST quality score greater than or equal to 150 and an alignment of at least 82% local identity. The sequences in each bin were assembled using PHRAP. Bins with several overlapping component sequences were assembled using DEEP PHRAP. The orientation of each template was determined based on the number and orientation of its component sequences.

[0165] Bins were compared to one another and those having local similarity of at least 82% were combined and reassembled. Bins having templates with less than 95% local identity were split. Templates were subjected to analysis by STITCHER/EXON MAPPER algorithms that analyze the probabilities of the presence of splice variants, alternatively spliced exons, splice junctions, differential expression of alternative spliced genes across tissue types or disease states, and the like. Assembly procedures were repeated periodically, and templates were annotated using BLAST against GenBank databases such as GBpri. An exact match was defined as having from 95% local identity over 200 base pairs through 100% local identity over 100 base pairs and a homolog match as having an E-value (or probability score) of ≦1×10−8. The templates were also subjected to frameshift FASTx against GENPEPT, and homolog match was defined as having an E-value of ≦1×10−8. Template analysis and assembly was described in U.S. Ser. No. 09/276,534, filed Mar. 25, 1999.

[0166] Following assembly, templates were subjected to BLAST, motif, and other functional analyses and categorized in protein hierarchies using methods described in U.S. Ser. No. 08/812,290 and U.S. Ser. No. 08/811,758, both filed Mar. 6, 1997; in U.S. Ser. No. 08/947,845, filed Oct. 9, 1997; and in U.S. Ser. No. 09/034,807, filed Mar. 4, 1998. Then templates were analyzed by translating each template in all three forward reading frames and searching each translation against the PFAM database of hidden Markov model-based protein families and domains using the HMMER software package (Washington University School of Medicine, St. Louis Mo.; http://pfam.wustl.edu/).

[0167] Templates were further analyzed using the bioinformatics tools described in the patents incorporated by reference herein, software applications such as MACDNASIS PRO software (Hitachi Software Engineering, South San Francisco Calif.) and LASERGENE software (DNASTAR), and queried against public databases such as the GenBank rodent, mammalian, vertebrate, prokaryote, and eukaryote databases, GenPept, SwissProt, BLOCKS, PRINTS, PFAM, and Prosite to acquire annotation.

[0168] The programs described above for the assembly and analysis of templates encoding electron transfer molecules were used to align the polynucleotides of the Sequence Listing with templates in LIFESEQ GOLD database (Incyte Pharmaceuticals). The templates that were annotated as electron transfer molecules provided the grouping and annotation of polynucleotides claimed herein as regulatory and coding sequences of a particular electron transfer molecule.

[0169] VII Chromosome Mapping

[0170] Radiation hybrid and genetic mapping data available from public resources such as the Stanford Human Genome Center (SHGC), Whitehead Institute for Genome Research (WIGR), and Genethon are used to determine if any of the polynucleotides presented in the Sequence Listing have been mapped. Any of the polynucleotides of a particular electron transfer molecule that have been mapped result in the assignment of all related regulatory and coding sequences of that electron transfer molecule mapping to the same location. The genetic map locations are described as ranges, or intervals, of human chromosomes. The map position of an interval, in centiMorgans (which is roughly equivalent to 1 megabase of human DNA), is measured relative to the terminus of the chromosome's p-arm.

[0171] VIII Hybridization Technologies and Analyses

Immobilization of Polynucleotides on a Substrate

[0172] Polynucleotides are applied to a substrate by one of the following methods. A mixture of polynucleotides is fractionated by gel electrophoresis and transferred to a nylon membrane by capillary transfer. Alternatively, the polynucleotides are individually ligated to a vector and inserted into bacterial host cells to form a library. The polynucleotides are then arranged on a substrate by one of the following methods. In the first method, bacterial cells containing individual clones are robotically picked and arranged on a nylon membrane. The membrane is placed on LB agar containing selective agent (carbenicillin, kanamycin, ampicillin, or chloramphenicol depending on the vector used) and incubated at 37° C. for 16 hr. The membrane is removed from the agar and consecutively placed colony side up in 10% SDS, denaturing solution (1.5 M NaCl, 0.5 M NaOH ), neutralizing solution (1.5 M NaCl, 1 M Tris, pH 8.0), and twice in 2×SSC for 10 min each. The membrane is then UV irradiated in a STRATALINKER UV-crosslinker (Stratagene).

[0173] In the second method, polynucleotides are amplified from bacterial vectors by thirty cycles of PCR using primers complementary to vector sequences flanking the insert. PCR amplification increases a starting concentration of 1-2 ng nucleic acid to a final quantity greater than 5 μg. Amplified nucleic acids from about 400 bp to about 5000 bp in length are purified using SEPHACRYL-400 beads (Amersham Pharmacia Biotech). Purified nucleic acids are arranged on a nylon membrane manually or using a dot/slot blotting manifold and suction device and are immobilized by denaturation, neutralization, and UV irradiation as described above. Purified nucleic acids are robotically arranged and immobilized on polymer-coated glass slides using the procedure described in U.S. Pat. No. 5,807,522. Polymer-coated slides are prepared by cleaning glass microscope slides (Corning, Acton Mass.) by ultrasound in 0.1% SDS and acetone, etching in 4% hydrofluoric acid (VWR Scientific Products, West Chester Pa.), coating with 0.05% aminopropyl silane (Sigma Aldrich) in 95% ethanol, and curing in a 110° C. oven. The slides are washed extensively with distilled water between and after treatments. The nucleic acids are arrayed onto the slide and then immobilized by exposing the array to UV irradiation using a STRATALINKERUV-crosslinker(Stratagene). Arrays are then washed at room temperature in 0.2% SDS and rinsed three times in distilled water. Non-specific binding sites are blocked by incubation of arrays in 0.2% casein in PBS (Tropix, Bedford Mass.) for 30 min at 60° C.; then the arrays are washed in 0.2% SDS and rinsed in distilled water as before.

Probe Preparation for Membrane Hybridization

[0174] Hybridization probes derived from the polynucleotides of the Sequence Listing are employed for screening cDNAs, mRNAs, or genomic DNA in membrane-based hybridizations. Probes are prepared by diluting the polynucleotides to a concentration of 40-50 ng in 45 μl TE buffer, denaturing by heating to 100° C. for five min, and briefly centrifuging. The denatured polynucleotide is then added to a REDIPRIME tube (Amersham Pharmacia Biotech), gently mixed until blue color is evenly distributed, and briefly centrifuged. Five microliters of [32P]dCTP is added to the tube, and the contents are incubated at 37° C. for 10 min. The labeling reaction is stopped by adding 5 μl of 0.2M EDTA, and probe is purified from unincorporated nucleotides using a PROBEQUANT G-50 microcolumn (Amersham Pharmacia Biotech). The purified probe is heated to 100° C. for five min, snap cooled for two min on ice, and used in membrane-based hybridizations as described below.

Probe Preparation for Polymer Coated Slide Hybridization

[0175] Hybridization probes derived from mRNA isolated from samples are employed for screening polynucleotides of the Sequence Listing in array-based hybridizations. Probe is prepared using the GEMbright kit (Incyte Pharmaceuticals) by diluting mRNA to a concentration of 200 ng in 9 μl TE buffer and adding 5 μl 5×buffer, 1 μl 0.1 M DTT, 3 μl Cy3 or Cy5 labeling mix, 1 μRNase inhibitor, 1 μl reverse transcriptase, and 5 μl 1×yeast control mRNAs. Yeast control mRNAs are synthesized by in vitro transcription from noncoding yeast genomic DNA (W. Lei, unpublished). As quantitative controls, one set of control mRNAs at 0.002 ng, 0.02 ng, 0.2 ng, and 2 ng are diluted into reverse transcription reaction mixture at ratios of 1:100,000, 1:10,000, 1:1000, and 1:100 (w/w) to sample mRNA respectively. To examine mRNA differential expression patterns, a second set of control mRNAs are diluted into reverse transcription reaction mixture at ratios of 1:3, 3:1, 1:10, 10:1, 1:25, and 25:1 (w/w). The reaction mixture is mixed and incubated at 37° C. for two hr. The reaction mixture is then incubated for 20 min at 85° C., and probes are purified using two successive CHROMA SPIN+TE 30 columns (Clontech). Purified probe is ethanol precipitated by diluting probe to 90 μl in DEPC-treated water, adding 2 μl 1 mg/ml glycogen, 60 μl 5 M sodium acetate, and 300 μl 100% ethanol. The probe is centrifuged for 20 min at 20,800×g, and the pellet is resuspended in 12 μl resuspension buffer, heated to 65° C. for five min, and mixed thoroughly. The probe is heated and mixed as before and then stored on ice. Probe is used in high density array-based hybridizations as described below.

Membrane-based Hybridization

[0176] Membranes are pre-hybridized in hybridization solution containing 1% Sarkosyl and 1×high phosphate buffer (0.5 M NaCl, 0.1 M Na2HPO4, 5 mM EDTA, pH 7) at 55° C. for two hr. The probe, diluted in 15 ml fresh hybridization solution, is then added to the membrane. The membrane is hybridized with the probe at 55° C. for 16 hr. Following hybridization, the membrane is washed for 15 min at 25° C. in 1 mM Tris (pH 8.0), 1% Sarkosyl, and four times for 15 min each at 25° C. in 1 mM Tris (pH 8.0). To detect hybridization complexes, XOMAT-AR film (Eastman Kodak, Rochester N.Y.) is exposed to the membrane overnight at −70° C., developed, and examined visually.

Polymer Coated Slide-based Hybridization

[0177] Probe is heated to 65° C. for five min, centrifuged five min at 9400 rpm in a 5415C microcentrifuge (Eppendorf Scientific, Westbury N.Y.), and then 18 μl is aliquoted onto the array surface and covered with a coverslip. The arrays are transferred to a waterproof chamber having a cavity just slightly larger than a microscope slide. The chamber is kept at 100% humidity internally by the addition of 140 μl of 5×SSC in a corner of the chamber. The chamber containing the arrays is incubated for about 6.5 hr at 60° C. The arrays are washed for 10 min at 45° C. in 1×SSC, 0.1% SDS, and three times for 10 min each at 45° C. in 0.1×SSC, and dried.

[0178] Hybridization reactions are performed in absolute or differential hybridization formats. In the absolute hybridization format, probe from one sample is hybridized to array elements, and signals are detected after hybridization complexes form. Signal strength correlates with probe mRNA levels in the sample. In the differential hybridization format, differential expression of a set of genes in two biological samples is analyzed. Probes from the two samples are prepared and labeled with different labeling moieties. A mixture of the two labeled probes is hybridized to the array elements, and signals are examined under conditions in which the emissions from the two different labels are individually detectable. Elements on the array that are hybridized to substantially equal numbers of probes derived from both biological samples give a distinct combined fluorescence (Shalon WO95/35505).

[0179] Hybridization complexes are detected with a microscope equipped with an Innova 70 mixed gas 10 W laser (Coherent, Santa Clara Calif.) capable of generating spectral lines at 488 nm for excitation of Cy3 and at 632 nm for excitation of Cy5. The excitation laser light is focused on the array using a 20×microscope objective (Nikon, Melville N.Y.). The slide containing the array is placed on a computer-controlled X-Y stage on the microscope and raster-scanned past the objective with a resolution of 20 micrometers. In the differential hybridization format, the two fluorophores are sequentially excited by the laser. Emitted light is split, based on wavelength, into two photomultiplier tube detectors (PMT R1477, Hamamatsu Photonics Systems, Bridgewater N.J.) corresponding to the two fluorophores. Appropriate filters positioned between the array and the photomultiplier tubes are used to filter the signals. The emission maxima of the fluorophores used are 565 nm for Cy3 and 650 nm for Cy5. The sensitivity of the scans is calibrated using the signal intensity generated by the yeast control mRNAs added to the probe mix. A specific location on the array contains a complementary DNA sequence, allowing the intensity of the signal at that location to be correlated with a weight ratio of hybridizing species of 1:100,000.

[0180] The output of the photomultiplier tube is digitized using a 12-bit RTI-835H analog-to-digital (A/D) conversion board (Analog Devices, Norwood Mass.) installed in an IBM-compatible PC computer. The digitized data are displayed as an image where the signal intensity is mapped using a linear 20-color transformation to a pseudocolor scale ranging from blue (low signal) to red (high signal). The data is also analyzed quantitatively. Where two different fluorophores are excited and measured simultaneously, the data are first corrected for optical crosstalk (due to overlapping emission spectra) between the fluorophores using each fluorophore's emission spectrum. A grid is superimposed over the fluorescence signal image such that the signal from each spot is centered in each element of the grid. The fluorescence signal within each element is then integrated to obtain a numerical value corresponding to the average intensity of the signal. The software used for signal analysis is the GEMTOOLS program (Incyte Pharmaceuticals).

[0181] IX Complementary Polynucleotides

[0182] Molecules complementary to the polynucleotide, or a fragment thereof, are used to detect, decrease, or inhibit gene expression. Although use of oligonucleotides comprising from about 15 to about 30 base pairs is described, the same procedure is used with larger or smaller fragments or their derivatives (e.g., PNAs). Appropriate oligonucleotides are selected using OLIGO 4.06 software (National Biosciences). To inhibit transcription by preventing promoter binding, a complementary oligonucleotide is designed to bind to the most unique 5′ sequence, most preferably about 10 nucleotides before the initiation codon of the open reading frame. To inhibit translation, a complementary oligonucleotide is designed to prevent ribosomal binding to the mRNA encoding the mammalian polypeptide.

[0183] In addition to using antisense molecules constructed to interrupt transcription or translation, modifications of gene expression can be obtained by designing antisense molecules to genomic sequences (such as enhancers or introns) or even to trans-acting regulatory genes. Similarly, antisense inhibition can be achieved using Hogeboom base-pairing methodology, also known as “triple helix” base pairing. Antisense molecules involved in triple helix pairing compromise the ability of the double helix to open sufficiently for the binding of polymerases, transcription factors, or regulatory molecules.

[0184] Such antisense molecules are placed in expression vectors and used to transform preferred cells or tissues. This may include introduction of the expression vector into a cell line to test efficacy; into an organ, tumor, synovial cavity, or the vascular system for transient or short term therapy; or into a stem cell or other reproducing lineage for long term or stable gene therapy. Transient expression may last for a month or more with a non-replicating vector and for three months or more if appropriate elements for inducing vector replication are used in the transformation/expression system.

[0185] Stable transformation of appropriate dividing cells with a vector encoding the antisense molecule can produce a transgenic cell line, tissue, or organism (U.S. Pat. No. 4,736,866). Those cells that assimilate and replicate sufficient quantities of the vector to allow stable integration also produce enough antisense molecules to compromise or entirely eliminate activity of the polynucleotide.

[0186] X Expression of the Mammalian Polypeptide

[0187] Expression and purification of the mammalian polypeptide are achieved using bacterial or virus-based expression systems. For expression in bacteria, cDNA is subcloned into a vector containing an antibiotic resistance gene and an inducible tac hybrid promoter in conjunction with the lac operator regulatory element that directs high levels of cDNA transcription. The recombinant vector is transformed into a BL21(DE3) bacterial host. Antibiotic resistant bacteria are induced with IPTG and express the mammalian polypeptide. Expression in eukaryotic cells is achieved by infecting Spodoptera frugiperda (Sf9) insect cells with recombinant baculovirus, Autographica californica nuclear polyhedrosis virus. The baculovirus polyhedrin gene is replaced with the mammalian cDNA by homologous recombination. The insect cells are infected with the virus, and the polyhedrin promoter drives high levels of expression.

[0188] For ease of purification, the mammalian polypeptide is synthesized as a fusion protein with glutathione-S-transferase (GST; Amersham Pharmacia Biotech) or a similar alternative such as FLAG. The fusion protein is purified on immobilized glutathione under conditions that maintain protein activity and antigenicity. After purification, the GST moiety is proteolytically cleaved from the mammalian polypeptide with thrombin. A fusion protein with FLAG, an 8-amino acid peptide, is purified using commercially available monoclonal and polyclonal anti-FLAG antibodies (Eastman Kodak, Rochester N.Y.).

[0189] XI Production of Antibodies

[0190] A denatured mammalian polypeptide from a reverse phase HPLC separation is obtained in quantities up to 75 mg. This denatured polypeptide is used to immunize mice or rabbits following standard protocols. About 100 μg is used to immunize a mouse, while up to 1 mg is used to immunize a rabbit. The denatured polypeptide is radioiodinated and incubated with murine B-cell hybridomas to screen for monoclonal antibodies. About 20 mg of polypeptide is sufficient for labeling and screening several thousand clones.

[0191] In another approach, the amino acid sequence translated from a polynucleotide of the invention is analyzed using PROTEAN software (DNASTAR) to determine regions of high immunogenicity. The optimal sequences for immunization are usually at the C-terminus, the N-terminus, and those intervening, hydrophilic regions of the polypeptide that are likely to be exposed to the external environment when the polypeptide is in its natural conformation. Typically, oligopeptides about 15 residues in length are synthesized using an ABI 431 Peptide synthesizer (PE Biosystems) using Fmoc-chemistry and then coupled to keyhole limpet hemocyanin (KLH; Sigma Aldrich) by reaction with M-maleimidobenzoyl-N-hydroxysuccinimide ester. If necessary, a cysteine may be introduced at the N-terminus of the peptide to permit coupling to KLH. Rabbits are immunized with the oligopeptide-KLH complex in complete Freund's adjuvant. The resulting antisera are tested for antipeptide activity by binding the peptide to plastic, blocking with 1% BSA, reacting with rabbit antisera, washing, and reacting with radioiodinated goat anti-rabbit IgG.

[0192] Hybridomas are prepared and screened using standard techniques. Hybridomas of interest are detected by screening with radioiodinated polypeptide to identify those fusions producing a particular electron transfer molecule-specific monoclonal antibody. In a typical protocol, wells of 96 well plates (FAST, Becton-Dickinson, Palo Alto Calif.) are coated with affinity-purified, specific rabbit-anti-mouse (or suitable anti-species Ig) antibodies at 10 mg/ml. The coated wells are blocked with 1% BSA and washed and exposed to supernatants from hybridomas. After incubation, the wells are exposed to radiolabeled polypeptide at 1 mg/ml. Clones producing antibodies bind a quantity of labeled polypeptide that is detectable above background.

[0193] Such clones are expanded and subjected to 2 cycles of cloning at 1 cell/3 wells. Cloned hybridomas are injected into pristane-treated mice to produce ascites, and monoclonal antibody is purified from the ascitic fluid by affinity chromatography on protein A (Amersham Pharmacia Biotech). Monoclonal antibodies with affinities of at least 108 M−1, preferably 109 to 1010 M−1 or stronger, are made by procedures well known in the art.

[0194] XII Purification of Polypeptide Using Specific Antibodies

[0195] Naturally occurring or recombinant mammalian polypeptide is substantially purified by immunoaffinity chromatography using antibodies specific for the polypeptide. An immunoaffinity column is constructed by covalently coupling the antibody to CNBr-activated SEPHAROSE resin (Amersham Pharmacia Biotech). Media containing the polypeptide is passed over the immunoaffinity column, and the column is washed using high ionic strength buffers in the presence of detergent to allow preferential absorbance of the polypeptide. After coupling, the polypeptide is eluted from the column using a buffer of pH 2-3 or a high concentration of urea or thiocyanate ion to disrupt antibody/polypeptide binding, and the polypeptide is collected.

[0196] XIII Screening Molecules or Compounds for Specific Binding

[0197] The polynucleotide, or fragments thereof, or the polypeptide, or portions thereof, are labeled with 32P-dCTP, Cy3-dCTP, or Cy5-dCTP (Amersham Pharmacia Biotech), or with BIODIPY or FITC (Molecular Probes), respectively. A library or a plurality of candidate molecules or compounds previously arranged on a substrate are incubated in the presence of labeled polynucleotide or polypeptide. After incubation under conditions for a polynucleotide or polypeptide, the substrate is washed. Any position on the substrate retaining label, that indicates specific binding or complex formation, identifies a ligand. Data obtained using different concentrations of the polynucleotide or polypeptide are used to calculate affinity between the labeled polynucleotide or polypeptide and the bound ligand.

[0198] XIV Two-Hybrid Screen

[0199] A yeast two-hybrid system, MATCHMAKER LexA Two-Hybrid system (Clontech Laboratories, Palo Alto Calif.), is used to screen for peptides that bind the mammalian polypeptide of the invention. A polynucleotide encoding the polypeptide is inserted into the multiple cloning site of a pLexA vector, ligated, and transformed into E. coli. cDNA, prepared from mRNA, is inserted into the multiple cloning site of a pB42AD vector, ligated, and transformed into E. coli to construct a cDNA library. The pLexA plasmid and pB42AD-cDNA library constructs are isolated from E. coli and used in a 2:1 ratio to co-transform competent yeast EGY48 [p8op-lacZ] cells using a polyethylene glycol/lithium acetate protocol. Transformed yeast cells are plated on synthetic dropout (SD) media lacking histidine (-His), tryptophan (-Trp), and uracil (-Ura), and incubated at 30° C. until the colonies have grown up and can be counted. The colonies are pooled in a minimal volume of 1×TE (pH 7.5), replated on SD/-His/-Leu/-Trp/-Ura media supplemented with 2% galactose (Gal), 1% raffinose (Raf), and 80 mg/ml 5-bromo-4-chloro-3-indolyl β-galactopyranoside (X-Gal), and subsequently examined for growth of blue colonies. Interaction between expressed polypeptide and cDNA fusion proteins activates expression of a LEU2 reporter gene in EGY48 and produces colony growth on media lacking leucine (−Leu). Interaction also activates expression of β-galactosidase from the p8op-lacZ reporter construct that produces blue color in colonies grown on X-Gal.

[0200] Positive interactions between expressed polypeptide and cDNA fusion proteins are verified by isolating individual positive colonies and growing them in SD/-Trp/-Ura liquid medium for 1 to 2 days at 30° C. A sample of the culture is plated on SD/-Trp/-Ura media and incubated at 30° C. until colonies appear. The sample is replica-plated on SD/-Trp/-Ura and SD/-His/-Trp/-Ura plates. Colonies that grow on SD containing histidine but not on media lacking histidine have lost the pLexA plasmid. Histidine-requiring colonies are grown on SD/Gal/Raf/X-Gal/-Trp/-Ura, and white colonies are isolated and propagated. The pB42AD-cDNA plasmid, which contains a polynucleotide encoding a protein that physically interacts with the mammalian polypeptide, can be isolated from the yeast cells and characterized.

[0201] XV Gene Transcript Analysis

[0202] The abundance sort program of the invention described in U.S. Pat. No. 5,840,484, tabulates and sorts by frequency the mRNA transcripts corresponding to each gene identified in a database. The process for obtaining this final data set, the profile of gene activity or transcript image, is referred to as “gene transcript analysis”.

[0203] A transcript analysis summarizes the presence and abundance of exact, unique, and homologous transcripts that are tissue specific. Such a collection of transcripts can help distinguish between normal tissue and that biopsied from a subject displaying a particular disorder. Comparison of these profiles identify polynucleotides that are not active, minimally active, or overactive. The RNA or expressed polypeptide is a candidate for intervention in the disease process. Where polynucleotide expression was absent, a therapeutic supplying the missing molecule would be preferred. In cases of underexpression, the polynucleotide or its product (mRNA or polypeptide) could also be supplied exogenously. Where a polynucleotide was overexpressed, antisense or inhibiting molecules or compounds are deemed appropriate. During or following treatment, observation of desired phenotypic changes and transcript images help determine whether therapeutic intervention is restoring or has restored the normal profile.

[0204] XVI Functional Assays

[0205] The activity of an electron transfer molecule is generally determined by measuring the change in the spectral absorbance of the prosthetic group of the molecule at a wavelength characteristic of its conversion between an oxidized and a reduced state in the presence of a suitable oxidoreductase enzyme and a secondary electron donor/acceptor, such as NAD+/NADH. The reduction of cytochrome b5 in the presence of NADH and NADH:cytochrome b5 reductase is presented as an example. Cytochrome b5 and NADH:cytochrome b5 reductase are incubated together in a suitable buffer, and the reaction is initiated by addition of NADH. The reaction is carried out in a glass cuvette incubated at 30-37° C. and is monitored over a period of time in a visible spectrophotometer at 565 nm. The rate of change in absorption measured at this wavelength is due to the reduction of the heme group in cytochrome b5 and is proportional to the activity of cytochrome b5 present.

[0206] All patents and publications mentioned in the specification are herein incorporated by reference. Various modifications and variations of the described method and system of the invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the described modes for carrying out the invention that are obvious to those skilled in the field of molecular biology or related fields are intended to be within the scope of the following claims.

1TABLE 1SEQ IDINCYTE IDNONOCLONETEMPLATELIBRARYFILING HISTORY (DOCKET NO;SEQ ID NO;FILING DATE)1hu010319825564221LG:350517.1BRSTDIT012hu007134712266979IB:076637.1UTRSNOT02PD-0288-P,575,12/18/1996|PD-0288-US,575,12/16/19973hu011700466422174LG:240805.4BRSTUNT014hu011800736413044LG:240805.4UTREDIT105hu012017636180012LG:240805.4BMARUNT026hu013229505884355LG:240805.4LIVRNON087hu013307296325092LG:240805.4LUNGDIN028hu009833066377218LG:240805.4FIBAUNT019hu012394285886010LG:240805.4LIVRNON0810hu011855636421181LG:240805.4BRSTUNT0111hu013138676479549LG:240805.4PROSTMC0112hu011404065949878LG:240805.4LIVRTUN0413hu012283885656380LG:240805.4BSCNNOT0314hu009817276325013LG:240805.4LUNGDIN0215hu011865676358853LG:240805.4CONFNOT0916hu011227325844535LG:240805.4BRAENOT0417hu010124365994013LG:244681.1FTUBTUT0218hu010026776419669LG:037054.7BRSTUNT0119hu009788333549771LG:234480.6BRONDIT0120hu012845996030694LG:234480.6BRAHNON0521hu010869794519787LG:234480.6SINJNOT0322hu010320836111313LG:234480.6MCLDTXT0323hu012105474437887LG:234480.6SINTNOT2224hu011230955911025LG:234480.6BRAIFEN0525hu013290436152806LG:234480.6ENDMUNT0426hu011168056119359LG:234480.6BRAHNON0527hu011029915714759LG:234480.6MASTTXT0128hu010136496099952LG:234480.6UTRENOT0929hu012433836209977LG:234480.6ARTANOT0630hu012933063153065LG:234480.6TLYMTXT0231hu011049194437787LG:234480.6SINTNOT2232hu013294334442819LG:234480.6SINTNOT2233hu009860136378670LG:234480.6FIBAUNT0134hu010783356015470LG:234480.6FIBRUNT0235hu010349934517716LG:234480.6SINJNOT0336hu013325796383466LG:234480.6FIBRUNT0237hu012676546495789LG:234480.6COLNNOT4138hu011753595811756LG:234480.6KIDCTMT0239hu011939833901675LG:234480.6LUNGNON0340hu00755546523345IB:779812.1MMLR2DT01PD-0044-P,2538,10/02/1995|PD-0044-US,2538,10/02/199641hu006685972024316IB:816379.1KERANOT02PD-0260-P,104,10/25/1996|PD-0116-1-US,1526,10/24/199742hu008999522663830IB:816379.1ADRENOT08PD-0317-P,1069,02/11/1997|PD-0317-US,1069,02/10/199843hu005041012069960IB:816379.1ISLTNOT01PD-0259-P,373,10/28/1996|PD-0259-US,373,10/28/199744hu000905022850044IB:816379.1BRSTTUT13PD-0336-P,806,03/18/199745hu009021402484903IB:816379.1BONRTUT01PD-0303-P,1777,01/27/199746hu005031711493337IB:816379.1PROSNON01PD-0198-P,493,07/29/1996|PD-0198-US,5100,07/28/199747hu00046235664658IB:816379.1SCORNOT01PD-0094-P,461,12/14/1995|PD-0094-US,461,12/12/199648hu00007392386476IB:816379.1THYMNOT02PD-0041-P,2075,09/26/1995|PD-0077-P,2075,10/02/1995|PD-0077-US,2075,10/02/199649hu00381091488003IB:816379.1HNT2AGT0150hu005624602634306IB:816379.1COLNTUT15PD-0305-P,1665,01/22/1997|PD-0305-US,1665,01/22/199851hu000391912318093IB:816379.1OVARNOT02PD-0045-1-US,2387,11/10/1997|PD-0293-P,560,12/13/199652hu00605418611497IB:816379.1COLNNOT01PD-0059-P,1003,11/10/1995|PD-0059-US,1003,11/08/199653hu00725335873135IB:816379.1LUNGAST01PD-0120-US,390,02/28/1997|PD-0124-P,390,03/13/199654hu006516532367584IB:816379.1ADRENOT07PD-0301-P,1460,12/19/1996|PD-0301-US,1460,12/17/199755hu0091661357744IB:816379.1PD-0009-US,257,07/08/199456hu00814652621001IB:816379.1PGANNOT01PD-0062-P,1272,11/22/1995|PD-0062-US,1272,11/22/199657hu001638081260150IB:816379.1MENITUT03PD-0147-P,2094,04/17/1996|PD-0147-US,2094,04/17/199758hu006874202365110IB:816379.1ADRENOT07PD-0301-P,592,12/19/1996|PD-0301-US,592,12/17/199759hu002389602364628IB:816379.1ADRENOT07PD-0301-P,415,12/19/1996|PD-0301-US,415,12/17/199760hu007763512869942IB:816379.1THYRNOT10PD-0395-P,704,07/02/1997|PD-0395-US,704,06/23/199861hu008832442858353IB:816379.1SININOT03PD-0343-P,92,03/25/1997|PD-0343-US,92,03/25/199862hu008165463034616IB:816379.1TLYMNOT05PD-0364-P,1406,05/02/1997|PD-0364-US,1406,04/30/199863hu00861826621158IB:816379.1PGANNOT01PD-0062-P,1340,11/22/1995|PD-0062-US,1340,11/22/199664hu001877182632061IB:816379.1COLNTUT15PD-0305-P,854,01/22/1997|PD-0305-US,854,01/22/199865hu00681549640040IB:816379.1BRSTNOT03PD-0061-US,946,11/15/1996|PD-0065-P,946,11/28/199566hu003395862841649IB:816379.1DRGLNOT01PD-0337-P,1803,03/18/1997|PD-0337-US,1803,03/05/199867hu010222986057485LG:171764.2BRAENOT0468hu011220084125481LG:234480.7BRSTTUT2669hu002287302965517IB:815588.1SCORNOT04PD-0360-P,968,04/24/1997|PD-0360-US,968,04/23/199870hu012590666208681LG:234480.8ARTANOT0671hu012719396075669LG:234480.8UTREDIT0972hu011446696566164LG:955064.1MCLDTXT0473hu013124546271522LG:956415.1BRAIFEN0374hu009868235560063LG:214288.6BRSTDIT0175hu012071335561495LG:214288.6BRSTDIT0176hu010605256433941LG:214288.6LUNGNON0777hu011087306456026LG:214288.6COLNDIC0178hu010940064121704LG:214288.6BRSTTUT2579hu010557026137123LG:214288.6BMARTXT0280hu012005495656338LG:214288.6BSCNNOT0381hu012562536137155LG:214288.6BMARTXT0282hu010293825943751LG:214288.6COLADIT0583hu010090786380182LG:214288.6FIBRUNT0284hu013215956409908LG:214288.6UTREDIT1085hu011646095697069LG:214288.6BRSTTUT1386hu012536743567727LG:214288.6BRONNOT0287hu011693536507225LG:214288.6BRAHNOT0288hu012068856389422LG:214288.6MIXDUNB0189hu013485825810417LG:214288.6KIDCTMT0290hu013389346522760LG:214288.6CONFTDT0291hu011644795646107LG:214288.6BRAITUT2392hu012879616397064LG:214288.6UTRENOT1093hu012360085943406LG:348773.1COLADIT0594rat00086191700294566ZS:210500.2RABFNOT02PZ-0013-P,872,08/08/1997|PZ-0013-US,872,08/07/199895rat00096533700309980ZS:210500.2RASDNOT02PZ-0028-P,1049,09/08/1997|PZ-0027-US,2303,09/08/199896rat00191537700933938ZS:210500.2RALINON03PZ-0075-P,1526,03/10/1998|PZ-0075-US,2466,03/09/199997rat00075375701904240ZS:210500.2RABYUNS09PZ-0131-P,4285,06/29/199998rat00219672701231886ZS:210500.2RASJNON03PZ-0098-P,1420,11/12/199899rat00223885700127612ZS:210500.2RABHNOT01PZ-0004-P,2491,07/09/1997|PZ-0004-US,2491,07/09/1998100rat00247348701828746ZS:210500.2RAKITXT09PZ-0132-P,973,08/10/1999101rat00069166701339683ZS:210500.2RALITXT08PZ-0092-P,1343,08/13/1998102rat00038669701439922ZS:210500.2RALINON08PZ-0113-P,2219,04/07/1999103rat00205020700483806ZS:210500.2RALINON03PZ-0059-P,1650,01/16/1998|PZ-0059-US,1650,01/12/1999104rat00000073700933808ZS:210500.2RALINON03PZ-0075-P,1477,03/10/1998|PZ-0075-US,2417,03/09/1999105rat00221180700635387ZS:210500.2RATONOT01PZ-0036-US,145,10/09/1998106rat00008019701186639ZS:210500.2RACONON02PZ-0085-P,177,06/11/1998107rat00033426700067896ZS:210500.2RABTNOT01PZ-0001-P,1401,06/12/1997|PZ-0001-US,1401,06/08/1998108rat00131752701654036ZS:210500.2RALITXT10PZ-0117-P,1385,05/07/1999109rat00230675701616311ZS:210500.2RALITXT61PZ-0127-P,156,07/07/1999110rat00056283700123547ZS:210500.2RABHNOT01PZ-0004-P,721,07/09/1997|PZ-0004-US,721,07/09/1998111rat00144276701727660ZS:210500.2RALITXT1APZ-0122-P,257,06/03/1999112hu013379475996159LG:999424.1FTUBTUT02113hu013100323786708LG:999424.1BRAHNOT05114hu009879484438637LG:999262.1SINTNOT22115hu012162373020423LG:999262.1PROSDIN01116hu010327204122257LG:999262.1BRSTTUT25117hu011191075479570LG:899715.1FIBPFEN06118hu013470505479760LG:899715.1FIBPFEN06119hu013433615479960LG:899715.1FIBPFEN06120hu011046465480114LG:899715.1FIBPFEN06121hu011793895473892LG:899715.1FIBPFEN06122hu009697725474141LG:899715.1FIBPFEN06123hu009947475475667LG:899715.1FIBPFEN06124hu012093765475060LG:899715.1FIBPFEN06125hu013300165481168LG:899715.1FIBPFEN06126hu011758815480121LG:899715.1FIBPFEN06127hu012649275477881LG:899715.1FIBPFEN06128hu011214705476185LG:899715.1FIBPFEN06129hu009960375474878LG:899715.1FIBPFEN06130hu010523255476523LG:899715.1FIBPFEN06131hu011375596597357LG:999424.4ARTANOT06132hu010920656597429LG:999424.4ARTANOT06133hu013236363787304LG:999424.4BRAHNOT05134hu010607286597257LG:999424.4ARTANOT06135hu012688366118845LG:999424.4BRAHNON05136hu012224736298190LG:230151.1UTREDIT07137hu012369946138222LG:230151.1BMARTXT03138hu003084701849578IB:234480.2LUNGFET03PD-0230-P,450,08/23/1996|PD-0230-US,450,08/22/1997139hu00267375661163IB:234480.2BRAINOT03PD-0088-P,1425,11/29/1995|PD-0088-US,3170,11/27/1996140hu004730302101509IB:234480.2BRAITUT02PD-0111-1-US,5693,12/05/1997|PD-0275-P,6153,12/06/1996141hu001734752923187IB:234480.3SININOT04PD-0344-P,810,03/17/1997|PD-0344-US,810,03/16/1998142hu008490202052778IB:234480.3LIVRFET02PD-0262-P,1216,10/31/1996143hu001680092347967IB:234480.3COLSUCT01PD-0278-P,56,12/05/1996|PD-0278-US,56,11/21/1997144hu00580866892747IB:234480.3STOMTUT01PD-0127-P,1131,03/08/1996145hu00927748154668IB:240805.5THP1PLB02146hu004030052473237IB:240805.5THP1NOT03PD-0286-P,1246,11/25/1996|PD-0286-US,1246,11/04/1997147hu008697782173121IB:240805.5ENDCNOT03PD-0279-P,1788,11/22/1996|PD-0279-US,1788,11/07/1997148hu000636072048670IB:240805.5LIVRFET02PD-0262-P,158,10/31/1996149hu002039091289023IB:240805.5BRAINOT11PD-0156-P,985,04/25/1996|PD-0156-US,985,04/25/1997150hu004524721997754IB:240805.5BRSTTUT03PD-0241-P,1221,10/01/1997|PD-0143-1-US,5251,10/01/1997151hu0083118355605IB:240805.5PD-0008-US,1564,06/27/1994152hu003720842293016IB:240805.5BRAINON01PD-0274-P,5097,11/20/1996153hu007963201888743IB:240805.5BLADTUT07PD-0238-P,1903,09/24/1996|PD-0238-US,1903,09/23/1997154hu006138271700085IB:240805.5BLADTUT05PD-0202-P,1281,07/31/1996|PD-0221-US,874,07/31/1997155hu006531842246684IB:240805.5HIPONON02PD-0258-P,3714,03/05/1997|PD-0258-US,3714,02/27/1998156hu005335581243521IB:240805.5LUNGNOT03PD-0158-P,929,04/22/1996157hu005780461682120IB:240805.5PROSNOT15PD-0200-P,11,07/24/1996|PD-0200-US,11,07/24/1997158hu00482792519530IB:240805.5MMLR2DT01PD-0044-P,1486,10/02/1995|PD-0044-US,1486,10/02/1996159hu00471785674959IB:240805.5CRBLNOT01PD-0089-US,2305,11/27/1996|PD-0093-P,609,12/18/1995160hu003358772246604IB:240805.5HIPONON02PD-0258-P,3670,03/05/1997|PD-0258-US,3670,02/27/1998161hu005275951450183IB:240805.5PLACNOT02PD-0193-P,1110,06/27/1996|PD-0167-US,2470,05/29/1997162hu00875185676179IB:240805.5CRBLNOT01PD-0093-P,1034,12/18/1995|PD-0089-US,2730,11/27/1996163hu009121101603276IB:240805.5LUNGNOT15PD-0208-P,2989,07/24/1996|PD-0208-US,2989,07/23/1997164hu00026601735309IB:240805.5TONSNOT01PD-0100-P,511,01/05/1996|PD-0100-US,511,01/03/1997165hu001032481853346IB:240805.5LUNGFET03PD-0230-P,1981,08/23/1996|PD-0230-US,1981,08/22/1997166hu006316111728347IB:240805.5PROSNOT14PD-0201-P,1827,07/29/1996|PD-0201-US,1827,07/28/1997|PD-0210P,1827,07/24/1996167hu004016752347508IB:240805.5TESTTUT02PD-0285-P,1544,11/21/1996|PD-0164-US,3026,05/15/1997168hu00676022770596IB:240805.5COLNCRT01PD-0110-US,1685,01/30/1997|PD-0110-P,340,01/30/1996169hu00950091269698IB:240805.5HNT2NOT01PD-0038-P,1027,06/16/1995170hu007807122345639IB:240805.5TESTTUT02PD-0164-US,2438,05/15/1997|PD-0285-P,956,11/21/1996171hu003926142313282IB:240805.5NGANNOT01PD-0297-P,2873,12/18/1996|PD-0297-US,2873,12/17/1997172hu00407933536888IB:240805.5LNODNOT02PD-0060-P,131,10/30/1995173hu00759320579434IB:240805.5BRAVTXT05PR-0003-US,1863,11/13/1996|PR-0004-P,1863,12/15/1995174hu00709083809810IB:240805.5LUNGNOT04PD-0121-P,360,02/29/1996|PD-0121-US,360,02/28/1997175hu008482242903460IB:240805.5DRGCNOT01PD-0337-US,6086,03/05/1998176hu00703783980041IB:240805.5TONGTUT01PD-0145-P,169,04/15/1996|PD-0145-US,169,04/15/1997177hu00805276158997IB:240805.5ADENINB01PD-0033-1-US,290,07/13/1995178hu009217823468653IB:240805.5BRAIDIT01PD-0384-P,972,06/06/1997|PD-0384-US,972,06/04/1998179hu003354872497291IB:240805.5ADRETUT05PD-0318-P,1870,02/11/1997|PD-0318-US,1870,02/09/1998180hu00549507820929IB:240805.5KERANOT02PD-0116-1-US,713,10/24/1997|PD-0116-P,713,02/26/1996|PD-0116-US,713,02/26/1997181hu00888223767530IB:240805.5LUNGNOT04PD-0140-P,1354,04/10/1996|PD-0121-US,2801,02/28/1997182hu00224887855022IB:240805.5NGANNOT01PD-0123-US,1166,02/28/1997|PD-0125-P,1166,03/07/1996183hu0093574432873IB:240805.5THP1NOB01PD-0001-3-US,6764,02/14/1994|PD-0001-4-US,6934,07/28/1994184hu00861918911244IB:240805.5STOMNOT02PD-0155-P,504,04/26/1996|PD-0155-US,504,04/25/1997185hu005349751913132IB:240805.5PROSTUT04PD-0197-US,3473,06/23/1997|PD-0232-P,905,09/05/1996186hu00031360772404IB:240805.5COLNCRT01PD-0110-US,2014,01/30/1997|PD-0110-P,669,01/30/1996187hu002815013115741IB:240805.5LUNGTUT13PD-0358-P,1952,04/18/1997|PD-0358-US,1952,04/17/1998188hu001281071750586IB:240805.5STOMTUT02PD-0235-P,1383,08/30/1996189hu002720722259695IB:240805.5OVARTUT01PD-0283-P,3754,11/21/1996|PD-0112-1-US,5614,11/14/1997190hu006511072913628IB:240805.5KIDNTUT15191hu00930901270440IB:240805.5HNT2NOT01PD-0038-P,1258,06/16/1995192hu002717062510064IB:240805.5CONUTUT01PD-0300-P,3179,12/20/1996|PD-0300-US,3179,12/18/1997193hu000089161611520IB:240805.5COLNTUT06PD-0206-P,3505,08/01/1996|PD-0206-US,3505,08/01/1997194hu0040592530512IB:240805.5THP1NOB01PD-0001-3-US,5057,02/14/1994|PD-0001-4-US,5227,07/28/1994195hu002839221557831IB:240805.5BLADTUT04PD-0203-P,4507,08/01/1996|PD-0203-US,4507,08/01/1997196hu00394641481021IB:240805.5LIVRBCT01PD-0079-P,188,10/04/1995|PD-0079-US,188,10/04/1996197hu007412982116071IB:240805.5BRSTTUT02PD-0255-P,219,10/23/1996198hu00509990989350IB:240805.5LVENNOT03PD-0134-P,1564,03/21/1996|PD-0134-US,1564,03/21/1997199hu003919751806228IB:240805.5SINTNOT13PD-0234-P,912,08/28/1996200hu00681668882564IB:240805.5THYRNOT02PD-0122-P,1602,02/29/1996|PD-0122-US,1602,02/28/1997201hu001576992379423IB:240805.5ISLTNOT01PD-0294-P,1550,12/20/1996|PD-0259-US,4650,10/28/1997202hu00240223994052IB:240805.5COLNNOT11PD-0129-P,2380,03/19/1996|PD-0129-US,2380,03/18/1997203hu00842100880888IB:240805.5THYRNOT02PD-0122-P,954,02/29/1996|PD-0122-US,954,02/28/1997204hu00533420764170IB:240805.5LUNGNOT04PD-0140-P,156,04/10/1996|PD-0121-US,1603,02/28/1997205hu002115561564580IB:240805.5HEALDIT02PR-0007-P,317,06/26/1996|PR-0007-US,317,06/25/1997206hu003917002170220IB:240805.5ENDCNOT03PD-0279-P,459,11/22/1996|PD-0279-US,459,11/07/1997207hu006223611898981IB:240805.5BLADTUT06PD-0238-P,32,09/24/1996|PD-0238-US,32,09/23/1997208hu006291112262145IB:240805.5UTRSNOT02PD-0288-P,2429,12/18/1996|PD-0288-US,2429,12/16/1997209hu007570041290739IB:240805.5BRAINOT11PD-0156-P,1694,04/25/1996|PD-0156-US,1694,04/25/1997210hu00382550692787IB:240805.5LUNGTUT02PD-0097-P,1386,12/20/1995|PD-0097-US,1386,12/20/1996211hu005160561650650IB:240805.5PROSTUT09PD-0199-P,3877,07/30/1996212hu0026830456716IB:240805.5PD-0008-US,2105,06/27/1994213hu008782001856963IB:240805.5PROSNOT18PD-0233-P,443,09/05/1996|PD-0233-US,443,09/05/1997214hu002352763028959IB:240805.5HEARFET02PD-0353-P,1179,04/18/1997|PD-0353-US,1179,03/17/1998215hu006527611580413IB:240805.5DUODNOT01PD-0207-P,711,07/29/1996|PD-0207-US,711,07/29/1997216hu00008766508309IB:240805.5TMLR3DT02PD-0081-P,1795,10/25/1995|PD-0081-US,1795,10/24/1996217hu000767452695558IB:240805.5UTRSNOT12PD-0346-US,4896,03/27/1998|PD-0346-P,618,03/27/1997218hu001777081661051IB:240805.5URETTUT01PD-0216-P,1454,07/31/1996|PD-0216-US,1454,07/30/1997219hu00588913693014IB:240805.5LUNGTUT02PD-0097-P,1459,12/20/1995|PD-0097-US,1459,12/20/1996220hu010700246413730LG:232035.2UTREDIT10221hu001734053927591IB:234480.4KIDNNOT19222hu00039514219065IB:234480.4STOMNOT01PD-0022-US,2887,02/07/1995223hu00026942217054IB:234480.4STOMNOT01PD-0022-US,1753,02/07/1995224hu00187054215070IB:234480.4STOMNOT01PD-0022-US,644,02/07/1995225hu00854314219390IB:234480.4STOMNOT01PD-0022-US,3122,02/07/1995226hu00885122218904IB:234480.4STOMNOT01PD-0022-US,2751,02/07/1995227hu0021735977197IB:234480.4SYNORAB01PD-0012-US,149,08/19/1994228hu003845263928041IB:234480.4KIDNNOT19229rat00071677700532674ZS:217274.1RAEONOT02PZ-0024-US,242,09/10/1998|PZ-0052-P,242,12/11/1997230rat00105537700520955ZS:217274.1RABHNOT02PZ-0021-US,2309,09/08/1998|PZ-0050-P,2309,12/11/1997231rat00177349700785531ZS:217274.1RABSNOT02PZ-0057-P,2193,01/16/1998|PZ-0057-US,2193,01/11/1999232rat00068188700525644ZS:217274.1RABMNOT01PZ-0022-US,1489,09/01/1998|PZ-0051-P,1489,12/12/1997233rat00145437700524023ZS:217274.1RABMNOT01PZ-0022-US,974,09/01/1998|PZ-0051-P,974,12/12/1997234hu013498466112575LG:232035.3MCLDTXT03235hu010094686385123LG:232035.3FIBRUNT02236hu011604206424123LG:232035.3BRSTUNT01237hu012999096396655LG:232035.3UTRENOT10238hu012464786178515LG:232035.3BMARUNT02239hu012852784440191LG:232035.3SINTNOT22240hu012644456386840LG:232035.3FIBRUNT02241hu001981873438090IB:244681.1PENCNOT05PD-0389-P,1908,07/02/1997|PD-0389-US,1908,06/24/1998242hu003506762103752IB:401992.4BRAITUT02PD-0111-1-US,6437,12/05/1997|PD-0275-P,6897,12/06/1996243hu008377462134070IB:198531.2ENDCNOT01PD-0257-P,538,10/23/1996|PD-0257-US,538,10/22/1997244hu00818732487437IB:198531.2HNT2AGT01245hu001713302215250IB:198531.2SINTFET03PD-0268-P,3146,10/31/1996|PD-0268-US,3146,10/30/1997246hu00471838345407IB:198531.2THYMNOT02PD-0041-P,837,09/26/1995|PD-0077-P,837,10/02/1995|PD-0077-US,837,10/02/1996247hu004969953244082IB:198531.2BRAINOT19PD-0370-P,944,05/29/1997|PD-0370-US,944,05/12/1998248hu006455412827143IB:214288.5TLYMNOT03PD-0363-P,100,05/02/1997|PD-0363-US,100,04/30/1998249hu006960572821267IB:214288.5ADRETUT06PD-0333-P,186,03/14/1997|PD-0333-US,186,03/12/1998250hu007929901742936IB:198531.3HIPONON01PD-0224-P,1823,08/28/1996|PD-0224-US,1823,08/26/1997251hu005499293335240IB:198531.3BRAIFET01PD-0369-P,1996,05/28/1997252hu008978822747156IB:198531.3LUNGTUT11PD-0326-US,2414,03/04/1997|PD-0326-P,847,03/07/1997253hu000161521355979IB:198531.3LUNGNOT09PD-0177-P,455,05/15/1996|PD-0177-US,455,05/14/1997254hu001032573187872IB:198531.3THYMNON04PD-0381-P,920,06/02/1997|PD-0381-US,920,06/02/1998255hu001237141369013IB:198531.3SCORNON02PD-0161-P,1613,04/29/1996|PD-0161-US,1613,04/29/1997256hu005529103565618IB:198531.3BRONNOT02PS-0003-P,536,06/06/1997|PS-0003-US,536,06/06/1997257hu008551232953422IB:198531.3KIDNFET01PD-0339-P,2298,03/14/1997|PD-0339-US,2298,03/12/1998258hu008543052331423IB:198531.3COLNNOT11PD-0289-P,1724,12/18/1996|PD-0289-US,1724,12/18/1997259hu003970242837656IB:198531.3DRGLNOT01PD-0337-P,166,03/18/1997|PD-0337-US,166,03/05/1998260hu0014364826403IB:198531.3SPLNFET01PD-0004-1-US,450,05/05/1995|PD-0004-US,815,02/02/1994261hu007056622235510IB:198531.3PANCTUT02PD-0191-US,2654,06/19/1997|PD-0295-P,496,12/20/1996262hu005930901213194IB:198531.3BRSTTUT01PD-0157-P,2341,04/26/1996|PD-0157-US,2341,04/25/1997263hu004596222716655IB:198531.3THYRNOT09PD-0331-P,842,02/13/1997|PD-0331-US,842,02/10/1998264hu004175481521103IB:198531.3BLADTUT04PD-0203-P,2555,08/01/1996|PD-0203-US,2555,08/01/1997265hu000768441558940IB:198531.3SPLNNOT04PD-0190-US,1794,06/19/1997|PD-0215-P,214,07/30/1996266hu007582351281986IB:198531.3COLNNOT16PD-0148-P,199,04/25/1996|PD-0148-US,199,04/25/1997267hu003392672936440IB:198531.3THYMFET02PD-0361-P,427,04/24/1997|PD-0361-US,427,04/23/1998268hu001669352360924IB:198531.3LUNGFET05PD-0281-P,1072,12/04/1996269hu00942197721037IB:198531.3SYNOOAT01PD-0099-US,2622,12/19/1996|PD-0101-P,744,01/04/1996270hu005258491282145IB:198531.3COLNNOT16PD-0148-P,334,04/25/1996|PD-0148-US,334,04/25/1997271hu006682922045951IB:198531.3THP1T7T01PD-0273-P,1525,10/31/1996|PD-0273-US,698,10/28/1997272hu000969271606444IB:198531.3LUNGNOT15PD-0208-P,2508,07/24/1996|PD-0208-US,2508,07/23/1997273hu008681742285437IB:198531.3BRAINON01PD-0274-P,800,11/20/1996274hu000015001512742IB:214288.6PANCTUT01PD-0196-P,944,06/21/1996275hu00598479974641IB:214288.6MUSCNOT02PD-0131-P,1013,03/19/1996|PD-0131-US,1013,03/18/1997276hu005766991981621IB:214288.6LUNGTUT03PD-0248-P,1017,09/27/1996|PD-0189-US,2315,06/19/1997277hu00115451547710IB:214288.6BEPINOT01PD-0056-P,373,10/31/1995|PD-0056-US,373,10/16/1996278hu000634413452386IB:214288.6UTRSNON03PD-0397-P,2648,07/02/1997|PD-0397-US,2648,06/30/1998279hu001170731541686IB:214288.6SINTTUT01PD-0210-US,1254,07/23/1997280hu000343732508157IB:214288.6CONUTUT01PD-0300-P,2388,12/20/1996|PD-0300-US,2388,12/18/1997281hu003213571336918IB:214288.6COLNNOT13PD-0173-P,1168,05/16/1996|PD-0173-US,1168,05/09/1997282hu006065321524878IB:214288.6UCMCL5T01PD-0194-P,169,06/28/1996|PD-0194-US,169,06/27/1997283hu003310791003042IB:214288.6BRSTNOT03PD-0149-P,1064,04/12/1996|PD-0149-US,1064,04/11/1997284hu00091149161598IB:214288.6ADENINB01PD-0033-1-US,1104,07/13/1995285hu0039034828378IB:214288.6SPLNFET01PD-0004-1-US,1181,05/05/1995286hu007430942231816IB:214288.6PROSNOT16PD-0290-P,1497,12/19/1996|PD-0290-US,1497,07/30/1997287hu006529352638052IB:214288.6BONTNOT01PD-0302-P,959,01/27/1997|PD-0302-US,959,01/23/1998288hu006398062284174IB:214288.6BRAINON01PD-0274-P,160,11/20/1996289hu0066168664295IB:214288.6PLACNOB01PD-0011-US,1136,07/15/1994290hu00698038672180IB:214288.6CRBLNOT01PD-0089-P,1249,11/30/1995|PD-0089-US,1249,11/27/1996291hu009425891683714IB:214288.6PROSNOT15PD-0200-P,652,07/24/1996|PD-0200-US,652,07/24/1997292hu00689928988257IB:214288.6LVENNOT03PD-0134-P,1374,03/21/1996|PD-0134-US,1374,03/21/1997293hu00201651178582IB:214288.6PLACNOB01294hu00616103957959IB:214288.6KIDNNOT05PD-0142-P,1538,04/10/1996|PD-0142-US,1538,04/10/1997|PD-02611-US,3277,10/29/1997295hu00300158805000IB:214288.6BRAVTXT05PR-0005-P,1552,01/10/1996|PR-0005-US,1552,01/10/1997296hu005345302963787IB:214288.6SCORNOT04PD-0360-P,281,04/24/1997|PD-0360-US,281,04/23/1998297hu009240513255588IB:214288.6OVARTUN01PD-0374-P,1446,06/04/1997|PD-0374-US,1446,05/18/1998298hu00256307268277IB:214288.6HNT2NOT01PD-0038-P,569,06/16/1995299hu00114972132527IB:214288.6BMARNOT02PD-0028-US,993,03/31/1995300hu003301982351574IB:214288.6COLSUCT01PD-0278-P,889,12/05/1996|PD-0278-US,889,11/21/1997301hu005592221427071IB:214288.6SINTBST01PD-0209-P,1498,07/23/1996|PD-0209-US,1498,07/22/1997302hu002574351302726IB:214288.6PLACNOT02PD-0167-P,130,05/30/1996|PD-0167-US,130,05/29/1997303hu006417713014326IB:214288.6MUSCNOT07PD-0359-P,1688,04/11/1997|PD-0359-US,1688,03/31/1998304hu001574812793994IB:214288.6COLNTUT16PD-0322-P,2147,03/06/1997|PD-0322-P,2147,03/06/1997|PD-0322-US,2147,03/06/1998|PD-0322-US,2147,03/06/1998305hu006495313361302IB:214288.6PROSBPT02PD-0390-P,224,06/30/1997|PD-0390-US,224,06/26/1998306hu002564662228136IB:214288.6SEMVNOT01PD-0266-P,1344,10/28/1996|PD-0266-US,1344,10/27/1997307hu006379503439101IB:214288.6PENCNOT06PD-0389-P,2369,07/02/1997|PD-0389-US,2369,06/24/1998308hu008913181284989IB:214288.6COLNNOT16PD-0148-P,1259,04/25/1996|PD-0148-US,1259,04/25/1997309hu00267556101709IB:214288.6ADRENOR01PD-0016-US,1581,10/14/1994310hu001892292572961IB:214288.6HIPOAZT01PD-0324-P,1995,03/04/1997|PD-0324-US,1995,02/26/1998311hu008038571386853IB:214288.6CARGDIT02PR-0008-P,356,06/04/1996|PR-0008-US,356,06/03/1997312hu00428667968283IB:214288.6BRSTNOT05PD-0133-P,3765,03/20/1996|PD-0133-US,3765,03/20/1997313hu005936492434871IB:214288.6BRAVUNT02PR-0012-P,1238,11/25/1996|PR-0002-1-US,4272,11/19/1997314hu00966556529702IB:214288.6BRAINOT03PD-0058-P,156,10/25/1995|PD-0088-US,156,11/27/1996|PD-0092-P,156,12/13/1995315hu00908022691852IB:214288.6LUNGTUT02PD-0097-P,1114,12/20/1995|PD-0097-US,1114,12/20/1996316hu00247720945009IB:214288.6RATRNOT02PD-0135-P,1422,03/20/1996|PD-0135-US,1422,03/19/1997317hu0009326338327IB:214288.6HUVENOB01PD-0003-3-US,2045,08/26/1994|PD-0003-1-US,4406,02/17/1994|PD0003-2-US,4766,04/28/1994318hu003845212662208IB:214288.6ADRENOT08PD-0317-P,386,02/11/1997|PD-0317-US,386,02/10/1998319hu003225841236346IB:214288.6LUNGFET03PD-0146-P,1685,04/17/1996|PD-0146-US,1685,04/16/1997320hu006704531671467IB:214288.6BMARNOT03PD-0218-1-US,1474,03/12/1998|PD-0218-P,1474,08/01/1996|PD-0218-US,1474,08/01/1997321hu000563381450164IB:214288.6PLACNOT02PD-0193-P,1096,06/27/1996|PD-0167-US,2456,05/29/1997322hu003771541661168IB:214288.6BRSTNOT09PD-0219-P,1909,07/26/1996323hu002894242675413IB:214288.6KIDNNOT19PD-0325-P,1547,03/05/1997324hu001388642071881IB:214288.6ISLTNOT01PD-0259-P,987,10/28/1996|PD-0259-US,987,10/28/1997325hu0017878541595IB:214288.6TBLYNOT01PD-0007-US,939,03/22/1994326hu008862983567727IB:214288.6BRONNOT02PS-0003-P,1376,06/06/1997|PS-0003-US,1376,06/16/1997327hu00527500438267IB:214288.6THYRNOT01PD-0049-P,1948,10/02/1995|PD-0049-US,1948,09/30/1996328hu006420451670227IB:214288.6BMARNOT03PD-0218-1-US,1070,03/12/1998|PD-0218-P,1070,08/01/1996|PD-0218-US,1070,08/01/1997329hu000931172733423IB:214288.6OVARTUT04P0-0313-P,1601,01/22/1997|PD-0313-US,1601,01/22/1998330hu00614740237IB:214288.6U937NOT01PD-0001-3-US,181,02/14/1994|PD-0001-US,181,07/17/1992|PD-0001-1-US,199,11/19/1992331hu00265154523746IB:214288.6MMLR2DT01PD-0044-P,2667,10/02/1995|PD-0044-US,2667,10/02/1996332hu001056831631414IB:214288.6COLNNOT19PD-0206-P,202,08/01/1996|PD-0206-US,202,08/01/1997333hu001172673327940IB:214288.6HEAONOT04PD-0387-P,2889,07/03/1997|PD-0387-US,2889,06/30/1998334hu00552139436786IB:214288.6THYRNOT01PD-0049-P,1400,10/02/1995|PD-0049-US,1400,09/30/1996335hu000848433036523IB:214288.6PENCNOT02PD-0375-P,13,06/02/1997|PD-0375-US,13,05/08/1998336hu006338541724062IB:214288.6PROSNOT14PD-0201-P,135,07/29/1996|PD-0201-US,135,07/28/1997|PD-0210-P,135,07/24/1996337hu006178181773452IB:214288.6MENTUNON3PD-0223-P,240,08/28/1996|PD-0223-US,240,08/27/1997338hu00168917188IB:214288.6U937NOT01PD-0001-3-US,140,02/14/1994|PD-0001-US,140,07/17/1992|PD0001-1-PCT,158,07/16/1993|PD-0001-1-US,158,11/19/1992339hu008977112728235IB:214288.6OVARTUT05PD-0313-P,3341,01/22/1997|PD-0313-US,3341,01/22/1998340hu008506882657709IB:214288.6LUNGTUT09PD-0310-P,2629,01/28/1997|PD-0310-US,2629,01/28/1998341hu0072410066598IB:214288.6HUVESTB01PD-0003-2-US,6020,04/28/1994|PD-0003-3-US,7136,08/26/1994342hu000174022434736IB:214288.6BRAVUNT02PR-0012-P,1188,11/25/1996|PR-0002-1-US,4222,11/19/19997343hu006020532050370IB:214288.6LIVRFET02PD-0262-P,590,10/31/1996344hu00521216858026IB:214288.6NGANNOT01PD-0123-US,2374,02/28/1997|PD-0125-P,2374,03/07/1996345hu004035232922053IB:214288.6SININOT04PD-0344-P,403,03/17/1997|PD-0344-US,403,03/16/1998346hu000751411486724IB:214288.6UCMCL5T01PD-0184-P,1264,06/24/1996|PD-0194-P,2587,06/28/1996|PD-0194-US,2587,06/27/1997347hu000224372319924IB:214288.6OVARNOT02PD-0293-P,1042,12/13/1996|PD-0045-1-US,2869,11/10/1997348hu002016832584108IB:214288.6BRAITUT22PD-0304-P,3129,01/28/1997|PD-0304-US,3129,01/28/1998349hu008600163318249IB:214288.6PROSBPT03PD-0390-P,2758,06/30/1997|PD-0390-US,2758,06/26/1998350hu006422161418795IB:214288.6KIDNNOT09PD-0186-P,317,06/25/1996|PD-0186-US,317,06/24/1997351hu000176471490935IB:214288.6UCMCL5T01PD-0184-P,1000,06/24/1996|PD-0194-P,2324,06/28/1996|PD-0194-US,2324,06/27/1997352hu003369221972806IB:214288.6UCMCL5T01PD-0194-US,3439,06/27/1997|PD-0272-P,838,10/23/1996353hu00155892857740IB:214288.6NGANNOT01PD-0123-US,2269,02/28/1997|PD-0125-P,2269,03/07/1996354hu00827284777632IB:214288.6COLNNOT05PD-0105-P,1046,01/30/1996|PD-0110-US,1046,01/30/1997355hu008957081443789IB:214288.6THYRNOT03PD-0162-P,3595,05/29/1996|PD-0162-US,3595,05/27/1997356hu002190123360182IB:214288.6PROSTUT16PD-0391-P,3488,06/30/1997|PD-0391-US,3488,06/19/1998357hu000330571490047IB:214288.6UCMCL5T01PD-0194-P,2158,06/28/1996|PD-0194-US,2158,06/27/1997|PD-0184-P,834,06/24/1996358hu00729121168121IB:214288.6LIVRNOT01PD-0064-P,769,10/10/1995|PD-0064-US,769,10/09/1996359hu009355011753578IB:214288.6LIVRTUT01PD-0220-P,978,07/30/1996360hu006444051705762IB:214288.6DUODNOT02PD-0207-P,2581,07/29/1996|PD-0207-US,2581,07/29/1997361hu00672261947412IB:214288.6RATRNOT02PD-0135-P,1982,03/20/1996|PD-0135-US,1982,03/19/1997362hu006814152769452IB:214288.6COLANOT02PD-0321-P,695,02/12/1997|PD-0321-P,695,02/12/1997|PD-0321-US,695,02/10/1998|PD-0321-US,695,02/10/1998363hu0135364559936IB:214288.6LUNGNOT01PD-0010-US,200,07/01/1994364hu00155187975960IB:214288.6MUSCNOT02PD-0131-P,1267,03/19/1996|PD-0131-US,1267,03/18/1997365hu00671536436218IB:214288.6THYRNOT01PD-0049-P,1188,10/02/1995|PD-0049-US,1188,09/30/1996366hu006647232912496IB:214288.6KIDNTUT15367hu008741091833183IB:214288.6BRAINON01PD-0222-P,598,08/23/1996368hu005153883323085IB:214288.6PTHYNOT03PD-0392-P,1103,07/01/1997|PD-0392-US,1103,06/26/1998369hu000819572595534IB:214288.6OVARTUT02PD-0312-P,733,01/21/1997|PD-0312-US,733,01/21/1998370hu00688447158522IB:214288.6ADENINB01PD-0033-1-US,129,07/13/1995371hu001203082739831IB:214288.6BRSTTUT14PD-0320-P,2223,02/13/1997|PD-0320-US,2223,02/11/1998372hu00700244702877IB:214288.6SYNORAT03PD-0096-P,2526,12/15/1995|PD-0096-US,2526,12/15/1995373hu006410242779245IB:214288.6OVARTUT03PD-0329-P,964,03/07/1997|PD-0329-US,964,03/05/1998374hu004453203687255IB:214288.6HEAANOT01PD-0351-US,3136,04/23/1998375hu008502301393468IB:214288.6THYRNOT03PD-0162-P,789,05/29/1996|PD-0162-US,789,05/27/1997376hu00381730870700IB:214288.6LUNGAST01PD-0120-US,2959,02/28/1997|PD-0120-P,734,02/29/1996377hu002295401629121IB:214288.6COLNPOT01PD-0206-P,2816,08/01/1996|PD-0206-US,2816,08/01/1997378hu004392412616289IB:214288.6GBLANOT01PD-0338-P,1023,03/14/1997|PD-0338-US,1023,03/12/1998379hu009441051225832IB:214288.6COLNNOT01PD-0154-P,85,04/19/1996|PD-0154-US,85,04/17/1997380hu0010749336001IB:214288.6HUVENOB01PD-0003-1-US,3141,02/17/1994|PD-0003-2-US,3314,04/28/1994|PD0003-3-US,593,08/26/1994381hu00580182541261IB:214288.6PD-0060-P,1209,10/30/1995|PD-0131-P,1249,03/19/1996|PD-0131-US,1249,03/18/1997382hu00682152986764IB:214288.6LVENNOT03PD-0134-P,968,03/21/1996|PD-0134-US,968,03/21/1997383hu007606423137305IB:214288.6SMCCNOT01PD-0377-P,1191,06/06/1997|PD-0377-US,1191,05/20/1998384hu007427421332445IB:214288.6PANCNOT07PD-0172-P,1235,05/23/1996|PD-0172-US,1235,05/22/1997385hu000822961233856IB:214288.6LUNGFET03PD-0146-P,638,04/17/1996|PD-0146-US,638,04/16/1997386hu006478032232952IB:214288.6PROSNOT16PD-0290-P,2027,12/19/1996|PD-0290-US,2027,07/30/1997387hu00098155838885IB:214288.6PROSTUT05PD-0119-P,1652,02/27/1996|PD-0119-US,1652,02/27/1997|PD-0119-1-US,186,09/30/1997388hu00540983830015IB:214288.6PROSTUT04PD-0117-P,2007,02/26/1996|PD-0117-US,2007,02/26/1997|PD-0197-US,431,06/23/1997389hu00823826968185IB:214288.6BRSTNOT05PD-0133-P,3720,03/20/1996|PD-0133-US,3720,03/20/1997390hu003164692266925IB:214288.6UTRSNOT02PD-0288-P,553,12/18/1996|PD-0288-US,553,12/16/1997391hu001866802232714IB:214288.6PROSNOT16PD-0290-P,1931,12/19/1996|PD-0290-US,1931,07/30/1997392hu001926841618829IB:214288.6BRAITUT12PD-0204-P,3326,07/26/1996393hu00509719862083IB:214288.6BRAITUT03PD-0126-1-US,1313,11/25/1997|PD-0126-P,1313,03/08/1996|PD-0126-US,1313,03/07/1997394hu00690657567832IB:214288.6MMLR3DT01PD-0057-P,351,10/26/1995|PD-0057-US,351,10/25/1996395hu003197771737115IB:214288.6COLNNOT22PD-0226-P,1606,08/22/1997|PD-0226-US,2195,08/22/1997396hu002599811565719IB:214288.6HEALDIT02PR-0007-P,669,06/26/1996|PR-0007-US,669,06/25/1997397hu005553993319527IB:214288.6PROSBPT03PD-0390-P,3260,06/30/1997|PD-0390-US,3260,06/26/1998398hu003121151860508IB:214288.6PROSNOT18PD-0233-P,1766,09/05/1996|PD-0233-US,1766,09/05/1997399hu006632111674224IB:214288.6BLADNOT05PD-0203-P,816,08/01/1996|PD-0203-US,816,08/01/1997400hu00322633909282IB:214288.6COLNNOT09PD-0129-P,751,03/19/1996|PD-0129-US,751,03/18/1997401hu002624412649949IB:214288.6THYMFET02PD-0361-P,2351,04/24/1997|PD-0361-US,2351,04/23/1998402hu004410562938018IB:214288.6THYMFET02PD-0361-P,1167,04/24/1997|PD-0361-US,1167,04/23/1998403hu002842232218628IB:214288.6LUNGNOT18PD-0263-P,116,10/28/1996|PD-0263-US,116,10/28/1996404hu001034692706495IB:214288.6PONSAZT01PD-0342-P,1054,03/24/1997|PD-0342-US,1054,03/17/1998405hu00133746105473IB:214288.6BMARNOT02PD-0028-US,653,03/31/1995406hu00224944791482IB:214288.6PROSTUT03PD-0107-P,905,01/29/1996|PD-0107-US,905,01/29/1997407hu007855003038523IB:214288.6BRSTNOT16PD-0350-P,538,04/16/1997|PD-0350-US,538,04/09/1998408hu00252881754354IB:214288.6BRAITUT02PD-0106-P,224,01/31/1996|PD-0106-US,224,01/31/1997|PD-0111-1-US,224,12/05/1997409hu004582082588364IB:214288.6BRAITUT22PD-0304-P,4797,01/28/1997|PD-0304-US,4797,01/28/1998410hu002986222467836IB:214288.6THYRNOT08PD-0394-P,2791,07/02/1997|PD-0394-US,2791,06/24/1998411hu004840491807159IB:214288.6SINTNOT13PD-0234-P,1244,08/28/1996412hu00911883483414IB:214288.6HNT2RAT01PD-0075-P,409,10/03/1995|PD-0075-US,409,10/03/1996413hu005913661878392IB:214288.6LEUKNOT03PD-0246-P,2539,10/04/1996|PD-0246-US,2539,10/02/1997414hu001896073122394IB:214288.6LNODNOT05PD-0356-P,750,04/29/1997|PD-0356-US,750,04/24/1998415hu009018491632586IB:214288.6COLNNOT19PD-0206-P,382,08/01/1996|PD-0206-US,382,08/01/1997416hu005768521754034IB:214288.6LIVRTUT01PD-0220-P,1130,07/30/1996417hu002626892615938IB:214288.6GBLANOT01PD-0338-P,873,03/14/1997|PD-0338-US,873,03/12/1998418hu00194559776401IB:214288.6COLNNOT05PD-0105-P,690,01/30/1996|PD-0110-US,690,01/30/1997419hu000959743253386IB:214288.6OVARTUN01PD-0374-P,278,06/04/1997|PD-0374-US,278,05/18/1998420hu0039929034572IB:766219.1THP1NOB01PD-0001-3-US,7660,02/14/1994|PD-0001-4-US,7830,07/28/1994421hu013293555613187LG:411605.7MONOTXN05422hu00529652198957IB:758551.1KIDNNOT02PD-0024-US,2062,02/27/1995423hu010541275613859LG:140649.1FIBRTXS07424hu003672612241085IB:075659.1PANCTUT02PD-0295-P,2198,12/20/1996|PD-0191-US,4356,06/19/1997425hu012169446304773LG:902506.4NERDTDN03426hu011695415949169LG:902506.4LIVRTUN04427hu009680225876719LG:902506.4BRAUNOT01428hu010429036507116LG:902506.4BRAHNOT02429hu012738366345009LG:902506.4LUNGDIS03430hu012704996345041LG:902506.4LUNGDIS03431hu010337386120407LG:902506.4BRAHNON05432hu012010326265395LG:902506.4MCLDTXN03433hu005240212781758IB:401992.9OVARTUT03PD-0329-P,2100,03/07/1997|PD-0329-US,2100,03/05/1998434hu003649881701981IB:401992.9BLADTUT05PD-0221-US,1609,07/31/1997|PD-0202-P,2016,07/31/1996435hu00932363759186IB:401992.9BRAITUT02PD-0111-1-US,2855,12/05/1997|PD-0111-P,673,02/22/1996|PD-0111-US,673,02/21/1997436hu011034465657662LG:334807.2BSCNNOT03437hu012030493787443LG:334807.2BRAHNOT05438hu010685103788702LG:334807.2BRAHNOT05439hu012139434668706LG:334807.2SINTNOT24440hu010448636056729LG:334807.2BRAENOT04441hu012009683762849LG:334807.2BRAHDIT03442hu010181016558417LG:334807.2BRAFNON02443hu013297336559956LG:334807.2BRAFNON02444hu013370956210954LG:334807.2ARTANOT06445hu012820875808476LG:334807.2BRAHNOT02446hu010907676555152LG:334807.2BRAFNON02447hu009791755888375LG:411449.4LIVRNON08448hu011829185880566LG:411449.4LIVRNON08449hu013433185884946LG:411449.4LIVRNON08450hu011478655889095LG:411449.4LIVRNON08451hu010747515880061LG:411449.4LIVRNON08452hu012962055890510LG:411449.4LIVRNON08453hu009704515885109LG:411449.4LIVRNON08454hu013250646129550LG:334807.3BRAHNON05455hu010656086127983LG:334807.3BRAHNON05456hu010464056111849LG:411449.5MCLDTXT03457hu012852015695240LG:411449.6BRSTTUT13458hu010133665815925LG:411449.6PROSTUS23459hu013264336138342LG:411449.6BMARTXT03460hu011472256522432LG:411449.6CONFTDT02461hu013442546310665LG:411449.6NERDTDN03462hu011281926129270LG:411449.6BRAHNON05463hu010671916408546LG:411449.6UTREDIT10464hu010704496305061LG:411449.6NERDTDN03465hu013240786588841LG:411449.6TLYMUNT03466hu010510126552781LG:411449.6BRAFNON02467hu013245576482476LG:411449.6PROSTMC01468hu010709296343922LG:411449.6LUNGDIS03469hu009830445919979LG:411449.6BRAIFET02470hu011706863783111LG:411449.6BRAHDIT04471hu009685304518248LG:411449.6SINJNOT03472hu000100062492677IB:475199.2ADRETUT05PD-0318-P,253,02/11/1997|PD-0318-US,253,02/09/1998473hu009571583357454IB:796437.1PROSTUT16PD-0391-P,2579,06/30/1997|PD-0391-US,2579,06/19/1998474hu012642316126885LG:334807.5BRAHNON05475hu00305008188581IB:475199.3CARDNOT01PD-0019-US,2898,01/05/1995476hu006318442135063IB:475199.3ENDCNOT01PD-0257-P,918,10/23/1996|PD-0257-US,918,10/22/1997477hu006673791331867IB:475199.4PANCNOT07PD-0172-P,1082,05/23/1996|PD-0172-US,1082,05/22/1997478hu002001133960113IB:475199.4HEARFET02PD-0353-US,3090,03/17/1998479hu006579751644841IB:475199.4HEARFET01PD-0212-P,743,07/26/1996480hu000901302081894IB:475199.4UTRSNOT08PD-0287-P,908,12/04/1996|PD-0287-US,908,11/19/1997481hu007310303069069IB:475199.4UTRSNOR01PD-0365-P,535,04/18/1997|PD-0365-US,535,04/16/1998482hu001127404323184IB:475199.4TLYMUNT01PS-0009-P,341,04/16/1998|PS-0009-US,341,04/16/1999483hu004051802539031IB:475199.4BONRTUT01PD-0303-P,552,01/27/1997484hu00801145742282IB:475199.4PANCNOT04PD-0214-US,1511,08/01/1997|PD-0118-P,521,02/26/1996|PD-0118-US,521,02/26/1997485hu007105422028355IB:475199.4KERANOT02PD-0260-P,1161,10/25/1996|PD-0116-1-US,2583,10/24/1997486hu00141175159425IB:475199.4ADENINB01PD-0033-US,353,03/29/1995|PD-0033-1-US,436,07/13/1995487hu00414290671593IB:475199.4CRBLNOT01PD-0089-P,1069,11/30/1995|PD-0089-US,1069,11/27/1996488hu002643152604050IB:475199.4LUNGTUT07PD-0310-P,253,01/28/1997|PD-0310-US,253,01/28/1998489hu000490623685138IB:475199.4HEAANOT01PD-0351-US,2445,04/23/1998490hu000596213957184IB:475199.4HEARFET02PD-0353-US,2230,03/17/1998491hu001669032908269IB:475199.4THYMNOT05PD-0393-P,1702,07/02/1997|PD-0393-US,1702,06/24/1998492hu00503917942890IB:475199.4ADRENOT03PD-0144-P,863,04/10/1996|PD-0144-US,863,04/10/1997493hu001349261332741IB:475199.4PANCNOT07PD-0172-P,1307,05/23/1996|PD-0172-US,1307,05/22/1997494hu004457421316096IB:475199.4BLADTUT02PD-0171-P,807,05/23/1996|PD-0171-US,807,05/22/1997495hu00336087289538IB:475199.4TMLR3DT01PD-0037-US,146,05/15/1995496hu00929610679064IB:475199.4UTRSNOT02PD-0095-P,273,12/29/1995|PD-0095-US,273,12/23/1996497hu000791462439313IB:475199.4EOSITXT01PR-0011-US,2352,08/29/1997|PR-0013-P,996,11/25/1996498hu00273268909094IB:475199.4COLNNOT09PD-0129-P,675,03/19/1996|PD-0129-US,675,03/18/1997499hu006289122670325IB:475199.4ESOGTUT02PD-0323-P,1390,03/05/1997|PD-0323-US,1390,03/02/1998500hu000867162443220IB:475199.4EOSITXT01PR-0013-P,2430,11/25/1996|PR-0011-US,3786,08/29/1997501hu006144762149587IB:475199.4BRAINOT09PD-0163-US,2432,05/20/1997|PD-0275-P,398,12/06/1996502hu00148645291706IB:475199.4TMLR3DT01PD-0037-US,757,05/15/1995503hu008336812665513IB:475199.4ADRENOT08PD-0317-P,1706,02/11/1997|PD-0317-US,1706,02/10/1998504hu005323882953235IB:475199.4KIDNFET01PD-0339-P,2225,03/14/1997|PD-0339-US,2225,03/12/1998505hu00436439890040IB:475199.4STOMTUT01PD-0127-P,435,03/08/1996506hu000889321609748IB:475199.4COLNTUT06PD-0206-P,3127,08/01/1996|PD-0206-US,3127,08/01/1997507hu001491782293179IB:475199.4BRAINON01PD-0274-P,5202,11/20/1996508hu004265942766633IB:475199.4BRSTNOT12PD-0320-P,1866,02/13/1997|PD-0320-US,1866,02/11/1998509hu000659472736649IB:475199.4OVARNOT09PD-0311-P,782,01/27/1997|PD-0311-US,782,01/23/1998510hu009158542304562IB:475199.4BRSTNOT05PD-0292-P,4157,12/19/1996|PD-0292-US,4157,12/18/1997511hu009441692763026IB:475199.4BRSTNOT12PD-0320-P,346,02/13/1997|PD-0320-US,346,02/11/1998512hu007755181377278IB:475199.4LUNGNOT10PD-0179-P,663,05/13/1996|PD-0179-US,663,05/09/1997513hu003693571998146IB:475199.4BRSTTUT03PD-0241-P,1380,10/01/1997|PD-0143-1-US,5410,10/01/1997514hu006689502790194IB:475199.4COLNTUT16PD-0322-P,409,03/06/1997|PD-0322-P,409,03/06/1997|PD-0322-US,409,03/06/1998|PD-0322-US,409,03/06/1998515hu008918292530965IB:475199.4GBLANOT02PD-0306-P,1105,01/27/1997|PD-0306-US,1105,01/23/1998516hu000360802664895IB:475199.4ADRENOT08PD-0317-P,1477,02/11/1997|PD-0317-US,1477,02/10/1998517hu009044101836569IB:475199.4BRAINON01PD-0222-P,1620,08/23/1996518hu005053811281254IB:475199.4COLNNOT16PD-0148-P,222,04/25/1996|PD-0148-US,222,04/25/1997519hu004314372658750IB:475199.4LUNGTUT09PD-0310-P,3084,01/28/1997|PD-0310-US,3084,/01/28/1998520hu008519111468402IB:475199.4PANCTUT02PD-0191-P,745,06/21/1996|PD-0191-US,745,06/19/1997521hu0004482894971IB:475199.4PITUNOT01PD-0017-US,537,10/05/1994522hu005625913202791IB:475199.4PENCNOT02PD-0375-P,1359,06/02/1997|PD-0375-US,1359,05/08/1998523hu006822641623750IB:475199.4BRAITUT13PD-0205-P,1504,07/26/1996|PD-0205-US,1504,07/24/1997524hu005058282269607IB:475199.4UTRSNOT02PD-0288-P,1600,12/18/1996|PD-0288-US,1600,12/16/1997525hu00881192555662IB:475199.4SCORNOT01PD-0066-P,1310,10/31/1995526hu004861653273425IB:475199.4PROSBPT06PD-0376-P,440,06/02/1997|PD-0376-US,440,05/15/1998527hu00741963488117IB:475199.4HNT2AGT01528hu00424866955963IB:475199.4KIDNNOT05PD-0261-1-US,2496,10/29/1997|PD-0142-P,757,04/10/1996|PD-0142-US,757,04/10/1997529hu00575940837468IB:475199.4PROSNOT07PD-0119-P,1178,02/27/1996|PD-0119-US,1178,02/27/1997|PD-0119-1-US,5198,09/30/1997530hu009526362668611IB:475199.4ESOGTUT02PD-0323-P,703,03/05/1997|PD-0323-US,703,03/02/1998531hu00777181641056IB:475199.4BRSTNOT03PD-0061-US,1306,11/15/1996|PD-0065-P,1306,11/28/1995532hu008206691624341IB:475199.4BRAITUT13PD-0205-P,1728,07/26/1996|PD-0205-US,1728,07/24/1997533hu009506572152009IB:475199.4BRAINOT09PD-0275-P,1126,12/06/1996|PD-0163-US,3160,05/20/1997534hu00492926672412IB:475199.4CRBLNOT01PD-0089-P,1324,11/30/1995|PD-0089-US,1324,11/27/1996535hu0038669168947IB:475199.4HUVESTB01PD-0003-2-US,6899,04/28/1994|PD-0003-3-US,8015,08/26/1994536hu006919351312213IB:475199.4COLNFET02PD-0168-P,1432,05/21/1996|PD-0168-US,1432,05/21/1997537hu00672864738387IB:475199.4TONSNOT01PD-0100-P,1406,01/05/1996|PD-0100-US,1406,01/03/1997538hu008248661869727IB:475199.4SKINBIT01PD-0253-P,1085,10/03/1996|PD-0253-US,1085,09/30/1997539hu008495542834526IB:475199.4TLYMNOT03PD-0363-P,2923,05/02/1997|PD-0363-US,2923,04/30/1998540hu006948801547894IB:475199.4PROSNOT06PD-0199-P,3994,07/30/1996541hu004885483566219IB:475199.4BRONNOT02PS-0003-P,791,06/06/1997|PS-0003-US,791,06/06/1997542hu00861598114170IB:475199.4TESTNOT01543hu007488752264814IB:475199.4UTRSNOT02PD-0288-P,3377,12/18/1996|PD-0288-US,3377,12/16/1997544hu00430192219339IB:475199.4STOMNOT01PD-0022-US,3085,02/07/1995545hu00001649733063IB:475199.4LUNGNOT03PD-0102-P,1089,01/18/1996546hu001821283118194IB:475199.4LUNGTUT13PD-0358-P,2885,04/18/1997|PD-0358-US,2885,04/17/1998547hu005500662661257IB:475199.4ADRENOT08PD-0317-P,24,02/11/1997|PD-0317-US,24,02/10/1998548hu004961302990381IB:475199.4KIDNFET02PD-0355-P,512,04/11/1997|PD-0355-US,512,03/30/1998549hu00515714548160IB:475199.4BEPINOT01PD-0056-P,504,10/31/1995|PD-0056-US,504,10/16/1996550hu007237511370295IB:475199.4BSTMNON02PD-0160-1-US,260,06/30/1998|PD-0160-P,260,04/26/1996551hu001509461887457IB:475199.4BLADTUT07PD-0238-P,1452,09/24/1996|PD-0238-US,1452,09/23/1997552hu001118782210818IB:475199.4SINTFET03PD-0268-P,1511,10/31/1996|PD-0268-US,1511,10/30/1997553hu001284653176964IB:475199.4UTRSTUT04PD-0383-P,1304,05/16/1997|PD-0383-US,1304,05/08/1998554hu005614744209737IB:475199.4BRONDIT01PS-0004-US,1039,12/13/1996|PS-0006-P,90,12/23/1997555hu00279622687475IB:475199.4UTRSNOT02PD-0095-P,2480,12/29/1995|PD-0095-US,2480,12/23/1996556hu008956003461089IB:475199.4293TF1T01PD-0385-P,1453,07/01/1997|PD-0385-US,1453,06/30/1998557hu00139834158748IB:475199.4ADENINB01PD-0033-US,184,03/29/1995|PD-0033-1-US,203,07/13/1995558hu00872570583799IB:475199.4PROSNOT02PD-0086-P,472,10/27/1995|PD-0086-US,472,10/21/1996559hu006248542784522IB:475199.4BRSTNOT13PD-0335-P,915,03/21/1997|PD-0335-US,915,03/20/1998560hu005713952441763IB:475199.4EOSITXT01PR-0013-P,1900,11/25/1996|PR-0011-US,3256,08/29/1997561hu00872139741986IB:475199.4PANCNOT04PD-0214-US,1472,08/01/1997|PD-0118-P,482,02/26/1996|PD-0118-US,482,02/26/1997562hu004982353336778IB:475199.4SPLNNOT10PD-0378-P,2152,06/05/1997|PD-0378-US,2152,05/19/1998563hu007369422631182IB:475199.4COLNTUT15PD-0305-P,519,01/22/1997|PD-0305-US,519,01/22/1998564hu00437945630531IB:475199.4KIDNNOT05PD-0063-P,1037,11/22/1995|PD-0261-1-US,1037,10/29/1997565hu006772472371227IB:475199.4ADRENOT07PD-0301-P,2795,12/19/1996|PD-0301-US,2795,12/17/1997566hu002870891001180IB:475199.4BRSTNOT03PD-0149-P,458,04/12/1996|PD-0149-US,458,04/11/1997567hu00893466270390IB:475199.4HNT2NOT01PD-0038-P,1247,06/16/1995568hu0053939846859IB:475199.4CORNNOT01PD-0006-1-US,624,06/07/1995|PD-0006-US,877,03/31/1994569hu00856774630234IB:475199.4KIDNNOT05PD-0063-P,928,11/22/1995|PD-0261-1-US,928,10/29/1997570hu006929961991586IB:475199.4CORPNOT02PD-0185-US,4814,06/26/1997|PD-0256-P,994,10/23/1996571hu009667683925490IB:475199.4KIDNNOT19572hu000304043401566IB:475199.4ESOGNOT03PD-0386-P,92,07/01/1997|PD-0386-US,92,06/24/1998573hu003325103338452IB:475199.4SPLNNOT10PD-0378-P,2551,06/05/1997|PD-0378-US,2551,05/19/1998574hu006501031921936IB:475199.4BRSTTUT01PD-0240-P,2513,09/30/1996|PD-0240-US,2513,09/29/1997575hu000039512406413IB:475199.4BSTMNON02PD-0160-1-US,2648,06/30/1998576hu005601523271032IB:475199.4BRAINOT20PD-0370-P,3973,05/29/1997|PD-0370-US,3973,05/12/1998577hu00825211579510IB:475199.4BRAVTXT05PR-0003-US,1890,11/13/1996|PR-0004-P,1890,12/15/1995578hu004704401999081IB:475199.4BRSTTUT03PD-0241-P,1765,10/01/1997|PD-0143-1-US,5795,10/01/1997579hu001747102118363IB:475199.4BRSTTUT02PD-0255-P,1034,10/23/1996580hu000494502650642IB:475199.4LUNGTUT13PD-0358-P,3765,04/18/1997|PD-0358-US,3765,04/17/1998581hu005163372766825IB:475199.4BRSTNOT12PD-0320-P,1954,02/13/1997|PD-0320-US,1954,02/11/1998582hu0077902194970IB:475199.4PITUNOT01PD-0017-US,536,10/05/1994583hu008707603173908IB:475199.4UTRSTUT04PD-0383-P,395,05/16/1997|PD-0383-US,395,05/08/1998584hu00507709837155IB:475199.4PROSNOT07PD-0119-P,1089,02/27/1996|PD-0119-US,1089,02/27/1997|PD-01191-US,5109,09/30/1997585hu00826066547537IB:475199.4BEPINOT01PD-0056-P,309,10/31/1995|PD-0056-US,309,10/16/1996586hu00526933672497IB:475199.4CRBLNOT01PD-0089-P,1348,11/30/1995|PD-0089-US,1348,11/27/1996587hu006347092720987IB:475199.4LUNGTUT10PD-0327-P,579,03/05/1997|PD-0327-US,579,03/03/1998588hu002792741003869IB:475199.4BRSTNOT03PD-0149-P,1385,04/12/1996|PD-0149-US,1385,04/11/1997589hu000467891259346IB:475199.4MENITUT03PD-0147-P,1751,04/17/1996|PD-0147-US,1751,04/17/1997590hu006867252474822IB:475199.4SMCANOT01PD-0298-P,113,01/30/1998|PD-0298-US,113,01/30/1998591hu012117966120495LG:334807.7BRAHNON05592hu012775696030522LG:334807.7BRAHNON05593hu012279136127887LG:334807.7BRAHNON05594hu00019002550609IB:230151.1BEPINOT01PD-0056-P,1262,10/31/1995|PD-0056-US,1262,10/16/1996595hu000749882834338IB:230151.1TLYMNOT03PD-0363-P,2867,05/02/1997|PD-0363-US,2867,04/30/1998596hu006822031209024IB:230151.1BRSTNOT02PD-0157-P,214,04/26/1996|PD-0157-US,214,04/25/1997597hu004059582160735IB:230151.1ENDCNOT02PD-0257-P,3672,10/23/1996|PD-0257-US,3672,10/22/1997598hu009024171006278IB:230151.1HEALDIT02PR-0006-P,950,03/26/1996|PR-0006-US,950,03/26/1997599hu008821392588088IB:230151.1BRAITUT22PD-0304-P,4695,01/28/1997|PD-0304-US,4695,01/28/1998600hu004449392160580IB:230151.1ENDCNOT02PD-0257-P,3592,10/23/1996|PD-0257-US,3592,10/22/1997601hu009967206523403LG:399851.3CONFTDT02602hu009796135953606LG:993791.1SKINTDT01603hu012179886372764LG:993791.1FIBAUNT02604hu011312676373435LG:993791.1FIBAUNT02605hu010571086387476LG:993791.1FIBRUNT02606hu011271566410750LG:993791.1UTREDIT10607hu013152576372052LG:993791.1FIBAUNT02608hu011279506305576LG:993791.1NERDTDN03609hu012775336122907LG:993791.1BRAHNON05610hu013136966422660LG:993791.1BRSTUNT01611hu012623796454929LG:993791.1COLNDIC01612hu011849356383359LG:993791.1FIBRUNT02613hu013097386422668LG:993791.1BRSTUNT01614hu012161506118137LG:993791.1BRAHNON05615hu013300556126413LG:993791.1BRAHNON05616hu010072356425148LG:993791.1BRSTUNT01617hu006272851857027IB:232035.1PROSNOT18PD-0233-P,473,09/05/1996|PD-0233-US,473,09/05/1997618rat00198924700368142ZS:221520.3RAHYNOT01PZ-0033-P,374,10/08/1997|PZ-0033-US,374,10/05/1998619rat00147149700494046ZS:221520.3RABCNOT01PZ-0042-P,1807,11/05/1997|PZ-0012-US,3608,08/04/1998620rat00122728700369876ZS:221520.3RAHYNOT01PZ-0033-P,1222,10/08/1997|PZ-0033-US,1222,10/05/1998621rat00102041700255036ZS:221520.3RABMNOT02PZ-0022-US,4154,09/01/1998|PZ-0030-P,665,10/08/1997622rat00244239700494879ZS:221520.3RABCNOT01PZ-0042-P,2222,11/05/1997|PZ-0012-US,4023,08/04/1998623hu00860841467072IB:232035.2LATRNOT01PD-0053-P,2338,10/10/1995|PD-0053-US,2338,10/09/1996624hu00329532464308IB:232035.2LATRNOT01PD-0053-P,1524,10/10/1995|PD-0053-US,1524,10/09/1996625hu002680882798569IB:232035.3NPOLNOT01PD-0340-P,1582,03/28/1997|PD-0340-US,1582,03/27/1998626hu007548012230026IB:232035.3PROSNOT16PD-0290-P,639,12/19/1996|PD-0290-US,639,07/30/1997627rat00227438700536442ZS:221520.5RAEONOT02PZ-0024-US,1652,09/10/1998|PZ-0052-P,1652,12/11/1997628rat00148580701608605ZS:221520.5RALITXT09PZ-0116-P,1049,04/29/1999629rat00148626700815950ZS:221520.5RABFNOT03PZ-0013-US,1517,08/07/1998|PZ-0063-P,424,02/10/1998630rat00068841700918115ZS:221520.5RAXSNOT01PZ-0100-P,1079,11/12/1998631rat00126954701257014ZS:221520.5RALITXT03PZ-0096-P,531,10/09/1998632rat00170875700461506ZS:221520.5RATHNOC02PZ-0049-P,75,11/07/1997|PZ-0049-US,75,11/06/1998633rat00059770700023402ZS:221520.5RANPNOT01PZ-0008-P,1143,07/10/1997|PZ-0008-US,1143,07/10/1998|PZ-0009-P,1143,07/09/1997634rat00159473701346456ZS:221520.5RALITXT11PZ-0094-P,1790,09/11/1998635rat00061995700123372ZS:221520.5RABHNOT01PZ-0004-P,663,07/09/1997|PZ-0004-US,663,07/09/1998636rat00239188700774145ZS:221520.5RABONOT01PZ-0077-P,1748,04/07/1998|PZ-0076-US,4052,04/06/1999637rat00226688701608169ZS:221520.5RALITXT09PZ-0116-P,927,04/29/1999638rat00079387700322834ZS:221520.5RAHINOT01PZ-0025-US,3006,09/09/1998|PZ-0025-P,393,09/12/1997639rat00069857701195154ZS:221520.5RALINOT02PZ-0026-US,1964,09/04/1998|PZ-0082-P,634,05/01/1998640rat00201032701509245ZS:221520.5RALITXT02PZ-0112-P,1245,03/08/1999641rat00100124700067453ZS:221520.5RABTNOT01PZ-0001-P,1239,06/12/1997|PZ-0001-US,1239,06/08/1998642rat00000065700478133ZS:221520.5RAFBNOT01PZ-0064-P,17,02/12/1998|PZ-0064-US,17,02/10/1999643rat00025121700372405ZS:221520.5RARANOT01PZ-0037-US,1759,10/06/1998|PZ-0037-P,570,10/09/1997644rat00111342700175226ZS:221520.5RASINOT01PZ-0005-P,118,07/09/1997|PZ-0005-US,118,07/09/1998645rat00012470700060734ZS:221520.5RAKINOT02PZ-0002-US,1530,06/09/1998|PZ-0002-P,788,06/13/1997646rat00243312700419934ZS:221520.5RAHANOT01PZ-0040-US,404,10/08/1998|PZ-0041-P,404,10/09/1997647rat00153024701444306ZS:221520.5RALITXT41PZ-0123-P,1376,06/04/1999648rat00093202701720942ZS:221520.5RALIUNT15PZ-0129-P,71,06/18/1999649rat00072036700420845ZS:221520.5RAHANOT01PZ-0040-US,700,10/08/1998|PZ-0041-P,700,10/09/1997650rat00122347700365506ZS:221520.5RAMGNOT01PZ-0046-P,269,11/04/1997|PZ-0046-US,269,11/03/1998651rat00128414701474948ZS:221520.5RALITXT41PZ-0123-P,1005,06/04/1999652rat00054660700323207ZS:221520.5RAHINOT01PZ-0025-US,3133,09/09/1998|PZ-0025-P,520,09/12/1997653rat00160662700067452ZS:221520.5RABTNOT01PZ-0001-P,1238,06/12/1997|PZ-0001-US,1238,06/08/1998654rat00243365700376957ZS:221520.5RALANOT01PZ-0040-US,1820,10/08/1998|PZ-0040-P,889,10/09/1997655hu001959651307933IB:232035.4COLNFET02PD-0168-P,150,05/21/1996|PD-0168-US,150,05/21/1997656hu004929883974283IB:232035.4ADRETUT06PD-0333-US,3410,03/12/1998657hu004105373422227IB:232035.4UCMCNOT04PD-0396-P,1291,07/03/1997|PD-0396-US,1291,06/30/1998658hu00133553721822IB:232035.4SYNOOAT01PD-0099-US,2823,12/19/1996|PD-0101-PD-0101-P,945,01/04/1996659hu003417161839034IB:232035.4EOSITXT01PR-0011-P,736,08/29/1996|PR-0011-US,736,08/29/1997660hu003191533210659IB:232035.4BLADNOT08PD-0367-P,628,05/29/1997|PD-0367-US,628,05/08/1998661hu008904102226674IB:232035.4SEMVNOT01PD-0266-P,933,10/28/1996|PD-0266-US,933,10/27/1997662hu007616311432972IB:232035.4BEPINON01PD-0181-P,1302,05/30/1996|PD-0181-US,1302,05/28/1997663hu004246182243725IB:232035.4PANCTUT02PD-0295-P,3053,12/20/1996|PD-0191-US,5211,06/19/1997664hu004616632546759IB:232035.4UTRSNOT11PD-0316-P,3395,01/29/1997|PD-0316-US,3395,01/26/1998665hu00471664259745IB:232035.4HNT2RAT01PD-0039-P,982,06/30/1995666hu0017573741970IB:232035.4TBLYNOT01PD-0007-US,1202,03/22/1994667hu000806971592324IB:232035.4CARGNOT01PR-0010-P,570,06/27/1996|PR-0010-US,570,06/26/1997668hu006849503898065IB:232035.4TLYMNOT05PD-0364-US,3326,04/30/1998669hu009107692735908IB:232035.4OVARNOT09PD-0311-P,478,01/27/1997|PD-0311-US,478,01/23/1998670hu006727732435175IB:232035.4BRAVUNT02PR-0012-P,1357,11/25/1996|PR-0002-1-US,4391,11/19/1997671hu007749492770076IB:232035.4COLANOT02PD-0321-P,923,02/12/1997|PD-0321-P,923,02/12/1997|PD-0321-US,923,02/10/1998|PD-0321-US,923,02/10/1998672hu009599761268496IB:232035.4BRAINOT09PD-0163-P,1025,05/21/1996|PD-0163-US,1025,05/20/1997673hu00124133523940IB:232035.4MMLR2DT01PD-0044-P,2736,10/02/1995|PD-0044-US,2736,10/02/1996674hu007173022365873IB:232035.4ADRENOT07PD-0301-P,879,12/19/1996|PD-0301-US,879,12/17/1997675hu00552353888182IB:232035.4PANCNOT05PD-0130-P,1053,03/26/1996676hu005441722471553IB:232035.4THP1NOT03PD-0286-P,737,11/25/1996|PD-0286-US,737,11/04/1997677hu009431612360352IB:232035.4LUNGEET05PD-0281-P,843,12/04/1996678hu006621832804594IB:232035.4BLADTUT08PD-0319-P,42,02/13/1997|PD-0319-US,42,02/10/1998679hu005909312684315IB:232035.4LUNGNOT23PD-0388-P,153,07/03/1997|PD-0388-US,153,06/19/1998680hu002359723181620IB:232035.4TLYJNOT01PD-0382-P,992,06/06/1997|PD-0382-US,992,05/21/1998681hu008671353566603IB:232035.4BRONNOT02PS-0003-P,941,06/06/1997|PS-0003-US,941,06/06/1997682hu007588333130394IB:232035.4LUNGTUT12PD-0358-P,1833,04/18/1997|PD-0358-US,1833,04/17/1998683hu00069795735448IB:232035.4TONSNOT01PD-0100-P,557,01/05/1996|PD-0100-US,557,01/03/1997684hu000886682149570IB:232035.4BRAINOT09PD-0163-US,2428,05/20/1997|PD-0275-P,394,12/06/1996685hu003787571257772IB:232035.4MENITUT03PD-0147-P,1047,04/17/1996|PD-0147-US,1047,04/17/1997686hu002710212728309IB:232035.4OVARTUT05PD-0313-P,3373,01/22/1997|PD-0313-US,3373,01/22/1998687hu002380101468878IB:232035.4PANCTUT02PD-0191-P,882,06/21/1996|PD-0191-US,882,06/19/1997688hu002412624349373IB:232035.4TLYMTXT01PS-0008-P,1233,04/16/1998|PS-0008-US,1233,04/16/1999689hu000004772095174IB:232035.4BRAITUT02PD-0111-1-US,3450,12/05/1997|PD-0275-P,3910,12/06/1996690hu004323352588957IB:232035.4LUNGNOT22PD-0328-P,271,03/06/1997|PD-0328-US,271,03/03/1998691hu000155631991653IB:232035.4CORPNOT02PD-0256-P,1003,10/23/1996|PD-0185-US,4823,06/26/1997692hu006461502257385IB:232035.4OVARTUT01PD-0283-P,2827,11/21/1996|PD-0112-1-US,4687,11/14/1997693hu00062618424822IB:232035.4BLADNOT01PD-0048-P,287,09/29/1995694hu000917602764187IB:232035.4BRSTNOT12PD-0320-P,846,02/13/1997|PD-0320-US,846,02/11/1998695hu00466331440571IB:232035.4THYRNOT01PD-0049-P,2748,10/02/1995|PD-0049-US,2748,09/30/1996696hu006243711451469IB:232035.4PENITUT01PD-0192-P,391,06/27/1996697hu00613446828745IB:232035.4PROSTUT04PD-0117-P,1654,02/26/1996|PD-0117-US,1654,02/26/1997|PD-0197-US,78,06/23/1997698hu001073791982096IB:232035.4LUNGTUT03PD-0248-P,1129,09/27/1996|PD-0189-US,2427,06/19/1997699hu007363442986448IB:232035.4CARGDIT01PD-0349-P,647,03/31/1997|PD-0349-US,647,03/31/1998700hu000495273319382IB:232035.4PROSBPT03PD-0390-P,3211,06/30/1997|PD-0390-US,3211,06/26/1998701hu001238942681484IB:232035.4SINIUCT01PD-0330-P,862,02/12/1997|PD-0330-US,862,02/10/1998702hu003625852279834IB:232035.4PROSNON01PD-0198-US,4203,07/28/1997|PD-0284-P,4203,12/05/1996703hu007729403201139IB:232035.4PENCNOT02PD-0375-P,750,06/02/1997|PD-0375-US,750,05/08/1998704hu005676512696415IB:232035.4UTRSNOT12PD-0346-US,5220,03/27/1998|PD-0346-P,938,03/27/1997705hu0088455179005IB:232035.4SYNORAB01PD-0012-US,1269,08/19/1994706hu002179681307950IB:232035.4COLNFET02PD-0168-P,156,05/21/1996|PD-0168-US,156,05/21/1997707hu006536862322036IB:232035.4OVARNOT02PD-0293-P,1648,12/13/1996|PD-0045-1-US,3475,11/10/1997708hu006662772777457IB:232035.4OVARTUT03PD-0329-P,138,03/07/1997|PD-0329-US,138,03/05/1998709hu006828731801673IB:232035.4COLNNOT27PD-0277-US,1163,09/23/1997|PD-0277-P,360,12/04/1996710hu009010022232170IB:232035.4PROSNOT16PD-0290-P,1672,12/19/1996|PD-0290-US,1672,07/30/1997711hu007121131311164IB:232035.4COLNFET02PD-0168-P,1123,05/21/1996|PD-0168-US,1123,05/21/1997712hu000900464346781IB:232035.4TLYMTXT01PS-0008-P,445,04/16/1998|PS-0008-US,445,04/16/1999713hu000165431271781IB:232035.4TESTTUT02PD-0164-P,212,05/16/1996|PD-0164-US,212,05/15/1997714hu001029351451452IB:232035.4PENITUT01PD-0192-P,383,06/27/1996715hu001703912503478IB:232035.4CONUTUT01PD-0300-P,563,12/20/1996|PD-0300-US,563,12/18/1997716hu002914332494513IB:232035.4ADRETUT05PD-0318-P,899,02/11/1997|PD-0318-US,899,02/09/1998717hu004339143325740IB:232035.4PTHYNOT03PD-0392-P,2338,07/01/1997|PD-0392-US,2338,06/26/1998718hu003791041505327IB:232035.4BRAITUT07PD-0183-P,1181,06/24/1996|PD-0183-US,1181,06/18/1997719hu006229601613557IB:232035.4COLNTUT06PD-0206-P,3884,08/01/1996|PD-0206-US,3884,08/01/1997720hu003163571254974IB:232035.4LUNGFET03PD-0146-P,4078,04/17/1996|PD-0146-US,4078,04/16/1997721hu003526382452005IB:232035.4ENDANOT01PD-0299-P,876,12/16/1996|PD-0299-US,876,12/04/1997722hu005423772612202IB:232035.4BRSTTUT13PD-0336-P,2,03/18/1997723hu0048452635154IB:232035.4HUVENOB01PD-0003-3-US,118,08/26/1994|PD-0003-1-US,2702,02/17/1994|PD-0003-2-US,2839,04/28/1994724hu009621383960285IB:232035.4HEARFET02PD-0353-US,3149,03/17/1998725hu00961725985780IB:232035.4LVENNOT03PD-0134-P,603,03/21/1996|PD-0134-US,603,03/21/1997726hu005454481839341IB:232035.4EOSITXT01PR-0011-P,839,08/29/1996|PR-0011-US,839,08/29/1997727hu006462491982581IB:232035.4LUNGTUT03PD-0248-P,1213,09/27/1996|PD-0189-US,2511,06/19/1997728hu003379641931150IB:232035.4COLNTUT03PD-0242-P,1308,09/25/1996|PD-0174-US,2978,05/13/1997729hu008544492452908IB:232035.4ENDANOT01PD-0299-P,1108,12/16/1996|PD-0299-US,1108,12/04/1997730hu012588926523007LG:197797.4CONFTDT02731hu010689806523607LG:197797.4CONFTDT02732rat00013687700434903ZS:217422.1RAHLNOT02PZ-0047-P,64,11/06/1997|PZ-0047-US,64,11/03/1998733rat00197623700934290ZS:217422.1RALINON03PZ-0075-P,1682,03/10/1998|PZ-0075-US,2622,03/09/1999734rat00079184700418829ZS:217422.1RAHANOT01PZ-0040-US,62,10/08/1998|PZ-0041-P,62,10/09/1997735rat00097770700249262ZS:217422.1RABHNOT02PZ-0021-US,3527,09/08/1998|PZ-0021-P,951,09/09/1997736rat00109965700418821ZS:217422.1RAHANOT01PZ-0040-US,60,10/08/1998|PZ-0041-P,60,10/09/1997737rat00104653700821102ZS:217422.1RAESNOT02PZ-0032-US,2024,10/07/1998|PZ-0074-P,787,03/13/1998738rat00142167701580728ZS:217422.1RALIUNT03PZ-0121-P,406,05/03/1999739rat00259341700435587ZS:217422.1RAHLNOT02PZ-0047-P,303,11/06/1997|PZ-0047-US,303,11/03/1998740hu006018273328503IB:411605.4HEAONOT04PD-0387-P,3096,07/03/1997|PD-0387-US,3096,06/30/1998741hu0002498940700IB:411605.6TBLYNOT01PD-0007-US,396,03/22/1994742hu009993455678683LG:197797.8BRAENOT02743hu010116016432644LG:197797.8LUNGNON07744hu011434116010062LG:197797.8FIBRUNT02745hu011223546556049LG:197797.8BRAFNON02746hu012155056107822LG:197797.8MCLDTXT03747hu010045636078778LG:197797.8BMARUNT02748hu010753416381042LG:197797.8FIBRUNT02749hu012719016612661LG:197797.8ARTANOT07750hu011891216544335LG:197797.8LNODNON02751hu012632666429658LG:197797.8LUNGNON07752hu012585505877503LG:197797.8BRAUNOT01753hu010918076603752LG:197797.8UTREDIT07754hu013252776564202LG:197797.8MCLDTXT04755hu010727566514218LG:197797.8THYMDIT01756hu013056684519243LG:197797.8SINJNOT03757hu010349664519149LG:197797.8SINJNOT03758hu012686356402167LG:197797.8UTRENOT10759hu009674413162188LG:197797.8TLYMTXT03760hu011856746544193LG:197797.8LNODNON02761hu010892575564022LG:197797.8BRSTDIT01762hu010708893762964LG:197797.8BRAHDIT03763hu0039695885665IB:411605.7LIVRNOT01PD-0014-US,461,09/07/1994764hu0023020278988IB:411605.7SYNORAB01PD-0012-US,1255,08/19/1994765hu0030023372104IB:411605.7PD-0001-4-US,59,07/28/1994766hu0043322169718IB:411605.7HUVESTB01PD-0003-2-US,7143,04/28/1994|PD-0003-3-US,8259,08/26/1994767hu00150706649490IB:411605.7CARCTXT02PR-0001-P,1115,11/17/1995|PR-0001-US,1115,11/15/1996768hu0027062326609IB:411605.7SPLNFET01PD-0004-US,1002,02/02/1994|PD-0004-US,1002,02/02/1994769hu0011912841719IB:411605.7TBLYNOT01PD-0007-US,1016,03/22/1994770hu0060871077013IB:411605.7SYNORAB01PD-0012-US,10,08/19/1994771hu008043081862465IB:411605.7PROSNOT19772hu002847113179407IB:411605.7TLYJNOT01PD-0382-P,388,06/06/1997|PD-0382-US,388,05/21/1998773hu0049028268007IB:411605.7HUVESTB01PD-0003-2-US,6562,04/28/1994|PD-0003-3-US,7678,08/26/1994774hu001397143079952IB:411605.7BRAIUNT01PD-0348-P,612,03/31/1997|PD-0348-US,612,03/30/1998775hu00231892892IB:411605.7U937NOT01PD-0001-3-US,723,02/14/1994|PD-0001-US,723,07/17/1992|PD-0001-1-PCT,814,07/16/1993|PD-0001-1-US,814,11/19/1992776hu00357416581245IB:411605.7BRAVTXT05PR-0003-US,2393,11/13/1996|PR-0004-P,2393,12/15/1995777hu005157801416IB:411605.7U937NOT01PD-0001-1-PCT,1297,07/16/1993|PD-0001-1-US,1297,11/19/1992|PD-0001-3-US,1297,02/14/1994778hu00620289536352IB:411605.7ADRENOT03PD-0144-US,1490,04/10/1997|PD-0055-P,255,10/24/1995|PD-0055-US,255,10/16/1996779hu006345364213912IB:411605.7BRONDIT01PS-0006-P,1967,12/23/1997|PS-0004-US,2916,12/13/1996780hu0029538152704IB:411605.7PD-0008-US,224,06/27/1994781hu006890902914553IB:411605.7THYMFET03PD-0345-P,232,03/21/1997|PD-0345-US,232,03/18/1998782hu00624894578971IB:411605.7BRAVTXT05PR-0003-US,1734,11/13/1996|PR-0004-P,1734,12/15/1995783rat00180808700768273ZS:220379.1RAHYNOT02PZ-0078-P,1373,04/06/1998|PZ-0033-US,3037,10/05/1998784rat00029077701242681ZS:220379.1RALINOH02PZ-0091-P,980,10/27/1998785rat00238831701246365ZS:220379.1RALINOH02PZ-0091-P,2355,10/27/1998786rat00157148701188745ZS:220379.1RACONON02PZ-0085-P,1468,06/11/1998787rat00228376700496220ZS:220379.1RAHINOT01PZ-0025-US,342,09/09/1998|PZ-0044-P,342,11/04/1997788rat00112998700370466ZS:220379.1RAHYNOT01PZ-0033-P,1505,10/08/1997|PZ-0033-US,1505,10/05/1998789rat00067297700315154ZS:220379.1RAESNOT01PZ-0032-P,722,10/08/1997|PZ-0032-US,722,10/07/1998790rat00099177700497170ZS:220379.1RAHINOT01PZ-0025-US,829,09/09/1998|PZ-0044-P,829,11/04/1997791rat00188749700770692ZS:220379.1RABONOT01PZ-0076-US,2604,04/06/1999|PZ-0077-P,300,04/07/1998792rat00149897700290724ZS:220379.1RAEPNOT01PZ-0015-P,706,08/05/1997|PZ-0015-US,706,08/04/1998793rat00102720700367624ZS:220379.1RAHYNOT01PZ-0033-P,126,10/08/1997|PZ-0033-US,126,10/05/1998794rat00119114700066526ZS:220379.1RABTNOT01PZ-0001-P,909,06/12/1997|PZ-0001-US,909,06/08/1998795rat00214272700061414ZS:220379.1RAKINOT02PZ-0002-P,1061,06/13/1997|PZ-0002-US,1803,06/09/1998796rat00166231701482761ZS:220379.1RALITXT42PZ-0109-P,1018,02/11/1999797rat00071074700541247ZS:220379.1RACONOT01PZ-0043-P,1407,11/04/1997|PZ-0014-US,2845,08/05/1998798rat00240806701193468ZS:220379.1RALINOT02PZ-0026-US,1543,09/04/1998|PZ-0082-P,213,05/01/1998799rat00017707700606709ZS:220379.1RALINOH01PZ-0053-P,110,12/12/1997|PZ-0053-US,110,12/11/1998800rat00103279700420587ZS:220379.1RAHANOT01PZ-0040-US,620,10/08/1998|PZ-0041-P,620,10/09/1997801rat00179213700593713ZS:220379.1RATRNOT04PZ-0062-P,1327,01/16/1998802rat00155382700928945ZS:220379.1RACONON04PZ-0085-P,3819,06/11/1998803rat00241944701189016ZS:220379.1RACONON02PZ-0085-P,1629,06/11/1998804hu007887511986692IB:902506.4LUNGAST01PD-0120-US,4303,02/28/1997|PD-0247-P,957,09/27/1996805hu002638982270579IB:902506.4PROSNON01PD-0198-US,118,07/28/1997|PD-0284-P,118,12/05/1996806hu006790883274021IB:902506.4PROSBPT06PD-0376-P,639,06/02/1997|PD-0376-US,639,05/15/1998807hu004114011347425IB:902506.4PROSNOT11PD-0175-P,1177,05/24/1996|PD-0175-US,1177,05/23/1997808hu00849869864155IB:902506.4BRAITUT03PD-0126-1-US,2148,11/25/1997|PD-0126-P,2148,03/08/1996|PD-0126-US,2148,03/07/1997809hu007331101423768IB:902506.4CARGDIT02PR-0008-P,1063,06/04/1996|PR-0008-US,1063,06/03/1997810hu005000942355551IB:902506.4LUNGNOT20PD-0282-P,630,12/04/1997|PD-0282-US,630,11/14/1997811hu006306133325114IB:902506.4PTHYNOT03PD-0392-P,2054,07/01/1997|PD-0392-US,2054,06/26/1998812hu004832111296794IB:902506.4PGANNOT03PD-0165-P,1588,05/28/1996|PD-0165-US,1588,05/23/1997813hu007260241340754IB:902506.4COLNTUT03PD-0174-US,1448,05/13/1997|PD-0174-P,737,05/13/1996814hu008046402695839IB:902506.4UTRSNOT12PD-0346-US,5009,03/27/1998|PD-0346-P,731,03/27/1997815hu004348401746423IB:902506.4STOMTUT02PD-0235-P,229,08/30/1996816hu003079311502674IB:902506.4BRAITUT07PD-0183-P,112,06/24/1996|PD-0183-US,112,06/18/1997817hu001182492899137IB:902506.4DRGCNOT01PD-0337-US,4433,03/05/1998818hu003591701294153IB:902506.4PGANNOT03PD-0165-P,756,05/28/1996|PD-0165-US,756,05/23/1997819hu008344243256826IB:902506.4OVARTUN01PD-0374-P,2112,06/04/1997|PD-0374-US,2112,05/18/1998820hu004913093244929IB:902506.4BRAINOT19PD-0370-P,1299,05/29/1997|PD-0370-US,1299,05/12/1998821hu006413941739432IB:902506.4HIPONON01PD-0224-P,69,08/28/1996|PD-0224-US,69,08/26/1997822hu005296833116132IB:902506.4LUNGTUT13PD-0358-P,2112,04/18/1997|PD-0358-US,2112,04/17/1998823hu002374991386061IB:902506.4CARGDIT02PR-0008-P,131,06/04/1996|PR-0008-US,131,06/03/1997824hu006971473337508IB:902506.4SPLNNOT10PD-0378-P,2315,06/05/1997|PD-0378-US,2315,05/19/1998825hu001973351905370IB:334807.1OVARNOT07PD-0249-P,2976,10/01/1996826hu007319872050014IB:411449.5LIVRFET02PD-0262-P,514,10/31/1996827hu007956291972386IB:411449.5UCMCL5T01PD-0194-US,3338,06/27/1997|PD-0272-P,737,10/23/1996828hu00885639463172IB:411449.5LATRNOT01PD-0053-P,2675,10/10/1995|PD-0053-US,2675,10/09/1996829hu007289781490003IB:411449.5UCMCL5T01PD-0194-P,2147,06/28/1996|PD-0194-US,2147,06/27/1997|PD-0184-P,823,06/24/1996830hu00531230239023IB:411449.5HIPONOT01PD-0026-US,6,02/23/1995831hu005027012096680IB:411449.5BRAITUT02PD-0111-1-US,3959,12/05/1997|PD-0275-P,4419,12/06/1996832hu001255312910217IB:411449.5KIDNTUT15833hu001618301698871IB:411449.5BLADTUT05PD-0221-US,466,07/31/1997|PD-0202-P,873,07/31/1996834hu001138162472307IB:411449.5THP1NOT03PD-0286-P,971,11/25/1996|PD-0286-US,971,11/04/1997835hu007632111689376IB:411449.5PROSTUT10PD-0200-P,2956,07/24/1996|PD-0200-US,2956,07/24/1997836hu00623901995171IB:411449.5KIDNTUT01PD-0137-P,37,03/25/1996|PD-0137-US,37,03/25/1997837hu004474213323088IB:411449.5PTHYNOT03PD-0392-P,1105,07/01/1997|PD-0392-US,1105,06/26/1998838hu005506272758260IB:411449.5THP1AZS08PD-0362-P,4482,05/01/1997|PD-0362-US,4482,04/29/1998839hu007401863448616IB:411449.5UTRSNON03PD-0397-P,510,07/02/1997|PD-0397-US,510,06/30/1998840hu004408383292975IB:411449.5BONRFET01PD-0368-P,1483,05/28/1997|PD-0368-US,1483,05/05/1998841hu00223687763788IB:411449.5LUNGNOT04PD-0121-US,1454,02/28/1997|PD-0140-P,7,04/10/1996842hu008723942476089IB:411449.5SMCANOT01PD-0298-P,452,01/30/1998|PD-0298-US,452,01/30/1998843hu008343783451002IB:411449.5UTRSNON03PD-0397-P,1853,07/02/1997|PD-0397-US,1853,06/30/1998844hu005545691625423IB:411449.5COLNPOT01PD-0206-P,2062,08/01/1996|PD-0206-US,2062,08/01/1997845hu007439962682429IB:411449.5SINIUCT01PD-0330-P,1155,02/12/1997|PD-0330-US,1155,02/10/1998846hu00919779491356IB:411449.5HNT2AGT01847hu001076211811236IB:411449.5PROSTUT12PD-0233-P,4420,09/05/1996|PD-0314-US,982,09/04/1997848hu003217042598057IB:411449.5OVARTUT02PD-0312-P,1654,01/21/1997|PD-0312-US,1654,01/21/1998849hu001046701984010IB:411449.5LUNGAST01PD-0120-US,3384,02/28/1997|PD-0247-P,38,09/27/1996850hu001026902830524IB:411449.5TLYMNOT03PD-0363-P,1463,05/02/1997|PD-0363-US,1463,04/30/1998851hu005273048248IB:411449.5852hu00017059321613IB:411449.5EOSIHET02PD-0067-P,3891,09/29/1995853hu00850406677686IB:411449.5CRBLNOT01PD-0093-P,1614,12/18/1995|PD-0089-US,3310,11/27/1996854hu007932032584176IB:411449.5BRAITUT22PD-0304-P,3154,01/28/1997|PD-0304-US,3154,01/28/1998855hu00732715638241IB:411449.5BRSTNOT03PD-0061-US,286,11/15/1996|PD-0065-P,286,11/28/1995856hu00242629257820IB:411449.5HNT2RAT01PD-0039-P,415,06/30/1995857hu00591902506236IB:411449.5TMLR3DT02PD-0081-P,1131,10/25/1995|PD-0081-US,1131,10/24/1996858hu006114782645110IB:411449.5OVARTUT03PD-0329-P,2367,03/07/1997|PD-0329-US,2367,03/05/1998859hu005149531957671IB:411449.5CONNNOT01PD-0244-P,1161,10/04/1996|PD-0244-US,1161,10/03/1997860hu008471342682468IB:411449.5SINIUCT01PD-0330-P,1176,02/12/1997|PD-0330-US,1176,02/10/1998861hu005274291302IB:411449.5U937NOT01PD-0001-1-PCT,1194,07/16/1993|PD-0001-1-US,1194,11/19/1992|PD-0001-3-US,1194,02/14/1994862hu007781523361311IB:411449.5PROSBPT02PD-0390-P,227,06/30/1997|PD-0390-US,227,06/26/1998863hu004835381355750IB:411449.5LUNGNOT09PD-0177-P,400,05/15/1996|PD-0177-US,400,05/14/1997864hu001697622173973IB:411449.5ENDCNOT03PD-0279-P,2047,11/22/1996|PD-0279-US,2047,11/07/1997865hu0062749457539IB:411449.5PD-0009-US,174,07/08/1994866hu006836722613128IB:411449.5BRSTTUT14PD-0320-P,4282,02/13/1997|PD-0320-US,4282,02/11/1998867hu006193582782774IB:411449.5BRSTNOT13PD-0335-P,216,03/21/1997|PD-0335-US,216,03/20/1998868hu003348461703167IB:334807.6DUODNOT02PD-0207-P,1739,07/29/1996|PD-0207-US,1739,07/29/1997869hu00538435806627IB:334807.6BSTMNOT01PD-0115-P,548,02/27/1996|PD-0115-US,548,02/27/1997870hu000459751831627IB:334807.6THP1AZT01PD-0236-P,683,08/30/1996|PD-0236-US,683,08/29/1997871hu00255713381954IB:334807.6HYPONOB01PD-0071-P,446,10/03/1995872hu003098303245690IB:334807.6BRAINOT19PD-0370-P,1641,05/29/1997|PD-0370-US,1641,05/12/1998873hu008383201593378IB:334807.6BRAINOT14PD-0204-P,166,07/26/1996874hu00600416928044IB:334807.6BRAINOT04PD-0132-P,1181,03/18/1996|PD-0132-US,1181,03/17/1997875hu006788141627474IB:334807.6COLNPOT01PD-0206-P,2480,08/01/1996|PD-0206-US,2480,08/01/1997876hu002203652750679IB:334807.6THP1AZS08PD-0362-P,562,05/01/1997|PD-0362-US,562,04/29/1998877hu00715266691867IB:902506.9LUNGTUT02PD-0097-P,1119,12/20/1995|PD-0097-US,1119,12/20/1996878hu00061515688682IB:902506.9LUNGTUT02PD-0097-P,92,12/20/1995|PD-0097-US,92,12/20/1996879hu012569885865786LG:034727.1COLTDIT04880hu013208066179644LG:244682.1BMARUNT02881hu002252721903494IB:815587.1OVARNOT07PD-0249-P,2256,10/01/1996882hu00492301434242IB:399851.1THYRNOT01PD-0049-P,401,10/02/1995|PD-0049-US,401,09/30/1996883hu001477083139053IB:399851.1SMCCNOT02PD-0377-P,1740,06/06/1997|PD-0377-US,1740,05/20/1998884hu00720528864652IB:399851.1BRAITUT03PD-0126-1-US,2336,11/25/1997|PD-0126-P,2336,03/08/1996|PD-0126-US,2336,03/07/1997885hu00662648631104IB:399851.1KIDNNOT05PD-0063-P,1223,11/22/1995|PD-0261-1-US,1223,10/29/1997886hu004252571729479IB:399851.1BRSTTUT08PD-0225-P,217,08/28/1996887hu011457986423435LG:459192.4BRSTUNT01888hu009906575712404LG:459192.4MASTTXT01889hu010332676100191LG:459192.4UTRENOT09890hu010645726096811LG:459192.4THP1TXT03891hu010146596411280LG:459192.4UTREDIT10892hu013439436514626LG:459192.4THYMDIT01893hu011723853787301LG:459192.4BRAHNOT05894hu012743836565167LG:459192.4MCLDTXT04895hu011260994667847LG:459192.4SINTNOT24896hu010964536411253LG:459192.4UTREDIT10897hu012806945842026LG:459192.4BRAENOT04898hu013032154518594LG:459192.4SINJNOT03899hu010820416541505LG:459192.4LNODNON02900hu001535082597277IB:197797.5OVARTUT02PD-0312-P,1355,01/21/1997|PD-0312-US,1355,01/21/1998901hu00928636923474IB:197797.5RATRNOT02PD-0135-P,1053,03/20/1996|PD-0135-US,1053,03/19/1997902hu004989071475844IB:197797.6LUNGTUT03PD-0189-US,1163,06/19/1997|PD-0189-P,1183,06/20/1996903hu011285305618571LG:449795.1THYMNOR02904hu011117916246764LG:449795.1TESTNOT17905hu012748005700115LG:449795.1DRGCNOT01906hu010752705951238LG:449795.1LIVRTUN04907hu010402996390391LG:449795.1BONRNOT01908hu012348466390312LG:449795.1BONRNOT01909hu012965343567447LG:449795.1BRONNOT02910hu011768716247056LG:449795.1TESTNOT17911hu009703765615260LG:449795.1THYMNOR02912hu001883281786291IB:197797.8BRAINOT10PD-0239-P,777,09/27/1996|PD-0239-US,777,09/24/1997913hu005127072779480IB:197797.8OVARTUT03PD-0329-P,1086,03/07/1997|PD-0329-US,1086,03/05/1998914hu004584461315024IB:197797.8BLADTUT02PD-0171-P,620,05/23/1996|PD-0171-US,620,05/22/1997915hu003107761786745IB:197797.8BRAINOT10PD-0239-P,956,09/27/1996|PD-0239-US,956,09/24/1997916hu008788811258759IB:197797.8MENITUT03PD-0147-P,1482,04/17/1996|PD-0147-US,1482,04/17/1997917hu006950581547727IB:197797.8PROSTUT04PD-0197-P,1890,06/21/1996|PD-0197-US,3425,06/23/1997918hu008095652100659IB:197797.8BRAITUT02PD-0111-1-US,5409,12/05/1997|PD-0275-P,5869,12/06/1996919hu004224602839374IB:197797.8DRGLNOT01PD-0337-P,853,03/18/1997|PD-0337-US,853,03/05/1998920hu002364741634458IB:197797.8COLNNOT19PD-0206-P,698,08/01/1996|PD-0206-US,698,08/01/1997921hu005043242702257IB:197797.8OVARTUT10PD-0341-P,3530,03/20/1997|PD-0341-US,3530,03/19/1998922hu006658462356088IB:230901.1LUNGNOT20PD-0282-P,787,12/04/1997|PD-0282-US,787,11/14/1997923hu00369297978769IB:230901.1BRSTNOT02PD-0157-P,1805,04/26/1996|PD-0157-US,1805,04/25/1997924hu007297232654856IB:230901.1THYMNOT04PD-0315-P,4208,01/30/1997|PD-0315-US,4208,01/30/1998925hu002285813181917IB:230901.1TLYJNOT01PD-0382-P,1089,06/06/1997|PD-0382-US,1089,05/21/1998926hu007479702016903IB:230901.1THP1NOT01PD-0273-US,1443,10/28/1997|PD-0273-P,147,10/31/1996927rat00217853701230984ZS:212821.1RASJNON03PZ-0098-P,950,11/12/1998928rat00105569700627723ZS:212821.1RAFBNOT01PZ-0064-P,1020,02/12/1998|PZ-0064-US,1020,02/10/1999929rat00066626700911955ZS:212821.1RAXSNOT02PZ-0100-P,2668,11/12/1998930rat00209690701280056ZS:212821.1RABXNOT02PZ-0087-P,313,08/11/1998931rat00193805700769886ZS:212821.1RAHYNOT02PZ-0078-P,2042,04/06/1998|PZ-0033-US,3706,10/05/1998932rat00080783700647424ZS:212821.1RAPINOT02PZ-0065-P,40,02/11/1998|PZ-0065-US,40,02/10/1999933rat00177525701396532ZS:212821.1RALITXT14PZ-0094-P,2968,09/11/1998934rat00068166700490877ZS:212821.1RABCNOT01PZ-0012-US,2025,08/04/1998|PZ-0042-P,224,11/05/1997935rat00129844700374582ZS:212821.1RALANOT01PZ-0040-US,1135,10/08/1998|PZ-0040-P,204,10/09/1997936rat00159187700373236ZS:212821.1RARANOT01PZ-0037-US,2040,10/06/1998|PZ-0037-P,851,10/09/1997937rat00126977700546735ZS:212821.1RASPNOT01PZ-0055-P,1423,12/12/1997|PZ-0003-US,3602,05/21/1998938rat00085597701194114ZS:212821.1RALINOT02PZ-0026-US,1697,09/04/1998|PZ-0082-P,367,05/01/1998939rat00002212701644894ZS:212821.1RALITXT40PZ-0120-P,434,05/06/1999940rat00240035700126003ZS:212821.1RABHNOT01PZ-0004-P,1788,07/09/1997|PZ-0004-US,1788,07/09/1998941rat00004910700642857ZS:212821.1RABUNOT01PZ-0058-P,1247,01/16/1998|PZ-0057-US,3605,01/11/1999942rat00150261701512158ZS:212821.1RALITXT02PZ-0112-P,1886,03/08/1999943rat00106163700479909ZS:212821.1RALINON03PZ-0059-P,89,01/16/1998|PZ-0059-US,89,01/12/1999944rat00035083700059536ZS:212821.1RAKINOT02PZ-0002-US,1020,06/09/1998|PZ-0002-P,278,06/13/1997945rat00203069700629237ZS:212821.1RAFBNOT01PZ-0064-P,1498,02/12/1998|PZ-0064-US,1498,02/10/1999946rat00028253701304081ZS:212821.1RASGNON05PZ-0105-P,652,12/10/1998947rat00078430701651203ZS:212821.1RALITXT10PZ-0117-P,566,05/07/1999948rat00056155700505437ZS:212821.1RALINON07PZ-0060-P,2054,01/16/1998|PZ-0059-US,4252,01/12/1999949rat00104549701484590ZS:212821.1RALITXT50PZ-0109-P,1369,02/11/1999950rat00108680701026436ZS:212821.1RAFANOT02PZ-0101-P,966,12/10/1998951rat00127454701467315ZS:212821.1RALITXT32PZ-0108-P,693,02/11/1999952rat00081843701484801ZS:212821.1RALITXT50PZ-0109-P,1412,02/11/1999953rat00137590700911350ZS:212821.1RAXSNOT02PZ-0100-P,2438,11/12/1998954rat00190565700461547ZS:212821.1RATHNOC02PZ-0049-P,92,11/07/1997|PZ-0049-US,92,11/09/1998955rat00013868700493031ZS:212821.1RABCNOT01PZ-0042-P,1273,11/05/1997|PZ-0012-US,3074,08/04/1998956rat00162269701490669ZS:212821.1RALITXT54PZ-0135-P,520,08/05/1999957rat00088471700514441ZS:212821.1RASNNOT01PZ-0054-P,1590,12/11/1997|PZ-0054-US,1590,12/10/1998958rat00093566701025551ZS:212821.1RAFANOT02PZ-0101-P,892,12/10/1998959rat00042779700396312ZS:212821.1RAHTNOT01PZ-0037-US,50,10/06/1998|PZ-0048-P,50,11/05/1997960rat00017885701485302ZS:212821.1RALITXT50P7-0109-P,1514,02/11/1999961rat00171598701913515ZS:212821.1RABYUNS03PZ-0125-P,853,06/29/1999962rat00189715701021709ZS:212821.1RAFANOT02PZ-0101-P,87,12/10/1998963rat00053789701186432ZS:212821.1RACONON02PZ-0085-P,67,06/11/1998964rat00175856700310390ZS:212821.1RAUCNOT01PZ-0029-P,230,09/11/1997|PZ-0029-US,230,09/04/1998965rat00164967700591163ZS:212821.1RATRNOT04PZ-0062-P,559,01/16/1998966rat00078693701290475ZS:212821.1RABXNOT04PZ-0090-P,317,08/12/1998967rat00066877700639812ZS:212821.1RATONOT01PZ-0036-US,1299,10/09/1998968rat00096796700052543ZS:212821.1RABTNOT01PZ-0001-P,8,06/12/1997|PZ-0001-US,8,06/08/1998969rat00161402701022008ZS:212821.1RAFANOT02PZ-0101-P,181,12/10/1998970rat00161602701468265ZS:212821.1RALITXT32PZ-0108-P,887,02/11/1999971rat00010529700769478ZS:212821.1RAHYNOT02PZ-0078-P,1872,04/06/1998|PZ-0033-US,3536,10/05/1998972rat00020781701464269ZS:212821.1RALITXT32PZ-0108-P,110,02/11/1999973rat00100296701827434ZS:212821.1RAKITXT09PZ-0132-P,592,08/10/1999974rat00185004701718036ZS:212821.1RAKITXT09PZ-0132-P,1479,08/10/1999975rat00024363700435067ZS:212821.1RAHLNOT02PZ-0047-P,124,11/06/1997|PZ-0047-US,124,11/03/1998976rat00211395700415992ZS:212821.1RAHTNOT01PZ-0037-US,384,10/06/1998|PZ-0048-P,384,11/05/1997977rat00061195700311142ZS:212821.1RAUCNOT01PZ-0029-P,520,09/11/1997|PZ-0029-US,520,09/04/1998978rat00003893700812651ZS:212821.1RAPINOT03PZ-0073-P,1226,03/11/1998|PZ-0073-US,1226,03/09/1999979rat00184074701021635ZS:212821.1RAFANOT02PZ-0101-P,67,12/10/1998980rat00028608700519425ZS:212821.1RABHNOT02PZ-0021-US,1575,09/08/1998|PZ-0050-P,1575,12/11/1997981rat00050865701489338ZS:212821.1RALITXT54PZ-0135-P,248,08/05/1999982rat00142197700275567ZS:212821.1RASINOT02PZ-0038-P,498,10/08/1997|PZ-0038-US,498,10/05/1998983hu009695304344032LG:401992.11SINDNOT01984rat00178844700370485ZS:271430.1RAHYNOT01PZ-0033-P,1516,10/08/1997|PZ-0033-US,1516,10/05/1998985hu005238412907890IB:293052.1THYMNOT05PD-0393-P,1543,07/02/1997|PD-0393-US,1543,06/24/1998986hu007596052781237IB:293052.1OVARTUT03PD-0329-P,1864,03/07/1997|PD-0329-US,1864,03/05/1998987rat00161197700933680ZS:223059.1RALINON03PZ-0075-P,1418,03/10/1998|PZ-0075-US,2358,03/09/1999988rat00214410701714807ZS:223059.1RABYUNN02PZ-0130-P,1205,06/29/1999989rat00016800700543268ZS:223059.1RASPNOT01PZ-0003-US,2502,05/21/1998|PZ-0055-P,323,12/12/1997990rat00113622700629946ZS:223059.1RATHNOT02PZ-0049-US,1640,11/06/1998|PZ-0072-P,99,03/12/1998991rat00090205700543958ZS:223059.1RASPNOT01PZ-0003-US,2702,05/21/1998|PZ-0055-P,523,12/12/1997992rat00165130700809939ZS:223059.1RAPINOT03PZ-0073-P,395,03/11/1998|PZ-0073-US,395,03/09/1999993rat00019997700275945ZS:223059.1RASINOT02PZ-0038-P,657,10/08/1997|PZ-0038-US,657,10/05/1998994rat00171632701260994ZS:223059.1RALINOH03PZ-0091-P,3061,10/27/1998995rat00188498701263538ZS:223059.1RABXNOT05PZ-0090-P,2606,08/12/1998996rat00044347700499733ZS:223059.1RAHINOT01PZ-0025-US,2145,09/09/1998|PZ-0044-P,2145,11/04/1997997rat00012121700363490ZS:223059.1RALMNON04PZ-0017-US,1150,08/05/1998|PZ-0035-P,1150,10/10/1997998rat00249136700820713ZS:216246.1RAESNOT02PZ-0032-US,1876,10/07/1998|PZ-0074-P,639,03/13/1998999rat00192355700530107ZS:216246.1RALMNOT01PZ-0045-P,1366,11/05/1997|PZ-0017-US,5163,08/05/19981000rat00227393700819863ZS:216246.1RAESNOT02PZ-0032-US,1575,10/07/1998|PZ-0074-P,338,03/13/19981001rat00057555700814470ZS:216246.1RABFNOT03PZ-0063-P,116,02/10/1998|PZ-0013-US,1209,08/07/19981002rat00085573701286468ZS:216246.1RABXNOT03PZ-0087-P,3309,08/11/19981003rat00194473700189527ZS:216246.1RATENOT01PZ-0020-P,844,08/06/1997|PZ-0020-US,844,07/31/19981004rat00193088701286761ZS:216246.1RABXNOT03PZ-0087-P,3453,08/11/19981005rat00029775700602464ZS:216246.1RASGNOT02PZ-0019-US,1205,08/04/1998|PZ-0071-P,425,03/11/19981006rat00177882700271991ZS:216246.1RASJNOT01PZ-0039-P,358,10/08/1997|PZ-0039-US,358,10/05/19981007rat00219996700856846ZS:216246.1RAXSNOT02PZ-0100-P,1980,11/12/19981008rat00233601701910492ZS:216246.1RABYUNN02PZ-0130-P,678,06/29/19991009rat00023406700591303ZS:216246.1RATRNOT04PZ-0062-P,572,01/16/19981010rat00111931701295547ZS:216246.1RABXNOT05PZ-0090-P,2902,08/12/19981011rat00107350700251664ZS:216246.1RABMNOT01PZ-0022-US,2440,09/01/1998|PZ-0022-P,516,09/11/19971012rat00142146700061690ZS:216246.1RAKINOT02PZ-0002-P,1185,06/13/1997|PZ-0002-US,1927,06/09/19981013rat00211383700522555ZS:216246.1RABMNOT01PZ-0022-US,388,09/01/1998|PZ-0051-P,388,12/12/19971014rat00044435700312605ZS:216246.1RAUCNOT01PZ-0029-P,1074,09/11/1997|PZ-0029-US,1074,09/04/19981015rat00021863700486975ZS:216246.1RATENOT01PZ-0020-US,2640,07/31/1998|PZ-0056-P,863,12/11/19971016rat00230438701280837ZS:216246.1RABXNOT02PZ-0087-P,685,08/11/19981017rat00184305701263345ZS:216246.1RABXNOT04PZ-0090-P,15,08/12/19981018rat00160545700130847ZS:216246.1RABHNOT01PZ-0004-P,3855,07/09/1997|PZ-0004-US,3855,07/09/19981019rat00225625701294142ZS:216246.1RABXNOT04PZ-0090-P,2080,08/12/19981020rat00052754700127864ZS:216246.1RABHNOT01PZ-0004-P,2606,07/09/1997|PZ-0004-US,2606,07/09/19981021rat00125754700419566ZS:216246.1RAHANOT01PZ-0040-US,287,10/08/1998|PZ-0041-P,287,10/09/19971022rat00216555700298707ZS:216246.1RAEONOT02PZ-0024-P,131,09/09/1997|PZ-0024-US,2045,09/10/19981023rat00249461700521683ZS:216246.1RABMNOT01PZ-0022-US,65,09/01/1998|PZ-0051-P,65,12/12/19971024rat00085625700489028ZS:216246.1RATENOT01PZ-0056-P,1684,12/11/1997|PZ-0020-US,3461,07/31/19981025rat00138547700821256ZS:216246.1RAESNOT02PZ-0032-US,2078,10/07/1998|PZ-0074-P,841,03/13/19981026rat00166582700297908ZS:216246.1RAEGNOT01PZ-0023-P,811,09/11/1997|PZ-0023-US,811,09/01/19981027rat00245747700129307ZS:216246.1RABHNOT01PZ-0004-P,3206,07/09/1997|PZ-0004-US,3206,07/09/19981028rat00177618700417150ZS:216246.1RAHTNOT01PZ-0037-US,790,10/06/1998|PZ-0048-P,790,11/05/19971029rat00249944700486715ZS:216246.1RATENOT01PZ-0020-US,2506,07/31/1998|PZ-0056-P,729,12/11/19971030rat00000920700268744ZS:216246.1RAADNOT03PZ-0011-US,1461,07/30/1998|PZ-0031-P,268,10/10/19971031rat00121523700174616ZS:216246.1RATENOT01PZ-0020-P,62,08/06/1997|PZ-0020-US,62,07/31/19981032rat00181521700489346ZS:216246.1RATENOT01PZ-0056-P,1793,12/11/1997|PZ-0020-US,3570,07/31/19981033rat00214904701270561ZS:216246.1RABPFET01PZ-0093-P,2550,09/08/19981034rat00052481701300219ZS:216246.1RABXNOT05PZ-0090-P,5180,08/12/19981035rat00134751700522758ZS:216246.1RABMNOT01PZ-0022-US,476,09/01/1998|PZ-0051-P,476,12/12/19971036rat00022566700068332ZS:216246.1RABTNOT01PZ-0001-P,1566,06/12/1997|PZ-0001-US,1566,06/08/19981037rat00040368700525582ZS:216246.1RABMNOT01PZ-0022-US,1463,09/01/1998|PZ-0051-P,1463,12/12-19971038rat00008580700300221ZS:216246.1RAEONOT02PZ-0024-US,2673,09/10/1998|PZ-0024-P,759,09/09/19971039rat00059250700533847ZS:216246.1RAEONOT02PZ-0024-US,682,09/10/1998|PZ-0052-P,682,12/11/19971040rat00191560701273613ZS:216246.1RABXNOT01PZ-0106-P,1111,01/11/19991041rat00017815701255660ZS:216246.1RALITXT03PZ-0096-P,115,10/09/19981042hu000428602747183IB:034727.1LUNGTUT11PD-0326-US,2425,03/04/1997|P0-0326-P,858,03/07/19971043hu00298010996393IB:034727.1KIDNTUT01PD-0137-P,740,03/25/1996|PD-0137-US,740,03/25/19971044hu009334201447832IB:034727.1PLACNOT02PD-0167-US,2113,05/29/1997|PD-0193-P,753,06/27/19961045hu00667284286060IB:034727.1EOSIHET02PD-0036-US,332,04/26/19951046hu003720393980387IB:244682.1LUNGTUT08PD-0326-US,4258,03/04/19971047rat00124233700250549ZS:290707.1RABHNOT02PZ-0021-P,1700,09/09/1997|PZ-0021-US,4276,09/08/19981048rat00239898700123628ZS:290707.1RABHNOT01PZ-0004-P,757,07/09/1997|PZ-0004-US,757,07/09/19981049hu005512662938247IB:334198.1THYMFET02PD-0361-P,1263,04/24/1997|PD-0361-US,1263,04/23/19981050hu0066684622377IB:334198.2ADENINB01PD-0005-US,1175,02/04/1994|PD-0033-US,1705,03/29/1995|PD-0033-1-US,2095,07/13/19951051hu005288771925075IB:334198.2BRSTNOT02PD-0240-P,195,09/30/1996|PD-0240-US,195,09/29/19971052hu008159781364475IB:334198.2SCORNON02PD-0161-P,25,04/29/1996|PD-0161-US,25,04/29/19971053hu006385893438723IB:334198.2PENCNOT06PD-0389-P,2229,07/02/1997|PD-0389-US,2229,06/24/19981054hu000310252303842IB:334198.2BRSTNOT05PD-0292-P,3843,12/19/1996|PD-0292-US,3843,12/18/19971055hu00499778691479IB:334198.2LUNGTUT02PD-0097-P,998,12/20/1995|PD-0097-US,998,12/20/19961056hu006789892097617IB:334198.2BRAITUT02PD-0111-1-US,4284,12/05/1997|PD-0275-P,4744,12/06/19961057hu00016195680352IB:334198.2UTRSNOT02PD-0095-P,703,12/29/1995|PD-0095-US,703,12/23/19961058hu00442156996586IB:334198.2KIDNTUT01PD-0137-P,832,03/25/1996|PD-0137-US,832,03/25/19971059hu009523411476048IB:334198.2LUNGTUT03PD-0189-US,1210,06/19/1997|PD-0189-P,1230,06/20/19961060hu009053372153735IB:334198.2BRAINOT09PD-0275-P,1772,12/06/1996|PD-0163-US,3806,05/20/19971061hu008390622397557IB:334198.2THP1AZT01PD-0296-P,1081,12/17/1996|PD-0236-US,1978,08/29/19971062hu008040972171748IB:334198.2ENDCNOT03PD-0279-P,1165,11/22/1996|PD-0279-US,1165,11/07/19971063hu008672423929904IB:334198.2KIDNNOT191064hu003467642734931IB:334198.2OVARNOT09PD-0311-P,107,01/27/1997|PD-0311-US,107,01/23/19981065hu007338552582411IB:334198.2KIDNTUT13PD-0325-P,4047,03/05/19971066hu005057773089081IB:334198.2HEAONOT03PD-0352-P,1715,04/18/1997|PD-0352-US,1715,04/24/19981067hu00439947663716IB:334198.2SCORNOT01PD-0094-P,153,12/14/1995|PD-0094-US,153,12/12/19961068hu008982542278413IB:334198.2PROSNON01PD-0198-US,3516,07/28/1997|PD-0284-P,3516,12/05/19961069hu0004313124810IB:334198.2ADENINB01PD-0033-US,2391,03/29/1995|PD-0005-US,2693,02/04/1994|PD-0033-1-US,2770,07/13/19951070hu001415062591180IB:334198.2LUNGNOT22PD-0328-P,1022,03/06/1997|PD-0328-US,1022,03/03/19981071hu005613034907489IB:334198.2TLYMNOT08PS-0007-P,1321,04/15/1999|PS-0007-US,1321,04/15/19991072hu00046521259698IB:334198.2HNT2RAT01PD-0039-P,964,06/30/19951073hu0015910321859IB:334198.2ADENINB01PD-0033-US,1553,03/29/1995|PD-0033-1-US,1945,07/13/1995|PD-0005-US,859,02/04/19941074hu003131472618859IB:334198.2GBLANOT01PD-0338-P,2065,03/14/1997|PD-0338-US,2065,03/12/19981075hu009012611450971IB:334198.2PENITUT01PD-0192-P,236,06/27/19961076hu006272303079454IB:334198.2BRAIUNT01PD-0348-P,422,03/31/1997|PD-0348-US,422,03/30/19981077hu002038351493650IB:334198.2PROSNON01PD-0198-US,5231,07/28/1997|PD-0198-P,624,07/29/19961078hu003862142370759IB:334198.2ADRENOT07PD-0301-P,2613,12/19/1996|PD-0301-US,2613,12/17/19971079hu009234432290353IB:334198.2BRAINON01PD-0274-P,3555,11/20/19961080hu007266142275525IB:334198.2PROSNON01PD-0198-US,2265,07/28/1997|PD-0284-P,2265,12/05/19961081hu003246752287631IB:334198.2BRAINON01PD-0274-P,2022,11/20/19961082hu006161492986658IB:334198.2CARGDIT01PD-0349-P,710,03/31/1997|PD-0349-US,710,03/31/19981083hu008234192452912IB:334198.2ENDANOT01PD-0299-P,1111,12/16/1996|PD-0299-US,1111,12/04/19971084hu003673082509602IB:334198.2CONUTUT01PD-0300-P,2985,12/20/1996|PD-0300-US,2985,12/18/19971085hu005540953467240IB:334198.2BRAIDIT01PD-0384-P,442,06/06/1997|PD-0384-US,442,06/04/19981086hu006471553079537IB:334198.2BRAIUNT01PD-0348-P,453,03/31/1997|PD-0348-US,453,03/30/19981087hu007613661271327IB:334198.2TESTTUT02PD-0164-P,87,05/16/1996|PD-0164-US,87,05/15/19971088hu00783265452363IB:334198.2TLYMNOT02PD-0073-P,1768,10/02/19951089hu005406973029510IB:334198.2HEARFET02PD-0353-P,1392,04/18/1997|PD-0353-US,1392,03/17/19981090hu008815552838736IB:334198.2DRGLNOT01PD-0337-P,585,03/18/1997|PD-0337-US,585,03/05/19981091hu004574952503774IB:334198.2CONUTUT01PD-0300-P,687,12/20/1996|PD-0300-US,687,12/18/19971092hu00364798683266IB:334198.2UTRSNOT02PD-0095-P,1448,12/29/1995|PD-0095-US,1448,12/23/19961093hu00110621679322IB:334198.2UTRSNOT02PD-0095-P,341,12/29/1995|PD-0095-US,341,12/23/19961094hu002770432941393IB:334198.2HEAONOT03PD-0352-P,1913,04/18/1997|PD-0352-US,1913,04/24/19981095hu002015871517789IB:334198.2PANCTUT01PD-0196-P,1634,06/21/19961096hu00320966217IB:334198.2U937NOT01PD-0001-3-US,165,02/14/1994|PD-0001-US,165,07/17/1992|PD-0001-1-US,183,11/19/19921097hu006930442697521IB:334198.2UTRSNOT12PD-0346-P,1411,03/27/1997|PD-0346-US,5696,03/27/19981098hu006344543279421IB:334198.2STOMFET02PD-0379-P,969,06/02/1997|PD-0379-US,969,05/15/19981099hu0071149554555IB:334198.2PD-0008-US,1131,06/27/19941100hu006105792742812IB:334198.2BRSTTUT14PD-0320-P,3396,02/13/1997|PD-0320-US,3396,02/11/19981101hu003409662583990IB:334198.2BRAITUT22PD-0304-P,3075,01/28/1997|PD-0304-US,3075,01/28/19981102hu004476622349158IB:334198.2COLSUCT01PD-0278-P,320,12/05/1996|PD-0278-US,320,11/21/19971103hu002675283567447IB:334198.2BRONNOT02PS-0003-P,1248,06/06/1997|PS-0003-US,1248,06/06/19971104hu005709832654142IB:334198.2THYMNOT04PD-0315-P,3877,01/30/1997|PD-0315-US,3877,01/30/19981105hu00589236266368IB:334198.2HNT2NOT01PD-0038-P,114,06/16/19951106hu00494959654402IB:334198.2EOSINOT03PR-0002-1-US,1583,11/19/1997|PR-0002-P,1583,12/13/1995|PR-0002-US,1583,12/12/19961107hu0085400021552IB:334198.2ADENINB01PD-0033-US,1477,03/29/1995|PD-0033-1-US,1869,07/13/1995|PD-0005-US,699,02/04/19941108hu00155044956044IB:334198.2KIDNNOT05PD-0261-1-US,2524,10/29/1997|PD-0142-P,785,04/10/1996|PD-0142-US,785,04/10/19971109hu00622162598239IB:334198.2BRSTNOT02PD-0061-P,281,11/15/1995|PD-0061-US,281,11/15/19961110hu003048142809547IB:334198.2TLYMNOT04PD-0363-P,6237,05/02/1997|PD-0363-US,6237,04/30/19981111hu000085641475663IB:334198.2LUNGTUT03PD-0189-US,1110,06/19/1997|PD-0189-P,1130,06/20/19961112hu001913282445935IB:334198.2THP1NOT03PD-0286-P,2356,11/25/1996|PD-0286-US,2356,11/04/19971113hu006523631513731IB:334198.2PANCTUT01PD-0196-P,666,06/21/19961114hu007603372586284IB:334198.2BRAITUT22PD-0304-P,3982,01/28/1997|PD-0304-US,3982,01/28/19981115hu004827082699720IB:334198.2OVARTUT10PD-0341-P,2608,03/20/1997|PD-0341-US,2608,03/19/19981116hu00342677479348IB:334198.2MMLR2DT01PD-0044-P,1277,10/02/1995|PD-0044-US,1277,10/02/19961117hu004952562752584IB:334198.2THP1AZS08PD-0362-P,1596,05/01/1997|PD-0362-US,1596,04/29/19981118hu002647851850751IB:334198.2LUNGFET03PD-0230-P,928,08/23/1996|PD-0230-US,928,08/22/19971119hu003346982133163IB:334198.2ENDCNOT01PD-0257-P,154,10/23/1996|PD-0257-US,154,10/22/19971120hu009394812154178IB:334198.2BRAINOT09PD-0275-P,1927,12/06/1996|PD-0163-US,3961,05/20/19971121rat00219199700179763ZS:206489.1RALUNOT01PZ-0006-P,676,07/10/1997|PZ-0006-US,676,07/10/19981122rat00177802700776044ZS:206489.2RAPINOT02PZ-0065-P,213,02/11/1998|PZ-0065-US,213,02/10/19991123rat00179794700860742ZS:206489.2RABGNOT02PZ-0076-P,1473,04/06/1998|PZ-0076-US,1473,04/06/19991124rat00199742700862233ZS:206489.2RABGNOT02PZ-0076-P,2100,04/06/1998|PZ-0076-US,2100,04/06/19991125hu003704771700421IB:235691.7BLADTUT05PD-0221-US,1011,07/31/1997|PD-0202-P,1418,07/31/19961126hu002017552914593IB:235691.7THYMFET03PD-0345-P,252,03/21/1997|PD-0345-US,252,03/18/19981127hu003529461878873IB:235691.7LEUKNOT03PD-0246-P,2728,10/04/1996|PD-0246-US,2728,10/02/19971128hu004229511391107IB:235691.7EOSINOT01PR-0009-P,1019,06/04/1996|PR-0009-US,1019,06/03/19971129hu005090642964175IB:235691.7SCORNOT04PD-0360-P,451,04/24/1997|PD-0360-US,451,04/23/19981130hu012639946313477LG:350527.5NERDTDN031131hu011152086613886LG:411605.10ARTANOT071132hu010727556270862LG:411605.11BRAIFEN031133hu010058585814585LG:411605.11PROSTUS231134hu010651706513219LG:411605.11THYMDIT011135hu011987826421324LG:411605.11BRSTUNT011136hu011489765864057LG:411605.11COLTDIT041137hu011631986401763LG:411605.11UTRENOT101138hu012816396378821LG:411605.11FIBAUNT011139hu011236286496712LG:411605.11COLNNOT411140hu011540396419875LG:411605.11BRSTUNT011141hu012063515822327LG:411605.11PROSTUS231142hu010147325813672LG:411605.11PROSTUS231143hu009861476408660LG:411605.12UTREDIT101144hu012159724518370LG:411605.12SINJNOT031145hu010510756517553LG:411605.12BRAFTDT021146hu012188526136188LG:411605.12BMARTXT021147hu011581326410975LG:411605.12UTREDIT101148hu010116225823548LG:411605.12PROSTUS231149hu013391666369723LG:411605.12ENDINOT011150hu010346966014804LG:411605.12FIBRUNT021151hu011590336398907LG:411605.12UTRENOT101152hu009947456568514LG:411605.12MCLDTXN051153hu010546535819602LG:411605.12PROSTUS231154hu013071846399030LG:411605.12UTRENOT101155hu011954316591075LG:411605.12TLYMUNT031156hu013026136257326LG:411605.12BMARTXT061157hu011910605698802LG:411605.12BRSTTUT131158rat00177217701229180ZS:221302.1RASJNON03PZ-0098-P,39,11/12/19981159rat00049893700934730ZS:221302.1RALINON03PZ-0075-P,1877,03/10/1998|PZ-0075-US,2817,03/09/19991160rat00187352700948690ZS:221302.1RASPNON02PZ-0099-P,1022,11/10/19981161rat00114238700295204ZS:221302.1RABFNOT02PZ-0013-P,1046,08/08/1997|PZ-0013-US,1046,08/07/19981162rat00177786701277731ZS:221302.1RABFNON02PZ-0097-P,1618,11/12/19981163rat00136648701334863ZS:221302.1RALINON08PZ-0034-US,2345,10/08/19981164rat00046766701274943ZS:221302.1RABFNON02PZ-0097-P,593,11/12/19981165rat00200496701275514ZS:221302.1RABFNON02PZ-0097-P,806,11/12/19981166rat00100831700127275ZS:221302.1RABHNOT01PZ-0004-P,2355,07/09/1997|PZ-0004-US,2355,07/09/19981167rat00132474701333270ZS:221302.1RALINON08PZ-0034-US,1716,10/08/19981168rat00144368701944168ZS:211420.2RALITXT1KPZ-0134-P,814,08/12/19991169rat00168417701466250ZS:211420.2RALITXT32PZ-0108-P,480,02/11/19991170rat00076851701944268ZS:211420.2RALITXT1KPZ-0134-P,833,08/12/19991171rat00216982701258551ZS:211420.2RALITXT03PZ-0096-P,883,10/09/19981172rat00248339701616185ZS:211420.2RALITXT61PZ-0127-P,123,07/07/19991173rat00213314700141178ZS:211420.2RALINOT01PZ-0010-P,970,07/10/1997|PZ-0010-US,970,07/10/19981174rat00105136701734388ZS:211420.2RALITXT1CPZ-0126-P,351,07/08/19991175rat00130615701725735ZS:211420.2RALITXT1APZ-0122-P,9,06/03/19991176rat00251888701339880ZS:211420.2RALITXT08PZ-0092-P,1425,08/13/19981177rat00221660701475064ZS:211420.2RALITXT41PZ-0123-P,1034,06/04/19991178rat00042254700303823ZS:211420.2RALINOT01PZ-0026-P,555,09/12/1997|PZ-0026-US,555,09/04/19981179rat00010468700524067ZS:211420.2RABMNOT01PZ-0022-US,984,09/01/1998|PZ-0051-P,984,12/12/19971180rat00120763701880885ZS:211420.2RALITXS02PZ-0133-P,1322,08/10/19991181rat00028407701396970ZS:211420.2RALITXT14PZ-0094-P,3057,09/11/19981182rat00107373700132732ZS:211420.2RALMNOT01PZ-0017-US,1998,08/05/1998|PZ-0017-P,384,08/06/19971183rat00121848700140788ZS:211420.2RALINOT01PZ-0010-P,885,07/10/1997|PZ-0010-US,885,07/10/19981184hu004755332234427IB:012835.1PANCTUT02PD-0295-P,201,12/20/1996|PD-0191-US,2359,06/19/19971185hu007645002242421IB:012835.1PANCTUT02PD-0295-P,2612,12/20/1996|PD-0191-US,4770,06/19/19971186hu005890512703885IB:405464.1OVARTUT10PD-0341-P,4112,03/20/1997|PD-0341-US,4112,03/19/19981187hu005186493328680IB:405464.1HEAONOT04PD-0387-P,3175,07/03/1997|PD-0387-US,3175,06/30/19981188hu00267484389504IB:017960.1THYMNOT02PD-0041-P,3211,09/26/1995|PD-0077-P,3211,10/02/1995|PD-0077-US,3211,10/02/19961189hu00467745343775IB:017960.1THYMNOT02PD-0041-P,253,09/26/1995|PD-0077-P,253,10/02/1995|PD-0077-US,253,10/02/19961190hu008668652749717IB:197797.10LUNGTUT11PD-0326-P,1699,03/07/1997|PD-0326-US,3266,03/04/19971191hu006796382795118IB:197797.10NPOLNOT01PD-0340-P,330,03/28/1997|PD-0340-US,330,03/27/19981192hu000000522544029IB:197797.10UTRSNOT11PD-0316-P,2400,01/29/1997|PD-0316-US,2400,01/26/19981193hu006799181488916IB:197797.10UCMCL5T01PD-0194-P,1896,06/28/1996|PD-0194-US,1896,06/27/1997|PD-0184P,567,06/24/19961194hu002210482482284IB:197797.10SMCANOT01PD-0298-P,2062,01/30/1998|PD-0298-US,2062,01/30/19981195hu003334501591308IB:197797.10CARGNOT01PR-0010-P,294,06/27/1996|PR-0010-US,294,06/26/19971196hu002362512748126IB:197797.10LUNGTUT11PD-0326-P,1175,03/07/1997|PD-0326-US,2742,03/04/19971197hu000139622477774IB:197797.10SMCANOT01PD-0298-P,845,01/30/1998|PD-0298-US,845,01/30/19981198hu000776012542849IB:197797.10UTRSNOT11PD-0316-P,2002,01/29/1997|PD-0316-US,2002,01/26/19981199hu003426803973829IB:197797.10ADRETUT06PD-0333-US,3227,03/12/19981200hu004757011699889IB:197797.10BLADTUT05PD-0202-P,1208,07/31/1996|PD-0221-US,801,07/31/19971201hu002951271475835IB:197797.10LUNGTUT03PD-0189-US,1161,06/19/1997|PD-0189-P,1181,06/20/19961202hu000058694346925IB:197797.10TLYMTXT01PS-0008-P,487,04/16/1998|PS-0008-US,487,04/16/19991203hu00918443854372IB:197797.10NGANNOT01PD-0123-US,954,02/28/1997|PD-0125-P,954,03/07/19961204hu007509081489193IB:197797.10UCMCL5T01PD-0194-P,1955,06/28/1996|PD-0194-US,1955,06/27/1997|PD-0184P,627,06/24/19961205hu00735159813961IB:197797.10OVARTUT01PD-0112-1-US,119,11/14/1997|PD-0112-P,119,02/22/1996|PD-0112-US,119,02/21/19971206hu00349275676879IB:197797.10CRBLNOT01PD-0093-P,1318,12/18/1995|PD-0089-US,3014,11/27/19961207hu007578512883157IB:197797.10UTRSTUT05PD-0346-US,2373,03/27/1998|PD-0346-P,4421,03/27/19971208hu006459641930333IB:197797.10COLNTUT03PD-0242-P,1059,09/25/1996|PD-0174-US,2729,05/13/19971209hu005993722465467IB:197797.10THYRNOT08PD-0394-P,2053,07/02/1997|PD-0394-US,2053,06/24/19981210hu004666773979618IB:197797.10LUNGTUT08PD-0326-US,4026,03/04/19971211hu008718671548750IB:197797.10PROSNOT06PD-0199-P,4543,07/30/19961212hu006698842482006IB:197797.10SMCANOT01PD-0298-P,1980,01/30/1998|PD-0298-US,1980,01/30/19981213hu000320053972034IB:197797.10ADRETUT06PD-0333-US,2450,03/12/19981214hu004060421302173IB:197797.10PLACNOT02PD-0167-P,1202,05/30/1996|PD-0167-US,1202,05/29/19971215hu000234901754053IB:197797.10LIVRTUT01PD-0220-P,1136,07/30/19961216hu005372011805622IB:197797.10SINTNOT13PD-0234-P,713,08/28/19961217hu00413338355076IB:197797.10RATRNOT01PD-0053-P,5220,10/10/1995|PD-0053-US,5220,10/09/19961218hu000869211445360IB:197797.10PLACNOT02PD-0193-P,109,06/27/1996|PD-0167-US,1469,05/29/19971219hu008224461915970IB:197797.10PROSTUT04PD-0232-P,1990,09/05/1996|PD-0197-US,4558,06/23/19971220hu00369125491397IB:197797.10HNT2AGT011221hu001493851405153IB:197797.10LATRTUT02PD-0187-P,1137,06/25/1996|PD-0176-US,3031,05/20/19971222hu000889091423720IB:197797.10CARGDIT02PR-0008-P,1050,06/04/1996|PR-0008-US,1050,06/03/19971223hu002895372875708IB:197797.10THYRNOT10PD-0395-P,3012,07/02/1997|PD-0395-US,3012,06/23/19981224hu00465993550170IB:197797.10BEPINOT01PD-0056-P,1116,10/31/1995|PD-0056-US,1116,10/16/19961225hu007096882278238IB:197797.10PROSNON01PD-0198-US,3436,07/28/1997|PD-0284-P,3436,12/05/19961226hu007858491332454IB:197797.10PANCNOT07PD-0172-P,1238,05/23/1996|PD-0172-US,1238,05/22/19971227hu00071401155152IB:197797.10THP1PLB021228hu001330161332142IB:197797.10PANCNOT07PD-0172-P,1140,05/23/1996|PD-0172-US,1140,05/22/19971229hu007123412683259IB:197797.10SINIUCT01PD-0330-P,1434,02/12/1997|PD-0330-US,1434,02/10/19981230hu006516212827925IB:197797.10TLYMNOT03PD-0363-P,428,05/02/1997|PD-0363-US,428,04/30/19981231hu008017232862812IB:197797.10SININOT03PD-0343-P,1492,03/25/1997|PD-0343-US,1492,03/25/19981232hu003251742122664IB:197797.10BRSTNOT07PD-0166-US,828,05/13/1997|PD-0276-P,828,11/21/19961233hu001234962554840IB:197797.10THYMNOT03PD-0315-P,1004,01/30/1997|PD-0315-US,1004,01/30/19981234hu006443722630572IB:197797.10COLNTUT15PD-0305-P,282,01/22/1997|PD-0305-US,282,01/22/19981235hu00452495465062IB:197797.10LATRNOT01PD-0053-P,1717,10/10/1995|PD-0053-US,1717,10/09/19961236hu006677232908988IB:197797.10THYMNOT05PD-0393-P,2027,07/02/1997|PD-0393-US,2027,06/24/19981237hu007746801870177IB:197797.10SKINBIT01PD-0253-P,1236,10/03/1996|PD-0253-US,1236,09/30/19971238hu009081883340773IB:197797.10SPLNNOT10PD-0378-P,3069,06/05/1997|PD-0378-US,3069,05/19/19981239hu00896372938004IB:197797.10CERVNOT01PD-0128-P,2451,03/22/19961240hu000957682848865IB:197797.10BRSTTUT13PD-0336-P,362,03/18/19971241hu000831102439949IB:197797.10EOSITXT01PR-0013-P,1235,11/25/1996|PR-0011-US,2591,08/29/19971242hu002412341414913IB:197797.10BRAINOT12PD-0159-P,922,06/20/1996|PD-0159-US,922,06/18/19971243hu003050632720175IB:197797.10LUNGTUT10PD-0327-P,247,03/05/1997|PD-0327-US,247,03/03/19981244hu003770002685714IB:197797.10LUNGNOT23PD-0388-P,609,07/03/1997|PD-0388-US,609,06/19/19981245hu002824032371533IB:197797.10ADRENOT07PD-0301-P,2911,12/19/1996|PD-0301-US,2911,12/17/19971246hu000036383088650IB:197797.10HEAONOT03PD-0352-P,1556,04/18/1997|PD-0352-US,1556,04/24/19981247hu005241182152591IB:197797.10BRAINOT09PD-0275-P,1359,12/06/1996|PD-0163-US,3393,05/20/19971248hu00307641780556IB:197797.10MYOMNOT01PD-0113-P,437,02/27/1996|PD-0113-US,437,02/27/19971249hu000406483947580IB:197797.10DRGCNOT01PD-0337-US,6903,03/05/19981250hu001167353981972IB:197797.10LUNGTUT08PD-0326-US,4719,03/04/19971251hu003440582659340IB:197797.10LUNGTUT09PD-0310-P,3309,01/28/1997|PD-0310-US,3309,01/28/19981252hu00060966937943IB:197797.10CERVNOT01PD-0128-P,2427,03/22/19961253hu004582461320953IB:197797.10BLADNOT04PD-0202-US,878,07/31/1997|PD-0170-P,882,05/29/19961254hu002986233972523IB:197797.10ADRETUT06PD-0333-US,2675,03/12/19981255hu000528691871348IB:197797.10SKINBIT01PD-0253-P,1636,10/03/1996|PD-0253-US,1636,09/30/19971256hu005307982660893IB:197797.10LUNGTUT09PD-0310-P,3914,01/28/1997|PD-0310-US,3914,01/28/19981257hu009616462665670IB:197797.10ADRENOT08PD-0317-P,1773,02/11/1997|PD-0317-US,1773,02/10/19981258hu009487133180353IB:197797.10TLYJNOT01PD-0382-P,642,06/06/1997|PD-0382-US,642,05/21/19981259hu005475481484296IB:197797.10CORPNOT02PD-0185-P,2878,06/26/1996|PD-0185-US,2878,06/26/19971260rat00151369701607583ZS:222773.1RALITXT09PZ-0116-P,773,04/29/19991261rat00127186700372543ZS:222773.1RARANOT01PZ-0037-US,1804,10/06/1998|PZ-0037-P,615,10/09/19971262rat00069932700781722ZS:222773.1RABSNOT02PZ-0057-P,547,01/16/1998|PZ-0057-US,547,01/11/19991263rat00192972701649506ZS:222773.1RALITXT10PZ-0117-P,57,05/07/19991264rat00035697700768474ZS:222773.1RAHYNOT02PZ-0078-P,1452,04/06/1998|PZ-0033-US,3116,10/05/19981265rat00026987700366914ZS:222773.1RAMGNOT01PZ-0046-P,622,11/04/1997|PZ-0046-US,622,11/03/19981266rat00163788700274636ZS:222773.1RASINOT02PZ-0038-P,145,10/08/1997|PZ-0038-US,145,10/05/19981267rat00168756700328048ZS:222773.1RASNNOT01PZ-0095-P,1168,09/09/1998|PZ-0054-US,3550,12/10/19981268rat00000372700485657ZS:222773.1RATENOT01PZ-0020-US,2023,07/31/1998|PZ-0056-P,246,12/11/19971269rat00202332700635667ZS:222773.1RATONOT01PZ-0036-US,240,10/09/19981270rat00110821701232896ZS:222773.1RASJNON03PZ-0098-P,2108,11/12/19981271rat00010175701580093ZS:222773.1RALIUNT03PZ-0121-P,245,05/03/19991272rat00190601700519840ZS:222773.1RABHNOT02PZ-0021-US,1786,09/08/1998|PZ-0050-P,1786,12/11/19971273rat00085202700627492ZS:222773.1RAFBNOT01PZ-0064-P,951,02/12/1998|PZ-0064-US,951,02/10/19991274rat00165071700530153ZS:222773.1RALMNOT01PZ-0045-P,1389,11/05/1997|PZ-0017-US,5186,08/05/19981275rat00035607701419250ZS:222773.1RASLNOT01PZ-0107-P,648,01/14/19991276rat00162742700636665ZS:222773.1RATONOT01PZ-0036-US,553,10/09/19981277rat00080178701343275ZS:222773.1RALITXT11PZ-0094-P,888,09/11/19981278rat00206754701319684ZS:222773.1RALITXT05PZ-0092-P,437,08/13/19981279rat00244717700766587ZS:222773.1RAHYNOT02PZ-0033-US,2350,10/05/1998|PZ-0078-P,686,04/06/19981280rat00078375701392692ZS:222773.1RALITXT14PZ-0094-P,2297,09/11/19981281rat00218796700785820ZS:222773.1RABSNOT02PZ-0057-P,2321,01/16/1998|PZ-0057-US,2321,01/11/19991282rat00112251700914592ZS:222773.1RAXSNOT02PZ-0100-P,3656,11/12/19981283rat00204007700625377ZS:222773.1RAFBNOT01PZ-0064-P,303,02/12/1998|PZ-0064-US,303,02/10/19991284rat00171140700785521ZS:222773.1RABSNOT02PZ-0057-P,2188,01/16/1998|PZ-0057-US,2188,01/11/19991285rat00131225700306832ZS:222773.1RASDNOT02PZ-0027-US,1332,09/08/1998|PZ-0028-P,78,09/08/19971286rat00125440700626941ZS:222773.1RAFBNOT01PZ-0064-P,762,02/12/1998|PZ-0064-US,762,02/10/19991287rat00170710700276565ZS:222773.1RASINOT02PZ-0038-P,855,10/08/1997|PZ-0038-US,855,10/05/19981288rat00125900700314659ZS:222773.1RAESNOT01PZ-0032-P,529,10/08/1997|PZ-0032-US,529,10/07/19981289rat00207810700420110ZS:222773.1RAHANOT01PZ-0040-US,462,10/08/1998|PZ-0041-P,462,10/09/19971290rat00114355700246776ZS:222773.1RABCNOT01PZ-0012-US,1145,08/04/19981291rat00252245700288432ZS:222773.1RASDNOT01PZ-0027-P,931,09/08/1997|PZ-0027-US,931,09/08/19991292rat00059151701519417ZS:222773.1RALITXT62PZ-0136-P,402,08/06/19991293rat00095233700629369ZS:222773.1RAFBNOT01PZ-0064-P,1537,02/12/1998|PZ-0064-US,1537,02/10/19991294rat00024880701025922ZS:222773.1RAFANOT02PZ-0101-P,924,12/10/19981295rat00036707700631958ZS:222773.1RATHNOT02PZ-0049-US,2279,11/06/1998|PZ-0072-P,738,03/12/19981296rat00227417700636674ZS:222773.1RATONOT01PZ-0036-US,558,10/09/19981297rat00150890700914122ZS:222773.1RAXSNOT02PZ-0100-P,3482,11/12/19981298rat00252960701024824ZS:222773.1RAFANOT02PZ-0101-P,839,12/10/19981299rat00038841700910639ZS:222773.1RAXSNOT02PZ-0100-P,2194,11/12/19981300hu005384912328033IB:124382.6COLNNOT11PD-0289-P,536,12/18/1996|PD-0289-US,536,12/18/19971301hu00384197579187IB:815661.1BRAVTXT05PR-0003-US,1793,11/13/1996|PR-0004-P,1793,12/15/19951302rat00200270700534404ZS:205952.1RAEONOT02PZ-0024-US,908,09/10/1998|PZ-0052-P,908,12/11/19971303rat00094481701344942ZS:205952.3RALITXT11PZ-0094-P,1394,09/11/19981304rat00210583700525076ZS:205952.3RABMNOT01PZ-0022-US,1281,09/01/1998|PZ-0051-P,1281,12/12/19971305rat00181406701292649ZS:205952.3RABXNOT04PZ-0090-P,1274,08/12/19981306rat00028541701654201ZS:205952.3RALITXT10PZ-0117-P,1421,05/07/19991307rat00216462700289551ZS:205952.3RAEPNOT01PZ-0015-P,230,08/05/1997|PZ-0015-US,230,08/04/19981308rat00133499700415338ZS:205952.3RAHTNOT01PZ-0037-US,163,10/06/1998|PZ-0048-P,163,11/05/19971309rat00254102700538084ZS:205952.3RACONOT01PZ-0014-US,1757,08/05/1998|PZ-0043-P,319,11/04/19971310rat00205869700485031ZS:205952.3RALINON03PZ-0059-P,2164,01/16/1998|PZ-0059-US,2164,01/12/19991311rat00151088701650221ZS:205952.3RALITXT10PZ-0117-P,272,05/07/19991312rat00170519701655217ZS:205952.3RALITXT10PZ-0117-P,1667,05/07/19991313rat00083093700305954ZS:205952.3RALINOT01PZ-0026-P,1134,09/12/1997|PZ-0026-US,1134,09/04/19981314rat00246380701468078ZS:205952.3RALITXT32PZ-0108-P,852,02/11/19991315hu012781896027904LG:401992.6TESTNOT111316hu010557646593314LG:401992.6UTREDIT141317hu012119966307844LG:401992.6NERDTDN031318hu010432756593514LG:401992.6UTREDIT141319hu010159015303918LG:401992.6BRSTDIT011320hu013445995885852LG:401992.7LIVRNON081321hu009967146523764LG:401992.7CONFTDT021322hu011110115993818LG:401992.7FTUBTUT021323hu013495895882855LG:401992.7LIVRNON081324hu010330036114074LG:401992.7SINITMT041325hu009985943567250LG:401992.7BRONNOT021326hu011039126114081LG:401992.7SINITMT041327hu012617235943729LG:401992.7COLADIT051328hu012631464211225LG:401992.7BRONDIT011329hu012782135885814LG:401992.7LIVRNON081330hu011526456605876LG:401992.7UTREDIT071331hu011567045697593LG:401992.7BRSTTUT131332hu012459404209022LG:401992.7BRONNOT021333hu010825366364143LG:401992.7ARTANOT071334hu012044793780874LG:401992.7BRAHDIT041335hu012667365886691LG:401992.7LIVRNON081336hu011658736512389LG:401992.7THYMDIT011337hu010288594516729LG:401992.7SINJNOT031338hu011689456522528LG:401992.7CONFTDT021339hu011597746299317LG:401992.7UTREDIT071340hu009795506354938LG:401992.7LUNGDIS031341hu011303356411611LG:401992.7UTREDIT101342hu013028306271241LG:401992.7BRAIFEN031343hu011031294438756LG:401992.7SINTNOT221344hu010191144438771LG:401992.7SINTNOT221345hu013119404443584LG:401992.7SINDNOT011346hu010094706098582LG:401992.7UTRENOT091347hu011718226361222LG:401992.7CONFNOT091348hu012851325883291LG:401992.7LIVRNON081349hu012156526366607LG:401992.7ARTANOT071350hu012934145954210LG:401992.7SKINTDT011351hu011209754515822LG:401992.7SINJNOT031352rat00036395700488315ZS:222830.3RATENOT01PZ-0056-P,1431,12/11/1997|PZ-0020-US,3208,07/31/19981353rat00028422701728973ZS:222830.3RALITXT1APZ-0122-P,491,06/03/19991354rat00118389700367922ZS:222830.3RAHYNOT01PZ-0033-P,265,10/08/1997|PZ-0033-US,265,10/05/19981355rat00216886700486083ZS:222830.3RATENOT01PZ-0020-US,2205,07/31/1998|PZ-0056-P,428,12/11/19971356rat00099149701484604ZS:222830.3RALITXT50PZ-0109-P,1372,02/11/19991357hu010121216480126LG:270051.8PROSTMC011358hu012421176373901LG:270051.8FIBAUNT021359hu011834115890253LG:270051.8LIVRNON081360hu010315366546449LG:270051.8LNODNON021361hu012133816424874LG:270051.8BRSTUNT011362hu011491226176089LG:270051.8BMARUNT021363hu011248225885588LG:270051.8LIVRNON081364hu012660245884115LG:270051.8LIVRNON081365hu011241846431732LG:270051.8LUNGNON071366hu010866016319383LG:270051.8LUNGDIN021367hu010703846006445LG:270051.8FIBRUNT021368hu010733825714842LG:270051.8MASTTXT011369hu010317396153505LG:270051.8ENDMUNT041370hu011153586245935LG:270051.8TESTNOT171371hu011537176306763LG:270051.8NERDTDN031372hu010259815945146LG:270051.8COLADIT051373hu013037935884982LG:270051.8LIVRNON081374hu012271776322160LG:270051.8LUNGDIN021375hu012394093154287LG:270051.8TLYMTXT021376hu011783546375238LG:270051.8FIBAUNT021377hu012691646246035LG:270051.8TESTNOT171378hu013488416537280LG:270051.8OVARDIN021379hu005317311319812IB:803140.1BLADNOT04PD-0202-US,565,07/31/1997|PD-0170-P,570,05/29/19961380hu004850951389252IB:803140.1EOSINOT01PR-0009-P,214,06/04/1996|PR-0009-US,214,06/03/19971381hu00443053886511IB:464689.10PANCNOT05PD-0130-P,716,03/26/19961382hu006881523275752IB:464689.10PROSBPT06PD-0376-P,1041,06/02/1997|PD-0376-US,1041,05/15/19981383hu00592769767583IB:464689.10LUNGNOT04PD-0140-P,1377,04/10/1996|PD-0121-US,2824,02/28/19971384hu004989632822820IB:464689.10ADRETUT06PD-0333-P,875,03/14/1997|PD-0333-US,875,03/12/19981385hu002134682231189IB:464689.10PROSNOT16PD-0290-P,1186,12/19/1996|PD-0290-US,1186,07/30/19971386hu006864982625106IB:464689.10PROSTUT12PD-0314-P,203,01/22/1997|PD-0314-US,2152,09/04/19971387hu001541702823682IB:464689.10ADRETUT06PD-0333-P,1294,03/14/1997|PD-0333-US,1294,03/12/19981388hu00747944500IB:233861.8U937NOT01PD-0001-3-US,384,02/14/1994|PD-0001-US,384,07/17/1992|PD-0001-1-PCT,442,07/16/1993|PD-0001-1-US,442,11/19/19921389hu00685584682041IB:233861.8UTRSNOT02PD-0095-P,3168,12/29/1995|PD-0095-US,3168,12/23/19961390hu00547949101255IB:233861.8ADRENOT01PD-0016-US,1342,10/14/19941391hu00030222219448IB:233861.8STOMNOT01PD-0022-US,3159,02/07/19951392hu00720500303290IB:233861.8TESTNOT04PD-0052-P,535,10/10/1995|PD-0052-US,535,10/09/19961393hu00204075207382IB:233861.8SPLNNOT02PD-0020-US,942,01/17/19951394hu00035425580332IB:233861.8BRAVTXT05PR-0003-US,2129,11/13/1996|PR-0004-P,2129,12/15/19951395hu0065041323424IB:233861.8ADENINB01PD-0005-US,1903,02/04/19941396hu003150832636808IB:233861.8BONTNOT01PD-0302-P,642,01/27/1997|PD-0302-US,642,01/23/19981397hu00221835895100IB:233861.8BRSTNOT05PD-0133-P,767,03/20/1996|PD-0133-US,767,03/20/19971398hu00497011988478IB:233861.8LVENNOT03PD-0134-P,106,03/21/1996|PD-0134-US,106,03/21/19971399hu00750217927899IB:233861.8BRAINOT04PD-0132-P,1130,03/18/1996|PD-0132-US,1130,03/17/19971400hu00397213215284IB:233861.8STOMNOT01PD-0022-US,785,02/07/19951401hu0025691221437IB:233861.8ADENINB01PD-0005-US,609,02/04/19941402hu0018147524011IB:233861.8ADENINB01PD-0005-US,2283,02/04/19941403hu0044958021857IB:233861.8ADENINB01PD-0005-US,858,02/04/19941404hu0071690821630IB:233861.8ADENINB01PD-0005-US,739,02/04/19941405hu007735841818131IB:233861.8PROSNOT20PD-0233-P,2982,09/05/1996|PD-0233-US,2982,09/05/19971406hu000404072663627IB:771292.1ADRENOT08PD-0317-P,1004,02/11/1997|PD-0317-US,1004,02/10/19981407hu010761925920138LG:464689.12BRAIFET021408hu009232211753287IB:795701.1LIVRTUT01PD-0220-P,881,07/30/19961409hu000072641812515IB:795701.1PROSTUT12PD-0314-US,1463,09/04/1997|PD-0233-P,4901,09/05/19961410hu008643911710659IB:795701.1PROSNOT16PD-0199-P,1043,07/30/1996|PD-0290-US,3413,07/30/19971411hu00384233176197IB:795701.1TLYMNOT011412hu005535861694075IB:795701.1COLNNOT23PD-0206-P,1186,08/01/1996|PD-0206-US,1186,08/01/19971413hu003856471753396IB:795701.1LIVRTUT01PD-0220-P,926,07/30/19961414hu004660191753376IB:795701.1LIVRTUT01PD-0220-P,916,07/30/19961415hu000516322635071IB:401992.6BONTNOT01PD-0302-P,87,01/27/1997|PD-0302-US,87,01/23/19981416hu0095096886657IB:401992.8LIVRNOT01PD-0014-US,1016,09/07/19941417hu00155335139171IB:401992.8LIVRNOT01PD-0064-P,244,10/10/1995|PD-0064-US,244,10/09/19961418hu010343105878526LG:475317.2BRAUNOT011419hu013048006600271LG:475317.2ARTANOT061420hu012600715561109LG:475317.2BRSTDIT011421hu011086025703148LG:475317.2DRGCNOT011422hu010851234443746LG:475317.2SINDNOT011423hu012244526428594LG:475317.2LUNGNON071424hu011164624343561LG:475317.2SINTNOT221425hu013327243021152LG:475317.2PROSDIN011426hu012055816213466LG:475317.2ARTANOT061427hu011824436376812LG:475317.2FIBAUNT011428hu011445095700295LG:475317.2DRGCNOT011429hu012053856364679LG:475317.2ARTANOT071430hu013208846489032LG:475317.2MIXDUNB011431hu010527926378287LG:475317.2FIBAUNT011432hu013126676349775LG:475317.2LUNGDIS031433hu011324886379980LG:475317.2FIBRUNT021434hu009720094516928LG:475317.2SINJNOT031435hu010949166412344LG:475317.2UTREDIT101436hu011583484518475LG:475317.2SINJNOT031437hu010859095704048LG:475317.2DRGCNOT011438hu009871536363156LG:475317.2CONFNOT091439hu009737536521229LG:475317.2CONFTDT021440hu013289856455607LG:475317.2COLNDIC011441hu010250916598793LG:475317.2ARTANOT061442hu010425086208789LG:475317.2ARTANOT061443hu010503666498438LG:475317.2COLNNOT411444hu013167123899830LG:475317.2LUNGNON031445hu011054844441007LG:475317.2SINTNOT221446hu011972214668358LG:475317.2SINTNOT241447hu010142696208589LG:475317.2ARTANOT061448hu011196243899623LG:475317.2LUNGNON031449hu011663704440405LG:475317.2SINTNOT221450hu012906076491681LG:475317.2MIXDUNB011451hu012353564443438LG:475317.2SINDNOT011452hu012137396208777LG:475317.2ARTANOT061453hu010129676513632LG:475317.2THYMDIT011454hu013473086431741LG:475317.2LUNGNON071455hu012427644438923LG:475317.2SINTNOT221456hu011419833023596LG:475317.2PROSDIN011457hu009810276513532LG:475317.2THYMDIT011458hu012258366023712LG:475317.2TESTNOT111459hu010219953022286LG:475317.2PROSDIN011460hu010729456598639LG:475317.2ARTANOT061461hu013356465692805LG:475317.2BRAUNOT021462hu012526495702665LG:475317.2DRGCNOT011463hu009712825562537LG:475317.2BRSTDIT011464hu012944286169636LG:475317.2UTRSTDT011465hu009913816376628LG:475317.2FIBAUNT011466hu013047796023337LG:475317.2TESTNOT111467hu011790676384872LG:475317.2FIBRUNT021468hu009922736363655LG:475317.2CONFNOT091469hu010945686010162LG:475317.2FIBRUNT021470hu012865484517845LG:475317.2SINJNOT031471hu011897623019790LG:475317.2PROSDIN011472hu003782721455594IB:798928.1COLNFET02PD-0168-US,1623,05/21/1997|PD-0195-P,72,06/19/19961473hu008343761433063IB:798928.1BEPINON01PD-0181-P,1341.05/30/1996|PD-0181-US,1341,05/28/19971474hu010952136422373LG:464689.5BRSTUNT011475hu011095506421660LG:464689.5BRSTUNT011476hu009794736298033LG:464689.5UTREDIT071477hu009883924121984LG:464689.5BRSTTUT251478hu010064766134672LG:464689.5BMARTXT021479hu012244296421768LG:464689.5BRSTUNT011480hu012229546100330LG:464689.5UTRENOT091481hu011999776559430LG:464689.5BRAFNON021482hu010649175873539LG:464689.5COLTDIT041483hu012533886053960LG:464689.5BRAENOT041484hu012124066426224LG:464689.5LUNGNON071485hu012986696310337LG:464689.8NERDTDN031486hu00276005715790IB:401992.10PROSTUT01PD-0138-P,636,03/25/1996|PD-0138-US,636,03/25/1997|PD-0139-P,636,04/10/19961487hu004699192782796IB:401992.10BRSTNOT13PD-0335-P,221.03/21/1997|PD-0335-US,221,03/20/19981488hu005460162822929IB:401992.10ADRETUT06PD-0333-P,926,03/14/1997|PD-0333-US,926,03/12/19981489hu003721632096038IB:401992.10BRAITUT02PD-0111-1-US,3758,12/05/1997|PD-0275-P,4218,12/06/19961490hu006436402219006IB:401992.10LUNGNOT18PD-0263-P,229,10/28/1996|PD-0263-US,229,10/28/19961491hu0064887889474IB:401992.10LIVRNOT01PD-0014-US,2734,09/07/19941492hu00229760714309IB:401992.10PROSTUT01PD-0138-P,179,03/25/1996|PD-0138-US,179,03/25/1997|PD-0139-P,179,04/10/19961493hu00285912715581IB:401992.10PROSTUT01PD-0138-P,570,03/25/1996|PD-0138-US,570,03/25/1997|PD-0139-P,570,04/10/19961494hu001400542085627IB:401992.10PANCNOT04PD-0291-P,188,12/17/19961495hu0004801288118IB:401992.10LIVRNOT01PD-0014-US,1935,09/07/19941496hu009541772815429IB:401992.10OVARNOT10PD-0341-P,2121,03/20/1997|PD-0341-US,2121,03/19/19981497hu00062127760074IB:401992.10BRAITUT02PD-0111-1-US,3177,12/05/1997|PD-0111-P,995,02/22/1996|PD-0111-US,995,02/21/19971498hu000460722025847IB:475317.3KERANOT02PD-0116-1-US,1953,10/24/1997|PD-0260-P,531,10/25/19961499hu002054733343173IB:475317.3SPLNNOT09PD-0378-P,846,06/05/1997|PD-0378-US,846,05/19/19981500hu00569891274309IB:475317.3PANCDIT03PD-0054-P,230,10/10/1995|PD-0054-US,230,10/08/19961501hu007796382601745IB:475317.3UTRSNOT10PD-0316-P,1295,01/29/1997|PD-0316-US,1295,01/26/19981502hu000067832892508IB:475317.3LUNGFET04PD-0357-P,1767,04/16/1997|PD-0357-US,1767,04/08/19981503hu003937031362055IB:475317.3LUNGNOT12PD-0188-P,721,06/19/1997|PD-0188-US,721,06/18/19971504hu003026682460609IB:475317.3THYRNOT08PD-0394-P,521,07/02/1997|PD-0394-US,521,06/24/19981505hu005607262715415IB:475317.3THYRNOT09PD-0331-P,361,02/13/1997|PD-0331-US,361,02/10/19981506hu000123323364921IB:475317.3PROSBPT02PD-0390-P,1478,06/30/1997|PD-0390-US,1478,06/26/19981507hu00732727606092IB:475317.3BRSTTUT01PD-0061-P,2796,11/15/1995|PD-0061-US,2796,11/15/19961508hu00336872274308IB:475317.3PANCDIT03PD-0054-P,229,10/10/1995|PD-0054-US,229,10/08/19961509hu008512943358609IB:475317.3PROSTUT16PD-0391-P,2949,06/30/1997|PD-0391-US,2949,06/19/19981510hu000493582640032IB:475317.3LUNGTUT08PD-0326-P,108,03/07/1997|PD-0326-US,108,03/04/19971511hu004897752731063IB:475317.5OVARTUT04PD-0313-P,605,01/22/1997|PD-0313-US,605,01/22/19981512hu000411042184244IB:475317.5SININOT01PD-0267-P,1635,10/31/1996|PD-0267-US,1635,10/29/19971513hu001411313204456IB:475317.5PENCNOT03PD-0375-P,2021,06/02/1997|PD-0375-US,2021,05/08/19981514hu00260911849715IB:475317.5NGANNOT01PD-0123-US,2904,02/28/1997|PD-0123-P,381,02/28/19961515hu005180802637127IB:475317.5BONTNOT01PD-0302-P,735,01/27/1997|PD-0302-US,735,01/23/19981516hu004659002531872IB:475317.5GBLANOT02PD-0306-P,1427,01/27/1997|PD-0306-US,1427,01/23/19981517hu003814352466966IB:475317.5THYRNOT08PD-0394-P,2541,07/02/1997|PD-0394-US,2541,06/24/19981518hu00268512855636IB:475317.5NGANNOT01PD-0123-US,1421,02/28/1997|PD-0125-P,1421,03/07/19961519hu006390073200905IB:475317.5PENCNOT02PD-0375-P,693,06/02/1997|PD-0375-US,693,05/08/19981520hu002851283045769IB:475317.5HEAANOT01PD-0351-P,1313,04/25/1998|PD-0351-US,1313,04/23/19981521hu00485343205471IB:475317.5MPHGNOT02PD-0040-P,1994,08/01/19951522hu009337502603222IB:475317.5UTRSNOT10PD-0316-P,1767,01/29/1997|PD-0316-US,1767,01/26/19981523hu009150573216147IB:475317.5TESTNOT07PD-0380-P,783,06/04/1997|PD-0380-US,783,05/14/19981524hu003838503345777IB:475317.5SPLNNOT09PD-0378-P,1767,06/05/1997|PD-0378-US,1767,05/19/19981525hu006349512296070IB:475317.5BRSTNOT05PD-0292-P,693,12/19/1996|PD-0292-US,693,12/18/19971526hu000984162210959IB:475317.5SINTFET03PD-0268-P,1568,10/31/1996|PD-0268-US,1568,10/30/19971527hu004582181721127IB:475317.5BLADNOT06PD-0221-US,2850,07/31/1997|PD-0221-P,872,08/22/19961528hu00199732546344IB:475317.5OVARNOT02PD-0045-1-US,1827,11/10/1997|PD-0045-P,1827,10/24/1995|PD-0045-US,1827,10/18/19961529hu005832763685024IB:475317.5HEAANOT01PD-0351-US,2401,04/23/19981530hu006373863044734IB:475317.5HEAANOT01PD-0351-P,943,04/25/1998|PD-0351-US,943,04/23/19981531hu003985851259249IB:475317.5MENITUT03PD-0147-P,1699,04/17/1996|PD-0147-US,1699,04/17/19971532hu006885572772012IB:475317.5COLANOT02PD-0321-P,1627,02/12/1997|PD-0321-P,1627,02/12/1997|PD-0321-US,1627,02/10/1998|PD-0321-US,1627,02/10/19981533hu00131101359806IB:475317.5SYNORAB01PD-0069-P,1190,10/04/1995|PD-0069-US,1190,10/04/19961534hu00010027850468IB:475317.5NGANNOT01PD-0123-US,3132,02/28/1997|PD-0123-P,609,02/28/19961535hu005005371814906IB:475317.5PROSNOT20PD-0233-P,2179,09/05/1996|PD-0233-US,2179,09/05/19971536hu000071753949616IB:475317.5DRGCNOT01PD-0337-US,7592,03/05/19981537hu004524052274011IB:475317.5PROSNON01PD-0198-US,1629,07/28/1997|PD-0284-P,1629,12/05/19961538hu00122835350870IB:475317.5LVENNOT01PD-0053-P,3988,10/10/1995|PD-0053-US,3988,10/09/19961539hu001431661863706IB:475317.5PROSNOT191540hu008912313950806IB:475317.5DRGCNOT01PD-0337-US,8010,03/05/19981541hu007420561511496IB:475317.5LUNGNOT14PD-0208-P,1279,07/24/1996|PD-0208-US,1279,07/23/19971542hu009303753871292IB:475317.5BMARNOT03PD-0218-1-US,2525,03/12/19981543hu009550632350519IB:475317.5COLSUCT01PD-0278-P,658,12/05/1996|PD-0278-US,658,11/21/19971544hu005475621500749IB:475317.5SINTBST01PD-0209-P,906,07/23/1996|PD-0209-US,906,07/22/19971545hu005415861430632IB:475317.5SINTBST01PD-0209-P,2447,07/23/1996|PD-0209-US,2447,07/22/19971546hu002252992532363IB:475317.5GBLANOT02PD-0306-P,1593,01/27/1997|PD-0306-US,1593,01/23/19981547hu00870269629781IB:475317.5KIDNNOT05PD-0063-P,747,11/22/1995|PD-0261-1-US,747,10/29/19971548hu002958921927213IB:475317.5BRSTNOT02PD-0240-P,753,09/30/1996|PD-0240-US,753,09/29/19971549hu006196591494133IB:475317.5PROSNON01PD-0198-US,5405,07/28/1997|PD-0198-P,798,07/29/19961550hu002643342664524IB:475317.5ADRENOT08PD-0317-P,1327,02/11/1997|PD-0317-US,1327,02/10/19981551hu006127152635976IB:475317.5BONTNOT01PD-0302-P,384,01/27/1997|PD-0302-US,384,01/23/19981552hu00653360825794IB:475317.5PROSNOT06PD-0117-P,724,02/26/1996|PD-0117-US,724,02/26/19971553hu002754242708985IB:475317.5PONSAZT01PD-0342-P,2159,03/24/1997|PD-0342-US,2159,03/17/19981554hu006434092538760IB:475317.5BONRTUT01PD-0303-P,450,01/27/19971555hu005946201491886IB:475317.5PROSNON01PD-0198-P,2094,07/29/1996|PD-0198-US,6701,07/28/19971556hu00493542575237IB:475317.5BRAVUNT01PR-0003-US,750,11/13/1996|PR-0004-P,750,12/15/19951557hu005294351909488IB:475317.5CONNTUT01PD-0252-P,681,10/01/1996|PD-0254-P,681,10/04/19961558hu003594171470258IB:475317.5PANCTUT02PD-0191-P,1191,06/21/1996|PD-0191-US,1191,06/19/19971559hu00547491980214IB:475317.5TONGTUT01PD-0145-P,220,04/15/1996|PD-0145-US,220,04/15/19971560hu00659429783555IB:475317.5MYOMNOT01PD-0113-P,1163,02/27/1996|PD-0113-US,1163,02/27/19971561hu008918812846664IB:475317.5DRGLNOT01PD-0337-P,3933,03/18/1997|PD-0337-US,3933,03/05/19981562hu003586862587840IB:475317.5BRAITUT22PD-0304-P,4590,01/28/1997|PD-0304-US,4590,01/28/19981563hu005689481417356IB:475317.5BRAINOT12PD-0159-P,2021,06/20/1996|PD-0159-US,2021,06/18/19971564hu00241110944899IB:475317.5RATRNOT02PD-0135-P,1397,03/20/1996|PD-0135-US,1397,03/19/19971565hu00143107588444IB:475317.5UTRSNOT01PD-0084-P,587,10/26/1995|PD-0084-US,587,10/18/19961566hu001621343043960IB:475317.5HEAANOT01PD-0351-P,684,04/25/1998|PD-0351-US,684,04/23/19981567hu004732303093611IB:475317.5BRSTNOT19PD-0350-P,3917,04/16/1997|PD-0350-US,3917,04/09/19981568hu005216051259091IB:475317.5MENITUT03PD-0147-P,1626,04/17/1996|PD-0147-US,1626,04/17/19971569hu002495102847230IB:475317.5DRGLNOT01PD-0337-P,4154,03/18/1997|PD-0337-US,4154,03/05/19981570hu003717402540514IB:475317.5BONRTUT01PD-0303-P,1029,01/27/19971571hu003439623441655IB:475317.5PENCNOT06PD-0389-P,3323,07/02/1997|PD-0389-US,3323,06/24/19981572hu006630942968152IB:475317.5HEAONOT02PD-0387-P,91,07/03/1997|PD-0387-US,91,06/30/19981573hu009452813398972IB:475317.5UTRSNOT16PD-0398-P,1093,07/01/1997|PD-0398-US,1093,06/24/19981574hu009383151307709IB:475317.5COLNFET02PD-0168-P,105,05/21/1996|PD-0168-US,105,05/21/19971575hu00790652699870IB:475317.5SYNORAT03PD-0096-P,1664,12/15/1995|PD-0096-US,1664,12/15/19951576hu00619751426967IB:475317.5BLADNOT01PD-0048-P,988,09/29/19951577hu009253642685492IB:475317.5LUNGNOT23PD-0388-P,542,07/03/1997|PD-0388-US,542,06/19/19981578hu008524653085872IB:475317.5HEAONOT03PD-0352-P,535,04/18/1997|PD-0352-US,535,04/24/19981579hu001796811391873IB:475317.5THYRNOT03PD-0162-P,37,05/29/1996|PD-0162-US,37,05/27/19971580hu004921882050275IB:475317.5LIVRFET02PD-0262-P,569,10/31/19961581hu000973951599482IB:475317.5BLADNOT031582hu00295593851914IB:475317.5NGANNOT01PD-0123-US,4,02/28/1997|PD-0125-P,4,03/07/19961583hu008349682899326IB:475317.5DRGCNOT01PD-0337-US,4517,03/05/19981584hu005271111720956IB:475317.5BLADNOT06PD-0221-US,2801,07/31/1997|PD-0221-P,823,08/22/19961585hu000472051251167IB:475317.5LUNGFET03PD-0146-P,2493,04/17/1996|PD-0146-US,2493,04/16/19971586hu002238602968428IB:475317.5HEAONOT02PD-0387-P,202,07/03/1997|PD-0387-US,202,06/30/19981587hu005714132800404IB:475317.5PENCNOT01PD-0332-P,246,03/06/1997|PD-0332-US,246,03/06/19981588hu009511331724869IB:475317.5PROSNOT14PD-0201-P,452,07/29/1996|PD-0201-US,452,07/28/1997|PD-0210-P,452,07/24/19961589hu000473642838913IB:475317.5DRGLNOT01PD-0337-P,654,03/18/1997|PD-0337-US,654,03/05/19981590hu00363337829618IB:475317.5PROSTUT04PD-0117-P,1906,02/26/1996|PD-0117-US,1906,02/26/1997|PD-0197US,330,06/23/19971591hu002353672219374IB:475317.5LUNGNOT18PD-0263-P,372,10/28/1996|PD-0263-US,372,10/28/19961592hu004891052843830IB:475317.5DRGLNOT01PD-0337-P,2717,03/18/1997|PD-0337-US,2717,03/05/19981593hu00424737630799IB:475317.5KIDNNOT05PD-0063-P,1123,11/22/1995|PD-0261-1-US,1123,10/29/19971594hu00738027880514IB:475317.5THYRNOT02PD-0122-P,815,02/29/1996|PD-0122-US,815,02/28/19971595hu007650721581022IB:475317.5DUODNOT01PD-0207-P,895,07/29/1996|PD-0207-US,895,07/29/19971596hu007453183094485IB:475317.5BRSTNOT19PD-0350-P,4257,04/16/1997|PD-0350-US,4257,04/09/19981597hu005264662749513IB:475317.5LUNGTUT11PD-0326-P,1635,03/07/1997|PD-0326-US,3202,03/04/19971598hu007831373441811IB:475317.5PENCNOT06PD-0389-P,3367,07/02/1997|PD-0389-US,3367,06/24/19981599hu008604931303826IB:475317.5PLACNOT02PD-0167-P,597,05/30/1996|PD-0167-US,597,05/29/19971600hu004491851343609IB:475317.5PROSNOT11PD-0175-P,1642,05/24/1996|PD-0175-US,1642,05/23/19971601hu008799002782204IB:475317.5BRSTNOT13PD-0335-P,1,03/21/1997|PD-0335-US,1,03/20/19981602hu00674677782307IB:475317.5MYOMNOT01PD-0113-P,897,02/27/1996|PD-0113-US,897,02/27/19971603hu006686742294574IB:475317.5BRSTNOT05PD-0292-P,91,12/19/1996|PD-0292-US,91,12/18/19971604hu007458793439540IB:475317.5PENCNOT06PD-0389-P,2526,07/02/1997|PD-0389-US,2526,06/24/19981605hu000301411991854IB:475317.5CORPNOT02PD-0256-P,1088,10/23/1996|PD-0185-US,4908,06/26/19971606hu004878892683006IB:475317.5SINIUCT01PD-0330-P,1339,02/12/1997|PD-0330-US,1339,02/10/19981607hu007071802747201IB:475317.5LUNGTUT11PD-0326-US,2428,03/04/1997|PD-0326-P,861,03/07/19971608hu006301682405011IB:475317.5BSTMNON02PD-0160-1-US,2283,06/30/19981609hu000816371500748IB:475317.5SINTBST01PD-0209-P,905,07/23/1996|PD-0209-US,905,07/22/19971610hu0017801981829IB:475317.5SYNORAB01PD-0012-US,2963,08/19/19941611hu001576072059058IB:475317.5OVARNOT03PD-0108-1-US,2054,10/01/1997|PD-0249-P,293,10/01/19961612hu006542823365287IB:475317.5PROSBPT02PD-0390-P,1622,06/30/1997|PD-0390-US,1622,06/26/19981613hu000878502841918IB:475317.5DRGLNOT01PD-0337-P,1934,03/18/1997|PD-0337-US,1934,03/05/19981614hu001946902269574IB:475317.5UTRSNOT02PD-0288-P,1590,12/18/1996|PD-0288-US,1590,12/16/19971615hu008410791442809IB:475317.5THYRNOT03PD-0162-P,3220,05/29/1996|PD-0162-US,3220,05/27/19971616hu002373952303642IB:475317.5BRSTNOT05PD-0292-P,3766,12/19/1996|PD-0292-US,3766,12/18/19971617hu005825191704346IB:475317.5DUODNOT02PD-0207-P,2131,07/29/1996|PD-0207-US,2131,07/29/19971618hu00878143700454IB:475317.5SYNORAT03PD-0096-P,1846,12/15/1995|PD-0096-US,1846,12/15/19951619hu008577321986414IB:475317.5LUNGAST01PD-0120-US,4218,02/28/1997|PD-0247-P,872,09/27/19961620hu002958542614735IB:475317.5GBLANOT01PD-0338-P,348,03/14/1997|PD-0338-US,348,03/12/19981621hu00486285589828IB:475317.5UTRSNOT01PD-0084-P,1030,10/26/1995|PD-0084-US,1030,10/18/19961622hu005472892899169IB:475317.5DRGCNOT01PD-0337-US,4447,03/05/19981623hu00557569850494IB:475317.5NGANNOT01PD-0123-US,3140,02/28/1997|PD-0123-P,617,02/28/19961624hu000333032683822IB:475317.5LUNGNOT23PD-0388-P,11,07/03/1997|PD-0388-US,11,06/19/19981625hu001313172887324IB:475317.5SINJNOT02PD-0343-US,3196,03/25/19981626hu001330911282535IB:475317.5COLNNOT16PD-0148-P,455,04/25/1996|PD-0148-US,455,04/25/19971627hu002851031360106IB:475317.5LUNGNOT12P0-0188-P,201,06/19/1997|PD-0188-US,201,06/18/19971628hu002622702785553IB:475317.5BRSTNOT13PD-0335-P,1325,03/21/1997|PD-0335-US,1325,03/20/19981629hu003900091842667IB:475317.5COLNNOT07PD-0243-P,661,09/25/19961630hu00463062435086IB:475317.5THYRNOT01PD-0049-P,724,10/02/1995|PD-0049-US,724,09/30/19961631hu000650491331643IB:475317.5PANCNOT07PD-0172-P,1031,05/23/1996|PD-0172-US,1031,05/22/19971632hu006575232587870IB:475317.5BRAITUT22PD-0304-P,4604,01/28/1997|PD-0304-US,4604,01/28/19981633hu006416653043852IB:475317.5HEAANOT01PD-0351-P,645,04/25/1998|PD-0351-US,645,04/23/19981634hu006854601928212IB:475317.5BRSTNOT02PD-0240-P,1100,09/30/1996|PD-0240-US,1100,09/29/19971635hu007018582538317IB:475317.5BONRTUT01PD-0303-P,281,01/27/19971636hu004922961492720IB:475317.5PROSNON01PD-0198-P,190,07/29/1996|PD-0198-US,4797,07/28/19971637hu009149471361335IB:475317.5LUNGNOT12PD-0188-P,531,06/19/1997|PD-0188-US,531,06/18/19971638hu005809852547050IB:475317.5UTRSNOT11PD-0316-P,3488,01/29/1997|PD-0316-US,3488,01/29/19981639hu008693283043641IB:475317.5HEAANOT01PD-0351-P,563,04/25/1998|PD-0351-US,563,04/23/19981640hu003061131259955IB:475317.5MENITUT03PD-0147-P,2013,04/17/1996|PD-0147-US,2013,04/17/19971641hu00041492946266IB:475317.5RATRNOT02PD-0135-P,1748,03/20/1996|PD-0135-US,1748,03/19/19971642hu009060553012448IB:475317.5MUSCNOT07PD-0359-P,1065,04/11/1997|PD-0359-US,1065,03/31/19981643hu00031696420025IB:475317.5BRSTNOT01PD-0051-P,3000,10/02/19951644hu00801890982741IB:475317.5TONGTUT01PD-0145-P,890,04/15/1996|PD-0145-US,890,04/15/19971645hu001717282509023IB:475317.5CONUTUT01PD-0300-P,2749,12/20/1996|PD-0300-US,2749,12/18/19971646hu001669312670392IB:475317.5ESOGTUT02PD-0323-P,1420,03/05/1997|PD-0323-US,1420,03/02/19981647hu007452632735656IB:475317.5OVARNOT09PD-0311-P,373,01/27/1997|PD-0311-US,373,01/23/19981648hu005513672885490IB:475317.5SINJNOT02PD-0343-US,2528,03/25/19981649hu008670701303890IB:475317.5PLACNOT02PD-0167-P,652,05/30/1996|PD-0167-US,652,05/29/19971650hu00682084872731IB:475317.5LUNGAST01PD-0120-US,253,02/28/1997|PD-0124-P,253,03/13/19961651hu00363449696718IB:475317.5SYNORAT03PD-0096-P,682,12/15/1995|PD-0096-US,682,12/15/19951652hu009640393688517IB:475317.5HEAANOT01PD-0351-US,3569,04/23/19981653rat00069019701093781ZS:214234.3RALUNOT02PZ-0103-P,935,12/10/19981654rat00253574701490564ZS:214234.3RALITXT54PZ-0135-P,495,08/05/19991655rat00054846701599183ZS:214234.3RALITXT13PZ-0118-P,156,05/12/19991656rat00007795701616219ZS:214234.3RALITXT61PZ-0127-P,131,07/07/19991657rat00176617700180910ZS:214234.3RAANOT01PZ-0011-P,4,08/06/1997|PZ-0011-US,4,07/30/19981658rat00114994701230439ZS:214234.3RASJNON03PZ-0098-P,662,11/12/19981659rat00209478701565987ZS:214234.3RALITXT77PZ-0128-P,520,07/07/19991660rat00139486701469043ZS:214234.3RALITXT32PZ-0108-P,1031,02/11/19991661rat00078966700813572ZS:214234.3RAPINOT03PZ-0073-P,1525,03/11/1998|PZ-0073-US,1525,03/09/19991662rat00120521701624629ZS:214234.3RALITXT83PZ-0133-P,3150,08/10/19991663rat00213144701320686ZS:214234.3RALITXT05PZ-0092-P,681,08/13/19981664rat00152143701506292ZS:214234.3RALITXT01PZ-0112-P,540,03/08/19991665rat00203903700361285ZS:214234.3RALMNON04PZ-0017-US,53,08/05/1998|PZ-0035-P,53,10/10/19971666rat00025460700182881ZS:214234.3RAADNOT01PZ-0011-P,736,08/06/1997|PZ-0011-US,736,07/30/19981667rat00082034700629418ZS:214234.3RAFBNOT01PZ-0064-P,1554,02/12/1998|PZ-0064-US,1554,02/10/19991668rat00052515701468416ZS:214234.3RALITXT32PZ-0108-P,908,02/11/19991669rat00117711701513663ZS:214234.3RALITXT02PZ-0112-P,2195,03/08/19991670rat00248310701605944ZS:214234.3RALITXT09PZ-0116-P,339,04/29/19991671rat00123355701491741ZS:214234.3RALITXT54PZ-0135-P,746,08/05/19991672rat00005860700539949ZS:214234.3RACONOT01PZ-0014-US,2364,08/05/1998|PZ-0043-P,926,11/04/19971673rat00217740701230808ZS:214234.3RASJNON03PZ-0098-P,860,11/12/19981674rat00021189700272961ZS:214234.3RASJNOT01PZ-0039-P,782,10/08/1997|PZ-0039-US,782,10/05/19981675rat00111777701300213ZS:214234.3RABXNOT05PZ-0090-P,5178,08/12/19981676rat00157434700628557ZS:214234.3RAFBNOT01PZ-0064-P,1275,02/12/1998|PZ-0064-US,1275,02/10/19991677rat00154482701318893ZS:214234.3RALITXT05PZ-0092-P,192,08/13/19981678rat00138760700136650ZS:214234.3RALMNOT01PZ-0017-P,2027,08/06/1997|PZ-0017-US,3641,08/05/19981679rat00188046701605366ZS:214234.3RALITXT09PZ-0116-P,205,04/29/19991680rat00255844701344948ZS:214234.3RALITXT11PZ-0094-P,1397,09/11/19981681rat00236299701617705ZS:214234.3RALITXT61PZ-0127-P,417,07/07/19991682rat00143999700303285ZS:214234.3RALINOT01PZ-0026-P,406,09/12/1997|PZ-0026-US,406,09/04/19981683rat00238796701445318ZS:214234.3RALITXT50PZ-0109-P,1983,02/11/19991684rat00040500701514224ZS:214234.3RALITXT02PZ-0112-P,2321,03/08/19991685rat00001036700148731ZS:214234.3RANPNOT01PZ-0008-P,1094,07/10/1997|PZ-0008-US,1094,07/10/1998|PZ-0009-P,1094,07/09/19971686rat00227113701465349ZS:214234.3RALITXT32PZ-0108-P,311,02/11/19991687rat00157121701517634ZS:214234.3RALITXT62PZ-0136-P,99,08/06/19991688rat00200366701425745ZS:214234.3RALINOT02PZ-0114-P,7,04/08/19991689rat00236142700504333ZS:214234.3RALINON07PZ-0060-P,1557,01/16/1998|PZ-0059-US,3755,01/12/19991690rat00183042701897857ZS:214234.3RABYUNS09PZ-0131-P,1039,06/29/19991691rat00016722701469758ZS:214234.3RALITXT32PZ-0108-P,1187,02/11/19991692rat00061390701441537ZS:214234.3RALINON08PZ-0113-P,2948,04/07/19991693rat00193403700628292ZS:214234.3RAFBNOT01PZ-0064-P,1189,02/12/1998|PZ-0064-US,1189,02/10/19991694rat00109704701582451ZS:214234.3RALIUNT03PZ-0121-P,875,05/03/19991695rat00176071701193139ZS:214234.3RALINOT02PZ-0082-P,129,05/01/1998|PZ-0026-US,1459,09/04/19981696rat00141862701417436ZS:214234.3RASLNOT01PZ-0107-P,45,01/14/19991697rat00155543701193977ZS:214234.3RALINOT02PZ-0026-US,1663,09/04/1998|PZ-0082-P,333,05/01/19981698rat00036447700609902ZS:214234.3RALINOH01PZ-0053-P,832,12/12/1997|PZ-0053-US,832,12/11/19981699rat00248561700361875ZS:214234.3RALMNON04PZ-0017-US,269,08/05/1998|PZ-0035-P,269,10/10/19971700rat00095634701246479ZS:214234.3RALINOH02PZ-0091-P,2402,10/27/19981701rat00233793701709889ZS:214234.3RALITXT92PZ-0136-P,1175,08/06/19991702rat00251696700503636ZS:214234.3RALINON07PZ-0060-P,1267,01/16/1998|PZ-0059-US,3465,01/12/19991703rat00098747701467565ZS:214234.3RALITXT32PZ-0108-P,753,02/11/19991704rat00174779700913464ZS:214234.3RAXSNOT02PZ-0100-P,3244,11/12/19981705rat00032013701511270ZS:214234.3RALITXT02PZ-0112-P,1699,03/08/19991706rat00130024701510462ZS:214234.3RALITXT02PZ-0112-P,1544,03/08/19991707rat00199788701485744ZS:214234.3RALITXT50PZ-0109-P,1614,02/11/19991708rat00040710701510883ZS:214234.3RALITXT02PZ-0112-P,1626,03/08/19991709rat00237200700629420ZS:214234.3RAFBNOT01PZ-0064-P,1555,02/12/1998|PZ-0064-US,1555,02/10/19991710rat00102606701474055ZS:214234.3RALITXT41PZ-0123-P,798,06/04/19991711rat00116043701465268ZS:214234.3RALITXT32PZ-0108-P,293,02/11/19991712rat00193013700297261ZS:214234.3RAEGNOT01PZ-0023-P,632,09/11/1997|PZ-0023-US,632,09/01/19981713rat00193411700624973ZS:214234.3RAFBNOT01PZ-0064-P,169,02/12/1998|PZ-0064-US,169,02/10/19991714rat00058115701466020ZS:214234.3RALITXT32PZ-0108-P,418,02/11/19991715rat00158342700931834ZS:214234.3RALINON03PZ-0075-US,1525,03/09/1999|PZ-0075-P,585,03/10/19981716rat00186206701466523ZS:214234.3RALITXT32PZ-0108-P,526,02/11/19991717rat00062852701470845ZS:214234.3RALITXT41PZ-0123-P,85,06/04/19991718rat00175712701490988ZS:214234.3RALITXT54PZ-0135-P,587,08/05/19991719rat00005882700769675ZS:214234.3RAHYNOT02PZ-0078-P,1942,04/06/1998|PZ-0033-US,3606,10/05/19981720rat00223962701435210ZS:214234.3RALITXT06PZ-0115-P,1304,04/08/19991721rat00224772701487591ZS:214234.3RALITXT50PZ-0109-P,1889,02/11/19991722rat00051487700821620ZS:214234.3RAESNOT02PZ-0032-US,2179,10/07/1998|PZ-0074-P,942,03/13/19981723rat00154780701427613ZS:214234.3RALINOT02PZ-0114-P,373,04/08/19991724rat00154826701560653ZS:214234.3RALITXT76PZ-0127-P,1522,07/07/19991725rat00059481701512645ZS:214234.3RALITXT02PZ-0112-P,1986,03/08/19991726rat00223849700769805ZS:214234.3RAHYNOT02PZ-0078-P,2006,04/06/1998|PZ-0033-US,3670,10/05/19981727rat00157296701514225ZS:214234.3RALITXT02PZ-0112-P,2322,03/08/19991728rat00057549700290655ZS:214234.3RAEPNOT01PZ-0015-P,676,08/05/1997|PZ-0015-US,676,08/04/19981729rat00167098700628888ZS:214234.3RAFBNOT01PZ-0064-P,1387,02/12/1998|PZ-0064-US,1387,02/10/19991730rat00147858701615842ZS:214234.3RALITXT61PZ-0127-P,31,07/07/19991731rat00063988700821482ZS:214234.3RAESNOT02PZ-0032-US,2140,10/07/1998|PZ-0074-P,903,03/13/19981732rat00000043700143947ZS:214234.3RAPRNOT01PZ-0009-US,392,07/09/19981733rat00130034701492871ZS:214234.3RALITXT54PZ-0135-P,977,08/05/19991734rat00123222701466168ZS:214234.3RALITXT32PZ-0108-P,459,02/11/19991735rat00002308701243343ZS:214234.3RALINOH02PZ-0091-P,1200,10/27/19981736rat00205115701491093ZS:214234.3RALITXT54PZ-0135-P,604,08/05/19991737rat00130832701560741ZS:214234.3RALITXT76PZ-0127-P,1539,07/07/19991738rat00191402700640940ZS:214234.3RABUNOT01PZ-0057-US,2695,01/11/1999|PZ-0058-P,337,01/16/19981739rat00044081701649230ZS:214234.3RALITXT40PZ-0120-P,1474,05/06/19991740rat00065250701940939ZS:214234.3RALITXT1KPZ-0134-P,173,08/12/19991741rat00016704701393081ZS:214234.3RALITXT14PZ-0094-P,2356,09/11/19981742rat00100918701397339ZS:214234.3RALITXT14PZ-0094-P,3119,09/11/19981743rat00205552700502073ZS:214234.3RALINON07PZ-0059-US,2778,01/12/1999|PZ-0060-P,580,01/16/19981744rat00108751700934938ZS:214234.3RALINON03PZ-0075-P,1974,03/10/1998|PZ-0075-US,2914,03/09/19991745rat00250825701714541ZS:214234.3RABYUNN01PZ-0124-P,1224,06/29/19991746rat00124790701343424ZS:214234.3RALITXT11PZ-0094-P,934,09/11/19981747rat00140918700229933ZS:214234.3RACONOT01PZ-0014-P,913,08/08/1997|PZ-0014-US,913,08/05/19981748rat00049451701093696ZS:214234.3RALUNOT02PZ-0103-P,903,12/10/19981749rat00139362701610104ZS:214234.3RALITXT09PZ-0116-P,1486,04/29/19991750rat00172338700288991ZS:214234.3RASDNOT01PZ-0027-P,1162,09/08/1997|PZ-0027-US,1162,09/08/19981751rat00207294700136250ZS:214234.3RALMNOT01PZ-0017-P,1868,08/06/1997|PZ-0017-US,3482,08/05/19981752hu008590251371843IB:464689.8BSTMNON02PD-0160-1-US,814,06/30/1998|PD-0160-P,814,04/26/19961753hu001517112688148IB:464689.9LUNGNOT23PD-0388-P,1522,07/03/1997|PD-0388-US,1522,06/19/19981754hu002689252875106IB:464689.9THYRNOT10PD-0395-P,2766,07/02/1997|PD-0395-US,2766,06/23/19981755hu00873888587415IB:464689.9UTRSNOT01PD-0084-P,277,10/26/1995|PD-0084-US,277,10/18/19961756rat00196343700190695ZS:215574.1RATENOT01PZ-0020-P,1436,08/06/1997|PZ-0020-US,1436,07/31/19981757rat00162259701283151ZS:215574.2RABXNOT02PZ-0087-P,1737,08/11/19981758rat00149803700228775ZS:215574.2RACONOT01PZ-0014-P,405,08/08/1997|PZ-0014-US,405,08/05/19981759rat00047971700417976ZS:215574.2RAHTNOT01PZ-0037-US,1072,10/06/1998|PZ-0048-P,1072,11/05/19971760rat00057844700179881ZS:215574.2RALUNOT01PZ-0006-P,720,07/10/1997|PZ-0006-US,720,07/10/19981761rat00096841701023034ZS:215574.2RAFANOT02PZ-0101-P,432,12/10/19981762rat00058693700524975ZS:215574.2RABMNOT01PZ-0022-US,1257,09/01/1998|PZ-0051-P,1257,12/12/19971763rat00161304700268791ZS:215574.2RAADNOT03PZ-0011-US,1485,07/30/1998|PZ-0031-P,292,10/10/19971764rat00188358700066924ZS:215574.2RABTNOT01PZ-0001-P,1054,06/12/1997|PZ-0001-US,1054,06/08/19981765rat00204174700294785ZS:215574.2RABFNOT02PZ-0013-P,927,08/08/1997|PZ-0013-US,927,08/07/19981766rat00235404700478479ZS:215574.2RATHNOT02PZ-0049-US,1616,11/06/1998|PZ-0072-P,75,03/12/19981767rat00144852700059848ZS:215574.2RAKINOT02PZ-0002-US,1171,06/09/1998|PZ-0002-P,429,06/13/19971768rat00062953700627741ZS:215574.3RAFBNOT01PZ-0064-P,1026,02/12/1998|PZ-0064-US,1026,02/10/19991769rat00192832700627895ZS:215574.3RAFBNOT01PZ-0064-P,1068,02/12/1998|PZ-0064-US,1068,02/10/19991770rat00039681701433720ZS:215574.3RALITXT06PZ-0115-P,1020,04/08/19991771rat00115488700498943ZS:215574.3RAHINOT01PZ-0025-US,1756,09/09/1998|PZ-0044-P,1756,11/04/19971772rat00193491700280214ZS:215574.3RAHYNOT01PZ-0033-P,9,10/08/1997|PZ-0033-US,9,10/05/19981773rat00167807700501772ZS:215574.3RALINON07PZ-0059-US,2636,01/12/1999|PZ-0060-P,438,01/16/19981774rat00086790700177732ZS:215574.3RASINOT01PZ-0005-P,1156,07/09/1997|PZ-0005-US,1156,07/09/19981775rat00199525701881119ZS:215574.3RALITXS02PZ-0133-P,1421,08/10/19991776rat00257665700533367ZS:215574.3RAEONOT02PZ-0024-US,491,09/10/1998|PZ-0052-P,491,12/11/19971777rat00158777701294328ZS:215574.3RABXNOT04PZ-0090-P,2166,08/12/19981778rat00102523700364549ZS:215574.3RAMGNOT01PZ-0046-P,7,11/04/1997|PZ-0046-US,7,11/03/19981779rat00202063700307292ZS:215574.3RASDNOT02PZ-0027-US,1497,09/08/1998|PZ-0028-P,243,09/08/19971780rat00067043701475321ZS:215574.3RALITXT41PZ-0123-P,1091,06/04/19991781rat00252273701944916ZS:215574.3RALITXT1KPZ-0134-P,951,08/12/19991782rat00060259701285043ZS:215574.3RABXNOT03PZ-0087-P,2643,08/11/19981783rat00027860701434268ZS:215574.3RALITXT06PZ-0115-P,1155,04/08/19991784rat00055734700628168ZS:215574.3RAFBNOT01PZ-0064-P,1151,02/12/1998|PZ-0064-US,1151,02/10/19991785rat00258360701192218ZS:215574.3RACONON04PZ-0085-P,3542,06/11/19981786rat00166056700534239ZS:215574.3RAEONOT02PZ-0024-US,836,09/10/1998|PZ-0052-P,836,12/11/19971787rat00152547700326287ZS:215574.3RASNNOT01PZ-0054-US,2766,12/10/1998|PZ-0095-P,384,09/09/19981788hu010412734448044LG:233861.1SINDNOT011789hu010841186538054LG:233861.5OVARDIN021790hu012164925660005LG:233861.5BSCNNOT031791hu012296876510029LG:233861.7BRAHNOT021792hu010677956480568LG:233861.7PROSTMC011793hu009673565812622LG:233861.7PROSTUS231794hu009897506354669LG:233861.7LUNGDIS031795hu013102324443286LG:233861.7SINDNOT011796hu010414136060942LG:233861.7BRAENOT041797hu012801126093338LG:233861.7THP1TXT031798hu013120175943867LG:233861.7COLADIT051799hu013031166312930LG:233861.7NERDTDN031800hu012142336127343LG:233861.7BRAHNON051801hu012170156131166LG:233861.7BMARTXT021802hu010491116059741LG:233861.7BRAENOT041803hu011075306012595LG:233861.7FIBRUNT021804hu011364405946232LG:233861.7LIVRTUN041805hu012200686350367LG:233861.7LUNGDIS031806hu011416156013556LG:233861.7FIBRUNT021807hu010620736383511LG:233861.7FIBRUNT021808hu011007926121245LG:233861.7BRAHNON051809hu010017836566762LG:233861.7MCLDTXN051810hu012380436350903LG:233861.7LUNGDIS031811hu010907146192825LG:233861.7MUSCDIN061812hu013047546383743LG:233861.7FIBRUNT021813hu012141885952122LG:233861.7LIVRTUN041814hu010851825992338LG:233861.7FTUBTUT021815hu011046775876091LG:233861.7BRAUNOT011816hu010653295887762LG:233861.7LIVRNON081817hu013152596264693LG:233861.7MCLDTXN031818hu011846351894667LG:233861.7THP1TXT041819hu012617566298742LG:233861.7UTREDIT071820hu013186455887801LG:233861.7LIVRNON081821hu012843286370049LG:233861.7ENDINOT011822hu011758526498016LG:233861.7COLNNOT411823hu012650786213424LG:233861.7ARTANOT061824hu011895235844137LG:233861.7BRAENOT041825hu012912786424826LG:233861.7BRSTUNT011826hu012506996058776LG:233861.7BRAENOT041827hu012818485839201LG:233861.7MCLDTXT021828hu009717816510129LG:233861.7BRAHNOT021829hu002717883105267IB:794649.2COLAUCT01PD-0371-P,1639,05/15/1997|PD-0371-US,1639,05/11/19981830rat00189898700062910ZS:219574.1RAKINOT02PZ-0002-P,1709,06/13/1997|PZ-0002-US,2451,06/09/19981831rat00167530700067568ZS:219574.1RABTNOT01PZ-0001-P,1287,06/12/1997|PZ-0001-US,1287,06/08/19981832rat00018842700308813ZS:219574.1RASDNOT02PZ-0027-US,1947,09/08/1998|PZ-0028-P,693,09/08/19971833rat00199561700180966ZS:219574.1RAADNOT01PZ-0011-P,28,08/06/1997|PZ-0011-US,28,07/30/19981834rat00164141700510020ZS:219574.2RASLTXT01PZ-0061-P,1456,01/16/1998|PZ-0061-US,3398,01/14/19991835rat00012080701335324ZS:219574.2RALINON08PZ-0034-US,2532,10/08/19981836rat00061336700918201ZS:219574.2RAXSNOT01PZ-0100-P,1114,11/12/19981837rat00171128701286045ZS:219574.2RABXNOT03PZ-0087-P,3113,08/11/19981838rat00104497700290714ZS:208685.1RAEPNOT01PZ-0015-P,701,08/05/1997|PZ-0015-US,701,08/04/19981839rat00241074700190967ZS:208685.1RATENOT01PZ-0020-P,1584,08/06/1997|PZ-0020-US,1584,07/31/19981840rat00052948700302994ZS:208685.1RALINOT01PZ-0026-P,324,09/12/1997|PZ-0026-US,324,09/04/19981841hu004088962010193IB:413486.3TESTNOT03PD-0270-P,996,10/31/1996|PD-0270-US,996,10/29/19971842hu006862972823003IB:413486.3ADRETUT06PD-0333-P,972,03/14/1997|PD-0333-US,972,03/12/19981843hu0088826659307IB:413486.3PD-0009-US,943,07/08/19941844hu006121562820251IB:413486.3BRSTNOT14PD-0335-P,3895,03/21/1997|PD-0335-US,3895,03/20/19981845hu004043281240147IB:413486.3LUNGTUT02PD-0158-P,1778,04/22/19961846hu0005245582699IB:413486.3HUVESTB01PD-0003-3-US,6156,08/26/19941847hu001244652825725IB:413486.3ADRETUT06PD-0333-P,2268,03/14/1997|PD-0333-US,2268,03/12/19981848hu00494520442IB:413486.3U937NOT01PD-0001-3-US,327,02/14/1994|PD-0001-US,327,07/17/1992|PD-0001-1-PCT,385,07/16/1993|PD-0001-1-US,385,11/19/19921849hu00808027725067IB:413486.3SYNOOAT01PD-0099-P,830,12/19/1995|PD-0099-US,830,12/19/19961850hu0002576682700IB:413486.3HUVESTB01PD-0003-3-US,6157,08/26/19941851hu00453158364676IB:413486.3PROSNOT01PD-0046-P,1620,09/29/1995|PD-0046-US,1620,09/27/19961852hu003161971686IB:413486.3U937NOT01PD-0001-1-PCT,1532,07/16/1993|PD-0001-1-US,1532,11/19/1992|PD-0001-3-US,1532,02/14/19941853hu0008749078129IB:413486.3SYNORAB01PD-0012-US,757,08/19/19941854hu004753722971626IB:413486.3HEAONOT02PD-0387-P,1464,07/03/1997|PD-0387-US,1464,06/30/19981855hu00616168189009IB:413486.3CARDNOT01PD-0019-US,3142,01/05/19951856hu00080866149464IB:413486.3FIBRNGT02PD-0018-US,1655,11/04/19941857hu00751458568750IB:413486.3MMLR3DT01PD-0057-P,592,10/26/1995|PD-0057-US,592,10/25/19961858hu009607261103IB:413486.3U937NOT01PD-0001-3-US,861,02/14/1994|PD-0001-US,861,07/17/1992|PD-0001-1-PCT,1013,07/16/1993|PD-0001-1-US,1013,11/19/1992|PD-0001-3-US,1013,02/14/19941859hu00610689993IB:413486.3U937NOT01PD-0001-1-PCT,908,07/16/1993|PD-0001-1-US,908,11/19/19921860hu0055733836161IB:413486.3HUVENOB01PD-0003-1-US,3227,02/17/1994|PD-0003-2-US,3408,04/28/1994|PD0003-3-US,687,08/26/19941861hu0035790742068IB:413486.3TBLYNOT01PD-0007-US,1266,03/22/19941862hu0069495046272IB:413486.3CORNNOT01PD-0006-US,615,03/31/19941863hu005350941471176IB:274440.1LUNGTUT03PD-0189-US,1296,06/19/1997|PD-0189-P,1316,06/20/19961864hu00343557911228IB:023525.10STOMNOT02PD-0155-P,499,04/26/1996|PD-0155-US,499,04/25/19971865hu00367821168804IB:023525.10LIVRNOT01PD-0064-P,925,10/10/1995|PD-0064-US,925,10/09/19961866hu00475174900839IB:023525.10BRSTTUT03PD-0143-1-US,1030,10/01/1997|PD-0143-US,1030,03/20/1997|PD-0133-P,5240,03/20/19961867hu001658563897459IB:023525.10TLYMNOT05PD-0364-US,3132,04/30/19981868hu001774321840483IB:023525.10EOSITXT01PR-0011-P,1246,08/29/1996|PR-0011-US,1246,08/29/19971869hu00309327899181IB:023525.10BRSTTUT03PD-0143-1-US,361,10/01/1997|PD-0143-US,361,03/20/1997|PD-0133-P,4571,03/20/19961870rat00077183701024520ZS:221237.4RAFANOT02PZ-0101-P,828,12/10/19981871rat00174770700420532ZS:221237.4RAHANOT01PZ-0040-US,585,10/08/1998|PZ-0041-P,585,10/09/19971872rat00181648700930974ZS:221237.4RALINON03PZ-0075-US,1146,03/09/1999|PZ-0075-P,206,03/10/19981873rat00231043700607265ZS:221237.4RALINOH01PZ-0053-P,243,12/12/1997|PZ-0053-US,243,12/11/19981874rat00241986701246834ZS:221237.4RALINOH02PZ-0091-P,2558,10/27/19981875rat00204820700609603ZS:221237.4RALINOH01PZ-0053-P,738,12/12/1997|PZ-0053-US,738,12/11/19981876rat00211971701396879ZS:221237.4RALITXT14PZ-0094-P,3042,09/11/19981877rat00156450701480622ZS:221237.4RALITXT42PZ-0109-P,592,02/11/19991878rat00058253701343245ZS:221237.4RALITXT11PZ-0094-P,878,09/11/19981879hu013336856554941LG:023525.11BRAFNON021880hu011023156559814LG:023525.11BRAFNON021881rat00212947700483216ZS:220065.1RALINON03PZ-0059-P,1418,01/16/1998|PZ-0059-US,1418,01/12/19991882rat00209119700483123ZS:220065.1RALINON03PZ-0059-P,1358,01/16/1998|PZ-0059-US,1358,01/12/19991883rat00093295700780819ZS:220065.2RABSNOT02PZ-0057-P,130,01/16/1998|PZ-0057-US,130,01/11/19991884rat00083975701485977ZS:220065.2RALITXT50PZ-0109-P,1659,02/11/19991885rat00139739701318240ZS:220065.2RALITXT06PZ-0094-P,593,09/11/19981886rat00194974701258865ZS:220065.2RALITXT03PZ-0096-P,977,10/09/19981887rat00002544700314533ZS:220065.2RAESNOT01PZ-0032-P,479,10/08/1997|PZ-0032-US,479,10/07/19981888rat00016900700435941ZS:220065.2RAHLNOT02PZ-0047-P,430,11/06/1997|PZ-0047-US,430,11/03/19981889rat00204309700313454ZS:220065.2RAESNOT01PZ-0032-P,107,10/08/1997|PZ-0032-US,107,10/07/19981890rat00181530700938719ZS:220065.2RALINON03PZ-0075-P,3673,03/10/1998|PZ-0075-US,4613,03/09/19991891rat00161335700420843ZS:220065.2RAHANOT01PZ-0040-US,699,10/08/1998|PZ-0041-P,699,10/09/19971892rat00190334701275345ZS:220065.2RABFNON02PZ-0097-P,733,11/12/19981893rat00010973700778749ZS:220065.2RAPINOT02PZ-0065-P,1085,02/11/1998|PZ-0065-US,1085,02/10/19991894rat00254820701394518ZS:220065.2RALITXT14PZ-0094-P,2653,09/11/19981895rat00013368701879481ZS:220065.2RALITXS02PZ-0133-P,720,08/10/19991896rat00061429700939406ZS:220065.2RALINON07PZ-0075-US,246,03/09/1999|PZ-0079-P,246,04/08/19981897rat00240367701909492ZS:220065.2RABYUNN02PZ-0130-P,238,06/29/19991898rat00006187700780985ZS:220065.2RABSNOT02PZ-0057-P,211,01/16/1998|PZ-0057-US,211,01/11/19991899rat00099014701318033ZS:220065.2RALITXT06PZ-0094-P,524,09/11/19981900rat00219642700525373ZS:220065.2RABMNOT01PZ-0022-US,1386,09/01/1998|PZ-0051-P,1386,12/12/19971901hu011278885920416LG:023525.7BRAIFET021902hu010399495885823LG:023525.7LIVRNON081903hu012177915881319LG:023525.7LIVRNON081904hu012027716270301LG:023525.7BRAIFEN031905hu013030616271586LG:023525.7BRAIFEN031906hu009836506552641LG:023525.7BRAFNON021907hu013264555891134LG:023525.7LIVRNON081908hu012796656116862LG:023525.8SINITMT041909hu009894246424889LG:023525.8BRSTUNT011910hu009928725616328LG:023525.8THYMNOR021911hu011638995990859LG:023525.8FTUBTUT021912hu011878666598719LG:023525.8ARTANOT061913hu013098996379254LG:023525.8FIBAUNT011914hu011003463760758LG:023525.8BRAHDIT031915hu012292105839547LG:023525.8FIBRUNT021916hu013335034515874LG:023525.8SINJNOT031917hu011435325476167LG:023525.8FIBPFEN061918hu010901906424790LG:023525.8BRSTUNT011919hu011427346370928LG:023525.8ENDIUNT011920hu013416266178092LG:023525.8BMARUNT021921hu010476605475523LG:023525.8FIBPFEN061922hu010405696496850LG:023525.8COLNNOT411923hu011181675894616LG:023525.8BRAYDIN031924hu013419625474001LG:023525.8FIBPFEN061925hu010766066065772LG:023525.8BRAENOT021926hu012465536152091LG:023525.8ENDMUNT041927hu013082946125646LG:023525.8BRAHNON051928hu012536736264310LG:023525.8MCLDTXN031929hu010189496538510LG:023525.8OVARDIN021930hu012959526262111LG:023525.8MCLDTXN031931hu011863876190138LG:023525.8MUSCDIN061932hu012927415941339LG:236453.4COLADIT051933hu011336573903719LG:236453.4LUNGNON031934hu009950526026458LG:236453.9TESTNOT111935hu012656966113765LG:037054.5SINITMT041936hu009907686262544LG:037054.5MCLDTXN031937hu013173206425437LG:037054.5BRSTUNT011938hu012425316211146LG:037054.5ARTANOT061939hu010372066114029LG:037054.5SINITMT041940hu013311196553732LG:037054.5BRAFNON021941hu010520586323421LG:037054.5LUNGDIN021942hu011136466296822LG:037054.5BRARTUT041943hu012710486606417LG:037054.5UTREDIT071944hu012043496496467LG:037054.5COLNNOT411945hu012524476518170LG:037054.5BRAFTDT021946hu011458706353795LG:037054.5LUNGDIS031947hu010483556604422LG:037054.5UTREDIT071948hu013141996386936LG:037054.5FIBRUNT021949hu013297256130913LG:037054.5MCLDTXN031950hu013179714519218LG:037054.5SINJNOT031951hu012548296435737LG:037054.5LUNGNON071952hu011882495475918LG:037054.5FIBPFEN061953hu012585936542807LG:037054.5LNODNON021954hu012086976317860LG:037054.5LUNGDIN021955hu009795223023731LG:037054.5PROSDIN011956hu013226386484989LG:037054.9MIXDUNB011957hu005792201467992IB:815336.1PANCTUT02PD-0191-P,617,06/21/1996|PD-0191-US,617,06/19/19971958hu00278027908408IB:023525.6COLNNOT09PD-0129-P,398,03/19/1996|PD-0129-US,398,03/18/19971959hu00150005487818IB:023525.8HNT2AGT011960hu00435663490900IB:023525.8HNT2AGT011961rat00104762700273719ZS:275389.1RASJNOT01PZ-0039-P,1058,10/08/1997|PZ-0039-US,1058,10/05/19981962hu011798633444223LG:413486.1BRONDIT011963hu010162115989011LG:413486.1MCLDTXT021964hu010033055872059LG:413486.1COLTDIT041965hu009775896095094LG:413486.1THP1TXT031966hu011302256093023LG:413486.1THP1TXT031967hu012053046075596LG:413486.1UTREDIT091968hu010174226419675LG:413486.1BRSTUNT011969hu012003776209547LG:413486.1ARTANOT061970hu010672256405076LG:413486.1UTREDIT101971hu010846316078425LG:413486.1UTREDIT091972hu010474665981860LG:413486.1MCLDTXT021973hu013438725983358LG:413486.1MCLDTXT021974hu010778235979930LG:413486.1MCLDTXT021975hu013268276261877LG:413486.1BRSTUNT011976hu013488056375405LG:413486.1FIBAUNT011977hu010908395981662LG:413486.1MCLDTXT021978hu010905966564362LG:413486.1MCLDTXT041979hu013258586422216LG:413486.1BRSTUNT011980hu012794633902250LG:413486.1LUNGNON031981hu009745695953976LG:413486.1SKINTDT011982hu010921026133582LG:413486.1BMARTXT021983hu013353023166285LG:413486.1TLYMTXT041984hu011721326154521LG:413486.1ENDMUNT041985hu010273175564143LG:413486.1BRSTDIT011986hu013124736131318LG:413486.1BMARTXT021987hu012532906114440LG:413486.1SINITMT041988hu010036756564795LG:413486.1MCLDTXT041989hu011243926131579LG:413486.1BMARTXT021990hu013118636299814LG:413486.1UTREDIT071991hu011923356151928LG:413486.1ENDMUNT041992hu013277236388403LG:413486.1COLNDIC011993hu012873326150440LG:413486.1ENDMUNT041994hu010453763165833LG:413486.1TLYMTXT041995hu010175596396535LG:413486.1UTRENOT101996hu010558196361347LG:413486.1CONFNOT091997hu010709685984828LG:413486.1MCLDTXT021998hu013269935987020LG:413486.1MCLDTXT021999hu011966966408470LG:413486.1UTREDIT102000hu011689946270190LG:413486.1BRAIFEN032001hu010711005983366LG:413486.1MCLDTXT022002hu010711026422308LG:413486.1BRSTUNT012003hu010140155908769LG:413486.1BRAIFEN052004hu011412195658363LG:413486.1BSCNNOT032005hu013170186454559LG:413486.1COLNDIC012006hu011173905475468LG:413486.1FIBPFEN062007hu010620776420636LG:413486.1BRSTUNT012008hu012161766538777LG:413486.1OVARDIN022009hu011550943444239LG:413486.1BRONDIT012010hu010229921896359LG:413486.1THP1TXT042011hu012082766112991LG:413486.1SINITMT042012hu011508845986966LG:413486.1MCLDTXT022013hu012826175809528LG:413486.1KIDCTMT022014hu013316765987770LG:413486.1MCLDTXT022015hu011489235988150LG:413486.1MCLDTXT022016hu011793356561673LG:413486.1MCLDTXT042017hu011329856425449LG:413486.1BRSTUNT012018hu011993366422516LG:413486.1BRSTUNT012019hu011856934516438LG:413486.1SINJNOT032020hu009694716514835LG:413486.1THYMDIT012021hu009755971895668LG:413486.1THP1TXT042022hu011140176170203LG:413486.1UTRSTDT012023hu010132906402652LG:413486.1UTRENOT102024hu012242066095029LG:413486.1THP1TXT032025hu012116155879126LG:413486.1BRAUNOT012026hu011411464123126LG:413486.1BRSTTUT252027hu012848005563507LG:413486.1BRSTDIT012028hu012075176123211LG:413486.1BRAHNON052029hu012476306371816LG:413486.1FIBAUNT022030hu010609453158120LG:413486.1TLYMTXT032031hu013326556402620LG:413486.1UTRENOT102032hu010157955954076LG:413486.1SKINTDT012033hu013098805870789LG:413486.1COLTDIT042034hu013468906419582LG:413486.1BRSTUNT012035hu011825956497557LG:413486.1COLNNOT412036rat00225961700269380ZS:202666.1RAADNOT03PZ-0011-US,1736,07/30/1998|PZ-0031-P,543,10/10/19972037rat00027224700061367ZS:202666.2RAKINOT02PZ-0002-P,1040,06/13/1997|PZ-0002-US,1782,06/09/19982038rat00216641700484428ZS:202666.2RALINON03PZ-0059-P,1878,01/16/1998|PZ-0059-US,1878,01/12/19992039hu010573406512973LG:952911.1THYMDIT012040hu0091488630396IB:236453.10THP1NOB01PD-0001-3-US,4967,02/14/1994|PD-0001-4-US,5137,07/28/19942041hu005824092113IB:236453.10U937NOT01PD-0001-1-PCT,1920,07/16/1993|PD-0001-1-US,1920,11/19/1992|PD-0001-3-US,1920,02/14/19942042hu001932052741933IB:236453.10BRSTTUT14PD-0320-P,3051,02/13/1997|PD-0320-US,3051,02/11/19982043hu00691687100690IB:236453.10ADRENOT01PD-0016-US,1018,10/14/19942044hu006017632304342IB:236453.10BRSTNOT05PD-0292-P,4070,12/19/1996|PD-0292-US,4070,12/18/19972045hu004594991807710IB:236453.6SINTNOT13PD-0234-P,1414,08/28/19962046hu007720541295954IB:236453.6PGANNOT03PD-0165-P,1325,05/28/1996|PD-0165-US,1325,05/23/19972047hu0009562552759IB:236453.8PD-0008-US,259,06/27/19942048hu001280362797366IB:236453.8NPOLNOT01PD-0340-P,1113,03/28/1997|PD-0340-US,1113,03/27/19982049hu008708332906493IB:236453.8THYMNOT05PD-0393-P,984,07/02/1997|PD-0393-US,984,06/24/19982050hu007082052729355IB:236453.9OVARTUT05PD-0313-P,3804,01/22/1997|PD-0313-US,3804,01/22/19982051rat00154045700910295ZS:259301.1RAXSNOT02PZ-0100-P,2066,11/12/19982052hu00875504782418IB:037054.5MYOMNOT01PD-0113-P,920,02/27/1996|PD-0113-US,920,02/27/19972053hu000618981430906IB:037054.5SINTBST01PD-0209-P,2519,07/23/1996|PD-0209-US,2519,07/22/19972054hu008531942455564IB:037054.6ENDANOT01PD-0299-P,1815,12/16/1996|PD-0299-US,1815,12/04/19972055hu008907903086914IB:037054.6HEAONOT03PD-0352-P,915,04/18/1997|PD-0352-US,915,04/24/19982056hu007604371634012IB:037054.7COLNNOT19PD-0206-P,635,08/01/1996|PD-0206-US,635,08/01/19972057hu008909981216570IB:037054.7BRSTTUT01PD-0157-P,3433,04/26/1996|PD-0157-US,3433,04/25/19972058hu001527592841268IB:037054.7DRGLNOT01PD-0337-P,1648,03/18/1997|PD-0337-US,1648,03/05/19982059hu00748297830485IB:037054.8PROSTUT04PD-0117-P,2114,02/26/1996|PD-0117-US,2114,02/26/1997|PD-0197US,538,06/23/19972060hu00958835233757IB:037054.8SINTNOT02PD-0023-US,524,02/22/19952061hu0079756557367IB:037054.8PD-0009-US,131,07/08/19942062hu000232422194388IB:037054.8THYRTUT03PD-0271-P,1679,10/31/19962063hu00219001766272IB:037054.8LUNGNOT04PD-0121-US,2271,02/28/1997|PD-0140-P,824,04/10/19962064hu00270032750798IB:037054.8BRAITUT01PD-0104-P,2049,01/30/19962065hu00119012935410IB:037054.8CERVNOT01PD-0128-P,1739,03/22/19962066hu00160405825399IB:037054.8PROSNOT06PD-0117-P,611,02/26/1996|PD-0117-US,611,02/26/19972067hu00190208601853IB:037054.8BRSTNOT02PD-0061-P,1466,11/15/1995|PD-0061-US,1466,11/15/19962068hu006263322522237IB:037054.8BRAITUT21PD-0304-P,1507,01/28/1997|PD-0304-US,1507,01/28/19982069hu001006871333153IB:037054.8PANCNOT07PD-0172-P,1431,05/23/1996|PD-0172-US,1431,05/22/19972070hu003206652085612IB:037054.8PANCNOT04PD-0291-P,185,12/17/19962071hu00239361935740IB:037054.8CERVNOT01PD-0128-P,1820,03/22/19962072hu00920049523577IB:037054.8MMLR2DT01PD-0044-P,2621,10/02/1995|PD-0044-US,2621,10/02/19962073hu00524608866666IB:037054.8BRAITUT03PD-0126-1-US,3167,11/25/1997|PD-0126-P,3167,03/08/1996|PD-0126-US,3167,03/07/19972074hu003646602951387IB:037054.8KIDNFET01PD-0339-P,1486,03/14/1997|PD-0339-US,1486,03/12/19982075hu008452621430663IB:037054.8SINTBST01PD-0209-P,2459,07/23/1996|PD-0209-US,2459,07/22/19972076hu006337091361476IB:037054.8LUNGNOT12PD-0188-P,571,06/19/1997|PD-0188-US,571,06/18/19972077hu004951461560126IB:037054.8SPLNNOT04PD-0190-US,2155,06/19/1997|PD-0215-P,575,07/30/19962078hu00913556744459IB:037054.8BRAITUT01PD-0104-P,246,01/30/19962079hu004288181797747IB:037054.8PROSTUT05PD-0119-1-US,3954,09/30/19972080hu005655752183401IB:037054.8SININOT01PD-0267-P,1318,10/31/1996|PD-0267-US,1318,10/29/19972081hu00827367603570IB:037054.8BRSTTUT01PD-0061-P,1987,11/15/1995|PD-0061-US,1987,11/15/19962082hu00786562942875IB:037054.8ADRENOT03PD-0144-P,857,04/10/1996|PD-0144-US,857,04/10/19972083hu002288781457010IB:037054.8COLNFET02PD-0168-US,2087,05/21/1997|PD-0195-P,536,06/19/19962084hu003566872212106IB:037054.8SINTFET03PD-0268-P,2013,10/31/1996|PD-0268-US,2013,10/30/19972085hu008789322451987IB:037054.8ENDANOT01PD-0299-P,872,12/16/1996|PD-0299-US,872,12/04/19972086hu005013431419958IB:037054.8KIDNNOT09PD-0186-P,704,06/25/1996|PD-0186-US,704,06/24/19972087hu005312251903227IB:037054.8OVARNOT07PD-0249-P,2163,10/01/19962088hu0010073835143IB:037054.8HUVENOB01PD-0003-3-US,107,08/26/1994|PD-0003-1-US,2691,02/17/1994|PD-0003-2-US,2828,04/28/19942089hu001145711647305IB:037054.8PROSTUT09PD-0199-P,2713,07/30/19962090hu001616242057559IB:037054.8BEPINOT01PD-0182-P,1446,09/25/19962091hu001616262079008IB:037054.8ISLTNOT01PD-0259-P,3003,10/28/1996|PD-0259-US,3003,10/28/19972092hu005341362174488IB:037054.8ENDCNOT03PD-0279-P,2213,11/22/1996|PD-0279-US,2213,11/07/19972093hu001076811806270IB:037054.8SINTNOT13PD-0234-P,926,08/28/19962094hu002577112472046IB:037054.8THP1NOT03PD-0286-P,882,11/25/1996|PD-0286-US,882,11/04/19972095hu002371921493214IB:037054.8PROSNON01PD-0198-P,425,07/29/1996|PD-0198-US,5032,07/28/19972096hu00770272853974IB:037054.8NGANNOT01PD-0123-US,787,02/28/1997|PD-0125-P,787,03/07/19962097hu00409950900309IB:037054.8BRSTTUT03PD-0133-P,5078,03/20/1996|PD-0143-1-US,868,10/01/1997|PD-0143-US,868,03/20/19972098hu004671723868358IB:037054.8BMARNOT03PD-0218-1-US,1748,03/12/19982099hu006099322914677IB:037054.8THYMFET03PD-0345-P,295,03/21/1997|PD-0345-US,295,03/18/19982100hu003189902322455IB:037054.8OVARNOT02PD-0293-P,1764,12/13/1996|PD-0045-1-US,3591,11/10/19972101hu00156990966061IB:037054.8BRSTNOT05PD-0133-P,2807,03/20/1996|PD-0133-US,2807,03/20/19972102hu007916821664515IB:037054.8BRSTNOT09PD-0219-P,1237,07/26/19962103hu00383668825238IB:037054.8PROSNOT06PD-0117-P,571,02/26/1996|PD-0117-US,571,02/26/19972104hu009564731556945IB:037054.8BLADTUT04PD-0203-P,4234,08/01/1996|PD-0203-US,4234,08/01/19972105hu008580682602985IB:037054.8UTRSNOT10PD-0316-P,1679,01/29/1997|PD-0316-US,1679,01/26/19982106hu007749531680495IB:037054.8STOMFET01PD-0217-P,1125,07/30/19962107hu007597281794004IB:037054.8PROSTUT05PD-0119-1-US,2498,09/30/19972108hu0088919583448IB:037054.8HUVESTB01PD-0003-3-US,6538,08/26/19942109hu006659771267536IB:037054.8BRAINOT09PD-0163-P,651,05/21/1996|PD-0163-US,651,05/20/19972110hu005202212106813IB:037054.8BRAITUT03PD-0126-1-US,4555,11/25/1997|PD-0275-P,8040,12/06/19962111hu007312101510165IB:037054.8LUNGNOT14PD-0208-P,828,07/24/1996|PD-0208-US,828,07/23/19972112hu000054431856492IB:037054.8PROSNOT18PD-0233-P,245,09/05/1996|PD-0233-US,245,09/05/19972113hu006412242266659IB:037054.8UTRSNOT02PD-0288-P,464,12/18/1996|PD-0288-US,464,12/16/19972114hu001172531558625IB:037054.8SPLNNOT04PD-0215-P,115,07/30/1996|PD-0190-US,1695,06/19/19972115hu00920305233733IB:037054.8SINTNOT02PD-0023-US,518,02/22/19952116hu003632331551996IB:037054.8PROSNOT06PD-0199-P,5710,07/30/19962117hu002227531986820IB:037054.8LUNGAST01PD-0120-US,4332,02/28/1997|PD-0247-P,986,09/27/19962118hu00394401877233IB:037054.8LUNGAST01PD-0120-US,1823,02/28/1997|PD-0124-P,1823,03/13/19962119hu002821542256047IB:037054.8OVARTUT01PD-0283-P,2267,11/21/1996|PD-0112-1-US,4127,11/14/19972120hu001832531911310IB:037054.8CONNTUT01PD-0252-P,1327,10/01/1996|PD-0254-P,1327,10/04/19962121hu00278213678398IB:037054.8CRBLNOT01PD-0093-P,1900,12/18/1995|PD-0089-US,3596,11/27/19962122hu000919241804361IB:037054.8SINTNOT13PD-0234-P,316,08/28/19962123hu00474271935092IB:037054.8CERVNOT01PD-0128-P,1668,03/22/19962124hu002605751905732IB:037054.8OVARNOT07PD-0249-P,3110,10/01/19962125hu002606921614400IB:037054.8BRAITUT12PD-0204-P,3628,07/26/19962126hu0088241335182IB:037054.8HUVENOB01PD-0003-3-US,135,08/26/1994|PD-0003-1-US,2719,02/17/1994|PD-0003-2-US,2856,04/28/19942127hu008911273326065IB:037054.8HEAONOT04PD-0387-P,2164,07/03/1997|PD-0387-US,2164,06/30/19982128hu00198146582185IB:037054.8PROSNOT02PD-0086-P,121,10/27/1995|PD-0086-US,121,10/21/19962129hu00791651991896IB:037054.8COLNNOT11PD-0129-P,1641,03/19/1996|PD-0129-US,1641,03/18/19972130hu009248631212159IB:037054.8BRSTTUT01PD-0157-P,1998,04/26/1996|PD-0157-US,1998,04/25/19972131hu00491649555259IB:037054.8SCORNOT01PD-0066-P,1199,10/31/19952132hu00739378798805IB:037054.8BRAVTXT04PR-0005-P,22,01/10/1996|PR-0005-US,22,01/10/19972133hu004789912626808IB:037054.8PROSTUT12PD-0314-US,2838,09/04/1997|PD-0314-P,889,01/22/19972134hu008205212758919IB:037054.8THP1AZS08PD-0362-P,4800,05/01/1997|PD-0362-US,4800,04/29/19982135hu000040881618796IB:037054.8BRAITUT12PD-0204-P,3315,07/26/19962136hu000190551640142IB:037054.8UTRSNOT06PD-0211-P,3626,07/25/1996|PD-0211-US,3626,07/24/19972137hu001386303228228IB:037054.8COTRNOT01PD-0372-P,440,05/14/1997|PD-0372-US,440,04/30/19982138hu00411573685491IB:037054.8UTRSNOT02PD-0095-P,2151,12/29/1995|PD-0095-US,2151,12/23/19962139hu005431811443405IB:037054.8THYRNOT03PD-0162-P,3455,05/29/1996|PD-0162-US,3455,05/27/19972140hu004075521305226IB:037054.8PLACNOT02PD-0167-P,673,05/30/1996|PD-0167-US,673,05/29/19972141hu00446342751876IB:037054.8BRAITUT01PD-0104-P,2397,01/30/19962142hu003740903289296IB:037054.8BONRFET01PD-0368-P,374,05/28/1997|PD-0368-US,374,05/05/19982143hu000650581555366IB:037054.8BLADTUT04PD-0203-P,3759,08/01/1996|PD-0203-US,3759,08/01/19972144hu004844062324241IB:037054.8OVARNOT02PD-0293-P,2301,12/13/1996|PD-0045-1-US,4128,11/10/19972145hu003461573201317IB:037054.8PENCNOT02PD-0375-P,813,06/02/1997|PD-0375-US,813,05/08/19982146hu004286071379439IB:037054.8LUNGNOT10PD-0179-P,1315,05/13/1996|PD-0179-US,1315,05/09/19972147hu004954152461925IB:037054.8THYRNOT08PD-0394-P,950,07/02/1997|PD-0394-US,950,06/24/19982148hu00722593902077IB:037054.8BRSTTUT03PD-0143-1-US,1590,10/01/1997|PD-0143-US,1590,03/20/1997|PD-0133-P,5800,03/20/19962149hu001556831482170IB:037054.8CORPNOT02PD-0185-P,2094,06/26/1996|PD-0185-US,2094,06/26/19972150hu00839215586905IB:037054.8UTRSNOT01PD-0084-P,114,10/26/1995|PD-0084-US,114,10/18/19962151hu008680812445442IB:037054.8THP1NOT03PD-0286-P,2185,11/25/1996|PD-0286-US,2185,11/04/19972152hu013222915850349LG:236453.11BRAENOT042153hu010536866520711LG:236453.11CONFTDT022154hu009847525742854LG:236453.12LUNGNON032155hu011211586589010LG:236453.12TLYMUNT032156hu010691405679919LG:236453.12BRAENOT022157hu012892791892562LG:236453.12THP1TXT042158hu012208635985587LG:236453.12MCLDTXT022159hu010443393780406LG:236453.12BRAHDIT042160hu012861524205646LG:236453.12BRONNOT022161hu013363636284143LG:236453.12SKINDIA012162hu011186096259745LG:236453.12BMARTXT062163hu009922236361023LG:236453.12CONFNOT092164hu011427396517006LG:236453.12THYMDIT012165hu013451886522491LG:236453.12CONFTDT022166hu011992456496384LG:236453.12COLNNOT412167hu012052605873053LG:236453.12COLTDIT042168hu012324316360111LG:236453.12CONFNOT092169hu011362505657335LG:236453.12BSCNNOT032170hu011567686395718LG:236453.12UTRENOT102171hu010206366260645LG:236453.12BMARTXT06

[0207]

2

TABLE 2

SEQ ID NO
CLONE
TEMPLATE
START
STOP

1
5564221
LG:2020790.1
1
247

2
2266979
IB:187861.1
1
241

3
6422174
LG:2023386.5
1
507

4
6413044
LG:2023386.5
1
134

5
6180012
LG:2023386.5
1
279

6
5884355
LG:2023386.5
1
210

7
6325092
LG:2023386.5
1
260

8
6377218
LG:2023386.5
2
117

9
5886010
LG:2023386.5
1
254

10
6421181
LG:2023386.5
12
181

11
6479549
LG:2023386.5
1
540

12
5949878
LG:2023386.5
1
337

13
5656380
LG:2023386.5
1
267

14
6325013
LG:2023386.5
4
60

15
6358853
LG:2023386.5
21
131

16
5844535
LG:2023386.5
1
259

17
5994013
LG:1909275.1
1
315

18
6419669
LG:1981103.3
1
545

19
3549771
LG:1907955.5
1
247

20
6030694
LG:1907955.5
1
239

21
4519787
LG:1907955.5
1
239

22
6111313
LG:1907955.5
2
306

23
4437887
LG:1907955.5
2
251

24
5911025
LG:1907955.5
2
292

25
6152806
LG:1907955.5
1
288

26
6119359
LG:1907955.5
1
457

27
5714759
LG:1907955.5
1
289

28
6099952
LG:1907955.5
5
270

29
6209977
LG:1907955.5
4
156

30
3153065
LG:1907955.5
2
168

31
4437787
LG:1907955.5
3
259

32
4442819
LG:1907955.5
1
285

33
6378670
LG:1907955.5
1
307

34
6015470
LG:1907955.5
1
266

35
4517716
LG:1907955.5
6
279

36
6383466
LG:1907955.5
1
291

37
6495789
LG:1907955.5
1
333

38
5811756
LG:1907955.5
1
317

39
3901675
LG:1907955.5
1
277

40
523345
IB:2056060.1
1
244

41
2024316
IB:2097880.1
1
283

42
2663830
IB:2097880.1
1
122

43
2069960
IB:2097880.1
1
129

44
2850044
IB:2097880.1
1
91

45
2484903
IB:2097880.1
1
84

46
1493337
IB:2097880.1
1
225

47
664658
IB:2097880.1
1
106

48
386476
IB:2097880.1
1
274

49
488003
IB:2097880.1
1
252

50
2634306
IB:2097880.1
1
251

51
2318093
IB:2097880.1
1
261

52
611497
IB:2097880.1
1
85

53
873135
IB:2097880.1
1
73

54
2367584
IB:2097880.1
1
229

55
57744
IB:2097880.1
1
191

56
621001
IB:2097880.1
1
145

57
1260150
IB:2097880.1
1
245

58
2365110
IB:2097880.1
1
227

59
2364628
IB:2097880.1
1
231

60
2869942
IB:2097880.1
1
254

61
2858353
IB:2097880.1
1
267

62
3034616
IB:2097880.1
1
209

63
621158
IB:2097880.1
1
145

64
2632061
IB:2097880.1
1
75

65
640040
IB:2097880.1
1
266

66
2841649
IB:2097880.1
1
232

67
6057485
LG:1695209.1
1
232

68
4125481
LG:1907955.3
1
271

69
2965517
IB:2095468.1
1
272

70
6208681
LG:1907955.4
1
264

71
6075669
LG:1907955.4
1
308

72
6566164
LG:1944384.1
1
475

73
6271522
LG:1946261.1
1
449

74
5560063
LG:2022353.5
1
261

75
5561495
LG:2022353.5
1
248

76
6433941
LG:2022353.5
1
452

77
6456026
LG:2022353.5
3
575

78
4121704
LG:2022353.5
1
269

79
6137123
LG:2022353.5
1
292

80
5656338
LG:2022353.5
1
279

81
6137155
LG:2022353.5
1
296

82
5943751
LG:2022353.5
1
288

83
6380182
LG:2022353.5
10
173

84
6409908
LG:2022353.5
1
64

85
5697069
LG:2022353.5
1
232

86
3567727
LG:2022353.5
1
167

87
6507225
LG:2022353.5
1
437

88
6389422
LG:2022353.5
1
302

89
5810417
LG:2022353.5
1
279

90
6522760
LG:2022353.5
1
529

91
5646107
LG:2022353.5
1
181

92
6397064
LG:2022353.5
1
180

93
5943406
LG:1922100.1
1
144

94
700294566
ZS:169425.2
1
280

95
700309980
ZS:169425.2
1
264

96
700933938
ZS:169425.2
1
261

97
701904240
ZS:169425.2
1
174

98
701231886
ZS:169425.2
1
226

99
700127612
ZS:169425.2
1
260

100
701828746
ZS:169425.2
1
281

101
701339683
ZS:169425.2
1
245

103
700483806
ZS:169425.2
3
279

104
700933808
ZS:169425.2
1
247

105
700635387
ZS:169425.2
1
248

106
701186639
ZS:169425.2
1
254

107
700067896
ZS:169425.2
1
201

108
701654036
ZS:169425.2
2
321

109
701616311
ZS:169425.2
7
292

110
700123547
ZS:169425.2
5
232

111
701727660
ZS:169425.2
4
270

112
5996159
LG:2029581.1
2
135

113
3786708
LG:2029581.1
1
188

114
4438637
LG:2029040.1
1
186

115
3020423
LG:2029040.1
1
272

116
4122257
LG:2029040.1
1
89

117
5479570
LG:1912304.1
1
256

118
5479760
LG:1912304.1
1
138

119
5479960
LG:1912304.1
1
173

120
5480114
LG:1912304.1
1
218

121
5473892
LG:1912304.1
1
192

122
5474141
LG:1912304.1
1
226

123
5475667
LG:1912304.1
1
206

124
5475060
LG:1912304.1
1
269

125
5481168
LG:1912304.1
1
177

126
5480121
LG:1912304.1
1
283

127
5477881
LG:1912304.1
1
212

128
5476185
LG:1912304.1
1
256

129
5474878
LG:1912304.1
1
258

130
5476523
LG:1912304.1
1
209

131
6597357
LG:2029581.4
1
362

132
6597429
LG:2029581.4
1
355

133
3787304
LG:2029581.4
58
251

134
6597257
LG:2029581.4
1
223

135
6118845
LG:2029581.4
1
402

136
6298190
LG:1916065.1
7
265

137
6138222
LG:1916065.1
2
295

138
1849578
IB:1907955.2
1
83

139
661163
IB:1907955.2
1
262

140
2101509
IB:1907955.2
1
165

141
2923187
IB:1907955.3
1
275

142
2052778
IB:1907955.3
1
274

143
2347967
IB:1907955.3
1
83

144
892747
IB:1907955.3
1
209

145
154668
IB:2096997.5
5
277

146
2473237
IB:2096997.5
1
226

147
2173121
IB:2096997.5
1
227

148
2048670
IB:2096997.5
1
261

149
1289023
IB:2096997.5
1
235

150
1997754
IB:2096997.5
1
229

151
55605
IB:2096997.5
1
191

152
2293016
IB:2096997.5
13
229

153
1888743
IB:2096997.5
1
255

154
1700085
IB:2096997.5
1
198

155
2246684
IB:2096997.5
1
254

156
1243521
IB:2096997.5
1
231

157
1682120
IB:2096997.5
1
196

158
519530
IB:2096997.5
1
244

159
674959
IB:2096997.5
1
258

160
2246604
IB:2096997.5
1
265

161
1450183
IB:2096997.5
1
231

162
676179
IB:2096997.5
1
248

163
1603276
IB:2096997.5
1
268

164
735309
IB:2096997.5
1
237

165
1853346
IB:2096997.5
1
265

166
1728347
IB:2096997.5
1
180

167
2347508
IB:2096997.5
1
242

168
770596
IB:2096997.5
1
274

169
269698
IB:2096997.5
2
357

170
2345639
IB:2096997.5
1
103

171
2313282
IB:2096997.5
1
211

172
536888
IB:2096997.5
1
230

173
579434
IB:2096997.5
1
266

174
809810
IB:2096997.5
1
280

175
2903460
IB:2096997.5
1
130

176
980041
IB:2096997.5
1
307

177
158997
IB:2096997.5
6
395

178
3468653
IB:2096997.5
3
261

179
2497291
IB:2096997.5
1
232

180
820929
IB:2096997.5
1
263

181
767530
IB:2096997.5
1
204

182
855022
IB:2096997.5
13
239

183
32873
IB:2096997.5
1
324

184
911244
IB:2096997.5
1
103

185
1913132
IB:2096997.5
1
104

186
772404
IB:2096997.5
1
172

187
3115741
IB:2096997.5
1
238

188
1750586
IB:2096997.5
1
219

189
2259695
IB:2096997.5
1
132

190
2913628
IB:2096997.5
1
146

191
270440
IB:2096997.5
1
185

192
2510064
IB:2096997.5
1
288

193
1611520
IB:2096997.5
1
129

194
30512
IB:2096997.5
1
208

195
1557831
IB:2096997.5
1
182

196
481021
IB:2096997.5
2
166

197
2116071
IB:2096997.5
1
263

198
989350
IB:2096997.5
1
274

199
1806228
IB:2096997.5
1
280

200
882564
IB:2096997.5
1
216

201
2379423
IB:2096997.5
1
229

202
994052
IB:2096997.5
1
219

203
880888
IB:2096997.5
1
244

204
764170
IB:2096997.5
1
294

205
1564580
IB:2096997.5
1
206

206
2170220
IB:2096997.5
1
236

207
1898981
IB:2096997.5
1
254

208
2262145
IB:2096997.5
1
217

209
1290739
IB:2096997.5
1
135

210
692787
IB:2096997.5
1
140

211
1650650
IB:2096997.5
1
190

212
56716
IB:2096997.5
24
245

213
1856963
IB:2096997.5
1
254

214
3028959
IB:2096997.5
1
329

215
1580413
IB:2096997.5
1
206

216
508309
IB:2096997.5
1
204

217
2695558
IB:2096997.5
1
284

218
1661051
IB:2096997.5
1
232

219
693014
IB:2096997.5
1
283

220
6413730
LG:1899061.4
1
246

221
3927591
IB:1907955.4
1
190

222
219065
IB:1907955.4
1
204

223
217054
IB:1907955.4
1
188

224
215070
IB:1907955.4
1
243

225
219390
IB:1907955.4
1
224

226
218904
IB:1907955.4
1
231

227
77197
IB:1907955.4
1
204

228
3928041
IB:1907955.4
4
143

229
700532674
ZS:162045.1
5
271

230
700520955
ZS:162045.1
1
263

231
700785531
ZS:162045.1
3
245

232
700525644
ZS:162045.1
12
257

233
700524023
ZS:162045.1
1
230

234
6112575
LG:1899061.5
1
263

235
6385123
LG:1899061.5
1
272

236
6424123
LG:1899061.5
1
234

237
6396655
LG:1899061.5
1
250

238
6178515
LG:1899061.5
1
282

239
4440191
LG:1899061.5
3
289

240
6386840
LG:1899061.5
1
276

241
3438090
IB:2097630.1
1
236

242
2103752
IB:2025662.4
1
247

243
2134070
IB:2098512.2
1
280

244
487437
IB:2098512.2
1
239

245
2215250
IB:2098512.2
1
187

246
345407
IB:2098512.2
1
197

247
3244082
IB:2098512.2
1
223

248
2827143
IB:2095471.5
1
245

249
2821267
IB:2095471.5
1
223

250
1742936
IB:2098512.3
1
315

251
3335240
IB:2098512.3
1
185

252
2747156
IB:2098512.3
1
226

253
1355979
IB:2098512.3
1
250

254
3187872
IB:2098512.3
1
334

255
1369013
IB:2098512.3
1
278

256
3565618
IB:2098512.3
1
185

257
2953422
IB:2098512.3
1
281

258
2331423
IB:2098512.3
1
106

259
2837656
IB:2098512.3
1
278

260
26403
IB:2098512.3
1
222

261
2235510
IB:2098512.3
1
262

262
1213194
IB:2098512.3
1
210

263
2716655
IB:2098512.3
1
257

264
1521103
IB:2098512.3
1
209

265
1558940
IB:2098512.3
1
218

266
1281986
IB:2098512.3
1
245

267
2936440
IB:2098512.3
1
249

268
2360924
IB:2098512.3
1
223

269
721037
IB:2098512.3
1
236

270
1282145
IB:2098512.3
1
250

271
2045951
IB:2098512.3
1
111

272
1606444
IB:2098512.3
1
217

273
2285437
IB:2098512.3
1
238

274
1512742
IB:2095471.6
1
254

275
974641
IB:2095471.6
1
189

276
1981621
IB:2095471.6
1
268

277
547710
IB:2095471.6
1
235

278
3452386
IB:2095471.6
1
224

279
1541686
IB:2095471.6
1
196

280
2508157
IB:2095471.6
1
234

281
1336918
IB:2095471.6
1
212

282
1524878
IB:2095471.6
1
186

283
1003042
IB:2095471.6
1
249

284
161598
IB:2095471.6
1
388

285
28378
IB:2095471.6
1
230

286
2231816
IB:2095471.6
1
246

287
2638052
IB:2095471.6
1
266

288
2284174
IB:2095471.6
1
241

289
64295
IB:2095471.6
1
135

290
672180
IB:2095471.6
1
227

291
1683714
IB:2095471.6
1
199

292
988257
IB:2095471.6
1
296

293
178582
IB:2095471.6
1
204

294
957959
IB:2095471.6
1
104

295
805000
IB:2095471.6
1
237

296
2963787
IB:2095471.6
1
295

297
3255588
IB:2095471.6
1
250

298
268277
IB:2095471.6
1
407

299
132527
IB:2095471.6
1
226

300
2351574
IB:2095471.6
1
195

301
1427071
IB:2095471.6
1
240

302
1302726
IB:2095471.6
1
227

303
3014326
IB:2095471.6
1
288

304
2793994
IB:2095471.6
1
288

305
3361302
IB:2095471.6
1
91

306
2228136
IB:2095471.6
55
230

307
3439101
IB:2095471.6
1
248

308
1284989
IB:2095471.6
1
273

309
101709
IB:2095471.6
1
172

310
2572961
IB:2095471.6
1
252

311
1386853
IB:2095471.6
1
268

312
968283
IB:2095471.6
1
272

313
2434871
IB:2095471.6
1
181

314
529702
IB:2095471.6
1
247

315
691852
IB:2095471.6
1
273

316
945009
IB:2095471.6
1
243

317
38327
IB:2095471.6
1
219

318
2662208
IB:2095471.6
1
75

319
1236346
IB:2095471.6
1
242

320
1671467
IB:2095471.6
1
242

321
1450164
IB:2095471.6
1
240

322
1661168
IB:2095471.6
1
203

323
2675413
IB:2095471.6
1
256

324
2071881
IB:2095471.6
1
247

325
41595
IB:2095471.6
1
289

326
3567727
IB:2095471.6
1
167

327
438267
IB:2095471.6
1
226

328
1670227
IB:2095471.6
1
107

329
2733423
IB:2095471.6
1
244

330
237
IB:2095471.6
1
318

331
523746
IB:2095471.6
1
189

332
1631414
IB:2095471.6
1
206

333
3327940
IB:2095471.6
1
263

334
436786
IB:2095471.6
1
230

335
3036523
IB:2095471.6
1
284

336
1724062
IB:2095471.6
1
201

337
1773452
IB:2095471.6
1
268

338
188
IB:2095471.6
1
289

339
2728235
IB:2095471.6
1
241

340
2657709
IB:2095471.6
1
231

341
66598
IB:2095471.6
1
161

342
2434736
IB:2095471.6
1
189

343
2050370
IB:2095471.6
1
259

344
858026
IB:2095471.6
1
264

345
2922053
IB:2095471.6
1
276

346
1486724
IB:2095471.6
1
169

347
2319924
IB:2095471.6
1
242

348
2584108
IB:2095471.6
1
282

349
3318249
IB:2095471.6
7
267

350
1418795
IB:2095471.6
1
226

351
1490935
IB:2095471.6
1
196

352
1972806
IB:2095471.6
1
274

353
857740
IB:2095471.6
1
211

354
777632
IB:2095471.6
1
242

355
1443789
IB:2095471.6
1
262

356
3360182
IB:2095471.6
2
259

357
1490047
IB:2095471.6
1
292

358
168121
IB:2095471.6
1
340

359
1753578
IB:2095471.6
1
187

360
1705762
IB:2095471.6
1
243

361
947412
IB:2095471.6
1
251

362
2769452
IB:2095471.6
1
240

363
59936
IB:2095471.6
1
218

364
975960
IB:2095471.6
1
117

365
436218
IB:2095471.6
1
200

366
2912496
IB:2095471.6
1
277

367
1833183
IB:2095471.6
1
232

368
3323085
IB:2095471.6
1
255

369
2595534
IB:2095471.6
1
253

370
158522
IB:2095471.6
15
403

371
2739831
IB:2095471.6
1
251

372
702877
IB:2095471.6
1
173

373
2779245
IB:2095471.6
1
259

374
3687255
IB:2095471.6
2
275

375
1393468
IB:2095471.6
1
257

376
870700
IB:2095471.6
1
142

377
1629121
IB:2095471.6
1
187

378
2616289
IB:2095471.6
1
240

379
1225832
IB:2095471.6
1
241

380
36001
IB:2095471.6
1
121

381
541261
IB:2095471.6
1
176

382
986764
IB:2095471.6
1
161

383
3137305
IB:2095471.6
1
277

384
1332445
IB:2095471.6
1
257

385
1233856
IB:2095471.6
1
146

386
2232952
IB:2095471.6
1
168

387
838885
IB:2095471.6
1
73

388
830015
IB:2095471.6
1
279

389
968185
IB:2095471.6
1
230

390
2266925
IB:2095471.6
1
251

391
2232714
IB:2095471.6
1
241

392
1618829
IB:2095471.6
3
194

393
862083
IB:2095471.6
1
255

394
567832
IB:2095471.6
5
255

395
1737115
IB:2095471.6
1
226

396
1565719
IB:2095471.6
1
199

397
3319527
IB:2095471.6
2
273

398
1860508
IB:2095471.6
1
253

399
1674224
IB:2095471.6
1
207

400
909282
IB:2095471.6
1
298

401
2649949
IB:2095471.6
1
264

402
2938018
IB:2095471.6
1
265

403
2218628
IB:2095471.6
1
261

404
2706495
IB:2095471.6
1
293

405
105473
IB:2095471.6
1
249

406
791482
IB:2095471.6
1
219

407
3038523
IB:2095471.6
1
262

408
754354
IB:2095471.6
1
234

409
2588364
IB:2095471.6
1
266

410
2467836
IB:2095471.6
1
229

411
1807159
IB:2095471.6
1
275

412
483414
IB:2095471.6
1
224

413
1878392
IB:2095471.6
1
270

414
3122394
IB:2095471.6
1
284

415
1632586
IB:2095471.6
1
203

416
1754034
IB:2095471.6
1
255

417
2615938
IB:2095471.6
1
240

418
776401
IB:2095471.6
1
237

419
3253386
IB:2095471.6
1
215

420
34572
IB:2041967.1
178
299

421
5613187
LG:2022251.2
1
202

422
198957
IB:2017588.1
1
182

423
5613859
LG:1915067.1
1
168

424
2241085
IB:186634.1
1
239

425
6304773
LG:2019095.3
1
482

426
5949169
LG:2019095.3
1
131

427
5876719
LG:2019095.3
1
297

428
6507116
LG:2019095.3
1
164

429
6345009
LG:2019095.3
1
296

430
6345041
LG:2019095.3
3
294

431
6120407
LG:2019095.3
1
554

432
6265395
LG:2019095.3
1
520

433
2781758
IB:2025662.9
1
243

434
1701981
IB:2025662.9
1
194

435
759186
IB:2025662.9
1
315

436
5657662
LG:2002932.6
1
230

437
3787443
LG:2002932.6
1
287

438
3788702
LG:2002932.6
1
291

439
4668706
LG:2002932.6
1
284

440
6056729
LG:2002932.6
1
533

441
3762849
LG:2002932.6
1
199

442
6558417
LG:2002932.6
1
103

443
6559956
LG:2002932.6
1
562

444
6210954
LG:2002932.6
1
302

445
5808476
LG:2002932.6
1
70

446
6555152
LG:2002932.6
1
432

447
5888375
LG:1994534.2
1
243

448
5880566
LG:1994534.2
2
257

449
5884946
LG:1994534.2
1
280

450
5889095
LG:1994534.2
1
234

451
5880061
LG:1994534.2
1
239

452
5890510
LG:1994534.2
1
251

453
5885109
LG:1994534.2
1
187

454
6129550
LG:2002932.1
1
533

455
6127983
LG:2002932.1
1
476

456
6111849
LG:1994534.3
1
271

457
5695240
LG:1994534.5
1
118

458
5815925
LG:1994534.5
1
260

459
6138342
LG:1994534.5
1
280

460
6522432
LG:1994534.5
1
491

461
6310665
LG:1994534.5
1
532

462
6129270
LG:1994534.5
1
394

463
6408546
LG:1994534.5
1
593

464
6305061
LG:1994534.5
1
534

465
6588841
LG:1994534.5
16
155

466
6552781
LG:1994534.5
1
550

467
6482476
LG:1994534.5
1
600

468
6343922
LG:1994534.5
1
176

469
5919979
LG:1994534.5
1
292

470
3783111
LG:1994534.5
1
306

471
4518248
LG:1994534.5
1
243

472
2492677
IB:2097928.2
1
144

473
3357454
IB:2073270.1
1
279

474
6126885
LG:2002932.3
1
535

475
188581
IB:2097928.3
1
142

476
2135063
IB:2097928.3
1
277

477
1331867
IB:2097928.4
1
251

478
3960113
IB:2097928.4
1
270

479
1644841
IB:2097928.4
1
208

480
2081894
IB:2097928.4
1
255

481
3069069
IB:2097928.4
1
295

482
4323184
IB:2097928.4
1
258

483
2539031
IB:2097928.4
1
228

484
742282
IB:2097928.4
1
213

485
2028355
IB:2097928.4
1
76

486
159425
IB:2097928.4
1
203

487
671593
IB:2097928.4
1
259

488
2604050
IB:2097928.4
1
147

489
3685138
IB:2097928.4
1
190

490
3957184
IB:2097928.4
1
278

491
2908269
IB:2097928.4
1
296

492
942890
IB:2097928.4
1
289

493
1332741
IB:2097928.4
1
248

494
1316096
IB:2097928.4
1
227

495
289538
IB:2097928.4
1
187

496
679064
IB:2097928.4
1
245

497
2439313
IB:2097928.4
1
260

498
909094
IB:2097928.4
1
300

499
2670325
IB:2097928.4
1
247

500
2443220
IB:2097928.4
1
123

501
2149587
IB:2097928.4
1
267

502
291706
IB:2097928.4
1
80

503
2665513
IB:2097928.4
1
238

504
2953235
IB:2097928.4
1
283

505
890040
IB:2097928.4
1
198

506
1609748
IB:2097928.4
1
169

507
2293179
IB:2097928.4
1
233

508
2766633
IB:2097928.4
1
245

509
2736649
IB:2097928.4
1
270

510
2304562
IB:2097928.4
1
104

511
2763026
IB:2097928.4
1
253

512
1377278
IB:2097928.4
1
239

513
1998146
IB:2097928.4
1
249

514
2790194
IB:2097928.4
1
302

515
2530965
IB:2097928.4
1
234

516
2664895
IB:2097928.4
1
245

517
1836569
IB:2097928.4
37
103

518
1281254
IB:2097928.4
1
228

519
2658750
IB:2097928.4
1
229

520
1468402
IB:2097928.4
1
185

521
94971
IB:2097928.4
39
226

522
3202791
IB:2097928.4
1
269

523
1623750
IB:2097928.4
1
170

524
2269607
IB:2097928.4
1
249

525
555662
IB:2097928.4
2
70

526
3273425
IB:2097928.4
1
237

527
488117
IB:2097928.4
9
239

528
955963
IB:2097928.4
1
236

529
837468
IB:2097928.4
1
257

530
2668611
IB:2097928.4
1
243

531
641056
IB:2097928.4
2
263

532
1624341
IB:2097928.4
1
205

533
2152009
IB:2097928.4
1
97

534
672412
IB:2097928.4
2
231

535
68947
IB:2097928.4
1
204

536
1312213
IB:2097928.4
1
76

537
738387
IB:2097928.4
1
227

538
1869727
IB:2097928.4
1
277

539
2834526
IB:2097928.4
1
271

540
1547894
IB:2097928.4
1
87

541
3566219
IB:2097928.4
1
302

542
114170
IB:2097928.4
1
208

543
2264814
IB:2097928.4
1
272

544
219339
IB:2097928.4
1
67

545
733063
IB:2097928.4
1
274

546
3118194
IB:2097928.4
1
278

547
2661257
IB:2097928.4
1
278

548
2990381
IB:2097928.4
2
260

549
548160
IB:2097928.4
1
239

550
1370295
IB:2097928.4
1
223

551
1887457
IB:2097928.4
1
259

552
2210818
IB:2097928.4
1
261

553
3176964
IB:2097928.4
1
175

554
4209737
IB:2097928.4
1
265

555
687475
IB:2097928.4
1
178

556
3461089
IB:2097928.4
1
234

557
158748
IB:2097928.4
1
190

558
583799
IB:2097928.4
1
76

559
2784522
IB:2097928.4
1
250

560
2441763
IB:2097928.4
1
217

561
741986
IB:2097928.4
1
263

562
3336778
IB:2097928.4
1
243

563
2631182
IB:2097928.4
1
242

564
630531
IB:2097928.4
1
272

565
2371227
IB:2097928.4
1
236

566
1001180
IB:2097928.4
1
254

567
270390
IB:2097928.4
1
346

568
46859
IB:2097928.4
1
258

569
630234
IB:2097928.4
1
224

570
1991586
IB:2097928.4
1
225

571
3925490
IB:2097928.4
1
177

572
3401566
IB:2097928.4
1
245

573
3338452
IB:2097928.4
1
260

574
1921936
IB:2097928.4
1
261

575
2406413
IB:2097928.4
1
230

576
3271032
IB:2097928.4
1
245

577
579510
IB:2097928.4
1
255

578
1999081
IB:2097928.4
1
114

579
2118363
IB:2097928.4
1
173

580
2650642
IB:2097928.4
1
230

581
2766825
IB:2097928.4
1
231

582
94970
IB:2097928.4
1
229

583
3173908
IB:2097928.4
2
175

584
837155
IB:2097928.4
1
255

585
547537
IB:2097928.4
1
251

586
672497
IB:2097928.4
1
247

587
2720987
IB:2097928.4
1
234

588
1003869
IB:2097928.4
1
239

589
1259346
IB:2097928.4
1
253

590
2474822
IB:2097928.4
1
238

591
6120495
LG:2002932.5
1
576

592
6030522
LG:2002932.5
1
257

593
6127887
LG:2002932.5
1
583

594
550609
IB:1916065.1
1
271

595
2834338
IB:1916065.1
1
269

596
1209024
IB:1916065.1
1
221

597
2160735
IB:1916065.1
1
268

598
1006278
IB:1916065.1
1
254

599
2588088
IB:1916065.1
1
244

600
2160580
IB:1916065.1
1
253

601
6523403
LG:2028962.1
1
604

602
5953606
LG:2016091.1
1
237

603
6372764
LG:2016091.1
1
267

604
6373435
LG:2016091.1
1
108

605
6387476
LG:2016091.1
1
248

606
6410750
LG:2016091.1
1
279

607
6372052
LG:2016091.1
1
278

608
6305576
LG:2016091.1
14
550

609
6122907
LG:2016091.1
1
550

610
6422660
LG:2016091.1
1
518

611
6454929
LG:2016091.1
1
563

612
6383359
LG:2016091.1
1
271

613
6422668
LG:2016091.1
1
535

614
6118137
LG:2016091.1
1
433

615
6126413
LG:2016091.1
6
348

616
6425148
LG:2016091.1
1
462

617
1857027
IB:1899061.1
1
237

618
700368142
ZS:157650.3
1
270

619
700494046
ZS:157650.3
3
94

620
700369876
ZS:157650.3
14
183

621
700255036
ZS:157650.3
7
136

622
700494879
ZS:157650.3
3
277

623
467072
IB:1899061.2
1
221

624
464308
IB:1899061.2
1
199

625
2798569
IB:1899061.3
1
95

626
2230026
IB:1899061.3
1
218

627
700536442
ZS:157650.5
1
284

628
701608605
ZS:157650.5
1
178

629
700815950
ZS:157650.5
1
227

630
700918115
ZS:157650.5
1
262

631
701257014
ZS:157650.5
9
216

632
700461506
ZS:157650.5
1
180

634
701346456
ZS:157650.5
1
181

635
700123372
ZS:157650.5
1
241

636
700774145
ZS:157650.5
42
235

637
701608169
ZS:157650.5
16
253

638
700322834
ZS:157650.5
1
235

639
701195154
ZS:157650.5
1
226

640
701509245
ZS:157650.5
1
246

641
700067453
ZS:157650.5
2
277

642
700478133
ZS:157650.5
1
282

643
700372405
ZS:157650.5
1
161

644
700175226
ZS:157650.5
1
244

645
700060734
ZS:157650.5
1
264

646
700419934
ZS:157650.5
5
284

647
701444306
ZS:157650.5
1
206

648
701720942
ZS:157650.5
1
285

649
700420845
ZS:157650.5
3
217

650
700365506
ZS:157650.5
1
266

651
701474948
ZS:157650.5
3
277

652
700323207
ZS:157650.5
1
226

653
700067452
ZS:157650.5
2
178

654
700376957
ZS:157650.5
1
100

655
1307933
IB:1899061.4
1
194

656
3974283
IB:1899061.4
3
268

657
3422227
IB:1899061.4
1
237

658
721822
IB:1899061.4
1
233

659
1839034
IB:1899061.4
1
283

660
3210659
IB:1899061.4
1
309

661
2226674
IB:1899061.4
1
226

662
1432972
IB:1899061.4
1
219

663
2243725
IB:1899061.4
1
190

664
2546759
IB:1899061.4
1
235

665
259745
IB:1899061.4
1
357

666
41970
IB:1899061.4
1
260

667
1592324
IB:1899061.4
1
192

668
3898065
IB:1899061.4
1
233

669
2735908
IB:1899061.4
1
246

670
2435175
IB:1899061.4
1
241

671
2770076
IB:1899061.4
1
252

672
1268496
IB:1899061.4
1
237

673
523940
IB:1899061.4
1
227

674
2365873
IB:1899061.4
1
234

675
888182
IB:1899061.4
1
243

676
2471553
IB:1899061.4
1
230

677
2360352
IB:1899061.4
173
270

678
2804594
IB:1899061.4
1
294

679
2684315
IB:1899061.4
1
237

680
3181620
IB:1899061.4
1
305

681
3566603
IB:1899061.4
2
228

682
3130394
IB:1899061.4
1
271

683
735448
IB:1899061.4
1
208

684
2149570
IB:1899061.4
1
135

685
1257772
IB:1899061.4
1
225

686
2728309
IB:1899061.4
1
252

687
1468878
IB:1899061.4
1
194

688
4349373
IB:1899061.4
1
269

689
2095174
IB:1899061.4
1
268

690
2588957
IB:1899061.4
1
200

691
1991653
IB:1899061.4
1
270

692
2257385
IB:1899061.4
1
71

693
424822
IB:1899061.4
1
222

694
2764187
IB:1899061.4
1
234

695
440571
IB:1899061.4
1
213

696
1451469
IB:1899061.4
1
246

697
828745
IB:1899061.4
1
284

698
1982096
IB:1899061.4
1
221

699
2986448
IB:1899061.4
1
281

700
3319382
IB:1899061.4
2
261

701
2681484
IB:1899061.4
5
249

702
2279834
IB:1899061.4
1
217

703
3201139
IB:1899061.4
1
271

704
2696415
IB:1899061.4
1
188

705
79005
IB:1899061.4
1
253

706
1307950
IB:1899061.4
1
200

707
2322036
IB:1899061.4
1
261

708
2777457
IB:1899061.4
1
252

709
1801673
IB:1899061.4
1
276

710
2232170
IB:1899061.4
1
228

711
1311164
IB:1899061.4
1
232

712
4346781
IB:1899061.4
1
250

713
1271781
IB:1899061.4
1
225

714
1451452
IB:1899061.4
1
253

715
2503478
IB:1899061.4
1
236

716
2494513
IB:1899061.4
1
329

717
3325740
IB:1899061.4
1
276

718
1505327
IB:1899061.4
1
222

719
1613557
IB:1899061.4
1
198

720
1254974
IB:1899061.4
1
260

721
2452005
IB:1899061.4
1
181

722
2612202
IB:1899061.4
1
190

723
35154
IB:1899061.4
1
224

724
3960285
IB:1899061.4
1
261

725
985780
IB:1899061.4
1
258

726
1839341
IB:1899061.4
1
272

727
1982581
IB:1899061.4
1
139

728
1931150
IB:1899061.4
1
268

729
2452908
IB:1899061.4
1
234

730
6523007
LG:2021143.3
1
540

731
6523607
LG:2021143.3
1
562

732
700434903
ZS:162199.1
3
150

733
700934290
ZS:162199.1
1
116

734
700418829
ZS:162199.1
1
109

735
700249262
ZS:162199.1
9
298

736
700418821
ZS:162199.1
1
110

737
700821102
ZS:162199.1
1
92

738
701580728
ZS:162199.1
3
217

739
700435587
ZS:162199.1
4
205

740
3328503
IB:2095693.4
1
255

741
40700
IB:2095693.6
1
162

742
5678683
LG:2021143.7
1
242

743
6432644
LG:2021143.7
1
430

744
6010062
LG:2021143.7
1
179

745
6556049
LG:2021143.7
1
501

746
6107822
LG:2021143.7
2
269

747
6078778
LG:2021143.7
1
291

748
6381042
LG:2021143.7
1
230

749
6612661
LG:2021143.7
1
526

750
6544335
LG:2021143.7
1
566

751
6429658
LG:2021143.7
1
437

752
5877503
LG:2021143.7
1
287

753
6603752
LG:2021143.7
1
543

754
6564202
LG:2021143.7
1
416

755
6514218
LG:2021143.7
1
496

756
4519243
LG:2021143.7
1
240

757
4519149
LG:2021143.7
1
278

758
6402167
LG:2021143.7
1
279

759
3162188
LG:2021143.7
2
253

760
6544193
LG:2021143.7
1
465

761
5564022
LG:2021143.7
1
249

762
3762964
LG:2021143.7
4
168

763
85665
IB:2095693.7
5
180

764
78988
IB:2095693.7
1
212

765
72104
IB:2095693.7
1
178

766
69718
IB:2095693.7
3
178

767
649490
IB:2095693.7
1
251

768
26609
IB:2095693.7
1
229

769
41719
IB:2095693.7
3
214

770
77013
IB:2095693.7
1
218

771
1862465
IB:2095693.7
1
114

772
3179407
IB:2095693.7
1
326

773
68007
IB:2095693.7
1
210

774
3079952
IB:2095693.7
3
305

775
892
IB:2095693.7
3
410

776
581245
IB:2095693.7
1
281

777
1416
IB:2095693.7
1
399

778
536352
IB:2095693.7
1
119

779
4213912
IB:2095693.7
1
213

781
2914553
IB:2095693.7
8
183

782
578971
IB:2095693.7
1
233

783
700768273
ZS:158823.1
1
279

784
701242681
ZS:158823.1
1
130

785
701246365
ZS:158823.1
1
260

786
701188745
ZS:158823.1
1
153

787
700496220
ZS:158823.1
1
279

788
700370466
ZS:158823.1
3
236

789
700315154
ZS:158823.1
1
159

790
700497170
ZS:158823.1
2
91

791
700770692
ZS:158823.1
2
98

792
700290724
ZS:158823.1
6
286

793
700367624
ZS:158823.1
1
80

794
700066526
ZS:158823.1
1
249

795
700061414
ZS:158823.1
1
68

796
701482761
ZS:158823.1
1
143

797
700541247
ZS:158823.1
1
203

798
701193468
ZS:158823.1
1
268

799
700606709
ZS:158823.1
2
140

800
700420587
ZS:158823.1
1
128

801
700593713
ZS:158823.1
1
209

802
700928945
ZS:158823.1
1
74

803
701189016
ZS:158823.1
1
217

804
1986692
IB:2093542.4
1
212

805
2270579
IB:2093542.4
1
266

806
3274021
IB:2093542.4
1
267

807
1347425
IB:2093542.4
1
231

808
864155
IB:2093542.4
1
251

809
1423768
IB:2093542.4
1
221

810
2355551
IB:2093542.4
1
238

811
3325114
IB:2093542.4
1
287

812
1296794
IB:2093542.4
1
246

813
1340754
IB:2093542.4
1
265

814
2695839
IB:2093542.4
1
295

815
1746423
IB:2093542.4
1
250

816
1502674
IB:2093542.4
1
283

817
2899137
IB:2093542.4
1
289

818
1294153
IB:2093542.4
1
254

819
3256826
IB:2093542.4
1
248

820
3244929
IB:2093542.4
1
256

821
1739432
IB:2093542.4
1
181

822
3116132
IB:2093542.4
1
293

823
1386061
IB:2093542.4
1
164

824
3337508
IB:2093542.4
1
260

825
1905370
IB:2022179.1
1
228

826
2050014
IB:2104284.5
1
273

827
1972386
IB:2104284.5
1
267

828
463172
IB:2104284.5
1
227

829
1490003
IB:2104284.5
1
266

830
239023
IB:2104284.5
1
214

831
2096680
IB:2104284.5
1
242

832
2910217
IB:2104284.5
1
266

833
1698871
IB:2104284.5
1
234

834
2472307
IB:2104284.5
1
239

835
1689376
IB:2104284.5
1
203

836
995171
IB:2104284.5
1
229

837
3323088
IB:2104284.5
1
254

838
2758260
IB:2104284.5
1
227

839
3448616
IB:2104284.5
1
250

840
3292975
IB:2104284.5
1
247

841
763788
IB:2104284.5
1
70

842
2476089
IB:2104284.5
1
234

843
3451002
IB:2104284.5
1
125

844
1625423
IB:2104284.5
1
203

845
2682429
IB:2104284.5
2
269

846
491356
IB:2104284.5
1
260

847
1811236
IB:2104284.5
1
251

848
2598057
IB:2104284.5
1
130

849
1984010
IB:2104284.5
1
256

850
2830524
IB:2104284.5
1
266

851
8248
IB:2104284.5
4
290

852
321613
IB:2104284.5
1
255

853
677686
IB:2104284.5
1
245

854
2584176
IB:2104284.5
1
277

855
638241
IB:2104284.5
1
251

856
257820
IB:2104284.5
1
193

857
506236
IB:2104284.5
1
203

858
2645110
IB:2104284.5
1
251

859
1957671
IB:2104284.5
1
262

860
2682468
IB:2104284.5
1
211

861
1302
IB:2104284.5
1
303

862
3361311
IB:2104284.5
2
248

863
1355750
IB:2104284.5
1
265

864
2173973
IB:2104284.5
1
238

865
57539
IB:2104284.5
1
188

866
2613128
IB:2104284.5
1
233

867
2782774
IB:2104284.5
1
257

868
1703167
IB:2022179.6
1
245

869
806627
IB:2022179.6
1
210

870
1831627
IB:2022179.6
1
262

871
381954
IB:2022179.6
5
200

872
3245690
IB:2022179.6
1
251

873
1593378
IB:2022179.6
1
237

874
928044
IB:2022179.6
1
172

875
1627474
IB:2022179.6
1
212

876
2750679
IB:2022179.6
1
278

877
691867
IB:2093542.9
1
255

878
688682
IB:2093542.9
1
243

879
5865786
LG:2000458.1
1
267

880
6179644
LG:1924906.1
1
316

881
1903494
IB:2095467.1
1
237

882
434242
IB:2101151.1
1
225

883
3139053
IB:2101151.1
1
282

884
864652
IB:2101151.1
10
189

885
631104
IB:2101151.1
1
248

886
1729479
IB:2101151.1
1
228

887
6423435
LG:1997596.3
1
476

888
5712404
LG:1997596.3
1
278

889
6100191
LG:1997596.3
1
279

890
6096811
LG:1997596.3
4
324

891
6411280
LG:1997596.3
2
161

892
6514626
LG:1997596.3
1
322

893
3787301
LG:1997596.3
1
70

894
6565167
LG:1997596.3
1
490

895
4667847
LG:1997596.3
1
106

896
6411253
LG:1997596.3
1
288

897
5842026
LG:1997596.3
1
282

898
4518594
LG:1997596.3
1
251

899
6541505
LG:1997596.3
1
559

900
2597277
IB:2022623.5
1
246

901
923474
IB:2022623.5
1
273

902
1475844
IB:2022623.6
1
182

903
5618571
LG:2001822.2
1
303

904
6246764
LG:2001822.2
1
579

905
5700115
LG:2001822.2
3
260

906
5951238
LG:2001822.2
3
333

907
6390391
LG:2001822.2
2
249

908
6390312
LG:2001822.2
2
239

909
3567447
LG:2001822.2
1
155

910
6247056
LG:2001822.2
1
603

911
5615260
LG:2001822.2
7
276

912
1786291
IB:2022623.8
1
263

913
2779480
IB:2022623.8
1
209

914
1315024
IB:2022623.8
1
245

915
1786745
IB:2022623.8
1
226

916
1258759
IB:2022623.8
1
208

917
1547727
IB:2022623.8
1
187

918
2100659
IB:2022623.8
1
230

919
2839374
IB:2022623.8
1
273

920
1634458
IB:2022623.8
1
211

921
2702257
IB:2022623.8
1
276

922
2356088
IB:1081640.1
1
105

923
978769
IB:1081640.1
1
168

924
2654856
IB:1081640.1
1
247

925
3181917
IB:1081640.1
1
307

926
2016903
IB:1081640.1
1
262

927
701230984
ZS:166646.1
1
245

928
700627723
ZS:166646.1
1
250

929
700911955
ZS:166646.1
1
262

930
701280056
ZS:166646.1
1
267

931
700769886
ZS:166646.1
1
259

932
700647424
ZS:166646.1
2
176

933
701396532
ZS:166646.1
1
102

934
700490877
ZS:166646.1
1
272

935
700374582
ZS:166646.1
1
269

936
700373236
ZS:166646.1
3
145

937
700546735
ZS:166646.1
1
281

938
701194114
ZS:166646.1
1
237

939
701644894
ZS:166646.1
1
319

940
700126003
ZS:166646.1
3
90

941
700642857
ZS:166646.1
2
205

942
701512158
ZS:166646.1
3
268

943
700479909
ZS:166646.1
1
265

944
700059536
ZS:166646.1
1
296

945
700629237
ZS:166646.1
1
265

946
701304081
ZS:166646.1
1
210

947
701651203
ZS:166646.1
1
196

948
700505437
ZS:166646.1
1
268

949
701484590
ZS:166646.1
1
276

950
701026436
ZS:166646.1
1
240

951
701467315
ZS:166646.1
1
286

952
701484801
ZS:166646.1
1
232

953
700911350
ZS:166646.1
1
258

954
700461547
ZS:166646.1
1
202

955
700493031
ZS:166646.1
1
284

956
701490669
ZS:166646.1
1
271

957
700514441
ZS:166646.1
2
301

958
701025551
ZS:166646.1
1
274

959
700396312
ZS:166646.1
3
71

960
701485302
ZS:166646.1
3
294

961
701913515
ZS:166646.1
1
228

962
701021709
ZS:166646.1
1
153

963
701186432
ZS:166646.1
1
195

964
700310390
ZS:166646.1
1
301

965
700591163
ZS:166646.1
1
231

966
701290475
ZS:166646.1
1
133

967
700639812
ZS:166646.1
1
194

969
701022008
ZS:166646.1
1
181

970
701468265
ZS:166646.1
1
248

971
700769478
ZS:166646.1
1
260

972
701464269
ZS:166646.1
1
230

973
701827434
ZS:166646.1
7
293

974
701718036
ZS:166646.1
9
295

975
700435067
ZS:166646.1
3
327

976
700415992
ZS:166646.1
1
250

977
700311142
ZS:166646.1
1
284

978
700812651
ZS:166646.1
1
273

979
701021635
ZS:166646.1
1
251

980
700519425
ZS:166646.1
1
184

981
701489338
ZS:166646.1
1
278

982
700275567
ZS:166646.1
1
299

983
4344032
LG:2005311.5
2
114

984
700370485
ZS:060925.1
1
220

985
2907890
IB:1896558.1
1
291

986
2781237
IB:1896558.1
1
224

987
700933680
ZS:156270.1
1
201

988
701714807
ZS:156270.1
1
78

989
700543268
ZS:156270.1
1
135

990
700629946
ZS:156270.1
2
80

991
700543958
ZS:156270.1
1
248

992
700809939
ZS:156270.1
1
215

993
700275945
ZS:156270.1
1
74

994
701260994
ZS:156270.1
1
201

995
701263538
ZS:156270.1
1
258

996
700499733
ZS:156270.1
1
196

997
700363490
ZS:156270.1
2
166

998
700820713
ZS:163272.1
1
265

999
700530107
ZS:163272.1
2
268

1000
700819863
ZS:163272.1
1
217

1001
700814470
ZS:163272.1
1
243

1002
701286468
ZS:163272.1
1
265

1003
700189527
ZS:163272.1
1
303

1004
701286761
ZS:163272.1
1
238

1005
700602464
ZS:163272.1
1
109

1006
700271991
ZS:163272.1
1
83

1007
700856846
ZS:163272.1
1
268

1008
701910492
ZS:163272.1
3
285

1009
700591303
ZS:163272.1
1
267

1010
701295547
ZS:163272.1
1
189

1011
700251664
ZS:163272.1
1
219

1012
700061690
ZS:163272.1
1
297

1013
700522555
ZS:163272.1
1
277

1014
700312605
ZS:163272.1
1
273

1015
700486975
ZS:163272.1
1
88

1016
701280837
ZS:163272.1
1
249

1017
701263345
ZS:163272.1
1
272

1018
700130847
ZS:163272.1
1
198

1019
701294142
ZS:163272.1
1
248

1020
700127864
ZS:163272.1
1
262

1021
700419566
ZS:163272.1
1
275

1022
700298707
ZS:163272.1
1
266

1023
700521683
ZS:163272.1
1
283

1024
700489028
ZS:163272.1
1
277

1025
700821256
ZS:163272.1
1
230

1026
700297908
ZS:163272.1
1
297

1027
700129307
ZS:163272.1
2
249

1028
700417150
ZS:163272.1
1
272

1029
700486715
ZS:163272.1
2
245

1030
700268744
ZS:163272.1
1
284

1031
700174616
ZS:163272.1
1
250

1032
700489346
ZS:163272.1
1
280

1033
701270561
ZS:163272.1
1
257

1034
701300219
ZS:163272.1
1
195

1035
700522758
ZS:163272.1
1
147

1036
700068332
ZS:163272.1
1
174

1037
700525582
ZS:163272.1
1
177

1038
700300221
ZS:163272.1
1
287

1039
700533847
ZS:163272.1
1
286

1040
701273613
ZS:163272.1
1
228

1041
701255660
ZS:163272.1
1
256

1042
2747183
IB:2033867.1
1
130

1043
996393
IB:2033867.1
1
60

1044
1447832
IB:2033867.1
1
57

1045
286060
IB:2033867.1
24
94

1046
3980387
IB:2106419.1
1
206

1047
700250549
ZS:019755.1
1
282

1048
700123628
ZS:019755.1
1
233

1049
2938247
IB:2024261.1
20
262

1050
22377
IB:2024261.2
1
268

1051
1925075
IB:2024261.2
1
277

1052
1364475
IB:2024261.2
1
203

1053
3438723
IB:2024261.2
1
248

1054
2303842
IB:2024261.2
1
255

1055
691479
IB:2024261.2
1
179

1056
2097617
IB:2024261.2
1
171

1057
680352
IB:2024261.2
1
220

1058
996586
IB:2024261.2
1
245

1059
1476048
IB:2024261.2
1
203

1060
2153735
IB:2024261.2
1
265

1061
2397557
IB:2024261.2
1
228

1062
2171748
IB:2024261.2
1
202

1063
3929904
IB:2024261.2
1
92

1064
2734931
IB:2024261.2
1
211

1065
2582411
IB:2024261.2
1
306

1066
3089081
IB:2024261.2
1
274

1067
663716
IB:2024261.2
1
245

1068
2278413
IB:2024261.2
1
276

1069
24810
IB:2024261.2
1
303

1070
2591180
IB:2024261.2
1
250

1071
4907489
IB:2024261.2
1
77

1072
259698
IB:2024261.2
1
364

1073
21859
IB:2024261.2
1
256

1074
2618859
IB:2024261.2
1
257

1075
1450971
IB:2024261.2
1
111

1076
3079454
IB:2024261.2
1
307

1077
1493650
IB:2024261.2
1
207

1078
2370759
IB:2024261.2
1
237

1079
2290353
IB:2024261.2
1
249

1080
2275525
IB:2024261.2
1
262

1081
2287631
IB:2024261.2
1
239

1082
2986658
IB:2024261.2
2
233

1083
2452912
IB:2024261.2
1
238

1084
2509602
IB:2024261.2
1
149

1085
3467240
IB:2024261.2
2
242

1086
3079537
IB:2024261.2
1
148

1087
1271327
IB:2024261.2
1
168

1088
452363
IB:2024261.2
1
229

1089
3029510
IB:2024261.2
1
267

1090
2838736
IB:2024261.2
1
246

1091
2503774
IB:2024261.2
1
158

1092
683266
IB:2024261.2
1
147

1093
679322
IB:2024261.2
1
119

1094
2941393
IB:2024261.2
1
139

1095
1517789
IB:2024261.2
1
202

1096
217
IB:2024261.2
8
277

1097
2697521
IB:2024261.2
1
265

1098
3279421
IB:2024261.2
1
236

1099
54555
IB:2024261.2
1
164

1100
2742812
IB:2024261.2
1
196

1101
2583990
IB:2024261.2
1
260

1102
2349158
IB:2024261.2
1
193

1103
3567447
IB:2024261.2
1
155

1104
2654142
IB:2024261.2
3
291

1105
266368
IB:2024261.2
4
356

1106
654402
IB:2024261.2
1
285

1107
21552
IB:2024261.2
1
253

1108
956044
IB:2024261.2
1
238

1109
598239
IB:2024261.2
1
238

1110
2809547
IB:2024261.2
1
252

1111
1475663
IB:2024261.2
1
191

1112
2445935
IB:2024261.2
1
226

1113
1513731
IB:2024261.2
1
196

1114
2586284
IB:2024261.2
1
219

1115
2699720
IB:2024261.2
1
264

1116
479348
IB:2024261.2
1
286

1117
2752584
IB:2024261.2
1
261

1118
1850751
IB:2024261.2
1
135

1119
2133163
IB:2024261.2
1
244

1120
2154178
IB:2024261.2
1
170

1121
700179763
ZS:173316.1
1
245

1122
700776044
ZS:173316.2
1
257

1123
700860742
ZS:173316.2
1
259

1124
700862233
ZS:173316.2
4
238

1125
1700421
IB:2094484.7
1
189

1126
2914593
IB:2094484.7
1
198

1127
1878873
IB:2094484.7
1
260

1128
1391107
IB:2094484.7
1
241

1129
2964175
IB:2094484.7
1
285

1130
6313477
LG:1996166.4
2
386

1131
6613886
LG:2022251.5
1
197

1132
6270862
LG:2022251.6
1
606

1133
5814585
LG:2022251.6
1
232

1134
6513219
LG:2022251.6
1
456

1135
6421324
LG:2022251.6
1
393

1136
5864057
LG:2022251.6
5
281

1137
6401763
LG:2022251.6
1
246

1138
6378821
LG:2022251.6
3
275

1139
6496712
LG:2022251.6
1
568

1140
6419875
LG:2022251.6
1
193

1141
5822327
LG:2022251.6
1
278

1142
5813672
LG:2022251.6
1
313

1143
6408660
LG:2022251.7
1
231

1144
4518370
LG:2022251.7
3
241

1145
6517553
LG:2022251.7
1
479

1146
6136188
LG:2022251.7
1
276

1147
6410975
LG:2022251.7
1
308

1148
5823548
LG:2022251.7
17
212

1149
6369723
LG:2022251.7
1
569

1150
6014804
LG:2022251.7
1
186

1151
6398907
LG:2022251.7
3
240

1152
6568514
LG:2022251.7
1
455

1153
5819602
LG:2022251.7
107
324

1154
6399030
LG:2022251.7
1
289

1155
6591075
LG:2022251.7
1
350

1156
6257326
LG:2022251.7
3
270

1157
5698802
LG:2022251.7
1
235

1158
701229180
ZS:158013.1
1
240

1159
700934730
ZS:158013.1
1
76

1160
700948690
ZS:158013.1
1
281

1161
700295204
ZS:158013.1
4
214

1162
701277731
ZS:158013.1
1
233

1163
701334863
ZS:158013.1
1
213

1164
701274943
ZS:158013.1
1
148

1165
701275514
ZS:158013.1
1
154

1166
700127275
ZS:158013.1
1
93

1167
701333270
ZS:158013.1
1
244

1168
701944168
ZS:168075.2
1
210

1169
701466250
ZS:168075.2
2
273

1170
701944268
ZS:168075.2
1
286

1171
701258551
ZS:168075.2
1
253

1172
701616185
ZS:168075.2
1
333

1173
700141178
ZS:168075.2
1
240

1174
701734388
ZS:168075.2
1
304

1175
701725735
ZS:168075.2
1
319

1176
701339880
ZS:168075.2
1
81

1177
701475064
ZS:168075.2
1
266

1178
700303823
ZS:168075.2
2
187

1179
700524067
ZS:168075.2
1
256

1180
701880885
ZS:168075.2
1
283

1181
701396970
ZS:168075.2
1
188

1182
700132732
ZS:168075.2
1
258

1183
700140788
ZS:168075.2
1
236

1184
2234427
IB:1448568.1
1
263

1185
2242421
IB:1448568.1
1
244

1186
2703885
IB:1537014.1
1
174

1187
3328680
IB:1537014.1
1
271

1188
389504
IB:1086288.1
1
221

1189
343775
IB:1086288.1
1
94

1190
2749717
IB:2022623.10
1
239

1191
2795118
IB:2022623.10
1
313

1192
2544029
IB:2022623.10
1
251

1193
1488916
IB:2022623.10
1
211

1194
2482284
IB:2022623.10
1
222

1195
1591308
IB:2022623.10
1
212

1196
2748126
IB:2022623.10
1
237

1197
2477774
IB:2022623.10
1
241

1198
2542849
IB:2022623.10
1
221

1199
3973829
IB:2022623.10
1
246

1200
1699889
IB:2022623.10
1
235

1201
1475835
IB:2022623.10
1
187

1202
4346925
IB:2022623.10
1
251

1203
854372
IB:2022623.10
1
251

1204
1489193
IB:2022623.10
1
208

1205
813961
IB:2022623.10
1
67

1206
676879
IB:2022623.10
1
282

1207
2883157
IB:2022623.10
1
248

1208
1930333
IB:2022623.10
1
265

1209
2465467
IB:2022623.10
1
233

1210
3979618
IB:2022623.10
1
297

1211
1548750
IB:2022623.10
1
177

1212
2482006
IB:2022623.10
1
235

1213
3972034
IB:2022623.10
1
279

1214
1302173
IB:2022623.10
1
293

1215
1754053
IB:2022623.10
1
246

1216
1805622
IB:2022623.10
1
252

1217
355076
IB:2022623.10
1
222

1218
1445360
IB:2022623.10
1
240

1219
1915970
IB:2022623.10
1
279

1220
491397
IB:2022623.10
1
237

1221
1405153
IB:2022623.10
1
264

1222
1423720
IB:2022623.10
1
219

1223
2875708
IB:2022623.10
1
283

1224
550170
IB:2022623.10
1
249

1225
2278238
IB:2022623.10
1
255

1226
1332454
IB:2022623.10
1
235

1227
155152
IB:2022623.10
1
193

1228
1332142
IB:2022623.10
1
99

1229
2683259
IB:2022623.10
1
310

1230
2827925
IB:2022623.10
1
258

1231
2862812
IB:2022623.10
1
276

1232
2122664
IB:2022623.10
1
268

1233
2554840
IB:2022623.10
1
245

1234
2630572
IB:2022623.10
1
254

1235
465062
IB:2022623.10
1
221

1236
2908988
IB:2022623.10
1
231

1237
1870177
IB:2022623.10
1
227

1238
3340773
IB:2022623.10
1
241

1239
938004
IB:2022623.10
1
262

1240
2848865
IB:2022623.10
1
268

1241
2439949
IB:2022623.10
1
103

1242
1414913
IB:2022623.10
1
135

1243
2720175
IB:2022623.10
1
93

1244
2685714
IB:2022623.10
1
254

1245
2371533
IB:2022623.10
1
217

1246
3088650
IB:2022623.10
1
253

1247
2152591
IB:2022623.10
1
226

1248
780556
IB:2022623.10
1
162

1249
3947580
IB:2022623.10
1
280

1250
3981972
IB:2022623.10
1
294

1251
2659340
IB:2022623.10
1
235

1252
937943
IB:2022623.10
1
304

1253
1320953
IB:2022623.10
1
240

1254
3972523
IB:2022623.10
1
278

1255
1871348
IB:2022623.10
1
125

1256
2660893
IB:2022623.10
1
229

1257
2665670
IB:2022623.10
1
247

1258
3180353
IB:2022623.10
1
296

1259
1484296
IB:2022623.10
1
262

1260
701607583
ZS:156579.1
1
303

1261
700372543
ZS:156579.1
1
268

1262
700781722
ZS:156579.1
1
266

1263
701649506
ZS:156579.1
1
261

1264
700768474
ZS:156579.1
1
251

1265
700366914
ZS:156579.1
1
263

1266
700274636
ZS:156579.1
1
199

1267
700328048
ZS:156579.1
1
296

1268
700485657
ZS:156579.1
1
279

1269
700635667
ZS:156579.1
1
254

1270
701232896
ZS:156579.1
1
143

1271
701580093
ZS:156579.1
1
350

1272
700519840
ZS:156579.1
1
274

1273
700627492
ZS:156579.1
1
249

1274
700530153
ZS:156579.1
1
280

1275
701419250
ZS:156579.1
1
221

1276
700636665
ZS:156579.1
1
244

1277
701343275
ZS:156579.1
1
251

1278
701319684
ZS:156579.1
1
138

1279
700766587
ZS:156579.1
1
260

1280
701392692
ZS:156579.1
1
246

1281
700785820
ZS:156579.1
1
259

1282
700914592
ZS:156579.1
1
237

1283
700625377
ZS:156579.1
1
246

1284
700785521
ZS:156579.1
1
244

1285
700306832
ZS:156579.1
1
258

1286
700626941
ZS:156579.1
1
78

1287
700276565
ZS:156579.1
1
201

1288
700314659
ZS:156579.1
1
283

1289
700420110
ZS:156579.1
1
157

1290
700246776
ZS:156579.1
1
161

1291
700288432
ZS:156579.1
1
251

1292
701519417
ZS:156579.1
1
284

1293
700629369
ZS:156579.1
1
260

1294
701025922
ZS:156579.1
1
262

1295
700631958
ZS:156579.1
1
268

1296
700636674
ZS:156579.1
1
247

1297
700914122
ZS:156579.1
1
277

1298
701024824
ZS:156579.1
1
158

1299
700910639
ZS:156579.1
1
243

1300
2328033
IB:2094098.6
1
255

1301
579187
IB:2095659.1
1
268

1302
700534404
ZS:173892.1
1
287

1303
701344942
ZS:173892.3
1
282

1304
700525076
ZS:173892.3
4
104

1305
701292649
ZS:173892.3
1
176

1306
701654201
ZS:173892.3
3
237

1307
700289551
ZS:173892.3
1
313

1308
700415338
ZS:173892.3
1
114

1309
700538084
ZS:173892.3
1
265

1310
700485031
ZS:173892.3
1
225

1311
701650221
ZS:173892.3
2
294

1312
701655217
ZS:173892.3
2
120

1313
700305954
ZS:173892.3
3
91

1314
701468078
ZS:173892.3
5
222

1315
6027904
LG:2005311.6
1
288

1316
6593314
LG:2005311.6
1
499

1317
6307844
LG:2005311.6
1
233

1318
6593514
LG:2005311.6
5
547

1319
5303918
LG:2005311.6
1
272

1320
5885852
LG:2005311.7
3
248

1321
6523764
LG:2005311.7
1
235

1322
5993818
LG:2005311.7
1
297

1323
5882855
LG:2005311.7
3
240

1324
6114074
LG:2005311.7
1
267

1325
3567250
LG:2005311.7
1
107

1326
6114081
LG:2005311.7
1
267

1327
5943729
LG:2005311.7
1
268

1328
4211225
LG:2005311.7
1
286

1329
5885814
LG:2005311.7
3
255

1330
6605876
LG:2005311.7
1
475

1331
5697593
LG:2005311.7
2
61

1332
4209022
LG:2005311.7
1
280

1333
6364143
LG:2005311.7
3
90

1334
3780874
LG:2005311.7
3
284

1335
5886691
LG:2005311.7
1
256

1336
6512389
LG:2005311.7
1
554

1337
4516729
LG:2005311.7
1
251

1338
6522528
LG:2005311.7
1
535

1339
6299317
LG:2005311.7
1
269

1340
6354938
LG:2005311.7
1
271

1341
6411611
LG:2005311.7
2
511

1342
6271241
LG:2005311.7
1
549

1343
4438756
LG:2005311.7
1
278

1344
4438771
LG:2005311.7
2
270

1345
4443584
LG:2005311.7
1
136

1346
6098582
LG:2005311.7
11
278

1347
6361222
LG:2005311.7
1
466

1348
5883291
LG:2005311.7
1
307

1349
6366607
LG:2005311.7
5
259

1350
5954210
LG:2005311.7
6
276

1351
4515822
LG:2005311.7
1
256

1352
700488315
ZS:156325.3
1
288

1353
701728973
ZS:156325.3
1
280

1354
700367922
ZS:156325.3
1
136

1355
700486083
ZS:156325.3
3
200

1356
701484604
ZS:156325.3
1
284

1357
6480126
LG:2018794.6
1
593

1358
6373901
LG:2018794.6
1
291

1359
5890253
LG:2018794.6
1
258

1360
6546449
LG:2018794.6
1
161

1361
6424874
LG:2018794.6
1
555

1362
6176089
LG:2018794.6
1
264

1363
5885588
LG:2018794.6
1
256

1364
5884115
LG:2018794.6
1
250

1365
6431732
LG:2018794.6
1
71

1366
6319383
LG:2018794.6
1
273

1367
6006445
LG:2018794.6
1
281

1368
5714842
LG:2018794.6
1
266

1369
6153505
LG:2018794.6
162
245

1370
6245935
LG:2018794.6
1
521

1371
6306763
LG:2018794.6
1
259

1372
5945146
LG:2018794.6
1
282

1373
5884982
LG:2018794.6
1
233

1374
6322160
LG:2018794.6
1
128

1375
3154287
LG:2018794.6
3
230

1376
6375238
LG:2018794.6
1
263

1377
6246035
LG:2018794.6
1
539

1378
6537280
LG:2018794.6
1
320

1379
1319812
IB:2080205.1
1
224

1380
1389252
IB:2080205.1
1
222

1381
886511
IB:2094678.10
1
142

1382
3275752
IB:2094678.10
1
251

1383
767583
IB:2094678.10
1
245

1384
2822820
IB:2094678.10
1
309

1385
2231189
IB:2094678.10
1
237

1386
2625106
IB:2094678.10
1
231

1387
2823682
IB:2094678.10
1
278

1388
500
IB:2022421.8
1
363

1389
682041
IB:2022421.8
1
230

1390
101255
IB:2022421.8
11
127

1391
219448
IB:2022421.8
1
194

1392
303290
IB:2022421.8
6
232

1393
207382
IB:2022421.8
1
210

1394
580332
IB:2022421.8
1
228

1395
23424
IB:2022421.8
1
271

1396
2636808
IB:2022421.8
1
250

1397
895100
IB:2022421.8
1
258

1398
988478
IB:2022421.8
1
59

1399
927899
IB:2022421.8
1
119

1400
215284
IB:2022421.8
1
330

1401
21437
IB:2022421.8
3
315

1402
24011
IB:2022421.8
3
278

1403
21857
IB:2022421.8
1
257

1404
21630
IB:2022421.8
1
302

1405
1818131
IB:2022421.8
1
145

1406
2663627
IB:2047198.1
1
238

1407
5920138
LG:2021282.7
1
308

1408
1753287
IB:2072495.1
1
217

1409
1812515
IB:2072495.1
1
239

1410
1710659
IB:2072495.1
1
114

1411
176197
IB:2072495.1
1
376

1412
1694075
IB:2072495.1
1
212

1413
1753396
IB:2072495.1
1
191

1414
1753376
IB:2072495.1
1
237

1415
2635071
IB:2025662.6
1
251

1416
86657
IB:2025662.8
1
201

1417
139171
IB:2025662.8
5
59

1418
5878526
LG:1925055.3
1
277

1419
6600271
LG:1925055.3
1
524

1420
5561109
LG:1925055.3
1
213

1421
5703148
LG:1925055.3
2
282

1422
4443746
LG:1925055.3
2
185

1423
6428594
LG:1925055.3
1
214

1424
4343561
LG:1925055.3
1
285

1425
3021152
LG:1925055.3
1
280

1426
6213466
LG:1925055.3
3
265

1427
6376812
LG:1925055.3
3
276

1428
5700295
LG:1925055.3
1
274

1429
6364679
LG:1925055.3
1
288

1430
6489032
LG:1925055.3
1
488

1431
6378287
LG:1925055.3
2
275

1432
6349775
LG:1925055.3
1
323

1433
6379980
LG:1925055.3
4
285

1434
4516928
LG:1925055.3
1
213

1435
6412344
LG:1925055.3
1
533

1436
4518475
LG:1925055.3
1
127

1437
5704048
LG:1925055.3
1
262

1438
6363156
LG:1925055.3
1
572

1439
6521229
LG:1925055.3
1
109

1440
6455607
LG:1925055.3
1
505

1441
6598793
LG:1925055.3
1
490

1442
6208789
LG:1925055.3
1
303

1443
6498438
LG:1925055.3
1
531

1444
3899830
LG:1925055.3
1
292

1445
4441007
LG:1925055.3
1
245

1446
4668358
LG:1925055.3
1
179

1447
6208589
LG:1925055.3
4
84

1448
3899623
LG:1925055.3
1
263

1449
4440405
LG:1925055.3
1
229

1450
6491681
LG:1925055.3
2
244

1451
4443438
LG:1925055.3
1
267

1452
6208777
LG:1925055.3
1
279

1453
6513632
LG:1925055.3
1
491

1454
6431741
LG:1925055.3
1
389

1455
4438923
LG:1925055.3
1
273

1456
3023596
LG:1925055.3
1
289

1457
6513532
LG:1925055.3
1
421

1458
6023712
LG:1925055.3
1
284

1459
3022286
LG:1925055.3
1
283

1460
6598639
LG:1925055.3
1
535

1461
5692805
LG:1925055.3
1
215

1462
5702665
LG:1925055.3
1
257

1463
5562537
LG:1925055.3
1
259

1464
6169636
LG:1925055.3
1
148

1465
6376628
LG:1925055.3
4
269

1466
6023337
LG:1925055.3
1
289

1467
6384872
LG:1925055.3
1
269

1468
6363655
LG:1925055.3
1
520

1469
6010162
LG:1925055.3
1
116

1470
4517845
LG:1925055.3
1
249

1471
3019790
LG:1925055.3
1
270

1472
1455594
IB:2075852.1
1
243

1473
1433063
IB:2075852.1
1
237

1474
6422373
LG:2021282.8
1
351

1475
6421660
LG:2021282.8
1
364

1476
6298033
LG:2021282.8
3
249

1477
4121984
LG:2021282.8
1
280

1478
6134672
LG:2021282.8
2
294

1479
6421768
LG:2021282.8
1
391

1480
6100330
LG:2021282.8
1
283

1481
6559430
LG:2021282.8
1
554

1482
5873539
LG:2021282.8
1
293

1483
6053960
LG:2021282.8
1
551

1484
6426224
LG:2021282.8
1
407

1485
6310337
LG:2021282.3
1
568

1486
715790
IB:2025662.10
3
270

1487
2782796
IB:2025662.10
1
84

1488
2822929
IB:2025662.10
1
269

1489
2096038
IB:2025662.10
1
216

1490
2219006
IB:2025662.10
1
85

1491
89474
IB:2025662.10
1
181

1492
714309
IB:2025662.10
10
291

1493
715581
IB:2025662.10
1
60

1494
2085627
IB:2025662.10
1
270

1495
88118
IB:2025662.10
1
232

1496
2815429
IB:2025662.10
1
328

1497
760074
IB:2025662.10
3
274

1498
2025847
IB:1925055.3
1
239

1499
3343173
IB:1925055.3
2
256

1500
274309
IB:1925055.3
8
340

1501
2601745
IB:1925055.3
1
202

1502
2892508
IB:1925055.3
1
266

1503
1362055
IB:1925055.3
1
255

1504
2460609
IB:1925055.3
1
236

1505
2715415
IB:1925055.3
1
245

1506
3364921
IB:1925055.3
1
209

1507
606092
IB:1925055.3
1
260

1508
274308
IB:1925055.3
4
355

1509
3358609
IB:1925055.3
1
275

1510
2640032
IB:1925055.3
1
236

1511
2731063
IB:1925055.5
1
259

1512
2184244
IB:1925055.5
1
273

1513
3204456
IB:1925055.5
1
294

1514
849715
IB:1925055.5
1
234

1515
2637127
IB:1925055.5
1
263

1516
2531872
IB:1925055.5
1
256

1517
2466966
IB:1925055.5
1
233

1518
855636
IB:1925055.5
1
240

1519
3200905
IB:1925055.5
1
283

1520
3045769
IB:1925055.5
1
148

1521
205471
IB:1925055.5
10
210

1522
2603222
IB:1925055.5
1
276

1523
3216147
IB:1925055.5
1
272

1524
3345777
IB:1925055.5
1
253

1525
2296070
IB:1925055.5
1
255

1526
2210959
IB:1925055.5
1
262

1527
1721127
IB:1925055.5
1
197

1528
546344
IB:1925055.5
1
219

1529
3685024
IB:1925055.5
1
316

1530
3044734
IB:1925055.5
1
288

1531
1259249
IB:1925055.5
1
242

1532
2772012
IB:1925055.5
1
248

1533
359806
IB:1925055.5
1
212

1534
850468
IB:1925055.5
1
189

1535
1814906
IB:1925055.5
1
250

1536
3949616
IB:1925055.5
1
148

1537
2274011
IB:1925055.5
1
275

1538
350870
IB:1925055.5
7
234

1539
1863706
IB:1925055.5
1
155

1540
3950806
IB:1925055.5
1
179

1541
1511496
IB:1925055.5
1
197

1542
3871292
IB:1925055.5
1
270

1543
2350519
IB:1925055.5
1
200

1544
1500749
IB:1925055.5
1
183

1545
1430632
IB:1925055.5
1
223

1546
2532363
IB:1925055.5
1
243

1547
629781
IB:1925055.5
1
257

1548
1927213
IB:1925055.5
1
204

1549
1494133
IB:1925055.5
1
211

1550
2664524
IB:1925055.5
1
234

1551
2635976
IB:1925055.5
1
254

1552
825794
IB:1925055.5
1
84

1553
2708985
IB:1925055.5
1
297

1554
2538760
IB:1925055.5
1
215

1555
1491886
IB:1925055.5
1
235

1556
575237
IB:1925055.5
1
253

1557
1909488
IB:1925055.5
1
247

1558
1470258
IB:1925055.5
1
181

1559
980214
IB:1925055.5
1
331

1560
783555
IB:1925055.5
1
284

1561
2846664
IB:1925055.5
1
285

1562
2587840
IB:1925055.5
1
248

1563
1417356
IB:1925055.5
1
224

1564
944899
IB:1925055.5
1
298

1565
588444
IB:1925055.5
1
221

1566
3043960
IB:1925055.5
1
301

1567
3093611
IB:1925055.5
1
290

1568
1259091
IB:1925055.5
1
224

1569
2847230
IB:1925055.5
1
271

1570
2540514
IB:1925055.5
1
253

1571
3441655
IB:1925055.5
1
219

1572
2968152
IB:1925055.5
1
316

1573
3398972
IB:1925055.5
1
257

1574
1307709
IB:1925055.5
1
225

1575
699870
IB:1925055.5
1
225

1576
426967
IB:1925055.5
1
232

1577
2685492
IB:1925055.5
1
266

1578
3085872
IB:1925055.5
2
95

1579
1391873
IB:1925055.5
1
252

1580
2050275
IB:1925055.5
1
268

1581
1599482
IB:1925055.5
1
195

1582
851914
IB:1925055.5
1
199

1583
2899326
IB:1925055.5
1
309

1584
1720956
IB:1925055.5
1
212

1585
1251167
IB:1925055.5
1
250

1586
2968428
IB:1925055.5
1
280

1587
2800404
IB:1925055.5
1
97

1588
1724869
IB:1925055.5
1
229

1589
2838913
IB:1925055.5
1
261

1590
829618
IB:1925055.5
1
201

1591
2219374
IB:1925055.5
1
240

1592
2843830
IB:1925055.5
1
265

1593
630799
IB:1925055.5
1
242

1594
880514
IB:1925055.5
1
251

1595
1581022
IB:1925055.5
1
177

1596
3094485
IB:1925055.5
1
267

1597
2749513
IB:1925055.5
1
233

1598
3441811
IB:1925055.5
1
228

1599
1303826
IB:1925055.5
1
249

1600
1343609
IB:1925055.5
1
238

1601
2782204
IB:1925055.5
1
247

1602
782307
IB:1925055.5
1
251

1603
2294574
IB:1925055.5
1
264

1604
3439540
IB:1925055.5
2
238

1605
1991854
IB:1925055.5
1
212

1606
2683006
IB:1925055.5
2
292

1607
2747201
IB:1925055.5
1
148

1608
2405011
IB:1925055.5
1
215

1609
1500748
IB:1925055.5
1
198

1610
81829
IB:1925055.5
1
183

1611
2059058
IB:1925055.5
1
263

1612
3365287
IB:1925055.5
1
151

1613
2841918
IB:1925055.5
1
287

1614
2269574
IB:1925055.5
1
255

1615
1442809
IB:1925055.5
1
99

1616
2303642
IB:1925055.5
1
249

1617
1704346
IB:1925055.5
1
232

1618
700454
IB:1925055.5
1
276

1619
1986414
IB:1925055.5
1
289

1620
2614735
IB:1925055.5
1
252

1621
589828
IB:1925055.5
1
267

1622
2899169
IB:1925055.5
1
287

1623
850494
IB:1925055.5
1
257

1624
2683822
IB:1925055.5
1
247

1625
2887324
IB:1925055.5
1
125

1626
1282535
IB:1925055.5
1
147

1627
1360106
IB:1925055.5
1
231

1628
2785553
IB:1925055.5
1
265

1629
1842667
IB:1925055.5
1
291

1630
435086
IB:1925055.5
1
222

1631
1331643
IB:1925055.5
1
147

1632
2587870
IB:1925055.5
1
214

1633
3043852
IB:1925055.5
1
287

1634
1928212
IB:1925055.5
1
291

1635
2538317
IB:1925055.5
1
199

1636
1492720
IB:1925055.5
1
212

1637
1361335
IB:1925055.5
1
259

1638
2547050
IB:1925055.5
1
254

1639
3043641
IB:1925055.5
1
263

1640
1259955
IB:1925055.5
1
125

1641
946266
IB:1925055.5
3
193

1642
3012448
IB:1925055.5
1
292

1643
420025
IB:1925055.5
1
204

1644
982741
IB:1925055.5
1
272

1645
2509023
IB:1925055.5
1
254

1646
2670392
IB:1925055.5
1
238

1647
2735656
IB:1925055.5
1
96

1648
2885490
IB:1925055.5
1
264

1649
1303890
IB:1925055.5
1
231

1650
872731
IB:1925055.5
1
201

1651
696718
IB:1925055.5
1
232

1652
3688517
IB:1925055.5
1
288

1653
701093781
ZS:165234.3
1
256

1654
701490564
ZS:165234.3
1
224

1655
701599183
ZS:165234.3
1
260

1656
701616219
ZS:165234.3
1
274

1657
700180910
ZS:165234.3
1
237

1658
701230439
ZS:165234.3
1
221

1659
701565987
ZS:165234.3
1
298

1660
701469043
ZS:165234.3
1
226

1661
700813572
ZS:165234.3
2
202

1662
701624629
ZS:165234.3
3
285

1663
701320686
ZS:165234.3
43
175

1664
701506292
ZS:165234.3
15
274

1665
700361285
ZS:165234.3
1
269

1666
700182881
ZS:165234.3
1
238

1667
700629418
ZS:165234.3
1
262

1668
701468416
ZS:165234.3
1
308

1669
701513663
ZS:165234.3
3
200

1670
701605944
ZS:165234.3
11
288

1671
701491741
ZS:165234.3
1
212

1672
700539949
ZS:165234.3
1
119

1673
701230808
ZS:165234.3
1
254

1674
700272961
ZS:165234.3
1
285

1675
701300213
ZS:165234.3
6
199

1676
700628557
ZS:165234.3
1
206

1677
701318893
ZS:165234.3
1
252

1678
700136650
ZS:165234.3
1
261

1679
701605366
ZS:165234.3
1
273

1680
701344948
ZS:165234.3
5
177

1681
701617705
ZS:165234.3
1
276

1682
700303285
ZS:165234.3
1
276

1683
701445318
ZS:165234.3
1
223

1684
701514224
ZS:165234.3
1
267

1685
700148731
ZS:165234.3
1
181

1686
701465349
ZS:165234.3
1
199

1687
701517634
ZS:165234.3
1
217

1689
700504333
ZS:165234.3
1
184

1690
701897857
ZS:165234.3
1
272

1691
701469758
ZS:165234.3
1
259

1693
700628292
ZS:165234.3
1
237

1694
701582451
ZS:165234.3
1
166

1695
701193139
ZS:165234.3
1
231

1696
701417436
ZS:165234.3
1
245

1697
701193977
ZS:165234.3
1
248

1698
700609902
ZS:165234.3
4
179

1699
700361875
ZS:165234.3
1
280

1700
701246479
ZS:165234.3
1
201

1701
701709889
ZS:165234.3
1
269

1702
700503636
ZS:165234.3
1
279

1703
701467565
ZS:165234.3
1
266

1704
700913464
ZS:165234.3
1
264

1705
701511270
ZS:165234.3
1
263

1706
701510462
ZS:165234.3
4
222

1707
701485744
ZS:165234.3
1
277

1708
701510883
ZS:165234.3
1
274

1709
700629420
ZS:165234.3
1
263

1710
701474055
ZS:165234.3
1
263

1711
701465268
ZS:165234.3
30
224

1712
700297261
ZS:165234.3
1
203

1713
700624973
ZS:165234.3
1
269

1714
701466020
ZS:165234.3
1
266

1715
700931834
ZS:165234.3
1
235

1716
701466523
ZS:165234.3
1
286

1717
701470845
ZS:165234.3
2
166

1718
701490988
ZS:165234.3
1
211

1719
700769675
ZS:165234.3
1
262

1721
701487591
ZS:165234.3
1
254

1722
700821620
ZS:165234.3
1
234

1724
701560653
ZS:165234.3
1
278

1725
701512645
ZS:165234.3
1
280

1726
700769805
ZS:165234.3
1
278

1727
701514225
ZS:165234.3
3
274

1728
700290655
ZS:165234.3
6
260

1729
700628888
ZS:165234.3
1
259

1730
701615842
ZS:165234.3
1
350

1731
700821482
ZS:165234.3
1
239

1732
700143947
ZS:165234.3
1
236

1733
701492871
ZS:165234.3
1
204

1734
701466168
ZS:165234.3
1
218

1735
701243343
ZS:165234.3
1
160

1736
701491093
ZS:165234.3
1
271

1737
701560741
ZS:165234.3
1
294

1738
700640940
ZS:165234.3
1
291

1739
701649230
ZS:165234.3
4
323

1740
701940939
ZS:165234.3
1
144

1741
701393081
ZS:165234.3
1
247

1742
701397339
ZS:165234.3
1
220

1743
700502073
ZS:165234.3
1
202

1744
700934938
ZS:165234.3
1
239

1745
701714541
ZS:165234.3
1
293

1746
701343424
ZS:165234.3
1
241

1747
700229933
ZS:165234.3
1
287

1748
701093696
ZS:165234.3
1
251

1749
701610104
ZS:165234.3
1
333

1750
700288991
ZS:165234.3
1
286

1751
700136250
ZS:165234.3
1
254

1752
1371843
IB:2094678.8
1
237

1753
2688148
IB:2094678.9
1
254

1754
2875106
IB:2094678.9
1
278

1755
587415
IB:2094678.9
7
100

1756
700190695
ZS:164307.1
1
277

1757
701283151
ZS:164307.2
1
146

1758
700228775
ZS:164307.2
1
121

1759
700417976
ZS:164307.2
1
229

1760
700179881
ZS:164307.2
1
193

1761
701023034
ZS:164307.2
1
215

1762
700524975
ZS:164307.2
1
277

1763
700268791
ZS:164307.2
1
253

1764
700066924
ZS:164307.2
1
207

1765
700294785
ZS:164307.2
1
223

1766
700478479
ZS:164307.2
1
229

1767
700059848
ZS:164307.2
1
194

1768
700627741
ZS:164307.3
1
232

1769
700627895
ZS:164307.3
1
231

1771
700498943
ZS:164307.3
6
94

1772
700280214
ZS:164307.3
1
84

1773
700501772
ZS:164307.3
1
271

1774
700177732
ZS:164307.3
1
195

1775
701881119
ZS:164307.3
1
293

1776
700533367
ZS:164307.3
1
147

1777
701294328
ZS:164307.3
1
246

1778
700364549
ZS:164307.3
1
96

1779
700307292
ZS:164307.3
1
280

1780
701475321
ZS:164307.3
1
207

1781
701944916
ZS:164307.3
1
240

1782
701285043
ZS:164307.3
1
245

1784
700628168
ZS:164307.3
1
219

1785
701192218
ZS:164307.3
1
117

1786
700534239
ZS:164307.3
1
277

1787
700326287
ZS:164307.3
3
256

1788
4448044
LG:2022180.2
1
274

1789
6538054
LG:2022180.6
1
563

1790
5660005
LG:2022180.6
1
262

1791
6510029
LG:2022180.7
1
572

1792
6480568
LG:2022180.7
1
508

1793
5812622
LG:2022180.7
1
292

1794
6354669
LG:2022180.7
1
192

1795
4443286
LG:2022180.7
1
248

1796
6060942
LG:2022180.7
1
297

1797
6093338
LG:2022180.7
1
284

1798
5943867
LG:2022180.7
1
277

1799
6312930
LG:2022180.7
1
374

1800
6127343
LG:2022180.7
1
407

1801
6131166
LG:2022180.7
1
322

1802
6059741
LG:2022180.7
1
94

1803
6012595
LG:2022180.7
1
281

1804
5946232
LG:2022180.7
1
285

1805
6350367
LG:2022180.7
1
297

1806
6013556
LG:2022180.7
1
268

1807
6383511
LG:2022180.7
1
156

1808
6121245
LG:2022180.7
1
499

1809
6566762
LG:2022180.7
1
534

1810
6350903
LG:2022180.7
1
300

1811
6192825
LG:2022180.7
1
312

1812
6383743
LG:2022180.7
1
88

1813
5952122
LG:2022180.7
1
333

1814
5992338
LG:2022180.7
1
300

1815
5876091
LG:2022180.7
1
282

1816
5887762
LG:2022180.7
1
265

1817
6264693
LG:2022180.7
1
572

1818
1894667
LG:2022180.7
1
248

1819
6298742
LG:2022180.7
8
274

1820
5887801
LG:2022180.7
1
273

1821
6370049
LG:2022180.7
1
436

1822
6498016
LG:2022180.7
1
335

1823
6213424
LG:2022180.7
1
292

1824
5844137
LG:2022180.7
1
254

1825
6424826
LG:2022180.7
1
476

1826
6058776
LG:2022180.7
3
377

1827
5839201
LG:2022180.7
1
95

1828
6510129
LG:2022180.7
1
507

1829
3105267
IB:2071401.2
1
294

1830
700062910
ZS:159749.1
2
303

1831
700067568
ZS:159749.1
1
268

1832
700308813
ZS:159749.1
1
100

1833
700180966
ZS:159749.1
1
264

1834
700510020
ZS:159749.2
1
245

1835
701335324
ZS:159749.2
1
204

1836
700918201
ZS:159749.2
1
88

1837
701286045
ZS:159749.2
1
254

1838
700290714
ZS:170990.1
1
290

1839
700190967
ZS:170990.1
1
150

1840
700302994
ZS:170990.1
1
289

1841
2010193
IB:2097646.3
1
80

1842
2823003
IB:2097646.3
1
244

1843
59307
IB:2097646.3
1
144

1844
2820251
IB:2097646.3
2
231

1845
1240147
IB:2097646.3
1
200

1846
82699
IB:2097646.3
1
145

1847
2825725
IB:2097646.3
3
167

1848
442
IB:2097646.3
13
497

1849
725067
IB:2097646.3
1
106

1850
82700
IB:2097646.3
1
188

1851
364676
IB:2097646.3
11
383

1852
1686
IB:2097646.3
1
264

1853
78129
IB:2097646.3
1
276

1854
2971626
IB:2097646.3
1
55

1855
189009
IB:2097646.3
1
241

1856
149464
IB:2097646.3
1
211

1857
568750
IB:2097646.3
3
268

1858
1103
IB:2097646.3
1
471

1859
993
IB:2097646.3
1
329

1860
36161
IB:2097646.3
1
197

1861
42068
IB:2097646.3
1
226

1862
46272
IB:2097646.3
1
223

1863
1471176
IB:652960.1
1
223

1864
911228
IB:2094701.10
1
258

1865
168804
IB:2094701.10
11
305

1866
900839
IB:2094701.10
3
125

1867
3897459
IB:2094701.10
1
256

1868
1840483
IB:2094701.10
1
253

1869
899181
IB:2094701.10
1
246

1870
701024520
ZS:157944.4
1
275

1871
700420532
ZS:157944.4
1
180

1872
700930974
ZS:157944.4
3
252

1873
700607265
ZS:157944.4
1
282

1874
701246834
ZS:157944.4
1
245

1875
700609603
ZS:157944.4
1
289

1876
701396879
ZS:157944.4
1
182

1877
701480622
ZS:157944.4
2
262

1878
701343245
ZS:157944.4
1
234

1879
6554941
LG:2020640.7
1
601

1880
6559814
LG:2020640.7
1
559

1881
700483216
ZS:159079.1
1
255

1882
700483123
ZS:159079.1
1
269

1883
700780819
ZS:159079.2
1
228

1884
701485977
ZS:159079.2
1
262

1885
701318240
ZS:159079.2
1
192

1886
701258865
ZS:159079.2
1
241

1887
700314533
ZS:159079.2
1
209

1888
700435941
ZS:159079.2
2
161

1889
700313454
ZS:159079.2
1
253

1890
700938719
ZS:159079.2
1
112

1891
700420843
ZS:159079.2
1
216

1892
701275345
ZS:159079.2
1
268

1893
700778749
ZS:159079.2
1
92

1894
701394518
ZS:159079.2
1
246

1895
701879481
ZS:159079.2
1
212

1896
700939406
ZS:159079.2
1
263

1897
701909492
ZS:159079.2
1
269

1898
700780985
ZS:159079.2
1
251

1899
701318033
ZS:159079.2
1
185

1900
700525373
ZS:159079.2
1
105

1901
5920416
LG:2020640.6
1
286

1902
5885823
LG:2020640.6
1
252

1903
5881319
LG:2020640.6
1
159

1904
6270301
LG:2020640.6
1
91

1905
6271586
LG:2020640.6
12
493

1906
6552641
LG:2020640.6
1
478

1907
5891134
LG:2020640.6
1
268

1908
6116862
LG:2020640.9
1
284

1909
6424889
LG:2020640.9
1
578

1910
5616328
LG:2020640.9
2
280

1911
5990859
LG:2020640.9
1
305

1912
6598719
LG:2020640.9
1
536

1913
6379254
LG:2020640.9
1
278

1914
3760758
LG:2020640.9
1
306

1915
5839547
LG:2020640.9
2
217

1916
4515874
LG:2020640.9
1
203

1917
5476167
LG:2020640.9
1
246

1918
6424790
LG:2020640.9
1
482

1919
6370928
LG:2020640.9
1
221

1920
6178092
LG:2020640.9
1
281

1921
5475523
LG:2020640.9
1
254

1922
6496850
LG:2020640.9
1
575

1923
5894616
LG:2020640.9
1
250

1924
5474001
LG:2020640.9
1
255

1925
6065772
LG:2020640.9
1
283

1926
6152091
LG:2020640.9
1
273

1927
6125646
LG:2020640.9
1
517

1928
6264310
LG:2020640.9
1
562

1929
6538510
LG:2020640.9
1
569

1930
6262111
LG:2020640.9
1
546

1931
6190138
LG:2020640.9
1
290

1932
5941339
LG:1900605.9
1
269

1933
3903719
LG:1900605.9
1
285

1934
6026458
LG:1900605.6
1
302

1935
6113765
LG:1981103.6
1
292

1936
6262544
LG:1981103.6
1
461

1937
6425437
LG:1981103.6
2
534

1938
6211146
LG:1981103.6
1
223

1939
6114029
LG:1981103.6
1
274

1940
6553732
LG:1981103.6
1
417

1941
6323421
LG:1981103.6
1
287

1942
6296822
LG:1981103.6
1
335

1943
6606417
LG:1981103.6
1
111

1944
6496467
LG:1981103.6
1
511

1945
6518170
LG:1981103.6
3
65

1946
6353795
LG:1981103.6
1
179

1947
6604422
LG:1981103.6
1
523

1948
6386936
LG:1981103.6
1
297

1949
6130913
LG:1981103.6
3
262

1950
4519218
LG:1981103.6
1
247

1951
6435737
LG:1981103.6
1
325

1952
5475918
LG:1981103.6
1
253

1953
6542807
LG:1981103.6
1
532

1954
6317860
LG:1981103.6
1
302

1955
3023731
LG:1981103.6
1
277

1956
6484989
LG:1981103.5
1
457

1957
1467992
IB:2094696.1
1
206

1958
908408
IB:2094701.6
1
66

1959
487818
IB:2094701.8
1
249

1960
490900
IB:2094701.8
1
268

1961
700273719
ZS:053563.1
1
254

1962
3444223
LG:2024986.3
1
141

1963
5989011
LG:2024986.3
1
292

1964
5872059
LG:2024986.3
1
296

1965
6095094
LG:2024986.3
1
318

1966
6093023
LG:2024986.3
1
298

1967
6075596
LG:2024986.3
1
306

1968
6419675
LG:2024986.3
1
510

1969
6209547
LG:2024986.3
1
294

1970
6405076
LG:2024986.3
3
205

1971
6078425
LG:2024986.3
3
282

1972
5981860
LG:2024986.3
1
278

1973
5983358
LG:2024986.3
1
281

1974
5979930
LG:2024986.3
1
272

1975
6261877
LG:2024986.3
1
282

1976
6375405
LG:2024986.3
2
273

1977
5981662
LG:2024986.3
3
272

1978
6564362
LG:2024986.3
1
532

1979
6422216
LG:2024986.3
1
497

1980
3902250
LG:2024986.3
1
274

1981
5953976
LG:2024986.3
1
322

1982
6133582
LG:2024986.3
9
281

1983
3166285
LG:2024986.3
3
244

1984
6154521
LG:2024986.3
7
326

1985
5564143
LG:2024986.3
1
261

1986
6131318
LG:2024986.3
6
223

1987
6114440
LG:2024986.3
2
267

1988
6564795
LG:2024986.3
1
615

1989
6131579
LG:2024986.3
1
296

1990
6299814
LG:2024986.3
2
287

1991
6151928
LG:2024986.3
3
245

1992
6388403
LG:2024986.3
1
327

1993
6150440
LG:2024986.3
3
275

1994
3165833
LG:2024986.3
3
269

1995
6396535
LG:2024986.3
1
285

1996
6361347
LG:2024986.3
1
305

1997
5984828
LG:2024986.3
1
284

1998
5987020
LG:2024986.3
1
282

1999
6408470
LG:2024986.3
9
545

2000
6270190
LG:2024986.3
1
522

2001
5983366
LG:2024986.3
1
293

2002
6422308
LG:2024986.3
1
509

2003
5908769
LG:2024986.3
2
295

2004
5658363
LG:2024986.3
1
263

2005
6454559
LG:2024986.3
1
596

2006
5475468
LG:2024986.3
1
276

2007
6420636
LG:2024986.3
1
493

2008
6538777
LG:2024986.3
1
147

2009
3444239
LG:2024986.3
1
263

2010
1896359
LG:2024986.3
1
246

2011
6112991
LG:2024986.3
2
273

2012
5986966
LG:2024986.3
1
271

2013
5809528
LG:2024986.3
1
286

2014
5987770
LG:2024986.3
1
282

2015
5988150
LG:2024986.3
1
269

2016
6561673
LG:2024986.3
1
570

2017
6425449
LG:2024986.3
1
139

2018
6422516
LG:2024986.3
1
79

2019
4516438
LG:2024986.3
1
259

2020
6514835
LG:2024986.3
1
580

2021
1895668
LG:2024986.3
1
250

2022
6170203
LG:2024986.3
1
286

2023
6402652
LG:2024986.3
1
288

2024
6095029
LG:2024986.3
1
331

2025
5879126
LG:2024986.3
2
264

2026
4123126
LG:2024986.3
2
90

2027
5563507
LG:2024986.3
1
246

2028
6123211
LG:2024986.3
1
571

2029
6371816
LG:2024986.3
1
172

2030
3158120
LG:2024986.3
2
158

2031
6402620
LG:2024986.3
1
269

2032
5954076
LG:2024986.3
1
266

2033
5870789
LG:2024986.3
1
281

2034
6419582
LG:2024986.3
1
517

2035
6497557
LG:2024986.3
1
184

2036
700269380
ZS:177283.1
1
309

2037
700061367
ZS:177283.2
3
95

2038
700484428
ZS:177283.2
1
255

2039
6512973
LG:1941236.1
1
548

2040
30396
IB:1900605.10
2
226

2041
2113
IB:1900605.10
1
443

2042
2741933
IB:1900605.10
1
237

2043
100690
IB:1900605.10
1
227

2044
2304342
IB:1900605.10
1
270

2045
1807710
IB:1900605.6
1
202

2046
1295954
IB:1900605.6
1
239

2047
52759
IB:1900605.8
1
234

2048
2797366
IB:1900605.8
3
245

2049
2906493
IB:1900605.8
1
277

2050
2729355
IB:1900605.9
3
255

2051
700910295
ZS:087251.1
1
71

2052
782418
IB:2104891.5
2
277

2053
1430906
IB:2104891.5
1
243

2054
2455564
IB:2104891.6
1
245

2055
3086914
IB:2104891.6
1
223

2056
1634012
IB:2104891.7
1
215

2057
1216570
IB:2104891.7
1
319

2058
2841268
IB:2104891.7
1
174

2059
830485
IB:2104891.8
1
249

2060
233757
IB:2104891.8
109
147

2061
57367
IB:2104891.8
1
210

2062
2194388
IB:2104891.8
1
240

2063
766272
IB:2104891.8
1
246

2064
750798
IB:2104891.8
1
215

2065
935410
IB:2104891.8
1
287

2066
825399
IB:2104891.8
1
249

2067
601853
IB:2104891.8
1
213

2068
2522237
IB:2104891.8
1
254

2069
1333153
IB:2104891.8
1
234

2070
2085612
IB:2104891.8
1
249

2071
935740
IB:2104891.8
1
278

2072
523577
IB:2104891.8
1
221

2073
866666
IB:2104891.8
23
75

2074
2951387
IB:2104891.8
1
264

2075
1430663
IB:2104891.8
1
247

2076
1361476
IB:2104891.8
1
251

2077
1560126
IB:2104891.8
1
218

2078
744459
IB:2104891.8
1
258

2079
1797747
IB:2104891.8
1
233

2080
2183401
IB:2104891.8
1
271

2081
603570
IB:2104891.8
1
254

2082
942875
IB:2104891.8
1
231

2083
1457010
IB:2104891.8
1
252

2084
2212106
IB:2104891.8
1
254

2085
2451987
IB:2104891.8
1
91

2086
1419958
IB:2104891.8
23
237

2087
1903227
IB:2104891.8
1
273

2088
35143
IB:2104891.8
1
165

2089
1647305
IB:2104891.8
1
197

2090
2057559
IB:2104891.8
1
270

2091
2079008
IB:2104891.8
1
228

2092
2174488
IB:2104891.8
1
165

2093
1806270
IB:2104891.8
1
279

2094
2472046
IB:2104891.8
1
229

2095
1493214
IB:2104891.8
1
223

2096
853974
IB:2104891.8
1
238

2097
900309
IB:2104891.8
1
284

2098
3868358
IB:2104891.8
1
184

2099
2914677
IB:2104891.8
1
280

2100
2322455
IB:2104891.8
1
263

2101
966061
IB:2104891.8
1
262

2102
1664515
IB:2104891.8
1
240

2103
825238
IB:2104891.8
1
232

2104
1556945
IB:2104891.8
1
206

2105
2602985
IB:2104891.8
1
283

2106
1680495
IB:2104891.8
1
230

2107
1794004
IB:2104891.8
1
276

2108
83448
IB:2104891.8
1
151

2109
1267536
IB:2104891.8
1
141

2110
2106813
IB:2104891.8
1
225

2111
1510165
IB:2104891.8
1
212

2112
1856492
IB:2104891.8
1
275

2113
2266659
IB:2104891.8
1
259

2114
1558625
IB:2104891.8
1
210

2115
233733
IB:2104891.8
209
249

2116
1551996
IB:2104891.8
1
199

2117
1986820
IB:2104891.8
1
259

2118
877233
IB:2104891.8
1
323

2119
2256047
IB:2104891.8
1
250

2120
1911310
IB:2104891.8
1
245

2121
678398
IB:2104891.8
3
300

2122
1804361
IB:2104891.8
1
264

2123
935092
IB:2104891.8
1
286

2124
1905732
IB:2104891.8
1
265

2125
1614400
IB:2104891.8
1
174

2126
35182
IB:2104891.8
1
232

2127
3326065
IB:2104891.8
1
231

2128
582185
IB:2104891.8
1
264

2129
991896
IB:2104891.8
1
270

2130
1212159
IB:2104891.8
1
226

2131
555259
IB:2104891.8
1
274

2132
798805
IB:2104891.8
1
276

2133
2626808
IB:2104891.8
1
244

2134
2758919
IB:2104891.8
1
135

2135
1618796
IB:2104891.8
1
208

2136
1640142
IB:2104891.8
1
206

2137
3228228
IB:2104891.8
1
168

2138
685491
IB:2104891.8
1
189

2139
1443405
IB:2104891.8
1
259

2140
1305226
IB:2104891.8
1
202

2141
751876
IB:2104891.8
1
228

2142
3289296
IB:2104891.8
1
99

2143
1555366
IB:2104891.8
1
215

2144
2324241
IB:2104891.8
1
247

2145
3201317
IB:2104891.8
1
95

2146
1379439
IB:2104891.8
1
191

2147
2461925
IB:2104891.8
1
226

2148
902077
IB:2104891.8
1
264

2149
1482170
IB:2104891.8
1
266

2150
586905
IB:2104891.8
1
305

2151
2445442
IB:2104891.8
1
232

2152
5850349
LG:1900605.10
1
138

2153
6520711
LG:1900605.10
1
466

2154
5742854
LG:1900605.11
1
294

2155
6589010
LG:1900605.11
1
447

2156
5679919
LG:1900605.11
1
107

2157
1892562
LG:1900605.11
1
188

2158
5985587
LG:1900605.11
1
264

2159
3780406
LG:1900605.11
2
316

2160
4205646
LG:1900605.11
1
250

2161
6284143
LG:1900605.11
1
247

2162
6259745
LG:1900605.11
1
274

2163
6361023
LG:1900605.11
1
522

2164
6517006
LG:1900605.11
1
66

2165
6522491
LG:1900605.11
1
257

2166
6496384
LG:1900605.11
1
558

2167
5873053
LG:1900605.11
1
274

2168
6360111
LG:1900605.11
1
473

2169
5657335
LG:1900605.11
1
244

2170
6395718
LG:1900605.11
2
180

2171
6260645
LG:1900605.11
1
177

[0208]

3

TABLE 3

SEQ ID NO
INCYTE ID N
GENBANK I
GENBANK ANNOTATION

1
hu01031982
g4753757
dJ798A17.1 (Flavin-containing Monooxygenase 1 (FMO-1)

2
hu00713471
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

3
hu01170046
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

4
hu01180073
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

5
hu01201763
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

6
hu01322950
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

7
hu01330729
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

8
hu00983306
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

9
hu01239428
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

10
hu01185563
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

11
hu01313867
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

12
hu01140406
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

13
hu01228388
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

14
hu00981727
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

15
hu01186567
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

16
hu01122732
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

17
hu01012436
g181260
Human somatic cytochrome c (HC5) processed pseudogene, complete cds.

18
hu01002677
g4200327
thioredoxin

19
hu00978833
g531404
Human mRNA for glutaredoxin.

20
hu01284599
g531404
Human mRNA for glutaredoxin.

21
hu01086979
g531404
Human mRNA for glutaredoxin.

22
hu01032083
g531404
Human mRNA for glutaredoxin.

23
hu01210547
g531404
Human mRNA for glutaredoxin.

24
hu01123095
g531404
Human mRNA for glutaredoxin.

25
hu01329043
g531404
Human mRNA for glutaredoxin.

26
hu01116805
g531404
Human mRNA for glutaredoxin.

27
hu01102991
g531404
Human mRNA for glutaredoxin.

28
hu01013649
g531404
Human mRNA for glutaredoxin.

29
hu01243383
g531404
Human mRNA for glutaredoxin.

30
hu01293306
g531404
Human mRNA for glutaredoxin.

31
hu01104919
g531404
Human mRNA for glutaredoxin.

32
hu01329433
g531404
Human mRNA for glutaredoxin.

33
hu00986013
g531404
Human mRNA for glutaredoxin.

34
hu01078335
g531404
Human mRNA for glutaredoxin.

35
hu01034993
g531404
Human mRNA for glutaredoxin.

36
hu01332579
g531404
Human mRNA for glutaredoxin.

37
hu01267654
g531404
Human mRNA for glutaredoxin.

38
hu01175359
g531404
Human mRNA for glutaredoxin.

39
hu01193983
g531404
Human mRNA for glutaredoxin.

40
hu00755546
g3877611
similar to cytochrome B561

41
hu00668597
g2662290
Human mRNA for cytochrome b5, partial cds.

42
hu00899952
g2662290
Human mRNA for cytochrome b5, partial cds.

43
hu00504101
g2662290
Human mRNA for cytochrome b5, partial cds.

44
hu00090502
g2662290
Human mRNA for cytochrome b5, partial cds.

45
hu00902140
g2662290
Human mRNA for cytochrome b5, partial cds.

46
hu00503171
g2662290
Human mRNA for cytochrome b5, partial cds.

47
hu00046235
g2662290
Human mRNA for cytochrome b5, partial cds.

48
hu00007392
g2662290
Human mRNA for cytochrome b5, partial cds.

49
hu00381091
g2662290
Human mRNA for cytochrome b5, partial cds.

50
hu00562460
g2662290
Human mRNA for cytochrome b5, partial cds.

51
hu00039191
g2662290
Human mRNA for cytochrome b5, partial cds.

52
hu00605418
g2662290
Human mRNA for cytochrome b5, partial cds.

53
hu00725335
g2662290
Human mRNA for cytochrome b5, partial cds.

54
hu00651653
g2662290
Human mRNA for cytochrome b5, partial cds.

55
hu00916613
g2662290
Human mRNA for cytochrome b5, partial cds.

56
hu00814652
g2662290
Human mRNA for cytochrome b5, partial cds.

57
hu00163808
g2662290
Human mRNA for cytochrome b5, partial cds.

58
hu00687420
g2662290
Human mRNA for cytochrome b5, partial cds.

59
hu00238960
g2662290
Human mRNA for cytochrome b5, partial cds.

60
hu00776351
g2662290
Human mRNA for cytochrome b5, partial cds.

61
hu00883244
g2662290
Human mRNA for cytochrome b5, partial cds.

62
hu00816546
g2662290
Human mRNA for cytochrome b5, partial cds.

63
hu00861826
g2662290
Human mRNA for cytochrome b5, partial cds.

64
hu00187718
g2662290
Human mRNA for cytochrome b5, partial cds.

65
hu00681549
g2662290
Human mRNA for cytochrome b5, partial cds.

66
hu00339586
g2662290
Human mRNA for cytochrome b5, partial cds.

67
hu01022298
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

68
hu01122008
g531404
Human mRNA for glutaredoxin.

69
hu00228730
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

70
hu01259066
g3603309
Human glutaredoxin mRNA, complete cds.

71
hu01271939
g3603309
Human glutaredoxin mRNA, complete cds.

72
hu01144669
g2961254
thioredoxin homolog

73
hu01312454
g2114207
glutaredoxin

74
hu00986823
g5295994
small subunit of cytochrome b of succinate dehydrogenase

75
hu01207133
g5295994
small subunit of cytochrome b of succinate dehydrogenase

76
hu01060525
g5295994
small subunit of cytochrome b of succinate dehydrogenase

77
hu01108730
g5295994
small subunit of cytochrome b of succinate dehydrogenase

78
hu01094006
g5295994
small subunit of cytochrome b of succinate dehydrogenase

79
hu01055702
g5295994
small subunit of cytochrome b of succinate dehydrogenase

80
hu01200549
g5295994
small subunit of cytochrome b of succinate dehydrogenase

81
hu01256253
g5295994
small subunit of cytochrome b of succinate dehydrogenase

82
hu01029382
g5295994
small subunit of cytochrome b of succinate dehydrogenase

83
hu01009078
g5295994
small subunit of cytochrome b of succinate dehydrogenase

84
hu01321595
g5295994
small subunit of cytochrome b of succinate dehydrogenase

85
hu01164609
g5295994
small subunit of cytochrome b of succinate dehydrogenase

86
hu01253674
g5295994
small subunit of cytochrome b of succinate dehydrogenase

87
hu01169353
g5295994
small subunit of cytochrome b of succinate dehydrogenase

88
hu01206885
g5295994
small subunit of cytochrome b of succinate dehydrogenase

89
hu01348582
g5295994
small subunit of cytochrome b of succinate dehydrogenase

90
hu01338934
g5295994
small subunit of cytochrome b of succinate dehydrogenase

91
hu01164479
g5295994
small subunit of cytochrome b of succinate dehydrogenase

92
hu01287961
g5295994
small subunit of cytochrome b of succinate dehydrogenase

93
hu01236008
g1911548
cytochrome c-like polypeptide [human, lung adenocarcinoma A549, Peptide, 190 aa]

94
rat00086191
g2911066
adrenodoxin-like protein

95
rat00096533
g2911066
adrenodoxin-like protein

96
rat00191537
g2911066
adrenodoxin-like protein

97
rat00075375
g2911066
adrenodoxin-like protein

98
rat00219672
g2911066
adrenodoxin-like protein

99
rat00223885
g2911066
adrenodoxin-like protein

100
rat00247348
g2911066
adrenodoxin-like protein

101
rat00069166
g2911066
adrenodoxin-like protein

102
rat00038669
g2911066
adrenodoxin-like protein

103
rat00205020
g2911066
adrenodoxin-like protein

104
rat00000073
g2911066
adrenodoxin-like protein

105
rat00221180
g2911066
adrenodoxin-like protein

106
rat00008019
g2911066
adrenodoxin-like protein

107
rat00033426
g2911066
adrenodoxin-like protein

108
rat00131752
g2911066
adrenodoxin-like protein

109
rat00230675
g2911066
adrenodoxin-like protein

110
rat00056283
g2911066
adrenodoxin-like protein

111
rat00144276
g2911066
adrenodoxin-like protein

112
hu01337947
g1911548
cytochrome c-like polypeptide [human, lung adenocarcinoma A549, Peptide, 190 aa]

113
hu01310032
g1911548
cytochrome c-like polypeptide [human, lung adenocarcinoma A549, Peptide, 190 aa]

114
hu00987948
g1911547
cytochrome c-like polypeptide [Human, lung adenocarcinoma A549, mRNA, 1041 nt].

115
hu01216237
g1911547
cytochrome c-like polypeptide [Human, lung adenocarcinoma A549, mRNA, 1041 nt].

116
hu01032720
g1911547
cytochrome c-like polypeptide [Human, lung adenocarcinoma A549, mRNA, 1041 nt].

117
hu01119107
g435963
thioredoxin-like protein

118
hu01347050
g435963
thioredoxin-like protein

119
hu01343361
g435963
thioredoxin-like protein

120
hu01104646
g435963
thioredoxin-like protein

121
hu01179389
g435963
thioredoxin-like protein

122
hu00969772
g435963
thioredoxin-like protein

123
hu00994747
g435963
thioredoxin-like protein

124
hu01209376
g435963
thioredoxin-like protein

125
hu01330016
g435963
thioredoxin-like protein

126
hu01175881
g435963
thioredoxin-like protein

127
hu01264927
g435963
thioredoxin-like protein

128
hu01121470
g435963
thioredoxin-like protein

129
hu00996037
g435963
thioredoxin-like protein

130
hu01052325
g435963
thioredoxin-like protein

131
hu01137559
g1911547
cytochrome c-like polypeptide [Human, lung adenocarcinoma A549, mRNA, 1041 nt].

132
hu01092065
g1911547
cytochrome c-like polypeptide [Human, lung adenocarcinoma A549, mRNA, 1041 nt].

133
hu01323636
g1911547
cytochrome c-like polypeptide [Human, lung adenocarcinoma A549, mRNA, 1041 nt].

134
hu01060728
g1911547
cytochrome c-like polypeptide [Human, lung adenocarcinoma A549, mRNA, 1041 nt].

135
hu01268836
g1911547
cytochrome c-like polypeptide [Human, lung adenocarcinoma A549, mRNA, 1041 nt].

136
hu01222473
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

137
hu01236994
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

138
hu00308470
g531404
Human mRNA for glutaredoxin.

139
hu00267375
g531404
Human mRNA for glutaredoxin.

140
hu00473030
g531404
Human mRNA for glutaredoxin.

141
hu00173475
g3603309
Human glutaredoxin mRNA, complete cds.

142
hu00849020
g3603309
Human glutaredoxin mRNA, complete cds.

143
hu00168009
g3603309
Human glutaredoxin mRNA, complete cds.

144
hu00580866
g3603309
Human glutaredoxin mRNA, complete cds.

145
hu00927748
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

146
hu00403005
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

147
hu00869778
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

148
hu00063607
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

149
hu00203909
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

150
hu00452472
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

151
hu00831183
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

152
hu00372084
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

153
hu00796320
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

154
hu00613827
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

155
hu00653184
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

156
hu00533558
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

157
hu00578046
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

158
hu00482792
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

159
hu00471785
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

160
hu00335877
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

161
hu00527595
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

162
hu00875185
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

163
hu00912110
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

164
hu00026601
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

165
hu00103248
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

166
hu00631611
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

167
hu00401675
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

168
hu00676022
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

169
hu00950091
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

170
hu00780712
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

171
hu00392614
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

172
hu00407933
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

173
hu00759320
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

174
hu00709083
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

175
hu00848224
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

176
hu00703783
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

177
hu00805276
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

178
hu00921782
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

179
hu00335487
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

180
hu00549507
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

181
hu00888223
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

182
hu00224887
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

183
hu00935744
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

184
hu00861918
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

185
hu00534975
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

186
hu00031360
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

187
hu00281501
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

188
hu00128107
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

189
hu00272072
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

190
hu00651107
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

191
hu00930901
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

192
hu00271706
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

193
hu00008916
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

194
hu00405925
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

195
hu00283922
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

196
hu00394641
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

197
hu00741298
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

198
hu00509990
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

199
hu00391975
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

200
hu00681668
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

201
hu00157699
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

202
hu00240223
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

203
hu00842100
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

204
hu00533420
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

205
hu00211556
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

206
hu00391700
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

207
hu00622361
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

208
hu00629111
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

209
hu00757004
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

210
hu00382550
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

211
hu00516056
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

212
hu00268304
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

213
hu00878200
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

214
hu00235276
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

215
hu00652761
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

216
hu00008766
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

217
hu00076745
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

218
hu00177708
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

219
hu00588913
g2588778
Human mRNA for cytochrome b large subunit of complex II, complete cds.

220
hu01070024
g3646127
Human mRNA for putative thioredoxin-like protein.

221
hu00173405
g531404
Human mRNA for glutaredoxin.

222
hu00039514
g531404
Human mRNA for glutaredoxin.

223
hu00026942
g531404
Human mRNA for glutaredoxin.

224
hu00187054
g531404
Human mRNA for glutaredoxin.

225
hu00854314
g531404
Human mRNA for glutaredoxin.

226
hu00885122
g531404
Human mRNA for glutaredoxin.

227
hu00217359
g531404
Human mRNA for glutaredoxin.

228
hu00384526
g531404
Human mRNA for glutaredoxin.

229
rat00071677
g2443331
Nfrl

230
rat00105537
g2443331
Nfrl

231
rat00177349
g2443331
Nfrl

232
rat00068188
g2443331
Nfrl

233
rat00145437
g2443331
Nfrl

234
hu01349846
g3646127
Human mRNA for putative thioredoxin-like protein.

235
hu01009468
g3646127
Human mRNA for putative thioredoxin-like protein.

236
hu01160420
g3646127
Human mRNA for putative thioredoxin-like protein.

237
hu01299909
g3646127
Human mRNA for putative thioredoxin-like protein.

238
hu01246478
g3646127
Human mRNA for putative thioredoxin-like protein.

239
hu01285278
g3646127
Human mRNA for putative thioredoxin-like protein.

240
hu01264445
g3646127
Human mRNA for putative thioredoxin-like protein.

241
hu00198187
g181260
Human somatic cytochrome c (HC5) processed pseudogene, complete cds.

242
hu00350676
g181228
Human cytochrome b5 mRNA, 3′ end.

243
hu00837746
g2702453
contains similarity to thioredoxin domains

244
hu00818732
g2702453
contains similarity to thioredoxin domains

245
hu00171330
g2702453
contains similarity to thioredoxin domains

246
hu00471838
g2702453
contains similarity to thioredoxin domains

247
hu00496995
g2702453
contains similarity to thioredoxin domains

248
hu00645541
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

249
hu00696057
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

250
hu00792990
g2702453
contains similarity to thioredoxin domains

251
hu00549929
g2702453
contains similarity to thioredoxin domains

252
hu00897882
g2702453
contains similarity to thioredoxin domains

253
hu00016152
g2702453
contains similarity to thioredoxin domains

254
hu00103257
g2702453
contains similarity to thioredoxin domains

255
hu00123714
g2702453
contains similarity to thioredoxin domains

256
hu00552910
g2702453
contains similarity to thioredoxin domains

257
hu00855123
g2702453
contains similarity to thioredoxin domains

258
hu00854305
g2702453
contains similarity to thioredoxin domains

259
hu00397024
g2702453
contains similarity to thioredoxin domains

260
hu00143648
g2702453
contains similarity to thioredoxin domains

261
hu00705662
g2702453
contains similarity to thioredoxin domains

262
hu00593090
g2702453
contains similarity to thioredoxin domains

263
hu00459622
g2702453
contains similarity to thioredoxin domains

264
hu00417548
g2702453
contains similarity to thioredoxin domains

265
hu00076844
g2702453
contains similarity to thioredoxin domains

266
hu00758235
g2702453
contains similarity to thioredoxin domains

267
hu00339267
g2702453
contains similarity to thioredoxin domains

268
hu00166935
g2702453
contains similarity to thioredoxin domains

269
hu00942197
g2702453
contains similarity to thioredoxin domains

270
hu00525849
g2702453
contains similarity to thioredoxin domains

271
hu00668292
g2702453
contains similarity to thioredoxin domains

272
hu00096927
g2702453
contains similarity to thioredoxin domains

273
hu00868174
g2702453
contains similarity to thioredoxin domains

274
hu00001500
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

275
hu00598479
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

276
hu00576699
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

277
hu00115451
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

278
hu00063441
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

279
hu00117073
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

280
hu00034373
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

281
hu00321357
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

282
hu00606532
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

283
hu00331079
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

284
hu00091149
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

285
hu00390348
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

286
hu00743094
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

287
hu00652935
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

288
hu00639806
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

289
hu00661686
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

290
hu00698038
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

291
hu00942589
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

292
hu00689928
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

293
hu00201651
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

294
hu00616103
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

295
hu00300158
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

296
hu00534530
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

297
hu00924051
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

298
hu00256307
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

299
hu00114972
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

300
hu00330198
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

301
hu00559222
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

302
hu00257435
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

303
hu00641771
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

304
hu00157481
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

305
hu00649531
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

306
hu00256466
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

307
hu00637950
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

308
hu00891318
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

309
hu00267556
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

310
hu00189229
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

311
hu00803857
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

312
hu00428667
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

313
hu00593649
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

314
hu00966556
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

315
hu00908022
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

316
hu00247720
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

317
hu00093263
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

318
hu00384521
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

319
hu00322584
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

320
hu00670453
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

321
hu00056338
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

322
hu00377154
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

323
hu00289424
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

324
hu00138864
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

325
hu00178785
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

326
hu00886298
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

327
hu00527500
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

328
hu00642045
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

329
hu00093117
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

330
hu00614740
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

331
hu00265154
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

332
hu00105683
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

333
hu00117267
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

334
hu00552139
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

335
hu00084843
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

336
hu00633854
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

337
hu00617818
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

338
hu00168917
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

339
hu00897711
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

340
hu00850688
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

341
hu00724100
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

342
hu00017402
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

343
hu00602053
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

344
hu00521216
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

345
hu00403523
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

346
hu00075141
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

347
hu00022437
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

348
hu00201683
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

349
hu00860016
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

350
hu00642216
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

351
hu00017647
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

352
hu00336922
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

353
hu00155892
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

354
hu00827284
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

355
hu00895708
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

356
hu00219012
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

357
hu00033057
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

358
hu00729121
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

359
hu00935501
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

360
hu00644405
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

361
hu00672261
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

362
hu00681415
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

363
hu01353645
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

364
hu00155187
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

365
hu00671536
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

366
hu00664723
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

367
hu00874109
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

368
hu00515388
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

369
hu00081957
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

370
hu00688447
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

371
hu00120308
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

372
hu00700244
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

373
hu00641024
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

374
hu00445320
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

375
hu00850230
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

376
hu00381730
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

377
hu00229540
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

378
hu00439241
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

379
hu00944105
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

380
hu00107493
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

381
hu00580182
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

382
hu00682152
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

383
hu00760642
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

384
hu00742742
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

385
hu00082296
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

386
hu00647803
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

387
hu00098155
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

388
hu00540983
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

389
hu00823826
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

390
hu00316469
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

391
hu00186680
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

392
hu00192684
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

393
hu00509719
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

394
hu00690657
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

395
hu00319777
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

396
hu00259981
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

397
hu00555399
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

398
hu00312115
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

399
hu00663211
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

400
hu00322633
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

401
hu00262441
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

402
hu00441056
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

403
hu00284223
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

404
hu00103469
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

405
hu00133746
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

406
hu00224944
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

407
hu00785500
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

408
hu00252881
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

409
hu00458208
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

410
hu00298622
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

411
hu00484049
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

412
hu00911883
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

413
hu00591366
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

414
hu00189607
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

415
hu00901849
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

416
hu00576852
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

417
hu00262689
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

418
hu00194559
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

419
hu00095974
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

420
hu00399290
g1911547
cytochrome c-like polypeptide [Human, lung adenocarcinoma A549, mRNA, 1041 nt].

421
hu01329355
g453964
ATL-derived factor/thioredoxin

422
hu00529652
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

423
hu01054127
g181232
Human p22-phox (CYBA) gene, exon 2.

424
hu00367261
g1667354
electron-transfer flavoprotein alpha-subunit

425
hu01216944
g2911066
adrenodoxin-like protein

426
hu01169541
g2911066
adrenodoxin-like protein

427
hu00968022
g2911066
adrenodoxin-like protein

428
hu01042903
g2911066
adrenodoxin-like protein

429
hu01273836
g2911066
adrenodoxin-like protein

430
hu01270499
g2911066
adrenodoxin-like protein

431
hu01033738
g2911066
adrenodoxin-like protein

432
hu01201032
g2911066
adrenodoxin-like protein

433
hu00524021
g703080
Human cytochrome b5 (CYB5) gene, exon 5.

434
hu00364988
g703080
Human cytochrome b5 (CYB5) gene, exon 5.

435
hu00932363
g703080
Human cytochrome b5 (CYB5) gene, exon 5.

436
hu01103446
g2443331
Nfrl

437
hu01203049
g2443331
Nfrl

438
hu01068510
g2443331
Nfrl

439
hu01213943
g2443331
Nfrl

440
hu01044863
g2443331
Nfrl

441
hu01200968
g2443331
Nfrl

442
hu01018101
g2443331
Nfrl

443
hu01329733
g2443331
Nfrl

444
hu01337095
g2443331
Nfrl

445
hu01282087
g2443331
Nfrl

446
hu01090767
g2443331
Nfrl

447
hu00979175
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

448
hu01182918
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

449
hu01343318
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

450
hu01147865
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

451
hu01074751
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

452
hu01296205
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

453
hu00970451
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

454
hu01325064
g2443331
Nfrl

455
hu01065608
g2443331
Nfrl

456
hu01046405
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

457
hu01285201
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

458
hu01013366
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

459
hu01326433
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

460
hu01147225
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

461
hu01344254
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

462
hu01128192
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

463
hu01067191
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

464
hu01070449
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

465
hu01324078
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

466
hu01051012
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

467
hu01324557
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

468
hu01070929
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

469
hu00983044
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

470
hu01170686
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

471
hu00968530
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

472
hu00010006
g2662290
Human mRNA for cytochrome b5, partial cds.

473
hu00957158
g790540
cytochrome B561

474
hu01264231
g2443331
Nfrl

475
hu00305008
g2662290
Human mRNA for cytochrome b5, partial cds.

476
hu00631844
g2662290
Human mRNA for cytochrome b5, partial cds.

477
hu00667379
g2662290
Human mRNA for cytochrome b5, partial cds.

478
hu00200113
g2662290
Human mRNA for cytochrome b5, partial cds.

479
hu00657975
g2662290
Human mRNA for cytochrome b5, partial cds.

480
hu00090130
g2662290
Human mRNA for cytochrome b5, partial cds.

481
hu00731030
g2662290
Human mRNA for cytochrome b5, partial cds.

482
hu00112740
g2662290
Human mRNA for cytochrome b5, partial cds.

483
hu00405180
g2662290
Human mRNA for cytochrome b5, partial cds.

484
hu00801145
g2662290
Human mRNA for cytochrome b5, partial cds.

485
hu00710542
g2662290
Human mRNA for cytochrome b5, partial cds.

486
hu00141175
g2662290
Human mRNA for cytochrome b5, partial cds.

487
hu00414290
g2662290
Human mRNA for cytochrome b5, partial cds.

488
hu00264315
g2662290
Human mRNA for cytochrome b5, partial cds.

489
hu00049062
g2662290
Human mRNA for cytochrome b5, partial cds.

490
hu00059621
g2662290
Human mRNA for cytochrome b5, partial cds.

491
hu00166903
g2662290
Human mRNA for cytochrome b5, partial cds.

492
hu00503917
g2662290
Human mRNA for cytochrome b5, partial cds.

493
hu00134926
g2662290
Human mRNA for cytochrome b5, partial cds.

494
hu00445742
g2662290
Human mRNA for cytochrome b5, partial cds.

495
hu00336087
g2662290
Human mRNA for cytochrome b5, partial cds.

496
hu00929610
g2662290
Human mRNA for cytochrome b5, partial cds.

497
hu00079146
g2662290
Human mRNA for cytochrome b5, partial cds.

498
hu00273268
g2662290
Human mRNA for cytochrome b5, partial cds.

499
hu00628912
g2662290
Human mRNA for cytochrome b5, partial cds.

500
hu00086716
g2662290
Human mRNA for cytochrome b5, partial cds.

501
hu00614476
g2662290
Human mRNA for cytochrome b5, partial cds.

502
hu00148645
g2662290
Human mRNA for cytochrome b5, partial cds.

503
hu00833681
g2662290
Human mRNA for cytochrome b5, partial cds.

504
hu00532388
g2662290
Human mRNA for cytochrome b5, partial cds.

505
hu00436439
g2662290
Human mRNA for cytochrome b5, partial cds.

506
hu00088932
g2662290
Human mRNA for cytochrome b5, partial cds.

507
hu00149178
g2662290
Human mRNA for cytochrome b5, partial cds.

508
hu00426594
g2662290
Human mRNA for cytochrome b5, partial cds.

509
hu00065947
g2662290
Human mRNA for cytochrome b5, partial cds.

510
hu00915854
g2662290
Human mRNA for cytochrome b5, partial cds.

511
hu00944169
g2662290
Human mRNA for cytochrome b5, partial cds.

512
hu00775518
g2662290
Human mRNA for cytochrome b5, partial cds.

513
hu00369357
g2662290
Human mRNA for cytochrome b5, partial cds.

514
hu00668950
g2662290
Human mRNA for cytochrome b5, partial cds.

515
hu00891829
g2662290
Human mRNA for cytochrome b5, partial cds.

516
hu00036080
g2662290
Human mRNA for cytochrome b5, partial cds.

517
hu00904410
g2662290
Human mRNA for cytochrome b5, partial cds.

518
hu00505381
g2662290
Human mRNA for cytochrome b5, partial cds.

519
hu00431437
g2662290
Human mRNA for cytochrome b5, partial cds.

520
hu00851911
g2662290
Human mRNA for cytochrome b5, partial cds.

521
hu00044828
g2662290
Human mRNA for cytochrome b5, partial cds.

522
hu00562591
g2662290
Human mRNA for cytochrome b5, partial cds.

523
hu00682264
g2662290
Human mRNA for cytochrome b5, partial cds.

524
hu00505828
g2662290
Human mRNA for cytochrome b5, partial cds.

525
hu00881192
g2662290
Human mRNA for cytochrome b5, partial cds.

526
hu00486165
g2662290
Human mRNA for cytochrome b5, partial cds.

527
hu00741963
g2662290
Human mRNA for cytochrome b5, partial cds.

528
hu00424866
g2662290
Human mRNA for cytochrome b5, partial cds.

529
hu00575940
g2662290
Human mRNA for cytochrome b5, partial cds.

530
hu00952636
g2662290
Human mRNA for cytochrome b5, partial cds.

531
hu00777181
g2662290
Human mRNA for cytochrome b5, partial cds.

532
hu00820669
g2662290
Human mRNA for cytochrome b5, partial cds.

533
hu00950657
g2662290
Human mRNA for cytochrome b5, partial cds.

534
hu00492926
g2662290
Human mRNA for cytochrome b5, partial cds.

535
hu00386691
g2662290
Human mRNA for cytochrome b5, partial cds.

536
hu00691935
g2662290
Human mRNA for cytochrome b5, partial cds.

537
hu00672864
g2662290
Human mRNA for cytochrome b5, partial cds.

538
hu00824866
g2662290
Human mRNA for cytochrome b5, partial cds.

539
hu00849554
g2662290
Human mRNA for cytochrome b5, partial cds.

540
hu00694880
g2662290
Human mRNA for cytochrome b5, partial cds.

541
hu00488548
g2662290
Human mRNA for cytochrome b5, partial cds.

542
hu00861598
g2662290
Human mRNA for cytochrome b5, partial cds.

543
hu00748875
g2662290
Human mRNA for cytochrome b5, partial cds.

544
hu00430192
g2662290
Human mRNA for cytochrome b5, partial cds.

545
hu00001649
g2662290
Human mRNA for cytochrome b5, partial cds.

546
hu00182128
g2662290
Human mRNA for cytochrome b5, partial cds.

547
hu00550066
g2662290
Human mRNA for cytochrome b5, partial cds.

548
hu00496130
g2662290
Human mRNA for cytochrome b5, partial cds.

549
hu00515714
g2662290
Human mRNA for cytochrome b5, partial cds.

550
hu00723751
g2662290
Human mRNA for cytochrome b5, partial cds.

551
hu00150946
g2662290
Human mRNA for cytochrome b5, partial cds.

552
hu00111878
g2662290
Human mRNA for cytochrome b5, partial cds.

553
hu00128465
g2662290
Human mRNA for cytochrome b5, partial cds.

554
hu00561474
g2662290
Human mRNA for cytochrome b5, partial cds.

555
hu00279622
g2662290
Human mRNA for cytochrome b5, partial cds.

556
hu00895600
g2662290
Human mRNA for cytochrome b5, partial cds.

557
hu00139834
g2662290
Human mRNA for cytochrome b5, partial cds.

558
hu00872570
g2662290
Human mRNA for cytochrome b5, partial cds.

559
hu00624854
g2662290
Human mRNA for cytochrome b5, partial cds.

560
hu00571395
g2662290
Human mRNA for cytochrome b5, partial cds.

561
hu00872139
g2662290
Human mRNA for cytochrome b5, partial cds.

562
hu00498235
g2662290
Human mRNA for cytochrome b5, partial cds.

563
hu00736942
g2662290
Human mRNA for cytochrome b5, partial cds.

564
hu00437945
g2662290
Human mRNA for cytochrome b5, partial cds.

565
hu00677247
g2662290
Human mRNA for cytochrome b5, partial cds.

566
hu00287089
g2662290
Human mRNA for cytochrome b5, partial cds.

567
hu00893466
g2662290
Human mRNA for cytochrome b5, partial cds.

568
hu00539398
g2662290
Human mRNA for cytochrome b5, partial cds.

569
hu00856774
g2662290
Human mRNA for cytochrome b5, partial cds.

570
hu00692996
g2662290
Human mRNA for cytochrome b5, partial cds.

571
hu00966768
g2662290
Human mRNA for cytochrome b5, partial cds.

572
hu00030404
g2662290
Human mRNA for cytochrome b5, partial cds.

573
hu00332510
g2662290
Human mRNA for cytochrome b5, partial cds.

574
hu00650103
g2662290
Human mRNA for cytochrome b5, partial cds.

575
hu00003951
g2662290
Human mRNA for cytochrome b5, partial cds.

576
hu00560152
g2662290
Human mRNA for cytochrome b5, partial cds.

577
hu00825211
g2662290
Human mRNA for cytochrome b5, partial cds.

578
hu00470440
g2662290
Human mRNA for cytochrome b5, partial cds.

579
hu00174710
g2662290
Human mRNA for cytochrome b5, partial cds.

580
hu00049450
g2662290
Human mRNA for cytochrome b5, partial cds.

581
hu00516337
g2662290
Human mRNA for cytochrome b5, partial cds.

582
hu00779021
g2662290
Human mRNA for cytochrome b5, partial cds.

583
hu00870760
g2662290
Human mRNA for cytochrome b5, partial cds.

584
hu00507709
g2662290
Human mRNA for cytochrome b5, partial cds.

585
hu00826066
g2662290
Human mRNA for cytochrome b5, partial cds.

586
hu00526933
g2662290
Human mRNA for cytochrome b5, partial cds.

587
hu00634709
g2662290
Human mRNA for cytochrome b5, partial cds.

588
hu00279274
g2662290
Human mRNA for cytochrome b5, partial cds.

589
hu00046789
g2662290
Human mRNA for cytochrome b5, partial cds.

590
hu00686725
g2662290
Human mRNA for cytochrome b5, partial cds.

591
hu01211796
g2443331
Nfrl

592
hu01277569
g2443331
Nfrl

593
hu01227913
g2443331
Nfrl

594
hu00019002
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

595
hu00074988
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

596
hu00682203
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

597
hu00405958
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

598
hu00902417
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

599
hu00882139
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

600
hu00444939
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

601
hu00996720
g4375935
dJ257I9.1 (similar to Cytochrome B)

602
hu00979613
g4928472
type 2 peroxiredoxin

603
hu01217988
g4928472
type 2 peroxiredoxin

604
hu01131267
g4928472
type 2 peroxiredoxin

605
hu01057108
g4928472
type 2 peroxiredoxin

606
hu01127156
g4928472
type 2 peroxiredoxin

607
hu01315257
g4928472
type 2 peroxiredoxin

608
hu01127950
g4928472
type 2 peroxiredoxin

609
hu01277533
g4928472
type 2 peroxiredoxin

610
hu01313696
g4928472
type 2 peroxiredoxin

611
hu01262379
g4928472
type 2 peroxiredoxin

612
hu01184935
g4928472
type 2 peroxiredoxin

613
hu01309738
g4928472
type 2 peroxiredoxin

614
hu01216150
g4928472
type 2 peroxiredoxin

615
hu01330055
g4928472
type 2 peroxiredoxin

616
hu01007235
g4928472
type 2 peroxiredoxin

617
hu00627285
g3646127
Human mRNA for putative thioredoxin-like protein.

618
rat00198924
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

619
rat00147149
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

620
rat00122728
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

621
rat00102041
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

622
rat00244239
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

623
hu00860841
g3646127
Human mRNA for putative thioredoxin-like protein.

624
hu00329532
g3646127
Human mRNA for putative thioredoxin-like protein.

625
hu00268088
g3646127
Human mRNA for putative thioredoxin-like protein.

626
hu00754801
g3646127
Human mRNA for putative thioredoxin-like protein.

627
rat00227438
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

628
rat00148580
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

629
rat00148626
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

630
rat00068841
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

631
rat00126954
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

632
rat00170875
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

633
rat00059770
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

634
rat00159473
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

635
rat00061995
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

636
rat00239188
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

637
rat00226688
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

638
rat00079387
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

639
rat00069857
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

640
rat00201032
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

641
rat00100124
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

642
rat00000065
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

643
rat00025121
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

644
rat00111342
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

645
rat00012470
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

646
rat00243312
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

647
rat00153024
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

648
rat00093202
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

649
rat00072036
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

650
rat00122347
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

651
rat00128414
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

652
rat00054660
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

653
rat00160662
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

654
rat00243365
g2970690
Mouse thioredoxin-related protein mRNA, complete cds.

655
hu00195965
g3646127
Human mRNA for putative thioredoxin-like protein.

656
hu00492988
g3646127
Human mRNA for putative thioredoxin-like protein.

657
hu00410537
g3646127
Human mRNA for putative thioredoxin-like protein.

658
hu00133553
g3646127
Human mRNA for putative thioredoxin-like protein.

659
hu00341716
g3646127
Human mRNA for putative thioredoxin-like protein.

660
hu00319153
g3646127
Human mRNA for putative thioredoxin-like protein.

661
hu00890410
g3646127
Human mRNA for putative thioredoxin-like protein.

662
hu00761631
g3646127
Human mRNA for putative thioredoxin-like protein.

663
hu00424618
g3646127
Human mRNA for putative thioredoxin-like protein.

664
hu00461663
g3646127
Human mRNA for putative thioredoxin-like protein.

665
hu00471664
g3646127
Human mRNA for putative thioredoxin-like protein.

666
hu00175737
g3646127
Human mRNA for putative thioredoxin-like protein.

667
hu00080697
g3646127
Human mRNA for putative thioredoxin-like protein.

668
hu00684950
g3646127
Human mRNA for putative thioredoxin-like protein.

669
hu00910769
g3646127
Human mRNA for putative thioredoxin-like protein.

670
hu00672773
g3646127
Human mRNA for putative thioredoxin-like protein.

671
hu00774949
g3646127
Human mRNA for putative thioredoxin-like protein.

672
hu00959976
g3646127
Human mRNA for putative thioredoxin-like protein.

673
hu00124133
g3646127
Human mRNA for putative thioredoxin-like protein.

674
hu00717302
g3646127
Human mRNA for putative thioredoxin-like protein.

675
hu00552353
g3646127
Human mRNA for putative thioredoxin-like protein.

676
hu00544172
g3646127
Human mRNA for putative thioredoxin-like protein.

677
hu00943161
g3646127
Human mRNA for putative thioredoxin-like protein.

678
hu00662183
g3646127
Human mRNA for putative thioredoxin-like protein.

679
hu00590931
g3646127
Human mRNA for putative thioredoxin-like protein.

680
hu00235972
g3646127
Human mRNA for putative thioredoxin-like protein.

681
hu00867135
g3646127
Human mRNA for putative thioredoxin-like protein.

682
hu00758833
g3646127
Human mRNA for putative thioredoxin-like protein.

683
hu00069795
g3646127
Human mRNA for putative thioredoxin-like protein.

684
hu00088668
g3646127
Human mRNA for putative thioredoxin-like protein.

685
hu00378757
g3646127
Human mRNA for putative thioredoxin-like protein.

686
hu00271021
g3646127
Human mRNA for putative thioredoxin-like protein.

687
hu00238010
g3646127
Human mRNA for putative thioredoxin-like protein.

688
hu00241262
g3646127
Human mRNA for putative thioredoxin-like protein.

689
hu00000477
g3646127
Human mRNA for putative thioredoxin-like protein.

690
hu00432335
g3646127
Human mRNA for putative thioredoxin-like protein.

691
hu00015563
g3646127
Human mRNA for putative thioredoxin-like protein.

692
hu00646150
g3646127
Human mRNA for putative thioredoxin-like protein.

693
hu00062618
g3646127
Human mRNA for putative thioredoxin-like protein.

694
hu00091760
g3646127
Human mRNA for putative thioredoxin-like protein.

695
hu00466331
g3646127
Human mRNA for putative thioredoxin-like protein.

696
hu00624371
g3646127
Human mRNA for putative thioredoxin-like protein.

697
hu00613446
g3646127
Human mRNA for putative thioredoxin-like protein.

698
hu00107379
g3646127
Human mRNA for putative thioredoxin-like protein.

699
hu00736344
g3646127
Human mRNA for putative thioredoxin-like protein.

700
hu00049527
g3646127
Human mRNA for putative thioredoxin-like protein.

701
hu00123894
g3646127
Human mRNA for putative thioredoxin-like protein.

702
hu00362585
g3646127
Human mRNA for putative thioredoxin-like protein.

703
hu00772940
g3646127
Human mRNA for putative thioredoxin-like protein.

704
hu00567651
g3646127
Human mRNA for putative thioredoxin-like protein.

705
hu00884551
g3646127
Human mRNA for putative thioredoxin-like protein.

706
hu00217968
g3646127
Human mRNA for putative thioredoxin-like protein.

707
hu00653686
g3646127
Human mRNA for putative thioredoxin-like protein.

708
hu00666277
g3646127
Human mRNA for putative thioredoxin-like protein.

709
hu00682873
g3646127
Human mRNA for putative thioredoxin-like protein.

710
hu00901002
g3646127
Human mRNA for putative thioredoxin-like protein.

711
hu00712113
g3646127
Human mRNA for putative thioredoxin-like protein.

712
hu00090046
g3646127
Human mRNA for putative thioredoxin-like protein.

713
hu00016543
g3646127
Human mRNA for putative thioredoxin-like protein.

714
hu00102935
g3646127
Human mRNA for putative thioredoxin-like protein.

715
hu00170391
g3646127
Human mRNA for putative thioredoxin-like protein.

716
hu00291433
g3646127
Human mRNA for putative thioredoxin-like protein.

717
hu00433914
g3646127
Human mRNA for putative thioredoxin-like protein.

718
hu00379104
g3646127
Human mRNA for putative thioredoxin-like protein.

719
hu00622960
g3646127
Human mRNA for putative thioredoxin-like protein.

720
hu00316357
g3646127
Human mRNA for putative thioredoxin-like protein.

721
hu00352638
g3646127
Human mRNA for putative thioredoxin-like protein.

722
hu00542377
g3646127
Human mRNA for putative thioredoxin-like protein.

723
hu00484526
g3646127
Human mRNA for putative thioredoxin-like protein.

724
hu00962138
g3646127
Human mRNA for putative thioredoxin-like protein.

725
hu00961725
g3646127
Human mRNA for putative thioredoxin-like protein.

726
hu00545448
g3646127
Human mRNA for putative thioredoxin-like protein.

727
hu00646249
g3646127
Human mRNA for putative thioredoxin-like protein.

728
hu00337964
g3646127
Human mRNA for putative thioredoxin-like protein.

729
hu00854449
g3646127
Human mRNA for putative thioredoxin-like protein.

730
hu01258892
g2897941
Human thioredoxin-like protein mRNA, complete cds.

731
hu01068980
g2897941
Human thioredoxin-like protein mRNA, complete cds.

732
rat00013687
g203718
Rat (Sprague-Dawley) cytochrome c pseudogene, clone Ch4A-RC9.

733
rat00197623
g203718
Rat (Sprague-Dawley) cytochrome c pseudogene, clone Ch4A-RC9.

734
rat00079184
g203718
Rat (Sprague-Dawley) cytochrome c pseudogene, clone Ch4A-RC9.

735
rat00097770
g203718
Rat (Sprague-Dawley) cytochrome c pseudogene, clone Ch4A-RC9.

736
rat00109965
g203718
Rat (Sprague-Dawley) cytochrome c pseudogene, clone Ch4A-RC9.

737
rat00104653
g203718
Rat (Sprague-Dawley) cytochrome c pseudogene, clone Ch4A-RC9.

738
rat00142167
g203718
Rat (Sprague-Dawley) cytochrome c pseudogene, clone Ch4A-RC9.

739
rat00259341
g203718
Rat (Sprague-Dawley) cytochrome c pseudogene, clone Ch4A-RC9.

740
hu00601827
g453963
Human mRNA for ATL-derived factor/thiredoxin.

741
hu00024989
g453963
Human mRNA for ATL-derived factor/thiredoxin.

742
hu00999345
g2897941
Human thioredoxin-like protein mRNA, complete cds.

743
hu01011601
g2897941
Human thioredoxin-like protein mRNA, complete cds.

744
hu01143411
g2897941
Human thioredoxin-like protein mRNA, complete cds.

745
hu01122354
g2897941
Human thioredoxin-like protein mRNA, complete cds.

746
hu01215505
g2897941
Human thioredoxin-like protein mRNA, complete cds.

747
hu01004563
g2897941
Human thioredoxin-like protein mRNA, complete cds.

748
hu01075341
g2897941
Human thioredoxin-like protein mRNA, complete cds.

749
hu01271901
g2897941
Human thioredoxin-like protein mRNA, complete cds.

750
hu01189121
g2897941
Human thioredoxin-like protein mRNA, complete cds.

751
hu01263266
g2897941
Human thioredoxin-like protein mRNA, complete cds.

752
hu01258550
g2897941
Human thioredoxin-like protein mRNA, complete cds.

753
hu01091807
g2897941
Human thioredoxin-like protein mRNA, complete cds.

754
hu01325277
g2897941
Human thioredoxin-like protein mRNA, complete cds.

755
hu01072756
g2897941
Human thioredoxin-like protein mRNA, complete cds.

756
hu01305668
g2897941
Human thioredoxin-like protein mRNA, complete cds.

757
hu01034966
g2897941
Human thioredoxin-like protein mRNA, complete cds.

758
hu01268635
g2897941
Human thioredoxin-like protein mRNA, complete cds.

759
hu00967441
g2897941
Human thioredoxin-like protein mRNA, complete cds.

760
hu01185674
g2897941
Human thioredoxin-like protein mRNA, complete cds.

761
hu01089257
g2897941
Human thioredoxin-like protein mRNA, complete cds.

762
hu01070889
g2897941
Human thioredoxin-like protein mRNA, complete cds.

763
hu00396958
g453963
Human mRNA for ATL-derived factor/thiredoxin.

764
hu00230202
g453963
Human mRNA for ATL-derived factor/thiredoxin.

765
hu00300233
g453963
Human mRNA for ATL-derived factor/thiredoxin.

766
hu00433221
g453963
Human mRNA for ATL-derived factor/thiredoxin.

767
hu00150706
g453963
Human mRNA for ATL-derived factor/thiredoxin.

768
hu00270623
g453963
Human mRNA for ATL-derived factor/thiredoxin.

769
hu00119128
g453963
Human mRNA for ATL-derived factor/thiredoxin.

770
hu00608710
g453963
Human mRNA for ATL-derived factor/thiredoxin.

771
hu00804308
g453963
Human mRNA for ATL-derived factor/thiredoxin.

772
hu00284711
g453963
Human mRNA for ATL-derived factor/thiredoxin.

773
hu00490282
g453963
Human mRNA for ATL-derived factor/thiredoxin.

774
hu00139714
g453963
Human mRNA for ATL-derived factor/thiredoxin.

775
hu00231892
g453963
Human mRNA for ATL-derived factor/thiredoxin.

776
hu00357416
g453963
Human mRNA for ATL-derived factor/thiredoxin.

777
hu00515780
g453963
Human mRNA for ATL-derived factor/thiredoxin.

778
hu00620289
g453963
Human mRNA for ATL-derived factor/thiredoxin.

779
hu00634536
g453963
Human mRNA for ATL-derived factor/thiredoxin.

780
hu00295381
g453963
Human mRNA for ATL-derived factor/thiredoxin.

781
hu00689090
g453963
Human mRNA for ATL-derived factor/thiredoxin.

782
hu00624894
g453963
Human mRNA for ATL-derived factor/thiredoxin.

783
rat00180808
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

784
rat00029077
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

785
rat00238831
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

786
rat00157148
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

787
rat00228376
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

788
rat00112998
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

789
rat00067297
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

790
rat00099177
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

791
rat00188749
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

792
rat00149897
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

793
rat00102720
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

794
rat00119114
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

795
rat00214272
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

796
rat00166231
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

797
rat00071074
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

798
rat00240806
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

799
rat00017707
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

800
rat00103279
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

801
rat00179213
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

802
rat00155382
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

803
rat00241944
g3688520
Rat mRNA for thiol-specific antioxidant protein (1-Cys peroxiredoxin).

804
hu00788751
g2911066
adrenodoxin-like protein

805
hu00263898
g2911066
adrenodoxin-like protein

806
hu00679088
g2911066
adrenodoxin-like protein

807
hu00411401
g2911066
adrenodoxin-like protein

808
hu00849869
g2911066
adrenodoxin-like protein

809
hu00733110
g2911066
adrenodoxin-like protein

810
hu00500094
g2911066
adrenodoxin-like protein

811
hu00630613
g2911066
adrenodoxin-like protein

812
hu00483211
g2911066
adrenodoxin-like protein

813
hu00726024
g2911066
adrenodoxin-like protein

814
hu00804640
g2911066
adrenodoxin-like protein

815
hu00434840
g2911066
adrenodoxin-like protein

816
hu00307931
g2911066
adrenodoxin-like protein

817
hu00118249
g2911066
adrenodoxin-like protein

818
hu00359170
g2911066
adrenodoxin-like protein

819
hu00834424
g2911066
adrenodoxin-like protein

820
hu00491309
g2911066
adrenodoxin-like protein

821
hu00641394
g2911066
adrenodoxin-like protein

822
hu00529683
g2911066
adrenodoxin-like protein

823
hu00237499
g2911066
adrenodoxin-like protein

824
hu00697147
g2911066
adrenodoxin-like protein

825
hu00197335
g2443331
Nfrl

826
hu00731987
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

827
hu00795629
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

828
hu00885639
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

829
hu00728978
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

830
hu00531230
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

831
hu00502701
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

832
hu00125531
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

833
hu00161830
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

834
hu00113816
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

835
hu00763211
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

836
hu00623901
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

837
hu00447421
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

838
hu00550627
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

839
hu00740186
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

840
hu00440838
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

841
hu00223687
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

842
hu00872394
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

843
hu00834378
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

844
hu00554569
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

845
hu00743996
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

846
hu00919779
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

847
hu00107621
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

848
hu00321704
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

849
hu00104670
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

850
hu00102690
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

851
hu00527304
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

852
hu00017059
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

853
hu00850406
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

854
hu00793203
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

855
hu00732715
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

856
hu00242629
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

857
hu00591902
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

858
hu00611478
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

859
hu00514953
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

860
hu00847134
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

861
hu00527429
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

862
hu00778152
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

863
hu00483538
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

864
hu00169762
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

865
hu00627494
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

866
hu00683672
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

867
hu00619358
g5295993
Human SDHD gene for small subunit of cytochrome b of succinate dehydrogenase, complete cds.

868
hu00334846
g2443331
Nfrl

869
hu00538435
g2443331
Nfrl

870
hu00045975
g2443331
Nfrl

871
hu00255713
g2443331
Nfrl

872
hu00309830
g2443331
Nfrl

873
hu00838320
g2443331
Nfrl

874
hu00600416
g2443331
Nfrl

875
hu00678814
g2443331
Nfrl

876
hu00220365
g2443331
Nfrl

877
hu00715266
g2911066
adrenodoxin-like protein

878
hu00061515
g2911066
adrenodoxin-like protein

879
hu01256988
g37118
Human gene for thioredoxin, exons 2 and 3.

880
hu01320806
g181261
Human somatic cytochrome c (HC6) processed pseudogene, complete cds.

881
hu00225272
g2351036
Human mRNA for cytochrome b small subunit of complex II, complete cds.

882
hu00492301
g4375935
dJ257I9.1 (similar to Cytochrome B)

883
hu00147708
g4375935
dJ257I9.1 (similar to Cytochrome B)

884
hu00720528
g4375935
dJ257I9.1 (similar to Cytochrome B)

885
hu00662648
g4375935
dJ257I9.1 (similar to Cytochrome B)

886
hu00425257
g4375935
dJ257I9.1 (similar to Cytochrome B)

887
hu01145798
g2662290
Human mRNA for cytochrome b5, partial cds.

888
hu00990657
g2662290
Human mRNA for cytochrome b5, partial cds.

889
hu01033267
g2662290
Human mRNA for cytochrome b5, partial cds.

890
hu01064572
g2662290
Human mRNA for cytochrome b5, partial cds.

891
hu01014659
g2662290
Human mRNA for cytochrome b5, partial cds.

892
hu01343943
g2662290
Human mRNA for cytochrome b5, partial cds.

893
hu01172385
g2662290
Human mRNA for cytochrome b5, partial cds.

894
hu01274383
g2662290
Human mRNA for cytochrome b5, partial cds.

895
hu01126099
g2662290
Human mRNA for cytochrome b5, partial cds.

896
hu01096453
g2662290
Human mRNA for cytochrome b5, partial cds.

897
hu01280694
g2662290
Human mRNA for cytochrome b5, partial cds.

898
hu01303215
g2662290
Human mRNA for cytochrome b5, partial cds.

899
hu01082041
g2662290
Human mRNA for cytochrome b5, partial cds.

900
hu00153508
g2967825
Human thioredoxin homolog mRNA, complete cds.

901
hu00928636
g2967825
Human thioredoxin homolog mRNA, complete cds.

902
hu00498907
g2897941
Human thioredoxin-like protein mRNA, complete cds.

903
hu01128530
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

904
hu01111791
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

905
hu01274800
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

906
hu01075270
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

907
hu01040299
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

908
hu01234846
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

909
hu01296534
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

910
hu01176871
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

911
hu00970376
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

912
hu00188328
g2967825
Human thioredoxin homolog mRNA, complete cds.

913
hu00512707
g2967825
Human thioredoxin homolog mRNA, complete cds.

914
hu00458446
g2967825
Human thioredoxin homolog mRNA, complete cds.

915
hu00310776
g2967825
Human thioredoxin homolog mRNA, complete cds.

916
hu00878881
g2967825
Human thioredoxin homolog mRNA, complete cds.

917
hu00695058
g2967825
Human thioredoxin homolog mRNA, complete cds.

918
hu00809565
g2967825
Human thioredoxin homolog mRNA, complete cds.

919
hu00422460
g2967825
Human thioredoxin homolog mRNA, complete cds.

920
hu00236474
g2967825
Human thioredoxin homolog mRNA, complete cds.

921
hu00504324
g2967825
Human thioredoxin homolog mRNA, complete cds.

922
hu00665846
g4500377
putative NADPH cytochrome reductase

923
hu00369297
g4500377
putative NADPH cytochrome reductase

924
hu00729723
g4500377
putative NADPH cytochrome reductase

925
hu00228581
g4500377
putative NADPH cytochrome reductase

926
hu00747970
g4500377
putative NADPH cytochrome reductase

927
rat00217853
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

928
rat00105569
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

929
rat00066626
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

930
rat00209690
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

931
rat00193805
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

932
rat00080783
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

933
rat00177525
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

934
rat00068166
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

935
rat00129844
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

936
rat00159187
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

937
rat00126977
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

938
rat00085597
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

939
rat00002212
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

940
rat00240035
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

941
rat00004910
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

942
rat00150261
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

943
rat00106163
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

944
rat00035083
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

945
rat00203069
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

946
rat00028253
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

947
rat00078430
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

948
rat00056155
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

949
rat00104549
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

950
rat00108680
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

951
rat00127454
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

952
rat00081843
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

953
rat00137590
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

954
rat00190565
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

955
rat00013868
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

956
rat00162269
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

957
rat00088471
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

958
rat00093566
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

959
rat00042779
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

960
rat00017885
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

961
rat00171598
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

962
rat00189715
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

963
rat00053789
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

964
rat00175856
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

965
rat00164967
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

966
rat00078693
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

967
rat00066877
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

968
rat00096796
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

969
rat00161402
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

970
rat00161602
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

971
rat00010529
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

972
rat00020781
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

973
rat00100296
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

974
rat00185004
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

975
rat00024363
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

976
rat00211395
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

977
rat00061195
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

978
rat00003893
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

979
rat00184074
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

980
rat00028608
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

981
rat00050865
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

982
rat00142197
g786396
cytochrome bc-1 complex core P {clone E518, estrogen induced gene} [rats, Sprague-Dawley,

983
hu00969530
g181228
Human cytochrome b5 mRNA, 3′ end.

984
rat00178844
g50622
Mouse cytochrome c pseudogene (MC2).

985
hu00523841
g5114277
iron-sulfur protein

986
hu00759605
g5114277
iron-sulfur protein

987
rat00161197
g57385
Rat mRNA for thioredoxin.

988
rat00214410
g57385
Rat mRNA for thioredoxin.

989
rat00016800
g57385
Rat mRNA for thioredoxin.

990
rat00113622
g57385
Rat mRNA for thioredoxin.

991
rat00090205
g57385
Rat mRNA for thioredoxin.

992
rat00165130
g57385
Rat mRNA for thioredoxin.

993
rat00019997
g57385
Rat mRNA for thioredoxin.

994
rat00171632
g57385
Rat mRNA for thioredoxin.

995
rat00188498
g57385
Rat mRNA for thioredoxin.

996
rat00044347
g57385
Rat mRNA for thioredoxin.

997
rat00012121
g57385
Rat mRNA for thioredoxin.

998
rat00249136
g3646128
thioredoxin-like protein

999
rat00192355
g3646128
thioredoxin-like protein

1000
rat00227393
g3646128
thioredoxin-like protein

1001
rat00057555
g3646128
thioredoxin-like protein

1002
rat00085573
g3646128
thioredoxin-like protein

1003
rat00194473
g3646128
thioredoxin-like protein

1004
rat00193088
g3646128
thioredoxin-like protein

1005
rat00029775
g3646128
thioredoxin-like protein

1006
rat00177882
g3646128
thioredoxin-like protein

1007
rat00219996
g3646128
thioredoxin-like protein

1008
rat00233601
g3646128
thioredoxin-like protein

1009
rat00023406
g3646128
thioredoxin-like protein

1010
rat00111931
g3646128
thioredoxin-like protein

1011
rat00107350
g3646128
thioredoxin-like protein

1012
rat00142146
g3646128
thioredoxin-like protein

1013
rat00211383
g3646128
thioredoxin-like protein

1014
rat00044435
g3646128
thioredoxin-like protein

1015
rat00021863
g3646128
thioredoxin-like protein

1016
rat00230438
g3646128
thioredoxin-like protein

1017
rat00184305
g3646128
thioredoxin-like protein

1018
rat00160545
g3646128
thioredoxin-like protein

1019
rat00225625
g3646128
thioredoxin-like protein

1020
rat00052754
g3646128
thioredoxin-like protein

1021
rat00125754
g3646128
thioredoxin-like protein

1022
rat00216555
g3646128
thioredoxin-like protein

1023
rat00249461
g3646128
thioredoxin-like protein

1024
rat00085625
g3646128
thioredoxin-like protein

1025
rat00138547
g3646128
thioredoxin-like protein

1026
rat00166582
g3646128
thioredoxin-like protein

1027
rat00245747
g3646128
thioredoxin-like protein

1028
rat00177618
g3646128
thioredoxin-like protein

1029
rat00249944
g3646128
thioredoxin-like protein

1030
rat00000920
g3646128
thioredoxin-like protein

1031
rat00121523
g3646128
thioredoxin-like protein

1032
rat00181521
g3646128
thioredoxin-like protein

1033
rat00214904
g3646128
thioredoxin-like protein

1034
rat00052481
g3646128
thioredoxin-like protein

1035
rat00134751
g3646128
thioredoxin-like protein

1036
rat00022566
g3646128
thioredoxin-like protein

1037
rat00040368
g3646128
thioredoxin-like protein

1038
rat00008580
g3646128
thioredoxin-like protein

1039
rat00059250
g3646128
thioredoxin-like protein

1040
rat00191560
g3646128
thioredoxin-like protein

1041
rat00017815
g3646128
thioredoxin-like protein

1042
hu00042860
g37118
Human gene for thioredoxin, exons 2 and 3.

1043
hu00298010
g37118
Human gene for thioredoxin, exons 2 and 3.

1044
hu00933420
g37118
Human gene for thioredoxin, exons 2 and 3.

1045
hu00667284
g37118
Human gene for thioredoxin, exons 2 and 3.

1046
hu00372039
g181261
Human somatic cytochrome c (HC6) processed pseudogene, complete cds.

1047
rat00124233
g2443331
Nfrl

1048
rat00239898
g2443331
Nfrl

1049
hu00551266
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1050
hu00666846
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1051
hu00528877
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1052
hu00815978
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1053
hu00638589
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1054
hu00031025
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1055
hu00499778
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1056
hu00678989
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1057
hu00016195
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1058
hu00442156
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1059
hu00952341
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1060
hu00905337
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1061
hu00839062
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1062
hu00804097
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1063
hu00867242
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1064
hu00346764
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1065
hu00733855
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1066
hu00505777
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1067
hu00439947
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1068
hu00898254
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1069
hu00043131
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1070
hu00141506
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1071
hu00561303
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1072
hu00046521
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1073
hu00159103
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1074
hu00313147
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1075
hu00901261
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1076
hu00627230
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1077
hu00203835
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1078
hu00386214
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1079
hu00923443
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1080
hu00726614
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1081
hu00324675
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1082
hu00616149
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1083
hu00823419
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1084
hu00367308
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1085
hu00554095
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1086
hu00647155
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1087
hu00761366
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1088
hu00783265
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1089
hu00540697
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1090
hu00881555
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1091
hu00457495
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1092
hu00364798
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1093
hu00110621
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1094
hu00277043
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1095
hu00201587
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1096
hu00320966
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1097
hu00693044
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1098
hu00634454
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1099
hu00711495
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1100
hu00610579
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1101
hu00340966
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1102
hu00447662
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1103
hu00267528
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1104
hu00570983
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1105
hu00589236
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1106
hu00494959
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1107
hu00854000
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1108
hu00155044
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1109
hu00622162
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1110
hu00304814
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1111
hu00008564
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1112
hu00191328
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1113
hu00652363
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1114
hu00760337
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1115
hu00482708
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1116
hu00342677
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1117
hu00495256
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1118
hu00264785
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1119
hu00334698
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1120
hu00939481
g897580
Human iron-regulatory protein 2 (IRP2) mRNA, partial cds.

1121
rat00219199
g3603233
Mouse type II peroxiredoxin 1 (PrxII-1) gene, promoter region and exon 1.

1122
rat00177802
g3603233
Mouse type II peroxiredoxin 1 (PrxII-1) gene, promoter region and exon 1.

1123
rat00179794
g3603233
Mouse type II peroxiredoxin 1 (PrxII-1) gene, promoter region and exon 1.

1124
rat00199742
g3603233
Mouse type II peroxiredoxin 1 (PrxII-1) gene, promoter region and exon 1.

1125
hu00370477
g181234
Human p22-phox (CYBA) gene, exon 5.

1126
hu00201755
g181234
Human p22-phox (CYBA) gene, exon 5.

1127
hu00352946
g181234
Human p22-phox (CYBA) gene, exon 5.

1128
hu00422951
g181234
Human p22-phox (CYBA) gene, exon 5.

1129
hu00509064
g181234
Human p22-phox (CYBA) gene, exon 5.

1130
hu01263994
g3171877
dJ127D3.2 (Flavin-containing Monooxygenase family protein)

1131
hu01115208
g453964
ATL-derived factor/thioredoxin

1132
hu01072755
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1133
hu01005858
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1134
hu01065170
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1135
hu01198782
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1136
hu01148976
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1137
hu01163198
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1138
hu01281639
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1139
hu01123628
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1140
hu01154039
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1141
hu01206351
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1142
hu01014732
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1143
hu00986147
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1144
hu01215972
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1145
hu01051075
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1146
hu01218852
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1147
hu01158132
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1148
hu01011622
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1149
hu01339166
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1150
hu01034696
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1151
hu01159033
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1152
hu00994745
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1153
hu01054653
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1154
hu01307184
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1155
hu01195431
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1156
hu01302613
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1157
hu01191060
g453963
Human mRNA for ATL-derived factor/thiredoxin.

1158
rat00177217
g677891
cytochrome b558 alpha-subunit

1159
rat00049893
g677891
cytochrome b558 alpha-subunit

1160
rat00187352
g677891
cytochrome b558 alpha-subunit

1161
rat00114238
g677891
cytochrome b558 alpha-subunit

1162
rat00177786
g677891
cytochrome b558 alpha-subunit

1163
rat00136648
g677891
cytochrome b558 alpha-subunit

1164
rat00046766
g677891
cytochrome b558 alpha-subunit

1165
rat00200496
g677891
cytochrome b558 alpha-subunit

1166
rat00100831
g677891
cytochrome b558 alpha-subunit

1167
rat00132474
g677891
cytochrome b558 alpha-subunit

1168
rat00144368
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1169
rat00168417
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1170
rat00076851
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1171
rat00216982
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1172
rat00248339
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1173
rat00213314
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1174
rat00105136
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1175
rat00130615
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1176
rat00251888
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1177
rat00221660
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1178
rat00042254
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1179
rat00010468
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1180
rat00120763
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1181
rat00028407
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1182
rat00107373
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1183
rat00121848
g3881842
Similarity to E. coli 2-oxoglutarate dehydrogenase (SW:ODO1_ECOLI); cDNA EST

1184
hu00475533
g181266
Human somatic cytochrome c (HS7) processed pseudogene, complete cds.

1185
hu00764500
g181266
Human somatic cytochrome c (HS7) processed pseudogene, complete cds.

1186
hu00589051
g984591
Human gene for 2-oxoglutarate dehydrogenase, exon 1 sequence.

1187
hu00518649
g984591
Human gene for 2-oxoglutarate dehydrogenase, exon 1 sequence.

1188
hu00267484
g984611
Human gene for 2-oxoglutarate dehydrogenase, exon 14, 15, 16, 17, 18 and 19 sequence.

1189
hu00467745
g984611
Human gene for 2-oxoglutarate dehydrogenase, exon 14, 15, 16, 17, 18 and 19 sequence.

1190
hu00866865
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1191
hu00679638
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1192
hu00000052
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1193
hu00679918
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1194
hu00221048
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1195
hu00333450
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1196
hu00236251
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1197
hu00013962
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1198
hu00077601
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1199
hu00342680
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1200
hu00475701
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1201
hu00295127
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1202
hu00005869
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1203
hu00918443
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1204
hu00750908
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1205
hu00735159
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1206
hu00349275
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1207
hu00757851
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1208
hu00645964
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1209
hu00599372
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1210
hu00466677
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1211
hu00871867
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1212
hu00669884
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1213
hu00032005
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1214
hu00406042
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1215
hu00023490
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1216
hu00537201
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1217
hu00413338
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1218
hu00086921
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1219
hu00822446
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1220
hu00369125
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1221
hu00149385
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1222
hu00088909
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1223
hu00289537
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1224
hu00465993
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1225
hu00709688
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1226
hu00785849
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1227
hu00071401
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1228
hu00133016
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1229
hu00712341
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1230
hu00651621
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1231
hu00801723
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1232
hu00325174
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1233
hu00123496
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1234
hu00644372
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1235
hu00452495
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1236
hu00667723
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1237
hu00774680
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1238
hu00908188
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1239
hu00896372
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1240
hu00095768
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1241
hu00083110
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1242
hu00241234
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1243
hu00305063
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1244
hu00377000
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1245
hu00282403
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1246
hu00003638
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1247
hu00524118
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1248
hu00307641
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1249
hu00040648
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1250
hu00116735
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1251
hu00344058
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1252
hu00060966
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1253
hu00458246
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1254
hu00298623
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1255
hu00052869
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1256
hu00530798
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1257
hu00961646
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1258
hu00948713
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1259
hu00547548
g2897941
Human thioredoxin-like protein mRNA, complete cds.

1260
rat00151369
g2351037
cytochrome b small subunit of complex II

1261
rat00127186
g2351037
cytochrome b small subunit of complex II

1262
rat00069932
g2351037
cytochrome b small subunit of complex II

1263
rat00192972
g2351037
cytochrome b small subunit of complex II

1264
rat00035697
g2351037
cytochrome b small subunit of complex II

1265
rat00026987
g2351037
cytochrome b small subunit of complex II

1266
rat00163788
g2351037
cytochrome b small subunit of complex II

1267
rat00168756
g2351037
cytochrome b small subunit of complex II

1268
rat00000372
g2351037
cytochrome b small subunit of complex II

1269
rat00202332
g2351037
cytochrome b small subunit of complex II

1270
rat00110821
g2351037
cytochrome b small subunit of complex II

1271
rat00010175
g2351037
cytochrome b small subunit of complex II

1272
rat00190601
g2351037
cytochrome b small subunit of complex II

1273
rat00085202
g2351037
cytochrome b small subunit of complex II

1274
rat00165071
g2351037
cytochrome b small subunit of complex II

1275
rat00035607
g2351037
cytochrome b small subunit of complex II

1276
rat00162742
g2351037
cytochrome b small subunit of complex II

1277
rat00080178
g2351037
cytochrome b small subunit of complex II

1278
rat00206754
g2351037
cytochrome b small subunit of complex II

1279
rat00244717
g2351037
cytochrome b small subunit of complex II

1280
rat00078375
g2351037
cytochrome b small subunit of complex II

1281
rat00218796
g2351037
cytochrome b small subunit of complex II

1282
rat00112251
g2351037
cytochrome b small subunit of complex II

1283
rat00204007
g2351037
cytochrome b small subunit of complex II

1284
rat00171140
g2351037
cytochrome b small subunit of complex II

1285
rat00131225
g2351037
cytochrome b small subunit of complex II

1286
rat00125440
g2351037
cytochrome b small subunit of complex II

1287
rat00170710
g2351037
cytochrome b small subunit of complex II

1288
rat00125900
g2351037
cytochrome b small subunit of complex II

1289
rat00207810
g2351037
cytochrome b small subunit of complex II

1290
rat00114355
g2351037
cytochrome b small subunit of complex II

1291
rat00252245
g2351037
cytochrome b small subunit of complex II

1292
rat00059151
g2351037
cytochrome b small subunit of complex II

1293
rat00095233
g2351037
cytochrome b small subunit of complex II

1294
rat00024880
g2351037
cytochrome b small subunit of complex II

1295
rat00036707
g2351037
cytochrome b small subunit of complex II

1296
rat00227417
g2351037
cytochrome b small subunit of complex II

1297
rat00150890
g2351037
cytochrome b small subunit of complex II

1298
rat00252960
g2351037
cytochrome b small subunit of complex II

1299
rat00038841
g2351037
cytochrome b small subunit of complex II

1300
hu00538491
g984599
Human gene for 2-oxoglutarate dehydrogenase, exon 5, 6, 7 and 8 sequence.

1301
hu00384197
g339648
Human thioredoxin (TXN) mRNA, complete cds.

1302
rat00200270
g220729
Rat mRNA for cytochrome b5.

1303
rat00094481
g220729
Rat mRNA for cytochrome b5.

1304
rat00210583
g220729
Rat mRNA for cytochrome b5.

1305
rat00181406
g220729
Rat mRNA for cytochrome b5.

1306
rat00028541
g220729
Rat mRNA for cytochrome b5.

1307
rat00216462
g220729
Rat mRNA for cytochrome b5.

1308
rat00133499
g220729
Rat mRNA for cytochrome b5.

1309
rat00254102
g220729
Rat mRNA for cytochrome b5.

1310
rat00205869
g220729
Rat mRNA for cytochrome b5.

1311
rat00151088
g220729
Rat mRNA for cytochrome b5.

1312
rat00170519
g220729
Rat mRNA for cytochrome b5.

1313
rat00083093
g220729
Rat mRNA for cytochrome b5.

1314
rat00246380
g220729
Rat mRNA for cytochrome b5.

1315
hu01278189
g181391
Human cytochrome b5 mRNA, complete cds.

1316
hu01055764
g181391
Human cytochrome b5 mRNA, complete cds.

1317
hu01211996
g181391
Human cytochrome b5 mRNA, complete cds.

1318
hu01043275
g181391
Human cytochrome b5 mRNA, complete cds.

1319
hu01015901
g181391
Human cytochrome b5 mRNA, complete cds.

1320
hu01344599
g703083
cytochrome b5

1321
hu00996714
g703083
cytochrome b5

1322
hu01111011
g703083
cytochrome b5

1323
hu01349589
g703083
cytochrome b5

1324
hu01033003
g703083
cytochrome b5

1325
hu00998594
g703083
cytochrome b5

1326
hu01103912
g703083
cytochrome b5

1327
hu01261723
g703083
cytochrome b5

1328
hu01263146
g703083
cytochrome b5

1329
hu01278213
g703083
cytochrome b5

1330
hu01152645
g703083
cytochrome b5

1331
hu01156704
g703083
cytochrome b5

1332
hu01245940
g703083
cytochrome b5

1333
hu01082536
g703083
cytochrome b5

1334
hu01204479
g703083
cytochrome b5

1335
hu01266736
g703083
cytochrome b5

1336
hu01165873
g703083
cytochrome b5

1337
hu01028859
g703083
cytochrome b5

1338
hu01168945
g703083
cytochrome b5

1339
hu01159774
g703083
cytochrome b5

1340
hu00979550
g703083
cytochrome b5

1341
hu01130335
g703083
cytochrome b5

1342
hu01302830
g703083
cytochrome b5

1343
hu01103129
g703083
cytochrome b5

1344
hu01019114
g703083
cytochrome b5

1345
hu01311940
g703083
cytochrome b5

1346
hu01009470
g703083
cytochrome b5

1347
hu01171822
g703083
cytochrome b5

1348
hu01285132
g703083
cytochrome b5

1349
hu01215652
g703083
cytochrome b5

1350
hu01293414
g703083
cytochrome b5

1351
hu01120975
g703083
cytochrome b5

1352
rat00036395
g1217592
Mouse mRNA for squalene epoxidase, complete cds.

1353
rat00028422
g1217592
Mouse mRNA for squalene epoxidase, complete cds.

1354
rat00118389
g1217592
Mouse mRNA for squalene epoxidase, complete cds.

1355
rat00216886
g1217592
Mouse mRNA for squalene epoxidase, complete cds.

1356
rat00099149
g1217592
Mouse mRNA for squalene epoxidase, complete cds.

1357
hu01012121
g1651201
cytochrome b561

1358
hu01242117
g1651201
cytochrome b561

1359
hu01183411
g1651201
cytochrome b561

1360
hu01031536
g1651201
cytochrome b561

1361
hu01213381
g1651201
cytochrome b561

1362
hu01149122
g1651201
cytochrome b561

1363
hu01124822
g1651201
cytochrome b561

1364
hu01266024
g1651201
cytochrome b561

1365
hu01124184
g1651201
cytochrome b561

1366
hu01086601
g1651201
cytochrome b561

1367
hu01070384
g1651201
cytochrome b561

1368
hu01073382
g1651201
cytochrome b561

1369
hu01031739
g1651201
cytochrome b561

1370
hu01115358
g1651201
cytochrome b561

1371
hu01153717
g1651201
cytochrome b561

1372
hu01025981
g1651201
cytochrome b561

1373
hu01303793
g1651201
cytochrome b561

1374
hu01227177
g1651201
cytochrome b561

1375
hu01239409
g1651201
cytochrome b561

1376
hu01178354
g1651201
cytochrome b561

1377
hu01269164
g1651201
cytochrome b561

1378
hu01348841
g1651201
cytochrome b561

1379
hu00531731
g1651201
cytochrome b561

1380
hu00485095
g1651201
cytochrome b561

1381
hu00443053
g476590
Human cytochrome B561, HCYTO B561, mRNA, partial cds.

1382
hu00688152
g476590
Human cytochrome B561, HCYTO B561, mRNA, partial cds.

1383
hu00592769
g476590
Human cytochrome B561, HCYTO B561, mRNA, partial cds.

1384
hu00498963
g476590
Human cytochrome B561, HCYTO B561, mRNA, partial cds.

1385
hu00213468
g476590
Human cytochrome B561, HCYTO B561, mRNA, partial cds.

1386
hu00686498
g476590
Human cytochrome B561, HCYTO B561, mRNA, partial cds.

1387
hu00154170
g476590
Human cytochrome B561, HCYTO B561, mRNA, partial cds.

1388
hu00747944
g30302
Human mRNA for cytochrome c1.

1389
hu00685584
g30302
Human mRNA for cytochrome c1.

1390
hu00547949
g30302
Human mRNA for cytochrome c1.

1391
hu00030222
g30302
Human mRNA for cytochrome c1.

1392
hu00720500
g30302
Human mRNA for cytochrome c1.

1393
hu00204075
g30302
Human mRNA for cytochrome c1.

1394
hu00035425
g30302
Human mRNA for cytochrome c1.

1395
hu00650413
g30302
Human mRNA for cytochrome c1.

1396
hu00315083
g30302
Human mRNA for cytochrome c1.

1397
hu00221835
g30302
Human mRNA for cytochrome c1.

1398
hu00497011
g30302
Human mRNA for cytochrome c1.

1399
hu00750217
g30302
Human mRNA for cytochrome c1.

1400
hu00397213
g30302
Human mRNA for cytochrome c1.

1401
hu00256912
g30302
Human mRNA for cytochrome c1.

1402
hu00181475
g30302
Human mRNA for cytochrome c1.

1403
hu00449580
g30302
Human mRNA for cytochrome c1.

1404
hu00716908
g30302
Human mRNA for cytochrome c1.

1405
hu00773584
g30302
Human mRNA for cytochrome c1.

1406
hu00040407
g1651199
cytochrome b561

1407
hu01076192
g939707
cytochrome b561

1408
hu00923221
g1651201
cytochrome b561

1409
hu00007264
g1651201
cytochrome b561

1410
hu00864391
g1651201
cytochrome b561

1411
hu00384233
g1651201
cytochrome b561

1412
hu00553586
g1651201
cytochrome b561

1413
hu00385647
g1651201
cytochrome b561

1414
hu00466019
g1651201
cytochrome b561

1415
hu00051632
g181391
Human cytochrome b5 mRNA, complete cds.

1416
hu00950968
g181226
Human cytochrome b5 mRNA, complete cds.

1417
hu00155335
g181226
Human cytochrome b5 mRNA, complete cds.

1418
hu01034310
g1651199
cytochrome b561

1419
hu01304800
g1651199
cytochrome b561

1420
hu01260071
g1651199
cytochrome b561

1421
hu01108602
g1651199
cytochrome b561

1422
hu01085123
g1651199
cytochrome b561

1423
hu01224452
g1651199
cytochrome b561

1424
hu01116462
g1651199
cytochrome b561

1425
hu01332724
g1651199
cytochrome b561

1426
hu01205581
g1651199
cytochrome b561

1427
hu01182443
g1651199
cytochrome b561

1428
hu01144509
g1651199
cytochrome b561

1429
hu01205385
g1651199
cytochrome b561

1430
hu01320884
g1651199
cytochrome b561

1431
hu01052792
g1651199
cytochrome b561

1432
hu01312667
g1651199
cytochrome b561

1433
hu01132488
g1651199
cytochrome b561

1434
hu00972009
g1651199
cytochrome b561

1435
hu01094916
g1651199
cytochrome b561

1436
hu01158348
g1651199
cytochrome b561

1437
hu01085909
g1651199
cytochrome b561

1438
hu00987153
g1651199
cytochrome b561

1439
hu00973753
g1651199
cytochrome b561

1440
hu01328985
g1651199
cytochrome b561

1441
hu01025091
g1651199
cytochrome b561

1442
hu01042508
g1651199
cytochrome b561

1443
hu01050366
g1651199
cytochrome b561

1444
hu01316712
g1651199
cytochrome b561

1445
hu01105484
g1651199
cytochrome b561

1446
hu01197221
g1651199
cytochrome b561

1447
hu01014269
g1651199
cytochrome b561

1448
hu01119624
g1651199
cytochrome b561

1449
hu01166370
g1651199
cytochrome b561

1450
hu01290607
g1651199
cytochrome b561

1451
hu01235356
g1651199
cytochrome b561

1452
hu01213739
g1651199
cytochrome b561

1453
hu01012967
g1651199
cytochrome b561

1454
hu01347308
g1651199
cytochrome b561

1455
hu01242764
g1651199
cytochrome b561

1456
hu01141983
g1651199
cytochrome b561

1457
hu00981027
g1651199
cytochrome b561

1458
hu01225836
g1651199
cytochrome b561

1459
hu01021995
g1651199
cytochrome b561

1460
hu01072945
g1651199
cytochrome b561

1461
hu01335646
g1651199
cytochrome b561

1462
hu01252649
g1651199
cytochrome b561

1463
hu00971282
g1651199
cytochrome b561

1464
hu01294428
g1651199
cytochrome b561

1465
hu00991381
g1651199
cytochrome b561

1466
hu01304779
g1651199
cytochrome b561

1467
hu01179067
g1651199
cytochrome b561

1468
hu00992273
g1651199
cytochrome b561

1469
hu01094568
g1651199
cytochrome b561

1470
hu01286548
g1651199
cytochrome b561

1471
hu01189762
g1651199
cytochrome b561

1472
hu00378272
g1651201
cytochrome b561

1473
hu00834376
g1651201
cytochrome b561

1474
hu01095213
g939707
cytochrome b561

1475
hu01109550
g939707
cytochrome b561

1476
hu00979473
g939707
cytochrome b561

1477
hu00988392
g939707
cytochrome b561

1478
hu01006476
g939707
cytochrome b561

1479
hu01224429
g939707
cytochrome b561

1480
hu01222954
g939707
cytochrome b561

1481
hu01199977
g939707
cytochrome b561

1482
hu01064917
g939707
cytochrome b561

1483
hu01253388
g939707
cytochrome b561

1484
hu01212406
g939707
cytochrome b561

1485
hu01298669
g476591
HCYTO B561

1486
hu00276005
g181391
Human cytochrome b5 mRNA, complete cds.

1487
hu00469919
g181391
Human cytochrome b5 mRNA, complete cds.

1488
hu00546016
g181391
Human cytochrome b5 mRNA, complete cds.

1489
hu00372163
g181391
Human cytochrome b5 mRNA, complete cds.

1490
hu00643640
g181391
Human cytochrome b5 mRNA, complete cds.

1491
hu00648878
g181391
Human cytochrome b5 mRNA, complete cds.

1492
hu00229760
g181391
Human cytochrome b5 mRNA, complete cds.

1493
hu00285912
g181391
Human cytochrome b5 mRNA, complete cds.

1494
hu00140054
g181391
Human cytochrome b5 mRNA, complete cds.

1495
hu00048012
g181391
Human cytochrome b5 mRNA, complete cds.

1496
hu00954177
g181391
Human cytochrome b5 mRNA, complete cds.

1497
hu00062127
g181391
Human cytochrome b5 mRNA, complete cds.

1498
hu00046072
g1651201
cytochrome b561

1499
hu00205473
g1651201
cytochrome b561

1500
hu00569891
g1651201
cytochrome b561

1501
hu00779638
g1651201
cytochrome b561

1502
hu00006783
g1651201
cytochrome b561

1503
hu00393703
g1651201
cytochrome b561

1504
hu00302668
g1651201
cytochrome b561

1505
hu00560726
g1651201
cytochrome b561

1506
hu00012332
g1651201
cytochrome b561

1507
hu00732727
g1651201
cytochrome b561

1508
hu00336872
g1651201
cytochrome b561

1509
hu00851294
g1651201
cytochrome b561

1510
hu00049358
g1651201
cytochrome b561

1511
hu00489775
g1651199
cytochrome b561

1512
hu00041104
g1651199
cytochrome b561

1513
hu00141131
g1651199
cytochrome b561

1514
hu00260911
g1651199
cytochrome b561

1515
hu00518080
g1651199
cytochrome b561

1516
hu00465900
g1651199
cytochrome b561

1517
hu00381435
g1651199
cytochrome b561

1518
hu00268512
g1651199
cytochrome b561

1519
hu00639007
g1651199
cytochrome b561

1520
hu00285128
g1651199
cytochrome b561

1521
hu00485343
g1651199
cytochrome b561

1522
hu00933750
g1651199
cytochrome b561

1523
hu00915057
g1651199
cytochrome b561

1524
hu00383850
g1651199
cytochrome b561

1525
hu00634951
g1651199
cytochrome b561

1526
hu00098416
g1651199
cytochrome b561

1527
hu00458218
g1651199
cytochrome b561

1528
hu00199732
g1651199
cytochrome b561

1529
hu00583276
g1651199
cytochrome b561

1530
hu00637386
g1651199
cytochrome b561

1531
hu00398585
g1651199
cytochrome b561

1532
hu00688557
g1651199
cytochrome b561

1533
hu00131101
g1651199
cytochrome b561

1534
hu00010027
g1651199
cytochrome b561

1535
hu00500537
g1651199
cytochrome b561

1536
hu00007175
g1651199
cytochrome b561

1537
hu00452405
g1651199
cytochrome b561

1538
hu00122835
g1651199
cytochrome b561

1539
hu00143166
g1651199
cytochrome b561

1540
hu00891231
g1651199
cytochrome b561

1541
hu00742056
g1651199
cytochrome b561

1542
hu00930375
g1651199
cytochrome b561

1543
hu00955063
g1651199
cytochrome b561

1544
hu00547562
g1651199
cytochrome b561

1545
hu00541586
g1651199
cytochrome b561

1546
hu00225299
g1651199
cytochrome b561

1547
hu00870269
g1651199
cytochrome b561

1548
hu00295892
g1651199
cytochrome b561

1549
hu00619659
g1651199
cytochrome b561

1550
hu00264334
g1651199
cytochrome b561

1551
hu00612715
g1651199
cytochrome b561

1552
hu00653360
g1651199
cytochrome b561

1553
hu00275424
g1651199
cytochrome b561

1554
hu00643409
g1651199
cytochrome b561

1555
hu00594620
g1651199
cytochrome b561

1556
hu00493542
g1651199
cytochrome b561

1557
hu00529435
g1651199
cytochrome b561

1558
hu00359417
g1651199
cytochrome b561

1559
hu00547491
g1651199
cytochrome b561

1560
hu00659429
g1651199
cytochrome b561

1561
hu00891881
g1651199
cytochrome b561

1562
hu00358686
g1651199
cytochrome b561

1563
hu00568948
g1651199
cytochrome b561

1564
hu00241110
g1651199
cytochrome b561

1565
hu00143107
g1651199
cytochrome b561

1566
hu00162134
g1651199
cytochrome b561

1567
hu00473230
g1651199
cytochrome b561

1568
hu00521605
g1651199
cytochrome b561

1569
hu00249510
g1651199
cytochrome b561

1570
hu00371740
g1651199
cytochrome b561

1571
hu00343962
g1651199
cytochrome b561

1572
hu00663094
g1651199
cytochrome b561

1573
hu00945281
g1651199
cytochrome b561

1574
hu00938315
g1651199
cytochrome b561

1575
hu00790652
g1651199
cytochrome b561

1576
hu00619751
g1651199
cytochrome b561

1577
hu00925364
g1651199
cytochrome b561

1578
hu00852465
g1651199
cytochrome b561

1579
hu00179681
g1651199
cytochrome b561

1580
hu00492188
g1651199
cytochrome b561

1581
hu00097395
g1651199
cytochrome b561

1582
hu00295593
g1651199
cytochrome b561

1583
hu00834968
g1651199
cytochrome b561

1584
hu00527111
g1651199
cytochrome b561

1585
hu00047205
g1651199
cytochrome b561

1586
hu00223860
g1651199
cytochrome b561

1587
hu00571413
g1651199
cytochrome b561

1588
hu00951133
g1651199
cytochrome b561

1589
hu00047364
g1651199
cytochrome b561

1590
hu00363337
g1651199
cytochrome b561

1591
hu00235367
g1651199
cytochrome b561

1592
hu00489105
g1651199
cytochrome b561

1593
hu00424737
g1651199
cytochrome b561

1594
hu00738027
g1651199
cytochrome b561

1595
hu00765072
g1651199
cytochrome b561

1596
hu00745318
g1651199
cytochrome b561

1597
hu00526466
g1651199
cytochrome b561

1598
hu00783137
g1651199
cytochrome b561

1599
hu00860493
g1651199
cytochrome b561

1600
hu00449185
g1651199
cytochrome b561

1601
hu00879900
g1651199
cytochrome b561

1602
hu00674677
g1651199
cytochrome b561

1603
hu00668674
g1651199
cytochrome b561

1604
hu00745879
g1651199
cytochrome b561

1605
hu00030141
g1651199
cytochrome b561

1606
hu00487889
g1651199
cytochrome b561

1607
hu00707180
g1651199
cytochrome b561

1608
hu00630168
g1651199
cytochrome b561

1609
hu00081637
g1651199
cytochrome b561

1610
hu00178019
g1651199
cytochrome b561

1611
hu00157607
g1651199
cytochrome b561

1612
hu00654282
g1651199
cytochrome b561

1613
hu00087850
g1651199
cytochrome b561

1614
hu00194690
g1651199
cytochrome b561

1615
hu00841079
g1651199
cytochrome b561

1616
hu00237395
g1651199
cytochrome b561

1617
hu00582519
g1651199
cytochrome b561

1618
hu00878143
g1651199
cytochrome b561

1619
hu00857732
g1651199
cytochrome b561

1620
hu00295854
g1651199
cytochrome b561

1621
hu00486285
g1651199
cytochrome b561

1622
hu00547289
g1651199
cytochrome b561

1623
hu00557569
g1651199
cytochrome b561

1624
hu00033303
g1651199
cytochrome b561

1625
hu00131317
g1651199
cytochrome b561

1626
hu00133091
g1651199
cytochrome b561

1627
hu00285103
g1651199
cytochrome b561

1628
hu00262270
g1651199
cytochrome b561

1629
hu00390009
g1651199
cytochrome b561

1630
hu00463062
g1651199
cytochrome b561

1631
hu00065049
g1651199
cytochrome b561

1632
hu00657523
g1651199
cytochrome b561

1633
hu00641665
g1651199
cytochrome b561

1634
hu00685460
g1651199
cytochrome b561

1635
hu00701858
g1651199
cytochrome b561

1636
hu00492296
g1651199
cytochrome b561

1637
hu00914947
g1651199
cytochrome b561

1638
hu00580985
g1651199
cytochrome b561

1639
hu00869328
g1651199
cytochrome b561

1640
hu00306113
g1651199
cytochrome b561

1641
hu00041492
g1651199
cytochrome b561

1642
hu00906055
g1651199
cytochrome b561

1643
hu00031696
g1651199
cytochrome b561

1644
hu00801890
g1651199
cytochrome b561

1645
hu00171728
g1651199
cytochrome b561

1646
hu00166931
g1651199
cytochrome b561

1647
hu00745263
g1651199
cytochrome b561

1648
hu00551367
g1651199
cytochrome b561

1649
hu00867070
g1651199
cytochrome b561

1650
hu00682084
g1651199
cytochrome b561

1651
hu00363449
g1651199
cytochrome b561

1652
hu00964039
g1651199
cytochrome b561

1653
rat00069019
g168747
phytoene dehydrogenase

1654
rat00253574
g168747
phytoene dehydrogenase

1655
rat00054846
g168747
phytoene dehydrogenase

1656
rat00007795
g168747
phytoene dehydrogenase

1657
rat00176617
g168747
phytoene dehydrogenase

1658
rat00114994
g168747
phytoene dehydrogenase

1659
rat00209478
g168747
phytoene dehydrogenase

1660
rat00139486
g168747
phytoene dehydrogenase

1661
rat00078966
g168747
phytoene dehydrogenase

1662
rat00120521
g168747
phytoene dehydrogenase

1663
rat00213144
g168747
phytoene dehydrogenase

1664
rat00152143
g168747
phytoene dehydrogenase

1665
rat00203903
g168747
phytoene dehydrogenase

1666
rat00025460
g168747
phytoene dehydrogenase

1667
rat00082034
g168747
phytoene dehydrogenase

1668
rat00052515
g168747
phytoene dehydrogenase

1669
rat00117711
g168747
phytoene dehydrogenase

1670
rat00248310
g168747
phytoene dehydrogenase

1671
rat00123355
g168747
phytoene dehydrogenase

1672
rat00005860
g168747
phytoene dehydrogenase

1673
rat00217740
g168747
phytoene dehydrogenase

1674
rat00021189
g168747
phytoene dehydrogenase

1675
rat00111777
g168747
phytoene dehydrogenase

1676
rat00157434
g168747
phytoene dehydrogenase

1677
rat00154482
g168747
phytoene dehydrogenase

1678
rat00138760
g168747
phytoene dehydrogenase

1679
rat00188046
g168747
phytoene dehydrogenase

1680
rat00255844
g168747
phytoene dehydrogenase

1681
rat00236299
g168747
phytoene dehydrogenase

1682
rat00143999
g168747
phytoene dehydrogenase

1683
rat00238796
g168747
phytoene dehydrogenase

1684
rat00040500
g168747
phytoene dehydrogenase

1685
rat00001036
g168747
phytoene dehydrogenase

1686
rat00227113
g168747
phytoene dehydrogenase

1687
rat00157121
g168747
phytoene dehydrogenase

1688
rat00200366
g168747
phytoene dehydrogenase

1689
rat00236142
g168747
phytoene dehydrogenase

1690
rat00183042
g168747
phytoene dehydrogenase

1691
rat00016722
g168747
phytoene dehydrogenase

1692
rat00061390
g168747
phytoene dehydrogenase

1693
rat00193403
g168747
phytoene dehydrogenase

1694
rat00109704
g168747
phytoene dehydrogenase

1695
rat00176071
g168747
phytoene dehydrogenase

1696
rat00141862
g168747
phytoene dehydrogenase

1697
rat00155543
g168747
phytoene dehydrogenase

1698
rat00036447
g168747
phytoene dehydrogenase

1699
rat00248561
g168747
phytoene dehydrogenase

1700
rat00095634
g168747
phytoene dehydrogenase

1701
rat00233793
g168747
phytoene dehydrogenase

1702
rat00251696
g168747
phytoene dehydrogenase

1703
rat00098747
g168747
phytoene dehydrogenase

1704
rat00174779
g168747
phytoene dehydrogenase

1705
rat00032013
g168747
phytoene dehydrogenase

1706
rat00130024
g168747
phytoene dehydrogenase

1707
rat00199788
g168747
phytoene dehydrogenase

1708
rat00040710
g168747
phytoene dehydrogenase

1709
rat00237200
g168747
phytoene dehydrogenase

1710
rat00102606
g168747
phytoene dehydrogenase

1711
rat00116043
g168747
phytoene dehydrogenase

1712
rat00193013
g168747
phytoene dehydrogenase

1713
rat00193411
g168747
phytoene dehydrogenase

1714
rat00058115
g168747
phytoene dehydrogenase

1715
rat00158342
g168747
phytoene dehydrogenase

1716
rat00186206
g168747
phytoene dehydrogenase

1717
rat00062852
g168747
phytoene dehydrogenase

1718
rat00175712
g168747
phytoene dehydrogenase

1719
rat00005882
g168747
phytoene dehydrogenase

1720
rat00223962
g168747
phytoene dehydrogenase

1721
rat00224772
g168747
phytoene dehydrogenase

1722
rat00051487
g168747
phytoene dehydrogenase

1723
rat00154780
g168747
phytoene dehydrogenase

1724
rat00154826
g168747
phytoene dehydrogenase

1725
rat00059481
g168747
phytoene dehydrogenase

1726
rat00223849
g168747
phytoene dehydrogenase

1727
rat00157296
g168747
phytoene dehydrogenase

1728
rat00057549
g168747
phytoene dehydrogenase

1729
rat00167098
g168747
phytoene dehydrogenase

1730
rat00147858
g168747
phytoene dehydrogenase

1731
rat00063988
g168747
phytoene dehydrogenase

1732
rat00000043
g168747
phytoene dehydrogenase

1733
rat00130034
g168747
phytoene dehydrogenase

1734
rat00123222
g168747
phytoene dehydrogenase

1735
rat00002308
g168747
phytoene dehydrogenase

1736
rat00205115
g168747
phytoene dehydrogenase

1737
rat00130832
g168747
phytoene dehydrogenase

1738
rat00191402
g168747
phytoene dehydrogenase

1739
rat00044081
g168747
phytoene dehydrogenase

1740
rat00065250
g168747
phytoene dehydrogenase

1741
rat00016704
g168747
phytoene dehydrogenase

1742
rat00100918
g168747
phytoene dehydrogenase

1743
rat00205552
g168747
phytoene dehydrogenase

1744
rat00108751
g168747
phytoene dehydrogenase

1745
rat00250825
g168747
phytoene dehydrogenase

1746
rat00124790
g168747
phytoene dehydrogenase

1747
rat00140918
g168747
phytoene dehydrogenase

1748
rat00049451
g168747
phytoene dehydrogenase

1749
rat00139362
g168747
phytoene dehydrogenase

1750
rat00172338
g168747
phytoene dehydrogenase

1751
rat00207294
g168747
phytoene dehydrogenase

1752
hu00859025
g476590
Human cytochrome B561, HCYTO B561, mRNA, partial cds.

1753
hu00151711
g476590
Human cytochrome B561, HCYTO B561, mRNA, partial cds.

1754
hu00268925
g476590
Human cytochrome B561, HCYTO B561, mRNA, partial cds.

1755
hu00873888
g476590
Human cytochrome B561, HCYTO B561, mRNA, partial cds.

1756
rat00196343
g30303
precursor (AA −84 to 241)

1757
rat00162259
g181240
cytochrome c-1

1758
rat00149803
g181240
cytochrome c-1

1759
rat00047971
g181240
cytochrome c-1

1760
rat00057844
g181240
cytochrome c-1

1761
rat00096841
g181240
cytochrome c-1

1762
rat00058693
g181240
cytochrome c-1

1763
rat00161304
g181240
cytochrome c-1

1764
rat00188358
g181240
cytochrome c-1

1765
rat00204174
g181240
cytochrome c-1

1766
rat00235404
g181240
cytochrome c-1

1767
rat00144852
g181240
cytochrome c-1

1768
rat00062953
g181238
cytochrome c1

1769
rat00192832
g181238
cytochrome c1

1770
rat00039681
g181238
cytochrome c1

1771
rat00115488
g181238
cytochrome c1

1772
rat00193491
g181238
cytochrome c1

1773
rat00167807
g181238
cytochrome c1

1774
rat00086790
g181238
cytochrome c1

1775
rat00199525
g181238
cytochrome c1

1776
rat00257665
g181238
cytochrome c1

1777
rat00158777
g181238
cytochrome c1

1778
rat00102523
g181238
cytochrome c1

1779
rat00202063
g181238
cytochrome c1

1780
rat00067043
g181238
cytochrome c1

1781
rat00252273
g181238
cytochrome c1

1782
rat00060259
g181238
cytochrome c1

1783
rat00027860
g181238
cytochrome c1

1784
rat00055734
g181238
cytochrome c1

1785
rat00258360
g181238
cytochrome c1

1786
rat00166056
g181238
cytochrome c1

1787
rat00152547
g181238
cytochrome c1

1788
hu01041273
g30302
Human mRNA for cytochrome c1.

1789
hu01084118
g181239
Human cytochrome c-1 gene, complete cds.

1790
hu01216492
g181239
Human cytochrome c-1 gene, complete cds.

1791
hu01229687
g30302
Human mRNA for cytochrome c1.

1792
hu01067795
g30302
Human mRNA for cytochrome c1.

1793
hu00967356
g30302
Human mRNA for cytochrome c1.

1794
hu00989750
g30302
Human mRNA for cytochrome c1.

1795
hu01310232
g30302
Human mRNA for cytochrome c1.

1796
hu01041413
g30302
Human mRNA for cytochrome c1.

1797
hu01280112
g30302
Human mRNA for cytochrome c1.

1798
hu01312017
g30302
Human mRNA for cytochrome c1.

1799
hu01303116
g30302
Human mRNA for cytochrome c1.

1800
hu01214233
g30302
Human mRNA for cytochrome c1.

1801
hu01217015
g30302
Human mRNA for cytochrome c1.

1802
hu01049111
g30302
Human mRNA for cytochrome c1.

1803
hu01107530
g30302
Human mRNA for cytochrome c1.

1804
hu01136440
g30302
Human mRNA for cytochrome c1.

1805
hu01220068
g30302
Human mRNA for cytochrome c1.

1806
hu01141615
g30302
Human mRNA for cytochrome c1.

1807
hu01062073
g30302
Human mRNA for cytochrome c1.

1808
hu01100792
g30302
Human mRNA for cytochrome c1.

1809
hu01001783
g30302
Human mRNA for cytochrome c1.

1810
hu01238043
g30302
Human mRNA for cytochrome c1.

1811
hu01090714
g30302
Human mRNA for cytochrome c1.

1812
hu01304754
g30302
Human mRNA for cytochrome c1.

1813
hu01214188
g30302
Human mRNA for cytochrome c1.

1814
hu01085182
g30302
Human mRNA for cytochrome c1.

1815
hu01104677
g30302
Human mRNA for cytochrome c1.

1816
hu01065329
g30302
Human mRNA for cytochrome c1.

1817
hu01315259
g30302
Human mRNA for cytochrome c1.

1818
hu01184635
g30302
Human mRNA for cytochrome c1.

1819
hu01261756
g30302
Human mRNA for cytochrome c1.

1820
hu01318645
g30302
Human mRNA for cytochrome c1.

1821
hu01284328
g30302
Human mRNA for cytochrome c1.

1822
hu01175852
g30302
Human mRNA for cytochrome c1.

1823
hu01265078
g30302
Human mRNA for cytochrome c1.

1824
hu01189523
g30302
Human mRNA for cytochrome c1.

1825
hu01291278
g30302
Human mRNA for cytochrome c1.

1826
hu01250699
g30302
Human mRNA for cytochrome c1.

1827
hu01281848
g30302
Human mRNA for cytochrome c1.

1828
hu00971781
g30302
Human mRNA for cytochrome c1.

1829
hu00271788
g1651201
cytochrome b561

1830
rat00189898
g1809118
Rat thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1831
rat00167530
g1809118
Rat thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1832
rat00018842
g1809118
Rat thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1833
rat00199561
g1809118
Rat thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1834
rat00164141
g1809118
Rat thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1835
rat00012080
g1809118
Rat thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1836
rat00061336
g1809118
Rat thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1837
rat00171128
g1809118
Rat thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1838
rat00104497
g2253160
Rat mRNA for mitochondrial isoform of cytochrome b5.

1839
rat00241074
g2253160
Rat mRNA for mitochondrial isoform of cytochrome b5.

1840
rat00052948
g2253160
Rat mRNA for mitochondrial isoform of cytochrome b5.

1841
hu00408896
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1842
hu00686297
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1843
hu00888266
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1844
hu00612156
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1845
hu00404328
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1846
hu00052455
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1847
hu00124465
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1848
hu00494520
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1849
hu00808027
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1850
hu00025766
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1851
hu00453158
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1852
hu00316197
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1853
hu00087490
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1854
hu00475372
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1855
hu00616168
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1856
hu00080866
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1857
hu00751458
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1858
hu00960726
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1859
hu00610689
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1860
hu00557338
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1861
hu00357907
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1862
hu00694950
g181241
Human somatic cytochrome c (HCS) gene, complete cds.

1863
hu00535094
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

1864
hu00343557
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1865
hu00367821
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1866
hu00475174
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1867
hu00165856
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1868
hu00177432
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1869
hu00309327
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1870
rat00077183
g204069
Rat electron transfer flavoprotein (ETF) alpha-subunit DNA, 3′ end.

1871
rat00174770
g204069
Rat electron transfer flavoprotein (ETF) alpha-subunit DNA, 3′ end.

1872
rat00181648
g204069
Rat electron transfer flavoprotein (ETF) alpha-subunit DNA, 3′ end.

1873
rat00231043
g204069
Rat electron transfer flavoprotein (ETF) alpha-subunit DNA, 3′ end.

1874
rat00241986
g204069
Rat electron transfer flavoprotein (ETF) alpha-subunit DNA, 3′ end.

1875
rat00204820
g204069
Rat electron transfer flavoprotein (ETF) alpha-subunit DNA, 3′ end.

1876
rat00211971
g204069
Rat electron transfer flavoprotein (ETF) alpha-subunit DNA, 3′ end.

1877
rat00156450
g204069
Rat electron transfer flavoprotein (ETF) alpha-subunit DNA, 3′ end.

1878
rat00058253
g204069
Rat electron transfer flavoprotein (ETF) alpha-subunit DNA, 3′ end.

1879
hu01333685
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1880
hu01102315
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1881
rat00212947
g297902
electron transfer flavoprotein beta subunit

1882
rat00209119
g297902
electron transfer flavoprotein beta subunit

1883
rat00093295
g297902
electron transfer flavoprotein beta subunit

1884
rat00083975
g297902
electron transfer flavoprotein beta subunit

1885
rat00139739
g297902
electron transfer flavoprotein beta subunit

1886
rat00194974
g297902
electron transfer flavoprotein beta subunit

1887
rat00002544
g297902
electron transfer flavoprotein beta subunit

1888
rat00016900
g297902
electron transfer flavoprotein beta subunit

1889
rat00204309
g297902
electron transfer flavoprotein beta subunit

1890
rat00181530
g297902
electron transfer flavoprotein beta subunit

1891
rat00161335
g297902
electron transfer flavoprotein beta subunit

1892
rat00190334
g297902
electron transfer flavoprotein beta subunit

1893
rat00010973
g297902
electron transfer flavoprotein beta subunit

1894
rat00254820
g297902
electron transfer flavoprotein beta subunit

1895
rat00013368
g297902
electron transfer flavoprotein beta subunit

1896
rat00061429
g297902
electron transfer flavoprotein beta subunit

1897
rat00240367
g297902
electron transfer flavoprotein beta subunit

1898
rat00006187
g297902
electron transfer flavoprotein beta subunit

1899
rat00099014
g297902
electron transfer flavoprotein beta subunit

1900
rat00219642
g297902
electron transfer flavoprotein beta subunit

1901
hu01127888
g297902
electron transfer flavoprotein beta subunit

1902
hu01039949
g297902
electron transfer flavoprotein beta subunit

1903
hu01217791
g297902
electron transfer flavoprotein beta subunit

1904
hu01202771
g297902
electron transfer flavoprotein beta subunit

1905
hu01303061
g297902
electron transfer flavoprotein beta subunit

1906
hu00983650
g297902
electron transfer flavoprotein beta subunit

1907
hu01326455
g297902
electron transfer flavoprotein beta subunit

1908
hu01279665
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1909
hu00989424
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1910
hu00992872
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1911
hu01163899
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1912
hu01187866
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1913
hu01309899
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1914
hu01100346
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1915
hu01229210
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1916
hu01333503
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1917
hu01143532
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1918
hu01090190
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1919
hu01142734
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1920
hu01341626
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1921
hu01047660
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1922
hu01040569
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1923
hu01118167
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1924
hu01341962
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1925
hu01076606
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1926
hu01246553
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1927
hu01308294
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1928
hu01253673
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1929
hu01018949
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1930
hu01295952
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1931
hu01186387
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1932
hu01292741
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

1933
hu01133657
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

1934
hu00995052
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

1935
hu01265696
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1936
hu00990768
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1937
hu01317320
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1938
hu01242531
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1939
hu01037206
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1940
hu01331119
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1941
hu01052058
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1942
hu01113646
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1943
hu01271048
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1944
hu01204349
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1945
hu01252447
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1946
hu01145870
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1947
hu01048355
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1948
hu01314199
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1949
hu01329725
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1950
hu01317971
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1951
hu01254829
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1952
hu01188249
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1953
hu01258593
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1954
hu01208697
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1955
hu00979522
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1956
hu01322638
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

1957
hu00579220
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1958
hu00278027
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1959
hu00150005
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1960
hu00435663
g297901
Human mRNA for electron transfer flavoprotein beta subunit.

1961
rat00104762
g204069
Rat electron transfer flavoprotein (ETF) alpha-subunit DNA, 3′ end.

1962
hu01179863
g181242
cytochrome c

1963
hu01016211
g181242
cytochrome c

1964
hu01003305
g181242
cytochrome c

1965
hu00977589
g181242
cytochrome c

1966
hu01130225
g181242
cytochrome c

1967
hu01205304
g181242
cytochrome c

1968
hu01017422
g181242
cytochrome c

1969
hu01200377
g181242
cytochrome c

1970
hu01067225
g181242
cytochrome c

1971
hu01084631
g181242
cytochrome c

1972
hu01047466
g181242
cytochrome c

1973
hu01343872
g181242
cytochrome c

1974
hu01077823
g181242
cytochrome c

1975
hu01326827
g181242
cytochrome c

1976
hu01348805
g181242
cytochrome c

1977
hu01090839
g181242
cytochrome c

1978
hu01090596
g181242
cytochrome c

1979
hu01325858
g181242
cytochrome c

1980
hu01279463
g181242
cytochrome c

1981
hu00974569
g181242
cytochrome c

1982
hu01092102
g181242
cytochrome c

1983
hu01335302
g181242
cytochrome c

1984
hu01172132
g181242
cytochrome c

1985
hu01027317
g181242
cytochrome c

1986
hu01312473
g181242
cytochrome c

1987
hu01253290
g181242
cytochrome c

1988
hu01003675
g181242
cytochrome c

1989
hu01124392
g181242
cytochrome c

1990
hu01311863
g181242
cytochrome c

1991
hu01192335
g181242
cytochrome c

1992
hu01327723
g181242
cytochrome c

1993
hu01287332
g181242
cytochrome c

1994
hu01045376
g181242
cytochrome c

1995
hu01017559
g181242
cytochrome c

1996
hu01055819
g181242
cytochrome c

1997
hu01070968
g181242
cytochrome c

1998
hu01326993
g181242
cytochrome c

1999
hu01196696
g181242
cytochrome c

2000
hu01168994
g181242
cytochrome c

2001
hu01071100
g181242
cytochrome c

2002
hu01071102
g181242
cytochrome c

2003
hu01014015
g181242
cytochrome c

2004
hu01141219
g181242
cytochrome c

2005
hu01317018
g181242
cytochrome c

2006
hu01117390
g181242
cytochrome c

2007
hu01062077
g181242
cytochrome c

2008
hu01216176
g181242
cytochrome c

2009
hu01155094
g181242
cytochrome c

2010
hu01022992
g181242
cytochrome c

2011
hu01208276
g181242
cytochrome c

2012
hu01150884
g181242
cytochrome c

2013
hu01282617
g181242
cytochrome c

2014
hu01331676
g181242
cytochrome c

2015
hu01148923
g181242
cytochrome c

2016
hu01179335
g181242
cytochrome c

2017
hu01132985
g181242
cytochrome c

2018
hu01199336
g181242
cytochrome c

2019
hu01185693
g181242
cytochrome c

2020
hu00969471
g181242
cytochrome c

2021
hu00975597
g181242
cytochrome c

2022
hu01114017
g181242
cytochrome c

2023
hu01013290
g181242
cytochrome c

2024
hu01224206
g181242
cytochrome c

2025
hu01211615
g181242
cytochrome c

2026
hu01141146
g181242
cytochrome c

2027
hu01284800
g181242
cytochrome c

2028
hu01207517
g181242
cytochrome c

2029
hu01247630
g181242
cytochrome c

2030
hu01060945
g181242
cytochrome c

2031
hu01332655
g181242
cytochrome c

2032
hu01015795
g181242
cytochrome c

2033
hu01309880
g181242
cytochrome c

2034
hu01346890
g181242
cytochrome c

2035
hu01182595
g181242
cytochrome c

2036
rat00225961
g801871
Rat mRNA for adrenodoxin, complete cds.

2037
rat00027224
g801871
Rat mRNA for adrenodoxin, complete cds.

2038
rat00216641
g801871
Rat mRNA for adrenodoxin, complete cds.

2039
hu01057340
g341002
Human adrenodoxin gene, exon 4.

2040
hu00914886
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2041
hu00582409
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2042
hu00193205
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2043
hu00691687
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2044
hu00601763
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2045
hu00459499
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2046
hu00772054
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2047
hu00095625
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2048
hu00128036
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2049
hu00870833
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2050
hu00708205
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2051
rat00154045
g550511
Rat (Sprague-Dawley) cytochrome c nuclear-encoded mitochondrial gene and flanks.

2052
hu00875504
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2053
hu00061898
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2054
hu00853194
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2055
hu00890790
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2056
hu00760437
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2057
hu00890998
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2058
hu00152759
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2059
hu00748297
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2060
hu00958835
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2061
hu00797565
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2062
hu00023242
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2063
hu00219001
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2064
hu00270032
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2065
hu00119012
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2066
hu00160405
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2067
hu00190208
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2068
hu00626332
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2069
hu00100687
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2070
hu00320665
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2071
hu00239361
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2072
hu00920049
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2073
hu00524608
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2074
hu00364660
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2075
hu00845262
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2076
hu00633709
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2077
hu00495146
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2078
hu00913556
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2079
hu00428818
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2080
hu00565575
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2081
hu00827367
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2082
hu00786562
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2083
hu00228878
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2084
hu00356687
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2085
hu00878932
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2086
hu00501343
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2087
hu00531225
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2088
hu00100738
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2089
hu00114571
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2090
hu00161624
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2091
hu00161626
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2092
hu00534136
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2093
hu00107681
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2094
hu00257711
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2095
hu00237192
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2096
hu00770272
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2097
hu00409950
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2098
hu00467172
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2099
hu00609932
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2100
hu00318990
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2101
hu00156990
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2102
hu00791682
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2103
hu00383668
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2104
hu00956473
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2105
hu00858068
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2106
hu00774953
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2107
hu00759728
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2108
hu00889195
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2109
hu00665977
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2110
hu00520221
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2111
hu00731210
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2112
hu00005443
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2113
hu00641224
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2114
hu00117253
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2115
hu00920305
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2116
hu00363233
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2117
hu00222753
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2118
hu00394401
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2119
hu00282154
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2120
hu00183253
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2121
hu00278213
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2122
hu00091924
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2123
hu00474271
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2124
hu00260575
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2125
hu00260692
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2126
hu00882413
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2127
hu00891127
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2128
hu00198146
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2129
hu00791651
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2130
hu00924863
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2131
hu00491649
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2132
hu00739378
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2133
hu00478991
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2134
hu00820521
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2135
hu00004088
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2136
hu00019055
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2137
hu00138630
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2138
hu00411573
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2139
hu00543181
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2140
hu00407552
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2141
hu00446342
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2142
hu00374090
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2143
hu00065058
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2144
hu00484406
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2145
hu00346157
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2146
hu00428607
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2147
hu00495415
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2148
hu00722593
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2149
hu00155683
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2150
hu00839215
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2151
hu00868081
g1809134
Human thioredoxin mRNA, nuclear gene encoding mitochondrial protein, complete cds.

2152
hu01322291
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2153
hu01053686
g182250
Human electron transfer flavoprotein alpha-subunit mRNA, complete cds.

2154
hu00984752
g182251
electron transport flavoprotein

2155
hu01121158
g182251
electron transport flavoprotein

2156
hu01069140
g182251
electron transport flavoprotein

2157
hu01289279
g182251
electron transport flavoprotein

2158
hu01220863
g182251
electron transport flavoprotein

2159
hu01044339
g182251
electron transport flavoprotein

2160
hu01286152
g182251
electron transport flavoprotein

2161
hu01336363
g182251
electron transport flavoprotein

2162
hu01118609
g182251
electron transport flavoprotein

2163
hu00992223
g182251
electron transport flavoprotein

2164
hu01142739
g182251
electron transport flavoprotein

2165
hu01345188
g182251
electron transport flavoprotein

2166
hu01199245
g182251
electron transport flavoprotein

2167
hu01205260
g182251
electron transport flavoprotein

2168
hu01232431
g182251
electron transport flavoprotein

2169
hu01136250
g182251
electron transport flavoprotein

2170
hu01156768
g182251
electron transport flavoprotein

2171
hu01020636
g182251
electron transport flavoprotein

	Number	Date	Country
Parent	08100523	Aug 1993	US
Child	09008119	Jan 1998	US

	Number	Date	Country
Parent	09008119	Jan 1998	US
Child	09535459	Mar 2000	US
Parent	08282991	Jul 1994	US
Child	08100523	Aug 1993	US
Parent	08196364	Feb 1994	US
Child	08282991	Jul 1994	US
Parent	08100523	Aug 1993	US
Child	08196364	Feb 1994	US
Parent	07977780	Nov 1992	US
Child	08100523	Aug 1993	US
Parent	07916491	Jul 1992	US
Child	07977780	Nov 1992	US

Polynucleotides encoding or regulating electron transfer molecules

Information

Publication Number

Date Filed

Date Published

Inventors

CPC

US Classifications

International Classifications

Abstract

Description

Claims

Parent Case Info

Continuations (1)

Continuation in Parts (6)